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A B S T R A C T
Background
Behavioural activation is a brief psychotherapeutic approach that seeks to change the way a person interacts with their environment.
Behavioural activation is increasingly receiving attention as a potentially cost-eective intervention for depression, which may require less
resources and may be easier to deliver and implement than other types of psychotherapy.
Objectives
To examine the eects of behavioural activation compared with other psychological therapies for depression in adults.
To examine the eects of behavioural activation compared with medication for depression in adults.
To examine the eects of behavioural activation compared with treatment as usual/waiting list/placebo no treatment for depression in
adults.
Search methods
We searched CCMD-CTR (all available years), CENTRAL (current issue), Ovid MEDLINE (1946 onwards), Ovid EMBASE (1980 onwards), and
Ovid PsycINFO (1806 onwards) on the 17 January 2020 to identify randomised controlled trials (RCTs) of 'behavioural activation', or the
main elements of behavioural activation for depression in participants with clinically diagnosed depression or subthreshold depression.
We did not apply any restrictions on date, language or publication status to the searches. We searched international trials registries via the
World Health Organization's trials portal (ICTRP) and ClinicalTrials.gov to identify unpublished or ongoing trials.
Selection criteria
We included randomised controlled trials (RCTs) of behavioural activation for the treatment of depression or symptoms of depression
in adults aged 18 or over. We excluded RCTs conducted in inpatient settings and with trial participants selected because of a physical
comorbidity. Studies were included regardless of reported outcomes.
Data collection and analysis
Two review authors independently screened all titles/abstracts and full-text manuscripts for inclusion. Data extraction and 'Risk of bias'
assessments were also performed by two review authors in duplicate. Where necessary, we contacted study authors for more information.
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Main results
FiLy-three studies with 5495 participants were included; 51 parallel group RCTs and two cluster-RCTs.
We found moderate-certainty evidence that behavioural activation had greater short-term eicacy than treatment as usual (risk ratio (RR)
1.40, 95% confidence interval (CI) 1.10 to 1.78; 7 RCTs, 1533 participants), although this dierence was no longer evident in sensitivity
analyses using a worst-case or intention-to-treat scenario. Compared with waiting list, behavioural activation may be more eective, but
there were fewer data in this comparison and evidence was of low certainty (RR 2.14, 95% CI 0.90 to 5.09; 1 RCT, 26 participants). No evidence
on treatment eicacy was available for behavioural activation versus placebo and behavioural activation versus no treatment.
We found moderate-certainty evidence suggesting no evidence of a dierence in short-term treatment eicacy between behavioural
activation and CBT (RR 0.99, 95% CI 0.92 to 1.07; 5 RCTs, 601 participants). Fewer data were available for other comparators. No evidence
of a dierence in short term-eicacy was found between behavioural activation and third-wave CBT (RR 1.10, 95% CI 0.91 to 1.33; 2
RCTs, 98 participants; low certainty), and psychodynamic therapy (RR 1.21, 95% CI 0.74 to 1.99; 1 RCT,60 participants; very low certainty).
Behavioural activation was more eective than humanistic therapy (RR 1.84, 95% CI 1.15 to 2.95; 2 RCTs, 46 participants; low certainty)
and medication (RR 1.77, 95% CI 1.14 to 2.76; 1 RCT; 141 participants; moderate certainty), but both of these results were based on a small
number of trials and participants. No evidence on treatment eicacy was available for comparisons between behavioural activation versus
interpersonal, cognitive analytic, and integrative therapies.
There was moderate-certainty evidence that behavioural activation might have lower treatment acceptability (based on dropout rate)
than treatment as usual in the short term, although the data did not confirm a dierence and results lacked precision (RR 1.64, 95% CI
0.81 to 3.31; 14 RCTs, 2518 participants). Moderate-certainty evidence did not suggest any dierence in short-term acceptability between
behavioural activation and waiting list (RR 1.17, 95% CI 0.70 to 1.93; 8 RCTs. 359 participants), no treatment (RR 0.97, 95% CI 0.45 to 2.09; 3
RCTs, 187 participants), medication (RR 0.52, 95% CI 0.23 to 1.16; 2 RCTs, 243 participants), or placebo (RR 0.72, 95% CI 0.31 to 1.67; 1 RCT;
96 participants; low-certainty evidence). No evidence on treatment acceptability was available comparing behavioural activation versus
psychodynamic therapy.
Low-certainty evidence did not show a dierence in short-term treatment acceptability (dropout rate) between behavioural activation and
CBT (RR 1.03, 95% CI 0.85 to 1.25; 12 RCTs, 1195 participants), third-wave CBT (RR 0.84, 95% CI 0.33 to 2.10; 3 RCTs, 147 participants);
humanistic therapy (RR 1.06, 95% CI 0.20 to 5.55; 2 RCTs, 96 participants) (very low certainty), and interpersonal, cognitive analytic, and
integrative therapy (RR 0.84, 95% CI 0.32 to 2.20; 4 RCTs, 123 participants).
Results from medium- and long-term primary outcomes, secondary outcomes, subgroup analyses, and sensitivity analyses are
summarised in the text.
Authors' conclusions
This systematic review suggests that behavioural activation may be more eective than humanistic therapy, medication, and treatment
as usual, and that it may be no less eective than CBT, psychodynamic therapy, or being placed on a waiting list. However, our confidence
in these findings is limited due to concerns about the certainty of the evidence.
We found no evidence of a dierence in short-term treatment acceptability (based on dropouts) between behavioural activation and most
comparison groups (CBT, humanistic therapy, waiting list, placebo, medication, no treatment or treatment as usual). Again, our confidence
in all these findings is limited due to concerns about the certainty of the evidence.
No data were available about the eicacy of behaioural activation compared with placebo, or about treatment acceptability comparing
behavioural activation and psychodynamic therapy, interpersonal, cognitive analytic and integrative therapies.
The evidence could be strengthened by better reporting and better quality RCTs of behavioural activation and by assessing working
mechanisms of behavioural activation.
P L A I N   L A N G U A G E   S U M M A R Y
Behavioural activation therapy for depression in adults
Review question
In this Cochrane review, we wanted to find out how well behavioural activation therapy works for depression in adults.
Why this is important
Depression is a common mental health problem that can cause a persistent feeling of sadness and loss of interest in people, activities, and
things that were once enjoyable. A person with depression may feel tearful, irritable, or tired most of the time, and may have problems
with sleep, concentration, and memory. These and other symptoms can make daily life more diicult than usual.
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Treatments for depression include medications (antidepressants) and psychological therapies (talking therapies). Behavioural activation
is a type of psychological therapy that encourages a person to develop or get back into activities which are meaningful to them. The therapy
involved scheduling activities and monitoring behaviours and looking at specific situations where changing these behaviours and activities
may be helpful. A therapist may support people in person, over the phone, or online, usually over multiple sessions.
It is important to know whether behavioural activation could be an eective and acceptable treatment to oer to people with depression.
What we did
In January 2020, we searched for studies of behavioural activation therapy for depression in adults (aged over 18 years). We looked for
randomised controlled trials, in which treatments were given to study participants at random; these studies give the most reliable evidence.
We included 53 studies involving 5495 participants. The studies compared behavioural activation with no treatment, standard or usual care,
a dummy treatment (placebo), taking medications, being on a waiting list for treatment, or other psychotherapies (cognitive behavioural
therapy (CBT), third-wave CBT, humanistic therapy, psychodynamic therapy, and integrative therapy).
The studies were conducted in 14 countries; most were conducted in the USA (27 studies). Most studies lasted from four to 16 weeks.
The outcomes we focussed on were how well the treatments worked and whether they were acceptable to participants. How well
treatments worked (eicacy) was measured by the number of people who responded well to treatment or no longer met criteria for
depression at the end of treatment. Acceptability was measured by counting how many people dropped out during the study.
What did we find?
Behavioural activation may treat depression better than receiving usual care. We were uncertain whether behavioural activation worked
better than medication or being on a waiting list, and we found no evidence for this outcome comparing behavioural activation to no
treatment or placebo treatment.
We found no dierences between behavioural activation and CBT in treating depression. Although we did not find enough evidence
to compare behavioural activation reliably with other psychotherapies, it may work better than humanistic therapy, and we found
no dierences between behavioural activation and third-wave CBT or psychodynamic therapy. No evidence was available comparing
behavioural activation to integrative therapies.
Behavioural activation is probably less acceptable to people than usual care. We found no dierences in acceptability of behavioural
activation compared with being on a waiting list, no treatment, taking antidepressants, or receiving a placebo treatment. We also found
no dierences in acceptability between behavioural activation and other psychotherapies studied (CBT, third-wave CBT, humanistic
therapy, integrative therapies). For behavioural activation compared with psychodynamic therapy, we found no evidence on treatment
acceptability.
Conclusions
Behavioural activation may be an eective and acceptable treatment for depression in adults. Oering this therapy in practice would give
people with depression greater treatment choice, and dierent formats and types of delivery could be explored to meet the demand for
mental health support. Our confidence in these findings is limited due to concerns about the certainty of the evidence.
Most findings were short-term, meaning that we cannot be sure behavioural activation would be helpful to people with depression in the
longer term.
Certainty of the evidence
Our certainty (confidence) in the evidence is mostly low to moderate. Some findings are based on only a few studies, with poorly reported
results, in which the participants knew which treatment they received. Therefore, we are not sure how reliable the results are. Our
conclusions may change if more studies are conducted.
Behavioural activation therapy for depression in adults (Review)












































































S U M M A R Y   O F   F I N D I N G S
 
Summary of findings 1.   Behavioural activation compared with CBT for depression in adults
Behavioural activation compared with CBT for depression in adults
Patient or population: depression in adults
Setting: various including primary care, computer-based at home, and university.
Intervention: behavioural activation
Comparison: CBT
Anticipated absolute effects* (95% CI)Outcomes
















up to 6 months (5-16 weeks)











Study populationtreatment acceptability up to 6
months (4-16 weeks)











ous) up to 6 months (4-16 weeks)
see comment SMD 0.12 higher






Measured with BDI, HRSD, CES-D,
PHQ-9, HSCL-25. SMD 0.12 represents
a difference between groups of 1.31
points on the BDI and 0.66 points on
the HRSD favouring CBT.
quality of life (continuous)
up to 6 months (12-16 weeks)







Measured with SF-36 physical compo-
nent and WHOQOL physical compo-
nent. SMD 0.04 represents a small ef-
fect.
social adjustment and function-
ing (continuous)
up to 6 months (12 weeks)







Measured with Social Adjustment
Scale and Sheehan Disability Scale.
SMD 0.13 represents a small effect.
anxiety symptoms (continuous)
up to 6 months (4-16 weeks)
see comment SMD 0.03 lower
(0.18 lower to 0.13 higher)
  646
(4 RCTs)
⊕⊕⊕⊝ Measured with BDI, HSCL-25, PHQ-9.










































































































































1 study no adverse events, 1 study three serious ad-
verse events in the behavioural activation arm (2 over-
dose, 1 self-harm) and eight serious adverse events in






Any adverse event summarised narra-
tively.
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 Majority of domains high or unclear risk of bias. High risk for conflict of interest, blinding of participants and personnel, and incomplete outcome data. Downgraded by one
level for high risk of bias.
2 No blinding of participants. Reporting bias unclear because protocol or trial registration missing in nine studies and high risk of bias in one study. Potential conflict of interest
in four4 studies. High risk of attrition bias in seven studies. Downgraded by one level for high risk of bias (not two levels because trials with higher weight are generally at lower
risk of bias).
3 Seven out of 12 studies wide confidence intervals, due to small sample sizes and low rates of dropout in both groups. Downgraded by one level for imprecision.
4 No blinding of participants. 6/15 studies no blinding of outcome assessors. 13/15 selective reporting domain unclear. Downgraded by one level for high risk of bias.
5 Risk of performance and attrition bias and potential conflict of interest. Downgraded by one level for high risk of bias.
6 Two small studies with serious risk of bias across domains (attrition bias, reporting bias, potential conflicts of interest). Downgraded by one level for imprecision and two levels
for high risk of bias.
7 One study all domains unclear or high; high risk of bias for randomisation, allocation, and blinding of participants and personnel. One study with risk of performance and
attrition bias and potential conflict of interest. Downgraded one level for high risk of bias.Two studies with most domains unclear or high have little weight in the analyses.
8 Various domains high risk of bias in all studies. Attrition bias high in both studies; dropout may be related to adverse events. Downgraded one level for high risk of bias.
 
 
Summary of findings 2.   Behavioural activation compared with third-wave CBT for depression in adults
Behavioural activation compared with third-wave CBT for depression in adults
Patient or population: depression in adults























































































































































Study populationtreatment efficacy up to 6 months
(4-8 weeks)









Study populationtreatment acceptability up to 6
months (4-8 weeks)










up to 6 months (4-8 weeks)
see comment SMD 0.14 lower





Measured with BDI and HRSD.
SMD 0.14 represents a differ-
ence between groups of 1.53
points on the BDI and 0.77
points on the HRSD favouring
BA.
quality of life (continuous)
up to 6 months (8 weeks)
mean score 1.13 MD 0.02 higher (0.96 lower to 1.00
higher)
  81 (1 RCT) ⊕⊕⊝⊝
LOW 5
Measured with Quality of Life
Inventory.
anxiety symptoms (continuous)
up to 6 months (4-8 weeks)







*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 Evidence of selective reporting and conflict of interest in both trials, in addition to other domains with risk of bias. Downgraded one level for high risk of bias.
2 Two small studies with wide confidence intervals. Downgraded one level for imprecision.
3 Ten domains with high risk of bias across three studies, including blinding, allocation concealment, and selective reporting. Treatment acceptability may be aected by lack of






































































































































4 Three small studies with wide confidence intervals. Downgraded one level for imprecision.
5 One small study with three domains at high risk of bias. Downgraded one level for imprecision and one level for high risk of bias. Because only one study was included, this
outcome could not be assessed for consistency of results.
 
 
Summary of findings 3.   Behavioural activation compared with humanistic therapy for depression in adults
Behavioural activation compared with humanistic therapy for depression in adults
Patient or population: depression in adults
Setting: university and community-based in the USA
Intervention: behavioural activation
Comparison: humanistic therapy
Anticipated absolute effects* (95% CI)Outcomes
Risk with human-
istic therapy













up to 6 months (8-10 weeks)














up to 6 months (2-10 weeks)












(continuous) up to 6 months (2-10 weeks)
mean score be-
tween 10 and 15








quality of life (continuous)
up to 6 months (2 weeks)
mean score 1.2 MD 0.80 higher (0.12 lower to 1.72
higher)
  50 (1 RCT) ⊕⊕⊝⊝
LOW 5
Measured with Quali-
ty of Life Inventory.
anxiety symptoms (continuous)
up to 6 months (2 weeks)
mean score 9.7 MD 1.30 lower (6.10 lower to 3.50
higher)
  50 (1 RCT) ⊕⊕⊝⊝
LOW 5
Measured with BAI.
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).






































































































































GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 Both small studies with several domains high risk of bias or unclear. Risk of attrition bias in both studies and reporting bias in one study may aect treatment eicacy outcome.
Downgraded one level for high risk of bias and one level for imprecision.
2 Many risk of bias domains unclear in one of the studies. Risk of attrition and reporting bias in the other study. Downgraded one level for high risk of bias and one level for
imprecision.
3 One study is religious behavioural activation rather than the conventional behavioural activation intervention. Downgraded one level for indirectness.
4 Two out of three studies mostly high and unclear risk of bias domains. Downgraded one level for high risk of bias.
5 One small study with most domains of the risk of bias tool unclear due to lack of information. Downgraded one level for high risk of bias and one level for imprecision. Because
only one study was included, this outcome could not be assessed for consistency of results.
 
 
Summary of findings 4.   Behavioural activation compared with psychodynamic for depression in adults
Behavioural activation compared with psychodynamic for depression in adults




Anticipated absolute effects* (95% CI)Outcomes
Risk with psy-
chodynamic











Study populationtreatment efficacy up to 6 months (12
weeks)








VERY LOW 1 2
 
depression symptoms
(continuous) up to 6 months (12
weeks)





VERY LOW 1 2
Measured with HRSD
social adjustment and functioning
(continuous) up to 6 months (12
weeks)
















































































































































*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 Four 'Risk of bias' domains unclear due to lack of information. Patients excluded from study for lack of adherence and because of dissatisfaction with treatment. This may
influence outcomes treatment eicacy, depression symptoms, and social adjustment and functioning. All other 'Risk of bias' domains high or unclear risk. Downgraded two levels
for high risk of bias.
2 Only one study with small sample size. Downgraded one level for imprecision. Because only one study was included, this outcome could not be assessed for consistency of results.
 
 
Summary of findings 5.   Behavioural activation compared with interpersonal, cognitive analytic, integrative for depression in adults
Behavioural activation compared with interpersonal, cognitive analytic, integrative for depression in adults
Patient or population: depression in adults
Setting: university and community-based in the USA
Intervention: behavioural activation
Comparison: interpersonal, cognitive analytic, integrative




















up to 6 months (4-12 weeks)












ous) up to 6 months (4-12 weeks)
see comment SMD 0.16 lower






Measured with BDI, Zung rating
scale, and HRSD. SMD 0.16 rep-







































































































































groups of 1.75 points on the BDI
and 0.88 points on the HRSD
favouring BA.
social adjustment and function-
ing (continuous)
up to 6 months (12 weeks)







Measured with Global Assess-
ment Scale.
anxiety symptoms (continuous)
up to 6 months (4 weeks)







Measured with the anxiety scale




2 suicide attempts and 1 case of suicidal thoughts in com-






Any adverse event summarised
narratively.
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 Only 2 low risk of bias domains across four studies. High risk of bias for randomisation and allocation concealment in 2/4 studies. Downgraded two levels for high risk of bias.
Downgraded one level for imprecision because of wide confidence intervals.
2 One small study with high risk of bias across multiple domains. Downgraded two levels for high risk of bias and one level for imprecision. Because only one study was included,
this outcome could not be assessed for consistency of results.
3 One very small study, so adverse events reported may not apply to a wider population receiving treatment. High risk of bias included lack of blinding and potential attrition bias
and selective reporting may influence reporting of adverse events. Downgraded one level for imprecision and one level for high risk of bias.
 
 
Summary of findings 6.   Behavioural activation compared with waiting list for depression in adults
Behavioural activation compared with waiting list for depression in adults
Patient or population: depression in adults









































































































































Anticipated absolute effects* (95% CI)Outcomes
Risk with
waiting list
















up to 6 months (4 weeks)










up to 6 months (1 to 10 weeks)










Three studies could not be included in meta-
analyses; no dropouts.
depression symptoms










Measured with BDI, HRSD, MADRS, PHQ-9, HS-
CL-25. SMD 1.04 represents a difference be-
tween groups of 11.37 points on the BDI and
5.75 points on the HRSD favouring BA.
quality of life (continuous)
up to 6 months (8 weeks)
mean score
0.75






Measured with quality of life inventory.
anxiety symptoms










Measured with BAI, Trait Anxiety Scale, and
GAD-7. SMD 0.91 represents a large effect.
adverse events
(6 weeks)
see comment   0 (1 RCT) see com-
ment
Any adverse event summarised narratively. No
adverse events.
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 One very small study with high risk of bias for five domains including allocation concealment and selective reporting. Downgraded one level for imprecision and one level for







































































































































2 Most studies high or unclear risk of bias with regard to blinding of participants and outcome assessors, selective reporting, and various other risks of bias: no baseline
characteristics reported, potential conflicts of interest. Downgraded one level for high risk of bias.
3 Only domain mostly scoring low risk of bias across studies (7/12) is random sequence generation. Blinding of outcome assessors unclear or high risk of bias in all but two studies.
Downgraded one level for high risk of bias.
4 Larger eects reported by smaller studies; smaller studies favouring waiting list are absent. Downgraded one level for risk of publication bias.
5 One study with high risk of bias for three domains including potential conflict of interest. Downgraded one level for high risk of bias and one level for imprecision. Because only
one study was included, this outcome could not be assessed for consistency of results.
6 All studies majority of domains unclear or high risk of bias. Some problems with randomisation and allocation concealment. Downgraded one level for high risk of bias.
7 Two studies reporting large eect in favour of behavioural activation while three find no dierence between study arms. Downgraded one level for inconsistency.
 
 
Summary of findings 7.   Behavioural activation compared with placebo for depression in adults
Behavioural activation compared with placebo for depression in adults
Patient or population: depression in adults
Setting: university and community-based in the USA
Intervention: behavioural activation
Comparison: placebo
Anticipated absolute effects* (95% CI)Outcomes
Risk with place-
bo














up to 6 months (16 weeks)








(continuous) up to 6 months
(2 weeks)
see comment SMD 0.18 lower





Measured with HRSD and Depression Adjec-
tive Checklist. SMD 0.18 represents a differ-
ence between groups of 1.97 points on the








Any adverse event summarised narratively.
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence







































































































































Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 Incomplete outcome data influences reporting of dropouts; downgraded one level for high risk of bias. Downgraded one level for imprecision due to large confidence intervals
resulting from relatively few dropouts. Because only one study was included, this outcome could not be assessed for consistency of results.
2 One study with poor reporting, which may indicate high risk of bias. Downgraded one level for high risk of bias.
3 Two small studies; one with large confidence intervals. Downgraded one level for imprecision.
4 Incomplete outcome data and potential conflict of interest may have influenced reporting of adverse events. Downgraded one level for high risk of bias. Downgraded one level
for imprecision as 96 participants would not be suicient to measure less frequently occurring side eects.
 
 
Summary of findings 8.   Behavioural activation compared with medication for depression in adults
Behavioural activation compared with medication for depression in adults
Patient or population: depression in adults
Setting: recruitment in community and through referral in the USA and Iran.
Intervention: behavioural activation
Comparison: medication
Anticipated absolute effects* (95% CI)Outcomes













treatment efficacy up to 6 months
(16 weeks)








up to 6 months (12-16 weeks)











(continuous) up to 6 months (12-16
weeks)
mean change in score be-
tween -8 and -14
mean difference 1.42 lower (4.80










Various physical side effects from antidepressant medication. One


















































































































































*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 The most concerning issue relating to risk of bias was the large number of dropouts from the medication study arm in particular. Downgraded one level for high risk of bias.
Because only one study was included, this outcome could not be assessed for consistency of results.
2 Incomplete outcome data for both studies. No blinding of participants. Potential conflict of interest for one study. Downgraded one level for high risk of bias.
3 Downgraded one level for imprecision; large variation in confidence interval, crossing zero.
4 Incomplete outcome data and potential conflict of interest may have influenced reporting of adverse events. Downgraded one level for high risk of bias.
 
 
Summary of findings 9.   Behavioural activation compared with no treatment for depression in adults
Behavioural activation compared with no treatment for depression in adults
Patient or population: depression in adults
Setting: universities in the USA and Japan
Intervention: behavioural activation
Comparison: no treatment
Anticipated absolute effects* (95% CI)Outcomes
Risk with no
treatment













up to 6 months (2-5 weeks)











(continuous) up to 6 months (2-5 weeks)












































































































































quality of life (continuous)
up to 6 months (5 weeks)






(continuous) up to 6 months (2 weeks)




*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: Our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 High risk of bias for blinding of participants (3/3), conflict of interest (1/3), and no baseline characteristics reported (1/3). Downgraded one level for high risk of bias.
2 One study mostly low risk of bias, one study mostly unclear risk of bias. Downgraded one level for high risk of bias.
3 Because only one study was included, this outcome could not be assessed for consistency of results.
4 One small study with four domains of bias unclear and two high risk of bias; performance bias and potential conflict of interest. Downgraded one level for high risk of bias and
one level for imprecision. Because only one study was included, this outcome could not be assessed for consistency of results.
 
 
Summary of findings 10.   Behavioural activation compared with treatment as usual for depression in adults
Behavioural activation compared with treatment as usual for depression in adults
Patient or population: depression in adults
Setting: primary care, local health centres, online, and nursing homes, in England, the USA, China, India, Indonesia, and Spain.
Intervention: behavioural activation
Comparison: treatment as usual




















up to 6 months (5-12 weeks)








Number needed to treat to achieve one bene-







































































































































53 per 100 75 per 100
(59 to 96)
Study populationtreatment acceptability
up to 6 months (5-12 weeks)












ous) up to 6 months (5-12 weeks)
see comment SMD 0.78 lower





Measured with PHQ-9, CES-D, BDI, HRSD, and
GDS. SMD 0.78 represents a difference be-
tween groups of 8.53 points on the BDI and
4.31 points on the HRSD.
quality of life (continuous)
up to 6 months (8-12 weeks)
see comment SMD 0.97 higher






Measured with SF-12 physical component
and WHOQOL. SMD 0.97 represents a large ef-
fect.
social adjustment and function-
ing (continuous)
up to 6 months (12 weeks)






Measured with Work and Social Adjustment
Scale (WSAS) and Sheehan Disability Scale.
SMD 1.27 represents a large effect.
anxiety symptoms
(continuous) up to 6 months (8-12
weeks)
see comment SMD 0.33 lower






Measured with GAD-7 and BAI. SMD 0.33 rep-
resents a small effect.
adverse events
(8-10 weeks)
behavioural activation arm: 103 events. treat-






Any adverse event summarised narratively
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 Mostly low risk of bias for sequence generation, allocation concealment, and selective reporting. Mostly high risk of bias only for blinding of participants and personnel. Some







































































































































2 Several studies with incomplete outcome data and potential conflict of interest. Randomisation and allocation concealment largely low risk of bias. Downgraded one level for
high risk of bias.
3 Pooled estimate is influenced by large eect in one small study. Downgraded one level for inconsistency.
4 Pooled estimate is driven by one study with large eect favouring behavioural activation. Wide confidence interval. Downgraded one level for inconsistency and one level for
imprecision.
5 One small study with three high risk of bias domains including incomplete outcome data. Other study unclear risk of selection bias, and high risk for attrition bias, reporting
bias, and conflict of interest. Downgraded two levels for high risk of bias. Although studies are small, estimates are consistent.
6 No blinding of participants/personnel and outcome assessors in 3/4 studies. Evidence of attrition bias (2/4), performance bias (3/4) and potential conflict of interest (3/4). No
evidence of selection bias in 2/4 studies, other two studies some information missing (unclear). Downgraded one level for high risk of bias.
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B A C K G R O U N D
Description of the condition
Depression, when diagnosed in a clinical setting, most oLen
refers to a major depressive disorder. It is characterised by
a period of at least two weeks of depressed mood, or a
persistent loss of interest or pleasure in activities which were
previously considered enjoyable, or both (APA 2013). A range
of symptoms may accompany these key features of depression,
including weight loss or weight gain, insomnia or hypersomnia
(excessive sleeping and/or sleepiness), psychomotor agitation
(mental and physical restlessness) or retardation (mental and
physical slowness), fatigue, loss of energy, feelings of excessive
guilt and worthlessness, diminished concentration, and recurrent
thoughts of death (APA 2013).
Depression is the fiLh global cause of disease burden in terms of
years lived with a disability (YLD), and was ranked in the top 10 of
YLD in 191 out of 195 countries worldwide (Vos 2017). In 2014, 7.1%
of the population living in the 28 countries of the European Union
was estimated to report depression, with higher rates reported by
women and by Europeans living in cities. Prevalence rates of self-
reported depression varied from 4% in 15- to 24-year-olds to 10%
in those aged 75 and over (Eurostat 2014).
Depression has a long-lasting impact on patients, their families, and
wider society. It is associated with marked personal and societal
economic losses due to healthcare costs for mental and comorbid
physical healthcare, reduced productivity in the workplace, and
years of life lost (Greenberg 2015). A meta-analysis of data from 35
countries found a 52% increased risk of mortality, aLer adjusting for
publication bias (Cuijpers 2014).
Description of the intervention
Clinical guidelines recommend pharmacological and psychological
interventions, alone or in combination, in the treatment of mild to
moderate depression in adults (NICE 2009).
The prescribing of antidepressants has increased dramatically
in many Western countries over the past 20 years, mainly with
the advent of selective serotonin reuptake inhibitors (SSRIs)
and other agents such as serotonin–noradrenaline reuptake
inhibitors (SNRIs) and noradrenalinergic and specific serotonergic
antidepressants (NaSSAs) (Ilyas 2012). Antidepressants remain
the mainstay of treatment for moderate to severe depression
in healthcare settings, whereas for subthreshold depressive
symptoms (not meeting the threshold for clinical diagnosis) or mild
depression, low-intensity psychosocial therapy and psychological
therapies are recommended (NICE 2009).
Whilst antidepressants are proven to be eective for the acute
treatment of depression for some people (Arroll 2009; Magni
2013; Cipriani 2009a; Cipriani 2009b; Cipriani 2010; Guaiana
2007), adherence rates remain very low (Hunot 2007; van
Geen 2009), in part because of patients' concerns about
side eects and dependency (Hunot 2007; Fawzi 2012).  Not
adhering to antidepressant medication is related to relapse and/
or recurrence, hospital visits and hospitalisation, worsening of
depression symptoms, and a lower likelihood of recovery (Ho
2016). Furthermore, surveys consistently demonstrate patients'
preference for psychological therapies over antidepressant
treatment (Churchill 2000; McHugh 2013; Riedel-Heller 2005).
Therefore, psychological therapies can be an important alternative
intervention or an additional treatment for depressive disorders.
A diverse range of psychological therapies is available for
the treatment of depression.  Psychological therapies may
be broadly categorised into four separate philosophical and
theoretical schools, comprising psychoanalytic/dynamic (Freud
1949; Jung 1963; Klein 1960), behavioural (Skinner 1953;
Watson 1924; Wolpe 1958), humanistic (Maslow 1943; May
1961; Rogers 1951), and cognitive approaches (Beck 1979;
Lazarus 1971). Each of these four schools incorporates several
dierent and overlapping psychotherapeutic approaches. Some
psychotherapeutic approaches, such as cognitive-analytic therapy
(CAT) (Ryle 1990), explicitly integrate components from several
theoretical schools. Other approaches, such as interpersonal
therapy (IPT) for depression (Klerman 1984), have been developed
to address characteristics considered specific to the disorder of
interest.
Behavioural therapy is a term that has been used to describe a
broad range of therapies using principles of operant conditioning,
in which behaviours are modified through learning. It became a
dominant force in the 1950s, drawing on the work of Skinner 1953,
Wolpe 1958, and Eysenck 1960. Behavioural therapy emphasises
the role of environmental cues in influencing the adoption and
maintenance of behaviours (Nelson-Jones 1990) and, in contrast
with psychoanalysis, was developed though experimentally- rather
than theoretically-derived principles (Rachman 1997).
With the advent of cognitive therapy in the 1970s, behavioural
therapy approaches based purely on operant (learning from
the consequences of behaviours) and respondent (responsive
behaviour as a result of a stimulus) principles became regarded as
insuicient. However, the interest in the feasibility of behavioural
treatments for depression has since been renewed (Dimidjian 2011;
Ekers 2014; Hopko 2003a). The term behavioural activation appears
to have been used for the first time in 1990, as a description of
the behavioural components in cognitive therapy (Hollon 1990).
Jacobson showed that the behavioural component of cognitive-
behavioural therapy (CBT) was as eective as the full package of
CBT, and developed a new and more comprehensive model of
behavioural activation that would be amenable to dissemination
(Jacobson 1996; Jacobson 2001). It would appear that 'behavioural
activation' has now become the commonly adopted description,
and we will use this term in the rest of this review to refer to the
intervention (Martell 2010).
How the intervention might work
Skinner proposed that depression was associated with an
interruption in established sequences of healthy behaviour that
were previously positively reinforced by the social environment
and were based on operant conditioning principles (in which
behaviour patterns are learnt, rather than instinctive) (Skinner
1953). In subsequent expansions of this model, reduction of
positively reinforced healthy behaviours has also been attributed to
a decrease in the number and range of reinforcing stimuli available
to the individual, lack of skill in obtaining positive reinforcement
(Lewinsohn 1974), increased frequency of punishment, or a
combination of two, or all of these (Lewinsohn 1984).
Behavioural activation therapy for depression in adults (Review)
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Behavioural activation can be defined as a brief psychotherapeutic
approach that seeks to change the way a person interacts with their
environment, aiming to:
1. increase access to positive reinforcers of healthy behaviours;
2. reduce avoidance behaviours that limit access to positive
reinforcement;
3. understand and address barriers to activation.
Treatments are collaborative and focused on the present. Many
diering techniques are incorporated into treatment; however all
use self-monitoring of a mood-environment link and scheduling
of new or adaptive behaviours to meet targets (Kanter 2010). In
doing so, the therapy helps people to make contact with potentially
reinforcing experiences (Jacobson 2001).
The original model of behavioural activation, developed by
Jacobson, was defined primarily by the elimination of cognitive
intervention elements (Dimidjian 2006). On the basis of its original
design, behavioural activation model components commonly
include developing a shared treatment rationale; promoting
access to meaningful events, activities, and consequences; activity
scheduling; developing social skills; and self-monitoring links
between behaviour and mood. In some cases the use of some form
of problem-solving or functional analysis are added to understand,
consider and overcome any potential barriers to the scheduling of
activities. In contrast to CBT, no attempt is made to directly change
cognitions. However, behavioural activation commonly involves
an exploration of how cognitive processes, such as rumination,
can limit access to behaviours and events which give positive
reinforcement, for example in stopping people with depression
from meeting up with friends or participating in physical exercise.
Why it is important to do this review
According to the clinical guidelines produced by the National
Institute for Health and Clinical Excellence (NICE), behavioural
activation is one of the recommended treatment options for
subthreshold depressive symptoms, mild to moderate depression,
and severe depression, along with CBT and IPT. However, the
guidelines acknowledge that evidence for behavioural activation
is currently less robust than for the other recommended therapies
(NICE 2009).
The eects of behavioural therapies for depression versus other
psychological therapies were previously examined in a Cochrane
Review, which reported that low- to moderate-certainty evidence
from 25 trials suggested that behavioural therapies and other
psychological therapies were equally eective (Shinohara 2013).
This Cochrane Review did not cover trials comparing behavioural
therapy to treatment as usual, nor did it include the emerging
literature on new treatment models of behavioural activation.
Two Cochrane Reviews of 'third-wave' cognitive and behavioural
therapies, one comparing the intervention to treatment as usual
and one comparing to other therapies, identified three trials
of behavioural activation for depression (Churchill 2013; Hunot
2013). The small number of trials together with the low certainty
of the evidence limited the ability to draw any conclusions on
eectiveness. Another systematic review of behavioural activation
found evidence from 26 trials, most of them low quality, indicating
that behavioural activation is more eective than a wide range of
control treatments, including medication (Ekers 2014).
There is no Cochrane Review that includes all behavioural
activation therapies currently used for the treatment of depression.
Behavioural activation is increasingly receiving attention as a
potentially cost-eective intervention for depression, which may
be delivered and implemented in settings with low-resources
or where the demand is greater than the availability of mental
health practitioners to deliver more complex treatments (Richards
2016). Given this resurgence of interest, a comprehensive review
of the comparative eectiveness and acceptability of behavioural
activation interventions for depression is timely to inform and
update clinical practice and future clinical guideline development.
O B J E C T I V E S
1. To examine the eects of behavioural activation compared with
all other psychological therapies for depression in adults.
2. To examine the eects of behavioural activation compared with
all medication for depression in adults.
3. To examine the eects of behavioural activation compared with
treatment as usual/ waiting list/placebo/no treatment control
conditions for depression in adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) were eligible for inclusion
in this review. We included trials employing a cross-over design
(whilst we acknowledge that this design is rarely used in
psychological therapy trials), but we only used data from the first
active treatment phase. Cluster-RCTs and pilot RCTs were also
eligible for inclusion.
Quasi-randomised controlled trials, in which treatment assignment
is decided through methods such as alternate days of the week,
were not eligible for inclusion. We included trials that replaced
dropouts without randomisation only when the proportion of
replaced participants was less than 20%.
Types of participants
Participant characteristics
Randomised controlled trials of adults aged 18 years and over of
any sex or gender were eligible for inclusion. We excluded trials that
involved participants under 18 years of age.
Setting
Trials could be conducted in a primary, secondary or community
setting. Trials conducted in a hospital clinic were included, but
we excluded trials involving inpatients. We included trials that
focused on specific populations - nurses, care givers, depressed
participants at a specific workplace - if all participants met criteria
for depression. Nursing homes in this review were considered
outpatient settings, as they are places of residence.
Diagnosis
We included all trials that focused on acute phase treatment of
clinically diagnosed depression or subthreshold depression.
1. We included trials adopting any standardised diagnostic
criteria to define participants suering from an acute phase
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
unipolar depressive disorder. Accepted diagnostic criteria
include Feighner criteria, Research Diagnostic Criteria and
criteria of the Diagnostic and Statistical Manual of Mental
Disorders, Third Edition ((DSM-III); APA 1980), DSM-III-Revised
((R); APA 1987), DSM-Fourth Edition ((IV); APA 1994), DSM-IV-Text
Revision ((TR); APA 2000), DSM-5 (APA 2013), and International
Classification of Diseases, Tenth Edition ((ICD-10); WHO 1992).
2. To fully represent the broad spectrum of severity of depressive
symptoms encountered by healthcare professionals in primary
care, we included trials that used non-operationalised
diagnostic criteria (ICD-Ninth Edition ((ICD-9); WHO 1978)
or a validated clinician or self-report depression symptom
questionnaire, such as the Hamilton Rating Scale for Depression
(HRSD) (Hamilton 1960), or the Beck Depression Inventory
(BDI) (Beck 1961), to identify depression cases as based on a
recognised threshold.
3. Subthreshold depression, also called subsyndromal,
subclinical, or minor depression, in which people experience
symptoms of depression but do not meet the threshold for
diagnosis. We accepted any trials that established subthreshold
depression based on the above diagnostic criteria or validated
depression symptom questionnaires.
When possible, we used accepted strategies for classifying mild,
moderate and severe depression on the basis of criteria used in
the evidence syntheses underpinning the NICE 2009 guidelines for
depression. NICE 2009 defines severity of depression in accordance
with DSM-IV (APA 1994) as follows: mild depression: few, if any,
symptoms in excess of the five required to make the diagnosis, with
symptoms resulting in only minor functional impairment. Moderate
depression: symptoms of functional impairment between 'mild'
and 'severe'. Severe depression: most symptoms, and marked
interference of the symptoms with functioning. Can occur with or
without psychotic symptoms.
We excluded trials focusing on chronic depression or treatment-
resistant depression (i.e. trials that list these conditions as inclusion
criteria). We also excluded trials in which participants were
receiving treatment to prevent relapse aLer a depressive episode
(i.e. where participants did not have symptoms of depression at
trial entry). Postnatal depression is considered a separate condition
with contributing factors distinct from major depressive disorder,
and we therefore excluded it.
If participants met the criteria for depression or subthreshold
depression as stated above, we included trials with people
described as ‘at risk of suicide’ or with dysthymia (persistent
depressive disorder), or other aective disorders such as panic
disorder, but otherwise we excluded these trials.
We did not include subgroup analyses of people with depression
selected from people with mixed diagnoses because such trials
would be susceptible to publication bias (the trial authors reported
such subgroup trials because the results were 'interesting'). In other
words, we included these trials only if the inclusion criteria for the
entire trial satisfied our eligibility criteria.
Comorbidity
Trials involving participants with comorbid physical or common
mental disorders were eligible for inclusion as long as the
comorbidity was not the focus of the trial. For example, we
excluded trials that focused on depression among individuals
with Parkinson's disease or aLer acute myocardial infarction but
accepted trials that may have included some participants with
Parkinson's disease or with acute myocardial infarction. This
decision was made because the intervention and study design may
in such cases be adapted for these specific populations. A separate
Cochrane Review of behavioural activation for the treatment of
depression in people with physical comorbidities is to be published
in 2020 (Upho 2019b).
Types of interventions
Experimental interventions
A previously published Cochrane Review for behavioural therapy
in depression provided a framework for psychological therapies,
including behavioural therapy (Shinohara 2013). Given recent
developments in literature and practice regarding behavioural
activation approaches, we consider behavioural activation as part
of behavioural therapies, rather than being classified as a 'third-
wave' therapy. In line with the behavioural therapy review, we
created the comparator categories of psychological therapies
on the basis of both treatment approach (e.g. their theoretical
background and the manuals they used) and content (what
therapeutic techniques they mainly used or what was their area of
focus). See also Appendix 1.
Behavioural activation
We included trials evaluating treatment approaches for depression
that are either explicitly called 'behavioural activation', or
treatments that are described using the main elements of
behavioural activation for depression, such as pleasant events
and activities, activity scheduling, positive reinforcement from
the environment, positive interaction or re-engagement with the
environment. This means that we included behavioural therapies in
the treatment group as long as they were described using the main
elements of behavioural activation. Experimental interventions
that contained some elements of behavioural therapy, such as CBT
or problem-solving therapy, were not eligible for inclusion.
Format of psychological therapies
Therapies delivered by therapists of all levels were eligible for
inclusion. This includes: 1) psychologists or psychotherapists
accredited by a professional body for psychology or psychotherapy,
who completed formal training to deliver psychological therapies,
2) those who received substantial training (more than a year) but
are not yet qualified, and 3) lay counsellors and non-specialist
therapists who have been specifically trained to deliver treatment
according to a behavioural activation protocol.
We included computerised and self-help interventions if they were
facilitated. This means at least some element of interaction with a
therapist was required.
Psychological therapies conducted on an individual or group basis
were eligible for inclusion.
The number of sessions was not limited, and we accepted
psychological therapies delivered in only one session.
Comparators
All comparators were accepted as long as they are not a type
of behavioural activation. We categorised psychological therapies
as behavioural therapy, social skills training/assertiveness
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training, relaxation therapy, CBT, third-wave CBT, psychodynamic,
humanistic and integrative approaches.
Behavioural therapy
We planned to include any behavioural therapies that did
not contain the main elements of behavioural activation as
comparators.
Social skills training/assertiveness training
The social skills training model (SST) proposes that depressed
people may have diiculty initiating, maintaining and ending
conversations (Jackson 1985). Because of these deficits, the
individual is unable to elicit mutually reinforcing behaviour from
other people in his or her environment. SST subsumes assertion
and conversational skills, together with more specialised subskills
such as dating and job interview skills. Dierent social contexts
may be targeted, for example interaction with friends, family
members, people at school, or at work, and interventions such as
instruction, modelling, rehearsal, feedback and reinforcement are
used to enable the development of new responses (Jackson 1985).
As assertiveness training represents a key component of SST, we
included it in the SST category.
Relaxation therapy
Relaxation training is a behavioural stress management technique
that induces a relaxation response, helping to switch o the
fight/flight response and causing levels of stress hormones in the
bloodstream to fall. A variety of techniques may be used to induce
relaxation, the most common of which is Jacobson's progressive
muscle relaxation training (Bernstein 1973).
Cognitive-behavioural therapies (CBTs)
In CBT, therapists aim to work together with people receiving
treatment to understand the link between thoughts, feelings
and behaviours, and to identify and modify unhelpful thinking
patterns and underlying assumptions about the self, others and
the world (Beck 1979). Cognitive change methods for depression
are targeted at the automatic thought level in the first instance
and include thought catching, reality testing and task assigning
as well as generating alternative strategies (Williams 1997).
Behavioural experiments are then used to re-evaluate underlying
beliefs and assumptions (Bennett-Levy 2004).  We categorised
these therapies into six subcategories: cognitive therapy, rational
emotive behaviour therapy, problem-solving therapy, self-control
therapy, a coping with depression course and other CBTs.
'Third-wave' cognitive and behavioural therapies (third-wave CBTs)
Third-wave CBT approaches have been developed more recently
and now exist alongside established therapies such as CBT.
Rather than focusing on the contents of thoughts, these therapies
tend to focus on the process and functions of thoughts and
an individual's relationship with thoughts and emotions. This
may include suppressing or avoidance of emotions, thoughts,
and bodily sensations (Hofmann 2008). Third-wave approaches
use strategies relating to mindfulness, emotions, acceptance,
relationships, values, goals, and understanding the thinking
process, to bring about changes in thinking (Hayes 2007). Drawing
from psychodynamic and humanistic principles, third-wave CBT
approaches place great emphasis on use of the therapeutic
relationship. We categorised these therapies into subcategories:
acceptance and commitment therapy, compassionate mind
training, functional analytic psychotherapy, metacognitive therapy,
mindfulness-based cognitive therapy, dialectical behaviour
therapy and other third-wave CBTs.
Psychodynamic therapies
Grounded in psychoanalytic theory (Freud 1949), psychodynamic
therapy (PD) uses the therapeutic relationship to explore and
resolve unconscious conflict through transference (projection of
feelings on to the therapist) and interpretation, with development
of insight and character change (within certain boundaries) as
therapeutic goals, and relief of symptoms as an indirect outcome.
Brief therapy models have been devised by Malan 1963, Mann
1973 and Strupp 1984. We categorised these therapies into four
subcategories: drive/structural model (Freud), relational model
(Strupp, Luborsky), integrative analytic model (Mann) and other
psychodynamic therapies.
Humanistic therapies
Contemporary models of humanistic therapies dier from
one another somewhat in clinical approach, but all focus
attention on the therapeutic relationship (Cain 2002), within
which therapist ‘core conditions’ of empathy, genuineness,
and unconditional acceptance and support (positive regard)
(Rogers 1951), are regarded as cornerstones for facilitating
insight and change.  We categorised these therapies into
seven subcategories:  person-centred therapy (Rogerian), gestalt
therapy, experiential therapies, transactional analysis, existential
therapy, non-directive/supportive therapies, and other humanistic
therapies.
Interpersonal, cognitive analytic and other integrative therapies
Integrative therapies are approaches that combine components of
dierent psychological therapy models. Integrative therapy models
include interpersonal therapy (IPT) (Klerman 1984), cognitive
analytic therapy (CAT; (Ryle 1990)), and Hobson’s conversational
model (Hobson 1985), manualised as psychodynamic
interpersonal therapy (Shapiro 1990). With its focus on the
interpersonal context, IPT was developed to specify what was
thought to be a set of helpful procedures commonly used
in psychotherapy for depressed outpatients (Weissman 2007),
drawing in part from attachment theory (Bowlby 1980), and
cognitive-behavioural therapy within a set timeframe (time-
limited). CAT, also devised as a time-limited psychotherapy,
integrates components from cognitive and psychodynamic
approaches. The conversational model integrates psychodynamic,
interpersonal and person-centred model components.
Counselling interventions traditionally draw from a wide range
of psychological therapy models, including person-centred,
psychodynamic and cognitive-behavioural approaches, applied
in combination, according to the theoretical orientation of
practitioners (Stiles 2008). Therefore, we usually included trials of
counselling with integrative therapies. However, if the counselling
intervention consists of a single discrete psychological therapy
approach, we categorised it as such, even if the intervention is
referred to as 'counselling'. If the intervention was manualised, this
would inform our classification.
Motivational interviewing and other forms of integrative therapy
approaches are also included in this category.
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Waiting list
Participants are randomly assigned to the active intervention group
or control group, and they will either receive the intervention first or
be assigned to a waiting list until all participants in the intervention
group have received the intervention. During the course of the trial,
people on the waiting list can receive any appropriate medical care.
Attention placebo
We define this as a control condition that is regarded as inactive by
both researchers and participants in a trial.
Psychological placebo
We define this as a control condition in a trial that is regarded by
researchers as inactive but is regarded by participants as active
(also called placebo therapy or sham treatment).
Medication
All medication prescribed with the goal to treat depression, most
commonly antidepressants; any dose, route of administration,
duration, and frequency.
Medical placebo
All types of medical placebos or 'sugar pills'.
No treatment
Trial participants not receiving any treatment for depression during
the course of the trial.
Treatment as usual
Treatment as usual, standard care, or usual care would be any
appropriate medical care during the course of the study. This may
for example involve monitoring of the person receiving treatment,
regular check-ups, no treatment, or any type of treatment. What
constitutes treatment as usual will depend on the setting and
healthcare system in which the study was conducted. If a study
arm fitted clearly in any of the above categories, for example 'no
treatment' or a type of psychological therapy, we categorised it as
such.
Excluded interventions
We excluded from the review trials of long-term, continuation, or
maintenance therapy interventions designed to prevent relapse
of depression or to treat chronic depressive disorders. Similarly,
we excluded trials of interventions designed to prevent a future
episode of depression.
We excluded psychological therapy models based on social
constructionist principles (that focus on the ways in which
individuals and groups participate in the construction of their
perceived social reality), including couples therapy, family therapy,
solution-focused therapy (de Shazer 1988), narrative therapy,
personal construct therapy, neuro-linguistic programming and
brief problem-solving (Watzlavick 1974). These therapies work with
patterns and dynamics of relating within and between family, social
and cultural systems to create a socially constructed framework
of ideas (O'Connell 2007), rather than focusing on an individual's
reality. A previously published Cochrane Review on couples therapy
for depression has recently been updated (Barbato 2018), and a
review of family therapy for depression is to be updated (Henken
2007).
Types of outcome measures
Primary outcomes
1. Treatment eicacy: the number of participants who responded
to treatment, as determined by changes in scores for Beck
Depression Inventory (BDI; Beck 1961), Hamilton Rating Scale
for Depression (HRSD; Hamilton 1960), or Montgomery-Asberg
Depression Rating Scale (MADRS; Montgomery 1979), or in
scores from any other validated depression scale. Many trials
define response as 50% or greater reduction on BDI, HRSD, etc.,
with some trials defining response using Jacobson's Reliable
Change Index; we accepted the trial authors' original definition.
If trials reported multiple measures of treatment eicacy, we
prioritised remission over clinically significant improvement,
and recovery or remission over response.
2. Treatment acceptability: the number of participants who
dropped out of the study for any reason aLer being randomised
and allocated to a study arm.
Secondary outcomes
1. Improvement in depression symptoms, based on a continuous
outcome of group mean scores at the end of treatment using
BDI, HAM-D, MADRS or any other validated depression scale
2. Quality of life, as assessed with the use of validated measures
such as Short Form (SF)-36 (Ware 1993), Health of the Nation
Outcome Scales (HoNOS; Wing 1994), EuroQol (Brooks 1995),
and World Health Organization Quality of Life (WHOQOL;
WHOQL 1998).
3. Social adjustment and social functioning, including Global
Assessment of Function (GAF) (Luborsky 1962) scores.
4. Improvement in anxiety symptoms, as measured using a
validated continuous scale, either assessor-rated, such as the
Hamilton Anxiety Scale (HAM-A) (Hamilton 1959), or self-report,
including the Trait subscale of the Spielberger State-Trait
Anxiety Inventory (STAI-T) (Spielberger 1983), and the Beck
Anxiety Inventory (BAI) (Beck 1988).
5. Adverse eects, such as counts of completed suicides,
attempted suicides, or worsening of symptoms were
summarised in narrative form. 
Management of time points
We summarised and categorised post-treatment outcomes and
outcomes at each reported follow-up point as follows: short term
(up to six months post-treatment), medium term (seven to 12
months post-treatment) and long term (longer than 12 months).
If data at multiple time points were available within one of our
categories, we used the latest time point.
Search methods for identification of studies
Electronic searches
The Cochrane Common Mental Disorders' Information Specialist
conducted searches on 17 January 2020 (and a previous search on
17 January 2019) in the following bibliographic databases using
relevant subject headings (controlled vocabularies) and search
syntax, appropriate to each resource. The search strategies were
designed to identify RCTs of 'behavioural activation', or the main
elements of behavioural activation for depression in participants
with clinically diagnosed depression or subthreshold depression.
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
• Cochrane Common Mental Disorders Trials Register (CCMD-
CTR); all available years (Appendix 2).
• Cochrane Central Register of Controlled Trials (CENTRAL;
current issue).
• Ovid MEDLINE (1946 onwards; Appendix 3).
• Ovid Embase (1980 onwards).
• Ovid PsycINFO (1806 onwards).
We did not apply any restrictions on date, language or publication
status to the searches.
We searched international trials registries via the World Health
Organization's trials portal (ICTRP) and ClinicalTrials.gov to identify
unpublished or ongoing trials.




We searched the following sources of grey literature (primarily for
dissertations and theses) on 17 January 2020:
• Open Grey (www.opengrey.eu/);
• ProQuest Dissertations & Theses Global (www.proquest.com/
products-services/pqdtglobal.html);
• DART-Europe E-theses Portal (www.dart-europe.eu/);
• EThOS - the British Libraries e-theses online service
(ethos.bl.uk/);
• Open Acces Theses and Dissertations (oatd.org).
Reference lists
We checked the reference lists of all included trials and relevant
systematic reviews to identify additional trials missed from the
original electronic searches (e.g. unpublished or in-press citations).
Personal communication
We contacted trial authors and subject experts for information on
unpublished or ongoing trials, or to request additional trial data.
Data collection and analysis
Selection of studies
Two review authors independently examined each title and
abstract obtained through the search strategy (EU, LR, SD, ESo).
We then obtained full articles of all trials identified by any one of
the review authors and two review authors independently assessed
full-texts according to the criteria relating to characteristics of
the studies, participants, and interventions (EU, LR, SD, ESo). We
discussed reasons for disagreement with a third reviewer (DE, DR,
RC), and contacted external experts or trial authors if necessary
in order to reach agreement. We recorded reasons for excluding
records at this stage. For all included studies, we linked multiple
reports from the same study. We presented a PRISMA flow diagram
to show the process of study selection (Moher 2009).
Data extraction and management
Two review authors independently extracted data from each
trial (EU, LR, ESa, ESo). These review authors discussed any
disagreement with an additional review author (DE, RC), and,
when necessary, contacted the authors of the trials for further
information.
We extracted and entered information for the following categories
into Covidence data extraction forms: trial design, source
of funding, study population, interventions and comparators,
outcomes and sample size.
Assessment of risk of bias in included studies
We assessed risk of bias for each included trial using the Cochrane
Collaboration's 'Risk of bias' tool (Higgins 2016), which considers
the following domains.
1. Risk of bias arising from the randomisation process, including
allocation and randomisation
2. Risk of bias due to deviations from the intended interventions,
including blinding of participants and people delivering the
interventions
3. Incomplete outcome data
4. Risk of bias in measurement of the outcome, including blinding
of outcome assessors
5. Selective outcome reporting
6. Other bias
In the assessment of risk of attrition bias (domain 5), we considered
the amount of missing outcome data in each study arm and judged
whether these data were likely to be missing at random.
In the 'other bias' domain we considered any other problems with
a study that may lead to bias, including the following items specific
to psychological therapy trials.
1. Treatment fidelity: was the therapy monitored against a manual
or a scale through audiotapes or videotapes?
2. Researcher allegiance/conflict of interest: did the researcher
have a vested interest for or against the therapies under
examination?
3. Therapist allegiance/conflict of interest: did the therapist have a
vested interest for or against the therapies provided?
For cluster-RCTs and cross-over trials, we used the templates
specifically designed to assess these types of trials, with the same
five domains.
We judged the risk of bias for each domain within and across trials,
and categorised this as low, unclear, or high risk of bias.
Two review authors independently assessed the risk of bias in
included trials (EU, LR, ESa, ESo) and discussed any disagreements
with a third review author (EU, LR, ESa, ESo, RC, DE). Where
necessary, we contacted trial authors for further information. We
presented all 'Risk of bias' data graphically, and narratively in the
text.
Measures of treatment e:ect
Continuous outcomes
Where trials used the same outcome measure for comparison, we
pooled data by calculating the mean dierence (MD) and 95%
confidence intervals (95% CIs). When trials used dierent measures
to assess the same outcome, we pooled data calculating the
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standardised mean dierence (SMD) and 95% 95% CIs. We used
both endpoint data and change from baseline data, depending
on availability. If both were available, we used endpoint data. In
accordance with the Cochrane Handbook, endpoint and change
from baseline data were combined in one meta-analysis but
included in dierent subgroups (Schünemann 2017a).
An SMD or MD of zero means that the intervention and control
groups have equivalent treatment eects. We anticipated that, for
most measures, a lower score will indicate greater improvement.
For example, a lower score on depression symptom instruments
such as the Hamilton Rating Scale for Depression (HRSD), Beck
Depression Inventory (BDI) or Patient Health Questionnaire (PHQ-9)
indicates an improvement in symptoms. In these cases, an SMD or
MD less than zero indicates that the intervention has a greater eect
than the control. An SMD or MD greater than zero indicates that the
intervention has a smaller eect than the control. Interpretation of
the SMD and MD is reversed in cases where a greater continuous
score indicates greater improvement.
To facilitate interpretation of results in terms of their clinical
relevance, we expressed SMDs for continuous outcomes in terms
of units on a commonly used participant-rated outcome (BDI)
and a commonly used clinician-rated instrument (HRSD). We
calculated these re-expressed estimates according to guidance in
the Cochrane Handbook (Schünemann 2017a).
Dichotomous outcomes
We analysed dichotomous outcomes by calculating risk ratios (RRs)
and 95% CIs for each comparison in Review Manager 5 (Review
Manager 2014).
In addition, we calculated the number needed to benefit
(NNTB) with 95% CIs for all dichotomous outcomes to facilitate
interpretation; this is the expected number of people who need
to receive the intervention rather than the comparator for one
additional person to achieve a beneficial outcome (Schünemann
2017a).
Unit of analysis issues
Cluster-randomised trials
We included cluster-randomised trials as long as proper adjustment
for the intracluster correlation could be conducted in accordance
with the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011).
Cross-over trials
We included trials employing a cross-over design in the review, but
we only used data from the first active treatment phase.
Trials with multiple treatment groups
Multiple-arm trials (those with more than two intervention arms)
can pose analytical problems in pair-wise meta-analysis. For trials
with more than two eligible arms, we managed data in this review
as follows.
Multiple experimental intervention groups versus a single control
group
If studies compared multiple eligible experimental interventions
with a single control group, we split the control group to enable
pair-wise comparisons.
One or more experimental intervention groups versus multiple control
groups
1. If studies used multiple 'active' comparator interventions,
we combined these comparator groups to compare to the
behavioural activation intervention group (objective 1/2).
2. If studies used multiple control groups including treatment as
usual/ waiting list/ attention placebo/ psychological placebo,
we combined the control groups to compare to the behavioural
activation intervention group (objective 3).
Dealing with missing data
We managed missing dichotomous data through intention-to-
treat (ITT) analysis, in which we assumed that participants who
dropped out aLer randomisation had a negative outcome. We
also conducted best/worse case scenarios for the clinical response
outcome, in which we assumed that dropouts in the active
treatment group had positive outcomes and those in the control
group had negative outcomes (best-case scenario), and that
dropouts in the active treatment group had negative outcomes
and those in the control group had positive outcomes (worst-case
scenario), thus providing boundaries for the observed treatment
eect. We gave these best/worst case scenarios greater emphasis in
the presentation of results if a large amount of information proved
to be missing.
We analysed missing continuous data on an endpoint basis,
including only participants with a final assessment, or by using the
last observation carried forward (LOCF) to the final assessment, if
trial authors reported LOCF data. When standard deviations (SDs)
were missing, we attempted to obtain these data by contacting
trial authors. When SDs were not available from trial authors, we
calculated them from P values, t values, CIs or standard errors (SEs),
if these were reported in the articles (Deeks 1997).
If a vast majority of SDs were available and only a minority
of SDs were unavailable or unobtainable, we used the method
devised by Furukawa and colleagues to impute SDs and calculate
percentage responders (da Costa 2012; Furukawa 2005; Furukawa
2006). We planned to interpret these data with caution and take
into account the degree of observed heterogeneity. We would also
planned to undertake a sensitivity analysis to examine the eect
of the decision to use imputed data. When conducting the review
however, this method for imputing data was not used.
If additional figures were not available or obtainable and it was
not deemed appropriate to use the Furukawa method as described
above, we did not include the trial data in the comparison of
interest.
Assessment of heterogeneity
We formally tested statistical heterogeneity using the Chi2 test,
which provides evidence of variation in eect estimates beyond
that of chance. Because the Chi2 test has low power to assess
heterogeneity when a small number of participants or trials are
included, we conservatively set the P value at 0.1 (Deeks 2017). We
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also quantified heterogeneity using the I2 statistic, which calculates
the percentage of variability due to heterogeneity rather than to
chance (Higgins 2003). We considered I2 statistic values in the range
of 50% to 90% to represent substantial statistical heterogeneity and
explored these further. However, the importance of the observed
I2 statistic depends on the magnitude and direction of treatment
eects and the strength of evidence for heterogeneity. Forest plots
generated in Review Manager 5 will provide an estimate of tau2, the
between-trial variance in a random-eects meta-analysis (Deeks
2017; Review Manager 2014).
Assessment of reporting biases
As far as possible, we minimised the impact of reporting biases
by undertaking comprehensive searches of multiple sources
(including trials registries), to identify unpublished material and
including non–English language publications.
We also tried to identify outcome reporting bias in trials by
recording all trial outcomes, planned and reported, and noting
where outcomes were missing. If we found evidence of missing
outcomes, we attempted to obtain any available data directly from
the trial authors.
Where suicient data were available, we constructed funnel plots
to establish the potential influence of reporting biases and small-
trial eects (Sterne 2017).
Data synthesis
We conducted a meta-analysis of included trials. Given the
potential heterogeneity of behavioural activation approaches for
inclusion, together with the likelihood of diering secondary
comorbid mental disorders in the population of interest, we used a
random-eects model in all analyses.
Subgroup analysis and investigation of heterogeneity
Clinical heterogeneity
We conducted the following subgroup analyses, depending on the
availability of suicient data for each outcome and comparison.
1. Participant age: old age in particular can be expected to
relate to treatment eect, as older people are more likely to
suer comorbidities. We conducted subgroup analyses with
participants younger than 65 years and those aged 65 years or
older.
2. Level of therapist: one of the oLen mentioned potential
benefits of less complex models of behavioural activation is
that therapies can be delivered by a therapist with minimal
training, or without a relevant accreditation. We expected
that this analysis by level of therapist would also account
for potential dierences by intervention complexities. We
conducted subgroup analyses according to the level of therapist
delivering behavioural activation, classified as:
a. accredited/received formal training of several years
(specialist); or
b. minimal training/lay counsellor (non-specialist); or
c. specialist in training; received substantial training but not yet
an accredited therapist.
3. Baseline depression severity: the severity of depression on entry
into the trial is expected to have an impact on outcomes.
We planned to categorise depression severity as subthreshold
depression, mild, moderate, or severe. As this was not possible
in practice, we used the categories of subtreshold/ mild
depression and moderate to severe depression instead (see
Dierences between protocol and review).
4. Length of treatment: we categorised treatment into those
delivered in one to three sessions and treatments of longer
duration. We anticipated that the length of treatment could
influence eectiveness.
5. Type of psychological therapy comparison: the type of
psychological therapy comparator used is likely to influence
the observed eectiveness of the intervention. When possible,
comparators were categorised as psychodynamic, behavioural,
humanistic, integrative, or cognitive-behavioural.
6. Type of control comparison: the type of control comparator
used is likely to influence the observed eectiveness of the
intervention. When possible, comparators were categorised
as waiting list, treatment as usual/usual care, no treatment,
attention placebo, or psychological placebo.
Sensitivity analysis
1. Trial quality: we excluded low- quality trials in a sensitivity
analysis, if we identified a number of higher-quality trials. As a
marker of quality, we used the 'allocation concealment' criteria
from the 'Risk of bias' assessment.
2. Mode of delivery: we excluded therapies delivered through
computer-based or electronic guidance without a substantial
face-to-face component.
3. Subthreshold depression: we planned to exclude trials of
subthreshold depression to determine whether our decision
to include non-clinical levels of depression had a substantial
impact on the results. We did not conduct this analysis, as it
would give the same results as subgroup analyses 3 (baseline
depression severity).
4. Group therapy: we excluded trials of group therapy for
behavioural activation as the mode of delivery of psychotherapy
could influence eectiveness of the therapy.
In addition to these planned sensitivity analyses, we performed
several sensitivity analyses to further explore findings of the review.
We removed one small study with a large weight (Analysis 1.1)
and one outlier (Analysis 10.3; Analysis 10.4). We also conducted
fixed-eect rather than random-eects analyses for comparisons
with smaller and larger studies and extreme estimates (Analysis 6.3;
Analysis 6.5; Analysis 10.3; Analysis 10.4) (see Dierences between
protocol and review).
'Summary of findings' tables
We constructed 'Summary of findings' tables to present the
main findings of the review. We reported the outcomes listed
below, when available, and presented standardised eect size
estimates and 95% CIs. Review author EU performed an assessment
of the certainty of the evidence for each outcome using the
GRADE approach (Schünemann 2017a). We used GRADEproGDT
to create our 'Summary of findings' tables (GRADEpro 2015),
and followed standard methods as described in the Cochrane
Handbook for Systematic Reviews of Interventions to prepare the
tables (Schünemann 2017b). Review authors LR and NM checked
GRADE assessments and 'Summary of findings' tables and tables
were revised to reflect discussion between EU, LR, and NM.
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For each of our main comparisons, we included the following
outcomes (measured up to 24 months).
1. Treatment eicacy (number of participants responding to
treatment).
2. Treatment acceptability (number of participants who dropped
out).
3. Improvement in depression outcomes as a continuous score.
4. Quality of life.
5. Social adjustment/ functioning score.
6. Improvement in anxiety symptoms as a continuous score.
The 'Summary of findings' table was created before writing our
discussion, abstract, and conclusions, so that the authors could
jointly consider the potential impact of the certainty of the
evidence for each outcome on the mean treatment eect and our
confidence in these findings. Our confidence in the mean treatment
eects based on the GRADE assessments was thus reflected in
the interpretation of the results, which informed the abstract, lay
summary, and discussion sections of the review.
R E S U L T S
Description of studies
Results of the search
Searches in all pre-specified databases were performed by the
Cochrane Common Mental Disorders' Information Specialist on 17
January 2019 and an update search was performed on 17 January
2020.
Figure 1 shows the selection of studies through screening of
abstracts and full-text papers. ALer duplicates were removed,
EU, SD, and LR screened titles and abstracts of 5823 records in
duplicate. For 380 records, full-texts were obtained and screened in
duplicate (EU, LR, ESo). Conflicts were resolved in discussion with
DE, DR, and RC. ALer linking records belonging to the same study,
53 studies were included in the qualitative synthesis and 49 studies
in meta-analyses. EU, LR, ESa, and ESo extracted data and assessed
the risk of bias in duplicate.
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Figure 1.   Study flow diagram.
 
Included studies
We included 53 studies in this systematic review. Two of these
studies were found as a result of the update search in January 2020.
Study design
FiLy-one studies were parallel group randomised controlled trials
(RCTs) and two were cluster-RCTs (Fleming 1980; Luo 2018). One
RCT allowed switching of placebo and medication treatment aLer
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eight weeks depending on participant preference (Dimidjian 2006),
and in one cross-over RCT treatments were switched between
groups aLer six weeks (Kelly 1983). For these two trials employing
a cross-over (Kelly 1983) and partial cross-over design (Dimidjian
2006), only outcome data for the first phase of the study are
included in meta-analyses of this review as per protocol.
Most trials had two study arms, with either two active treatments
or an active and a control group (31 studies). The other studies had
three arms (13 studies), four arms (seven studies), five arms (two
studies), or six arms (two studies). If study arms were variations
of the same treatment, for example two types of behavioural
activation, these data were combined in the meta-analyses of this
review.
Sample size
The 53 included studies had 5495 participants, ranging from less
than six participants per study arm (Skinner 1984) to an average of
352 participants per study arm (Gilbody 2017).
Setting
Many studies did not report on the setting and appear to have
been conducted at a university or medical centre. Recruitment
settings that were reported included: universities (Armento 2012;
Cullen 2003; Gawrysiak 2009; Hammen 1975; Kelly 1983; McCluskey
2018; McIndoo 2016; McNamara 1986; Shaw 1977; Takagaki 2016;
Taylor 1977; Weinberg 1978; Wilson 1983; Zeiss 1979; Zemestani
2016) , medical centres including psychiatric outpatient facilities
(Toghyani 2018; van den Hout 1995), community mental health
services, primary care and community health centres (Bolton 2014;
Bosanquet 2017; Bowe 2014; Chang 2018; Chowdhary 2016; Ekers
2011; Gilbody 2017; Nasrin 2017; Kanter 2015; Richards 2017), and
nursing homes or facilities for older people (Luo 2020; Meeks 2008;
Raue 2019). Several interventions were computer-based or phone-
based and supported from a distance (Carlbring 2013; Carlbring
2013a; Ly 2014; Stiles-Shields 2019).
Studies were conducted in the USA (27 studies), UK (five studies),
Iran (three studies), Sweden (three studies), Australia (two studies),
Canada (two studies), India (two studies), Brazil (one study), China
(one study), Hong Kong (one study), Indonesia (one study), Iraq
(one study), Japan (one study), the Netherlands (one study), South
Korea (one study), and Spain (one study).
Participants
We extracted data on participant age, sex, ethnic group,
socioeconomic characteristics (household income, occupation/
employment, education level), depression severity, and comorbid
anxiety. In this section we briefly summarise the information
available in study reports.
Age
Most studies included adult participants of all ages. Four studies
included only adults up to 60 years old (Dimidjian 2006; Hemanny
2019; Nasrin 2017; Wilson 1983), seven studies included only
participants aged 65 and over (Bosanquet 2017; Chang 2018;
Gilbody 2017; Luo 2020; Meeks 2008; Raue 2019; Xie 2019), and
in four studies samples were exclusively made up of young adult
college/university students with an average age between 18 and 24
(Gawrysiak 2009; McIndoo 2016; Takagaki 2016; Zemestani 2016).
Dierences in results for treatment eicacy and treatment
acceptability by participant age (under 65 and aged 65 and over) are
explored in subgroup analyses (Analysis 11.1; Analysis 11.2).
Sex
Six studies included only women (Fuchs 1977; Kornblith 1980;
Padfield 1976; Rehm 1982; Thomas 1987; Toghyani 2018). Two
studies included more men than women (39% and 38% women,
respectively) (Cullen 2003; Takagaki 2016). In all other studies that
reported on the sex of participants (36 studies), women represented
between 58% and 93% of the sample.
Ethnicity
Five studies included participants of a specific region or ethnic
group: people from various islands in Indonesia (Arjadi 2018),
a sample of African American participants (Bowe 2014), Puerto
Ricans (Comas Díaz 1981), and Latinos living in the USA (Collado
2016; Kanter 2015).
The other 14 studies reporting on participant ethnicity inlcuded
predominantly White American or White British participants (58%
to 99%), except for a study from Brazil reporting a mix of
participants from three ethnic groups (Hemanny 2019).
Socioeconomic characteristics
Studies collected data on income, level of education, and
employment status or occupation. It is diicult to compare
study participants as these characteristics are time- and place-
dependent. In many studies the sample represented a mix of
people with various socioeconomic characteristics.
Some studies predominantly recruited participants of a higher
socioeconomic status. For example, in the study by Ly and
colleagues 7% of participants were unemployed and 63% had
attended university (Ly 2014). Similarly, in the study by Carlbring
and colleagues 9% of participants were unemployed and 62%
had attended university (Carlbring 2013a), and in Arjadi 2018
unemployment was 8% and university attendance 55%.
Other studies had samples with predominantly people from a lower
socioeconomic status, and some of these studies were conducted
in low- and middle-income countries, or with people from such
countries. For example, in seven studies a majority of participants
had completed no more than primary education (Bolton 2014;
Chang 2018; Chowdhary 2016; Comas Díaz 1981; Luo 2020;
Weobong 2017; Xie 2019). In six studies levels of unemployment
ranged from 50% to 100% (Bolton 2014; Chowdhary 2016; Comas
Díaz 1981; Kanter 2015; Thomas 1987; Weobong 2017).
Severity of depression
For most studies, inclusion criteria specified a range or lower limit
of depression symptoms using a commonly used screening tool
such as the Patient Health Questionnaire (PHQ-9), Beck Depression
Inventory (BDI), or Hamilton Rating Scale for Depression (HRSD).
In 25 studies, only people with diagnosed major depressive
disorder or moderate to severe depression symptoms were
included (Arjadi 2018; Bosanquet 2017; Bowe 2014; Chang 2018;
Chowdhary 2016; Collado 2016; Cullen 2003; Dimidjian 2006;
Hemanny 2019; McNamara 1986; Meeks 2008; Moradveisi 2015;
Nasrin 2017; Padfield 1976; Rehm 1982; Richards 2017; Kanter 2015;
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Shaw 1977; Stiles-Shields 2019; Thompson 1987; Toghyani 2018;
van den Hout 1995; Weobong 2017; Xie 2019; Zemestani 2016).
In 16 studies, people with various levels of depression severity
(mild, moderate, severe) were included (Armento 2012; Carlbring
2013a; Ekers 2011; Fleming 1980; Gawrysiak 2009; Hammen 1975;
Kelly 1983; Ly 2014; McCluskey 2018; McIndoo 2016; Raue 2019;
Skinner 1984; Taylor 1977; Thomas 1987; Weinberg 1978; Wilson
1983). Participants in 11 of these studies predominantly had
major depressive disorder, or moderate to severe symptoms of
depression (Armento 2012; Carlbring 2013a; Ekers 2011; Fleming
1980; Gawrysiak 2009; Kelly 1983; Ly 2014; McIndoo 2016; Raue
2019; Taylor 1977; Thomas 1987).
Three studies included only participants with subthreshold
depression or minimal to mild symptoms (Gilbody 2017; Takagaki
2016; Vázquez 2014).
Based on this information from eligibility criteria and descriptions
of the study samples, we can conclude that, in most studies, the
majority of participants were suering from moderate to severe
levels of depression.
Anxiety
Most studies did not report on numbers of participants with
comorbid anxiety. Anxiety disorder was an exclusion criteria in six
trials (Chang 2018; Jacobson 1996; Kornblith 1980; Rehm 1982;
Toghyani 2018; van den Hout 1995). In eight studies that reported
on anxiety among participants, levels of anxiety disorder varied
from 11% (Moradveisi 2015) to 65% (Collado 2016).
Intervention
Description of intervention
Behavioural activation interventions were described in dierent
ways, and some were specifically designed for the study setting or
population. All interventions are described in the Characteristics of
included studies tables. Examples include the following.
1. Behavioural Activities Intervention (BE-ACTIV) for nursing home
residents (Luo 2020; Meeks 2008)
2. Healthy Activity Programme (HAP) for treatment of moderate
to severe depression in primary care in India (Chowdhary 2016;
Weobong 2017)
3. Culturally Enhanced Behavioural Activation (CEBA) for African
American communities (Bowe 2014)
4. Behavioural Activation for Latinos (BAL) for a low-income
Spanish speaking Latino community (Kanter 2015)
5. Behavioural Activation of Religious Behaviors (BARB) (Armento
2012)
Others were described as behavioural activation or behavioural
therapy based on Lewinsohns' approach (McNamara 1986; Padfield
1976; Shaw 1977; Skinner 1984; Taylor 1977; Thompson 1987;
Vázquez 2014; Weinberg 1978), Behavioural Activation Treatment
for Depression (BATD) (Bolton 2014; Collado 2016; Gawrysiak 2009;
McCluskey 2018; Nasrin 2017), or behavioural activation based on
the intervention evaluated by Fuch and Rehm (Fleming 1980; Fuchs
1977; Kornblith 1980; Rehm 1982; Thomas 1987; van den Hout
1995).
Level of therapist
For several trials, behavioural activation was delivered by a
specialist in training (Carlbring 2013a; Fleming 1980; Fuchs 1977;
Kelly 1983; McNamara 1986; Shaw 1977; Thomas 1987; Thompson
1987; Weinberg 1978; Zeiss 1979; Zemestani 2016), or a non-
specialist (Arjadi 2018; Bolton 2014; Bosanquet 2017; Chang 2018;
Chowdhary 2016; Collado 2016; Ekers 2011; Gilbody 2017; Luo 2020;
Raue 2019; Richards 2017; Weobong 2017; Xie 2019), rather than a
mental health specialist.
Trials published before the 1990s regularly used graduate or
doctoral students to deliver interventions within the trial setting,
even if the treatment would normally be delivered by accredited
mental health specialists who completed formal training. In recent
years, several behavioural activation interventions evaluated in
trials have been delivered by non-specialists such as primary care
workers or lay health workers, with a view to test an alternative
therapy feasible for delivery in settings with limited resources.
Duration and format
Most of the interventions were delivered face-to-face. Four studies
involved initial or occasional face-to-face contact, with most of the
intervention delivered via phone calls (Armento 2012; Bosanquet
2017; Chang 2018; Gilbody 2017). One intervention was delivered
through a series of conference calls (Vázquez 2014), three were
delivered online (Arjadi 2018; Carlbring 2013a; Carlbring 2013),
and two used a smartphone app in combination with contact
via phone or email (Ly 2014; Stiles-Shields 2019). The exclusion
of studies delivering interventions without a substantial face-to-
face component is explored in sensitivity analyses (Analysis 20.1;
Analysis 20.2; Analysis 21.1; Analysis 21.2).
Most interventions were delivered once or twice a week
(Chowdhary 2016; Dimidjian 2006; Fleming 1980; Hemanny 2019;
Moradveisi 2015; Richards 2017; Shaw 1977; Thompson 1987;
Toghyani 2018), and a few interventions were delivered in only
one session (Armento 2012; Gawrysiak 2009; Nasrin 2017). Most
interventions were delivered over a period of four to 12 weeks, with
the longest duration being 16 weeks (Richards 2017).
Therapy sessions were usually up to an hour in duration, with
others lasting between 90 minutes and two hours (Bowe 2014;
Comas Díaz 1981; Fleming 1980; Fuchs 1977; Gawrysiak 2009;
Kornblith 1980; McCluskey 2018; Nasrin 2017; Rehm 1982; Shaw
1977; Toghyani 2018; van den Hout 1995; Vázquez 2014; Xie 2019;
Zemestani 2016).
In most of the studies interventions were delivered to individuals,
while 10 were delivered in a group format (Fleming 1980; Kornblith
1980; Rehm 1982; Shaw 1977; Thomas 1987; Toghyani 2018; van den
Hout 1995; Vázquez 2014; Xie 2019; Zemestani 2016), and three used
a mixed individual/group format (Bowe 2014; Fuchs 1977; Takagaki
2016). We performed sensitivity analyses to explore outcomes for




Psychological therapies other than behavioural activation, which
were used as comparators, included the following.
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• CBT (Bolton 2014; Dimidjian 2006; Hemanny 2019; Jacobson
1996; McNamara 1986; Rehm 1982; Richards 2017; Stiles-Shields
2019; Taylor 1977; Thomas 1987; Thompson 1987; Vázquez 2014;
Weinberg 1978; Wilson 1983)
• Third-wave cognitive and behavioural therapies (Ly 2014;
McIndoo 2016; Zemestani 2016)
• Humanistic therapy (Armento 2012; Collado 2016; McNamara
1986)
• Psychodynamic therapy (Thompson 1987)
• Interpersonal, cognitive analytic, and other integrative
therapies (Kornblith 1980; Padfield 1976; Toghyani 2018;
Weinberg 1978)
We categorised cognitive processing therapy and cognitive therapy
as CBT. Emotional awareness training, general counselling, and
general psychotherapy were included as an integrative therapies.
Other non-therapy comparators included the following.
1. Waiting list (Bolton 2014; Carlbring 2013a; Carlbring 2013; Cullen
2003; McIndoo 2016; Nasrin 2017; Taylor 1977; Stiles-Shields
2019; Weinberg 1978; Zemestani 2016)
2. Placebo; medical placebo (Dimidjian 2006), and attention
placebo (Hammen 1975)
3. Medication (Dimidjian 2006; Moradveisi 2015)
4. No treatment (Gawrysiak 2009; Hammen 1975; McCluskey 2018;
Takagaki 2016)
5. Treatment as usual (Bosanquet 2017; Ekers 2011; Gilbody 2017;
Hemanny 2019; Kanter 2015; Luo 2020; Meeks 2008; Xie 2019)
If treatment as usual comprised medication or therapy it was
added to the relevant medication or therapy comparisons. Online
'minimal psychoeducation', referral to mental health services and
enhanced usual care (described as 'routine consultation and
referral to services) were categorised as treatment as usual. Self-
monitoring, described as 'no change from normal activities', was
categorised as no treatment.
Outcomes
Studies reported data on all of the seven outcomes specified for this
review. We report meta-analyses and forest plots for all outcomes at
short-term, medium-term, and long-term endpoints, and subgroup
analyses for primary outcomes treatment eicacy and treatment
acceptability (dropouts) at short-term time endpoints.
Most data are available for depression symptoms, as measured by
commonly used instruments for depression severity such as the
BDI or HRSD. Depression symptom outcomes were more commonly
reported than treatment eicacy. For treatment eicacy, we
encountered multiple measures across studies, and sometimes
multiple measures within one study. If a study reported multiple
measures of treatment eicacy, we prioritised as follows: remission
over clinically significant improvement, and recovery or remission
over response.
For six studies data were missing and standard deviations could not
be calculated (Bowe 2014; Comas Díaz 1981; Fleming 1980; Kelly
1983; Skinner 1984; Zeiss 1979). These studies are not included in
any meta-analyses. For some studies data were missing but could
be calculated (Fuchs 1977; Gardner 1981; McCluskey 2018; Shaw
1977; van den Hout 1995).
Data on adverse events are summarised narratively in Table 1.
Excluded studies
ALer obtaining full-text manuscripts, a total of 256 studies were
excluded (259 full-text records) (Figure 1). Of the studies excluded
at this stage, 120 studies were of participants with a physical
comorbidity. These studies were included at the title and abstract
screening stage as they informed a Cochrane review focussed on
this population (Upho 2019b). A further 78 studies were excluded
because the intervention was not behavioural activation, or
behavioural activation was a component but not the key ingredient
of the intervention. Another 33 studies were excluded because they
were not RCTs. We were unable to exclude these studies at the stage
of title and abstract screening because the abstracts did not clearly
specified the study design and/or intervention. These records are
not listed in this review.
Among the 25 studies (28 references) which are listed as Excluded
studies in this review, the most common reasons for exclusion were
wrong comparator (k = 10) and interventions with no interaction
with a therapist (k = 5). Further reasons for exclusion are listed in
the Characteristics of excluded studies table.
In addition to the excluded studies, authors were contacted to
check whether studies identified through protocols had been
published. FiLeen studies (20 references) are listed as ongoing
(Characteristics of ongoing studies) and eight are awaiting
classification (Studies awaiting classification).
Risk of bias in included studies
Out of 53 included studies, for 46 studies one or more risk of bias
domains were initially rated as 'unclear' because information was
missing from the study report and/or trial registration/ protocol. For
25 studies the author could not be contacted; 15 of these studies
were published before 1990. Authors of two old studies replied but
could no longer provide the requested information (Gardner 1981;
Hammen 1975).
Allocation
Eighteen studies were rated as low risk of selection bias (Figure
2; Figure 3). The others, particularly older studies, either did not
report suicient information on randomisation and/or allocation
concealment or were found to be at high risk of bias. In several
studies randomisation was performed correctly, but a researcher
involved in the study was aware of the allocation participant list
(McIndoo 2016; Meeks 2008; Zemestani 2016).
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Figure 2.   'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.
Random sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of participants and personnel (performance bias): All outcomes
Blinding of outcome assessment (detection bias): All outcomes
Incomplete outcome data (attrition bias): All outcomes
Selective reporting (reporting bias)
Other bias
0% 25% 50% 75% 100%
Low risk of bias Unclear risk of bias High risk of bias
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Arjadi 2018 + + - + - + +
Armento 2012 ? ? - ? + ? ?
Bolton 2014 + + - ? + + +
Bosanquet 2017 + + - - + + -
Bowe 2014 ? ? - - - ? -
Carlbring 2013 + + - - + ? -
Carlbring 2013a + ? - - - - -
Chang 2018 + + - + + - ?
Chowdhary 2016 + + ? ? + ? -
Collado 2016 + + - + - - +
Comas Díaz 1981 ? ? - ? ? ? +
Cullen 2003 ? ? ? ? - ? ?
Dimidjian 2006 + + - + - ? -
Ekers 2011 + + - + - + -
Fleming 1980 ? ? - ? ? ? -
Fuchs 1977 ? - - ? ? ? -
Gardner 1981 ? ? - - - ? ?
Gawrysiak 2009 ? ? - ? + ? -
Gilbody 2017 + + - - - + -
Hammen 1975 ? ? ? ? ? ? ?
Hemanny 2019 ? ? ? + - - -
Jacobson 1996 + + - + + ? ?
Kanter 2015 + + - + - ? -
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Figure 3.   (Continued)
Jacobson 1996 + + - + + ? ?
Kanter 2015 + + - + - ? -
Kelly 1983 ? ? - - ? ? ?
Kornblith 1980 - - - + - ? -
Luo 2020 ? ? - ? + ? -
Ly 2014 + + - + + - -
McCluskey 2018 + ? - ? ? ? +
McIndoo 2016 + - - ? + - -
McNamara 1986 ? ? - - - ? -
Meeks 2008 + - - + - - -
Moradveisi 2015 + + - - - ? ?
Nasrin 2017 + ? - ? ? ? ?
Padfield 1976 ? ? - + ? ? ?
Raue 2019 ? - - - - + -
Rehm 1982 ? ? - + - ? +
Richards 2017 + + - + - + -
Shaw 1977 ? ? - + ? ? ?
Skinner 1984 ? ? - - - ? -
Stiles-Shields 2019 + + - - - ? -
Takagaki 2016 + + - + + ? +
Taylor 1977 - - - - ? ? ?
Thomas 1987 ? ? - - - ? ?
Thompson 1987 ? ? - ? - ? -
Toghyani 2018 ? ? - ? - ? -
van den Hout 1995 ? ? - - ? ? ?
Vázquez 2014 + ? - + + ? ?
Weinberg 1978 - - - - ? ? ?
Weobong 2017 + + - + ? + ?
Wilson 1983 ? ? - + - ? +
Xie 2019 + ? - - ? + ?
Zeiss 1979 ? ? - ? - ? -
Zemestani 2016 + - - - + ? ?
 
Blinding
Blinding of participants and personnel (performance bias) was
not achieved in any of the included studies (Figure 2) and
is rarely attempted for psychological therapy interventions. In
18 studies, authors limited the risk of detection bias through
blinding of outcome assessors. Where outcome assessors were
not blinded this was usually because participants self-completed
questionnaires on symptoms of depression.
Incomplete outcome data
There was evidence of incomplete outcome data in 25 studies,
and an assessment of 'unclear' risk of attrition bias in a further 14
studies. Issues included no or unclear reporting of participants who
dropped out of the trial, unclear reasons for dropout, the exclusion
of participants who dropped out from the analyses, or a substantial
dierence in dropout rates between the dierent study arms.
Selective reporting
For the majority of studies, no reference was made to a study
protocol or online trial registration. Nine studies were rated as
low risk of reporting bias, because a protocol or trial registration
was available and no dierences with the results were found.
For seven studies, there were discrepancies in outcomes reported
between the methods section, trial registration, or protocol, and
the published study results (Carlbring 2013a; Chang 2018; Collado
2016; Hemanny 2019; Ly 2014; McIndoo 2016; Meeks 2008). For
example, reporting of extra outcomes, no reporting of outcomes
listed in the protocol, a change in the measures used, or dierences
in time points reported.
Other potential sources of bias
Other issues that were rated as a high risk of bias were identified
for 26 studies. This included issues relevant to the conduct of
trials in psychotherapy, such as low treatment fidelity of therapists,
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researcher or therapist allegiance to one of the interventions,
or a conflict of interest from researchers or therapists. For
example, several trials were conducted by authors who were
involved in the development of the intervention. Another common
potential source of bias was any indication of inadequate
randomisation, for example with extremely small sample sizes (less
than 10 participants per study arm) and substantial dierences in
participant characteristics between study arms.
E:ects of interventions
See: Summary of findings 1 Behavioural activation compared with
CBT for depression in adults; Summary of findings 2 Behavioural
activation compared with third-wave CBT for depression in
adults; Summary of findings 3 Behavioural activation compared
with humanistic therapy for depression in adults; Summary of
findings 4 Behavioural activation compared with psychodynamic
for depression in adults; Summary of findings 5 Behavioural
activation compared with interpersonal, cognitive analytic,
integrative for depression in adults; Summary of findings 6
Behavioural activation compared with waiting list for depression in
adults; Summary of findings 7 Behavioural activation compared
with placebo for depression in adults; Summary of findings 8
Behavioural activation compared with medication for depression
in adults; Summary of findings 9 Behavioural activation compared
with no treatment for depression in adults; Summary of findings
10 Behavioural activation compared with treatment as usual for
depression in adults
Behavioural activation versus psychological therapies
Included studies compared behavioural activation with CBT,
third-wave CBT, humanistic therapy, psychodynamic therapy, and
interpersonal, cognitive analytic, and integrative therapy.
Comparison 1. Behavioural activation versus cognitive-
behavioural therapy (CBT)
Short-term outcomes
Moderate- to very low-certainty evidence from randomised
controlled trials (RCTs) showed no statistically significant
dierences in short-term (up to six months) outcomes
between behavioural activation and CBT in terms of treatment
eicacy (risk ratio (RR) 0.99, 95% CI 0.92 to 1.07; 5 RCTs,
601 participants; moderate-certainty evidence) (Analysis 1.1),
treatment acceptability (RR 1.03, 95% CI 0.85 to 1.25; 12 trials, 1195
participants) (Analysis 1.2; low certainty), depression symptoms
(standardised mean dierence (SMD) 0.12, 95% CI -0.08 to 0.32;
high heterogeneity I2 52%; 16 RCTS, 1205 participants) (Analysis
1.3), quality of life (SMD 0.04, 95% CI -0.20 to 0.28; 2 RCTs, 268
participants; moderate-certainty evidence) (Analysis 1.4), social
adjustment and functioning (SMD -0.13, 95% CI -0.50 to 0.24; 2 RCTs,
111 participants; very low-certainty evidence) (Analysis 1.5), and
anxiety symptoms (SMD -0.03, 95% CI -0.18 to 0.13; 4 RCTs, 646
participants; moderate-certainty evidence) (Analysis 1.6).
One small study (Vázquez 2014) has a high weight in the analyses
comparing the treatment eicacy of behavioural activation and
CBT because none of the participants had depression at follow-up.
Removing this study made the pooled estimate less precise but did
not substantially change the estimate (RR 0.94, 95% CI 0.81 to 1.10).
Medium- and long-term outcomes
One study (Richards 2017) compared outcomes between a
behavioural activation and a CBT group in the medium term (seven
to 12 months) and long term (>12 months), and found no evidence
of a dierence in treatment eicacy (medium term: RR 1.00, 95%
CI 0.86 to 1.16; 364 participants, long term: (RR 0.93, 95% CI 0.81 to
1.08;356 participants)), treatment acceptability (medium term: RR
1.25, 95% CI 0.97 to 1.62; 440 participants, long term: RR 1.16, 95%
CI 0.90 to 1.49; 440 participants), depression symptoms (medium
term: SMD -0.18, 95% CI -0.38 to 0.02; 380 participants, long term:
(SMD 0.00, 95% CI -0.21 to 0.21; 364 participants), quality of life
(medium term: SMD 0.15, 95% CI -0.07 to 0.37, long term: SMD 0.06,
95% CI -0.15 to 0.28), and anxiety symptoms (medium term: SMD
0.02, 95% CI -0.20 to 0.23; 337 participants, long term: SMD -0.10,
95% CI -0.31 to 0.12; 332 participants).
Adverse events
Adverse events was included as an outcome in two trials; one
reported no adverse events (Stiles-Shields 2019), and the other
reported three serious adverse events in the behavioural activation
arm (two overdose, one self-harm) and eight serious adverse events
in the CBT arm (seven overdose, one self-harm) (Richards 2017)
(Table 1).
Funnel plots revealed no indications of publication bias for
treatment acceptability and depression symptoms.
Comparison 2. Behavioural activation versus third-wave CBT
Short-term outcomes
Three RCTs contributed low-certainty evidence comparing
behavioural activation with third-wave CBT.
Low-certainty evidence showed no statistically significant
dierences for short-term (up to six months) outcomes between
behavioural activation and third-wave CBT in terms of treatment
eicacy (RR 1.10, 95% CI 0.91 to 1.33; 2 RCTs, 98 participants)
(Analysis 2.1), treatment acceptability (RR 0.84, 95% CI 0.33 to 2.10;
3 RCTs, 147 participants) (Analysis 2.2), depression symptoms (SMD
-0.14, 95% CI -0.47 to 0.18; 3 RCTs, 147 participants) (Analysis 2.3),
quality of life (MD 0.02, 95% CI -0.96 to 1.00; 1 RCT, 81 participants)
(Analysis 2.4), and anxiety symptoms (MD 0.69, 95% CI -0.68 to 2.06;
3 RCTs, 147 participants) (Analysis 2.5).
Data on social adjustment and functioning and adverse events were
not reported.
Comparison 3. Behavioural activation versus humanistic
therapy
Short-term outcomes
Three RCTs contributed moderate- to very low-certainty evidence
on the comparison of short-term (up to six months) outcomes
between behavioural activation and humanistic therapy.
Low-certainty evidence showed greater treatment eicacy for
behavioural activation compared with humanistic therapy (RR 1.84,
95% CI 1.15 to 2.95; 2 RCTs, 46 participants) (Analysis 3.1). Three
people would need to receive treatment for one person with
depression to benefit.
Low- to very low-certainty evidence showed no statistically
significant dierence in treatment acceptability (RR 1.06, 95% CI
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0.20 to 5.55; 2 RCTs, 96 participants, very low certainty) (Analysis
3.2), quality of life (MD 0.80, 95% CI -0.12 to 1.72; 1 RCT, 50
participants; low certainty) (Analysis 3.4), or anxiety symptoms (MD
-1.30, 95% CI -6.10 to 3.50; 1 RCT, 50 participants; low certainty)
(Analysis 3.5).
Moderate-certainty evidence indicated that depression symptoms
improved more in those assigned to behavioural activation
compared with those assigned to humantistic therapy (MD -3.75,
95% CI -6.72 to -0.78; 3 RCTs, 93 participants) (Analysis 3.3).
Data on social adjustment and functioning and adverse events were
not reported.
Comparison 4. Behavioural activation versus psychodynamic
therapy
Short-term outcomes
Very low-certainty evidence from one RCT (60 participants) showed
no dierence between behavioural activation and psychodynamic
therapy for short-term outcomes treatment eicacy (RR 1.21, 95%
CI 0.74 to 1.99) (Analysis 4.1), depression symptoms (MD -1.10,
95% CI -4.35 to 2.15) (Analysis 4.2), and social adjustment and
functioning (MD 2.10, 95% CI -4.92 to 9.12) (Analysis 4.3).
Data on treatment acceptability, quality of life, anxiety symptoms,
and adverse events were not reported.
Comparison 5. Behavioural activation versus interpersonal,
cognitive analytic, and integrative therapy
Short-term outcomes
Very low-certainty evidence showed no dierence between
behavioural activation and interpersonal, cognitive analytic,
and integrative therapies for short-term outcomes treatment
acceptability (RR 0.84, 95% CI 0.32 to 2.20; 4 RCTs, 123 participants)
(Analysis 5.1), depression symptoms (SMD -0.16, 95% CI -0.59 to
0.28; 4 RCTs, 103 participants) (Analysis 5.2), social adjustment and
functioning (MD -3.92, 95% CI -16.78 to 8.93; 1 RCT, 39 participants)
(Analysis 5.3), and anxiety symptoms (MD -0.39, 95% CI -11.78 to
11.00; 1 RCT, 15 participants) (Analysis 5.4).
Data on treatment eicacy and quality of life were not reported.
Adverse events
Padfield 1976 reported there were no adverse events in the
behavioural activation study arm and two suicide attempts and
one case of suicidal thoughts in the comparator arm (low-certainty
evidence) (Table 1).
Behavioural activation versus other comparators
Included studies compared behavioural activation with being on a
waiting list, receiving a placebo, medication (anti-depressants), no
treatment, or treatment as usual.
Comparison 6. Behavioural activation versus waiting list
Short-term outcomes
Moderate- to low-certainty evidence suggested there is no
dierence in treatment eicacy (RR 2.14, 95% CI 0.90 to 5.09; 1
RCT, 26 participants; low certainty) (Analysis 6.1) and treatment
acceptability (RR 1.17, 95% CI 0.70 to 1.93; 8 RCTs, 359 participants;
moderate certainty) (Analysis 6.2) in the short term (up to six
months) between behavioural activation and waiting list.
Low-certainty evidence showed that those who received
behavioural activation had a greater short-term reduction in
depression symptoms than those on a waiting list (SMD -1.04, 95%
CI -1.44 to -0.63; 12 RCTs, 619 participants) (Analysis 6.3). The funnel
plot indicates that smaller studies with results favouring waiting list
may be missing from these data (Figure 4).
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Figure 4.   Funnel plot of comparison: 6 behavioural activation vversus waiting list, outcome: 6.3 depression
symptoms.










Short-term (up to 6 months)
 
Low-certainty evidence indicated benefits of behavioural activation
compared with waiting list for anxiety symptoms (SMD -0.91, 95%
CI -1.59 to -0.23; 5 RCTs, 424 participants) (Analysis 6.5), but not for
quality of life (MD 0.03, 95% CI -0.70 to 0.76; 1 RCT, 80 participants)
(Analysis 6.4).
No data were reported on social adjustment and functioning.
Estimates for depression symptoms and anxiety symptoms
suggested a large eect and high level of heterogeneity (I2 75%
and 87%, respectively). To test how robust these findings are, we
conducted sensitivity analyses with fixed-eect instead of random-
eects models. The pooled estimates were reduced to SMD -0.72
(95% CI -0.89 to -0.55) for depression symptoms (Analysis 24.1) and
SMD -0.54 (95% CI -0.74 to -0.33) for anxiety symptoms (Analysis
24.2).
Adverse events
The authors of a trial comparing behavioural activation to CBT
and waiting list reported that no adverse events took place (Stiles-
Shields 2019)(Table 1).
Comparison 7. Behavioural activation versus placebo
Short-term outcomes
Two RCTs contributed low-certainty evidence comparing
behavioural activation to a placebo. One study used a medical
placebo (Dimidjian 2006) and one used an attention placebo
(Hammen 1975).
No dierence between behavioural activation and placebo was
found for treatment acceptability (RR 0.72, 95% CI 0.31 to 1.67; 1
RCT; 96 participants) (Analysis 7.1) and depression symptoms (SMD
-0.18, 95% CI -0.57 to 0.20; 2 RCTs, 108 participants) (Analysis 7.2).
No data were reported for treatment eicacy, quality of life, anxiety
symptoms, and social adjustment and functioning.
Adverse events
One RCT reported various physical side eects from the medication
placebo, and no adverse events for the behavioural activation
group (Dimidjian 2006) (Table 1).
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Comparison 8. Behavioural activation versus medication
Short-term outcomes
One RCT (141 participants) on treatment eicacy, with treatment
eicacy being higher for behavioural activation than medication
(RR 1.77, 95% CI 1.14 to 2.76; 1 RCT, 141 participants) (Analysis 8.1).
We judged this evidence to be of moderate certainty following the
GRADE approach. However, because this evidence is based on data
from one trial only, we were not able to assess inconsistency in
results between trials.
Moderate-certainty evidence showed no dierence between
behavioural activation and medication in short-term treatment
acceptability (RR 0.52, 95% CI 0.23 to 1.16; 2 RCTs, 243 participants)
(Analysis 8.2). Low-certainty evidence showed no dierence in
short-term symptoms of depression (MD -1.42, 95% CI -4.80 to
1.96; 2 RCTs, 180 participants; I2 83% indicating high heterogeneity)
(Analysis 8.3).
No data were reported on quality of life, anxiety symptoms, and
social adjustment and functioning.
Medium- and long-term outcomes
One RCT (reported medium-term (seven to 12 months) outcomes
comparing behavioural activation to medication. There was no
dierence in treatment acceptability between the groups (RR 0.86,
95% CI 0.31 to 2.37; 100 participants) (Analysis 8.2). Symptoms of
depression decreased more in the behavioural activation than the
medication group (MD -2.34, 95% CI -3.84 to -0.84; 100 participants)
(Analysis 8.3).
Adverse events
In one RCT comparing CBT, medication, and medical placebo
to behavioural activation, a range of physical side eects were
reported for the medication and placebo study arms (Dimidjian
2006). There was one case of suicide in the medication arm. No
adverse events of behavioural activation were reported (Table 1).
This information is also included in the behavioural activation and
placebo comparison in Summary of findings 7.
Comparison 9. Behavioural activation versus no treatment
Short-term outcomes
Three RCTs contributed data on short-term (up to six months)
outcomes to the comparison of behavioural activation versus no
treatment.
Moderate-certainty evidence indicated there was no dierence
between behavioural activation and no treatment in treatment
acceptability (RR 0.97, 95% CI 0.45 to 2.09; 3 RCTs, 187 participants)
(Analysis 9.1).
Moderate-certainty evidence showed a benefit of behavioural
activation in improvement in depression symptoms (MD -6.10,
95% CI -7.87 to -4.33; 3 RCTs, 187 participants) (Analysis 9.2), and
high-certainty evidence showed greater improvements in quality
of life for behavioural activation compared with no treatment (MD
0.07, 95% CI 0.03 to 0.11; 1 RCT, 118 participants) (Analysis 9.3).
Low-certainty evidence indicated a greater reduction in anxiety
symptoms for behavioural activation compared with no treatment
(MD -5.50, 95% CI -10.01 to -0.99; 1 RCT, 30 participants) (Analysis
9.4).
No data were reported on treatment eicacy, social adjustment and
functioning, and adverse events.
Medium- and long-term outcomes
One RCT reported on medium-term outcomes comparing
behavioural activation to no treatment. Results showed no
dierence in treatment acceptability (RR 1.57, 95% CI 0.65 to
3.79; 124 participants)(Analysis 9.1). There was a greater reduction
in depression symptoms for the behavioural activation group
compared with the no treatment group (MD -2.83, 95% CI -5.32 to
-0.34; 118 participants) (Analysis 9.2).
Comparison 10. Behavioural activation versus treatment as
usual
Short-term outcomes
FiLeen RCTs contributed very low- to moderate-certainty evidence
on short term (up to six months) outcomes for behavioural
activation versus treatment as usual.
Moderate-certainty evidence indicated greater treatment eicacy
for behavioural activation compared with treatment as usual (RR
1.40, 95% CI 1.10 to 1.78; 7 RCTs, 1533 participants) (Analysis 10.1),
although this dierence was not found in sensitivity analyses using
a worst-case or intention-to-treat scenario (Analysis 26.1; Analysis
28.1). Moderate-certainty evidence suggested greater treatment
acceptability, as indicated by dropouts, for treatment as usual,
although results lacked precision (RR 1.64, 95% CI 0.81 to 3.31; 14
RCTs, 2518 participants) (Analysis 10.2).
Low-certainty evidence suggested a benefit of behavioural
activation in terms of depression symptoms (SMD -0.78, 95% CI
-1.05 to -0.51; 15 RCTs, 2208 participants) (Analysis 10.3), and
social adjustment and functioning (SMD -1.27, 95% CI -1.74 to
-0.81; 2 RCTs, 88 participants) (Analysis 10.5). Very low-certainty
evidence suggested a greater improvement in quality of life for
behavioural activation compared with treatment as usual (SMD
0.97, 95% CI 0.38 to 1.57; 6 RCTs, 1299 participants) (Analysis
10.4). Moderate-certainty evidence showed a greater improvement
in anxiety symptoms for behavioural activation compared with
treatment as usual (SMD -0.33, 95% CI -0.45 to -0.21; 4 RCTs, 1063
participants) (Analysis 10.6).
In the study by Luo and colleagues (Luo 2020), large eects were
reported favouring behavioural activation over treatment as usual
for depressions symptoms and quality of life. Removing this study
from the analyses changed the pooled estimate of depression
symptoms (SMD -0.57, 95% CI -0.75 to -0.39) and quality of life (SMD
0.34, 95% CI 0.03 to 0.66).
Estimates for depression symptoms and quality of life suggested a
large eect. To test how robust these findings are, we conducted
sensitivity analyses with fixed-eect instead of random-eects
models. The pooled estimates changed to SMD -0.48 (95% CI -0.57
to -0.39) for depression symptoms (Analysis 25.1) and SMD 0.25
(95% CI 0.14 to 0.37) for quality of life (Analysis 25.2).
Funnel plots reveal no indication of publication bias for treatment
eicacy, treatment acceptability, and depression symptoms. The
I2 test statistic suggests high levels of statistical heterogeneity
for short-term outcomes treatment eicacy (84%), acceptability
(85%), depression symptoms (85%), and quality of life (95%), and
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medium-term outcomes treatment acceptability (94%) and quality
of life (72%).
Medium- and long-term outcomes
Five RCTs reported medium term (seven to 12 months) and/or long
term (> 12 months) estimates comparing behavioural activation to
treatment as usual.
There was evidence of a dierence in medium term treatment
eicacy (RR 1.23, 95% CI 1.07 to 1.42; 2 RCTs, 1012 participants)
(Analysis 10.1), but not for treatment acceptability (RR 2.84, 95% CI
0.92 to 8.75; 4 RCTs, 1726 participants) (Analysis 10.2). Long-term
treatment acceptability favoured treatment as usual (RR 2.17, 95%
CI 1.39 to 3.39; 1 RCT, 485 participants).
Medium-term depression symptoms showed greater improvement
for behavioural activation than treatment as usual (SMD -0.23, 95%
CI -0.38 to -0.08; 4 RCTs, 1381 participants), while no dierence was
found for long term depression symptoms (SMD 0.02, 95% CI -0.19
to 0.23; 1 RCT, 343 participants).
There was no dierence in quality of life in the medium term (SMD
0.14, 95% CI -0.12 to 0.40; 2 RCTs, 879 participants) and long term
(SMD -0.09, 95% CI -0.30 to 0.13; 1 RCT, 325 participants).
A greater reduction in anxiety symptoms was found for behavioural
activation compared with treatment as usual in the medium term
(SMD -0.27, 95% CI -0.41 to -0.12; 2 RCTs, 851 participants), but
not in the long term (SMD -0.08, 95% CI -0.29 to 0.14; 1 RCT; 332
participants).
Adverse events
Three studies with a 'treatment as usual' comparator reported on
adverse events (Table 1). Two studies of participants aged 65 and
older reported a large number of suspected or potential adverse
events. In Bosanquet 2017 there were 47 suspected adverse events
in the behavioural activation group, and 34 in the treatment
as usual group. In Gilbody 2017 there were 37 adverse events
in the behavioural activation group and 44 in the treatment as
usual group, but none of these were thought to be related to the
interventions. In a study of people with severe depression, there
was one suicide attempt and 18 unplanned hospitalisations in the
behavioural activation arm and one suicide attempt, 26 unplanned
hospitalisations, and two deaths in the comparator arm (Weobong
2017).
Subgroup analyses
Inclusion of studies in subgroup analyses was dependent on the
information provided within those studies. For some studies, we
could not obtain the data needed to correctly categorise the study.
Subgroup analyses were performed for the primary outcomes (up
to six months) for the following comparisons with data available
from more than one study.
• Behavioural activation versus other control groups (other than
psychological therapies) by age (under 65 and 65 and over)
(Analysis 11.1 Analysis 11.2)
• Behavioural activation versus other psychological therapies by
type of therapist delivering behavioural activation (specialist,
specialist in training, non-specialist) (Analysis 12.1; Analysis
12.2)
• Behavioural activation versus other control groups by type
of therapist (specialist, specialist in training, non-specialist)
(Analysis 13.1; Analysis 13.2)
• Behavioural activation versus other control groups by severity
of depression symptoms (subthreshold/ moderate to severe
depression) (Analysis 14.1; Analysis 14.2)
• Behavioural activation versus other control groups by length of
therapy (one to three and more than three sessions) (Analysis
15.1)
• Behavioural activation versus other psychological therapies
by type of comparator therapy (CBT, third-wave CBT,
psychodynamic/humanist/integrative) (Analysis 16.1; Analysis
16.2)
• Behavioural activation versus other control groups by type
of other control group (treatment as usual, waiting list, no
treatment, placebo, other comparator) (Analysis 17.1; Analysis
17.2)
Comparison 11. Age
There was no dierence between age groups in treatment eicacy
(under 65: RR 2.03, 95% CI 1.49 to 2.75, 65 and over: RR 3.32,
95% CI 0.20 to 54.59) and treatment acceptability (under 65: RR
0.83, 95% CI 0.49 to 1.40, 65 and over: RR 1.30, 95% CI 0.26
to 6.38 for behavioural activation versus comparators other than
psychological therapies.
Comparisons 12 and 13. Type of therapist
There was no dierence between types of therapists in treatment
eicacy (specialist: RR 1.11, 95% CI 0.93 to 1.32, specialist in
training: RR 1.13, 95% CI 0.85 to 1.49, non-specialist: RR 1.30, 95% CI
0.86 to 1.98) and treatment acceptability for behavioural activation
versus other psychological therapies (specialist: RR 0.88, 95% CI
0.62 to 1.25, specialist in training: RR 0.83, 95% CI 0.31 to 2.25, non-
specialist: RR 1.05, 95% CI 0.84 to 1.31).
There was no dierence between types of therapists in treatment
eicacy (specialist: RR 1.71, 95% CI 1.08 to 2.70, specialist in training
no data, non-specialist: RR 1.49, 95% CI 1.13 to 1.97) for behavioural
activation versus comparators other than psychological therapies.
Behavioural activation was less acceptable (higher percentage of
dropouts) than other comparators for interventions delivered by
non-specialists (RR 2.20, 95% CI 1.06 to 4.57), and more acceptable
than other comparators for interventions delivered by specialists
(RR 0.65, 95% CI 0.47 to 0.89). There was no dierence with
behavioural activation delivered by specialists in training (RR 1.35,
95% CI 0.42 to 4.35).
Comparison 14. Severity of depressions symptoms
Behavioural activation showed greater treatment eicacy than
comparators other than psychological therapies for participants
with moderate to severe depression (RR 1.62, 95% CI 1.41 to 1.85),
than for those with subthreshold depression (RR 1.09, 95% CI 1.01
to 1.17).
There was no dierence in the treatment acceptability
of behavioural activation and other comparators between
participants with subthreshold depression (RR 4.30, 95% CI 0.46 to
40.44) and those with moderate to severe depression (RR 1.04, 95%
CI 0.55 to 1.97).
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Comparison 15. Length of therapy
No data were available to compare the treatment eicacy
of behavioural activation versus comparators other than
psychological therapies between short and longer length therapy.
There was no dierence for treatment acceptability of behavioural
activation versus comparators other than psychological therapies
between a short (RR 1.03, 95% CI 0.53 to 2.03) and a longer length
of therapy (RR 1.35, 95% CI 0.76 to 2.37).
Comparison 16. Type of comparator therapy
Behavioural activation showed a greater treatment eicacy when
compared with psychodynamic, humanist, or integrative therapies
(RR 1.50, 95% CI 1.24 to 1.81) than when compared with CBT
(RR 0.99, 95% CI 0.91 to 1.07), but there was no dierence for
behavioural activation versus third-wave CBT (RR 1.08, 95% CI 0.91
to 1.29).
There was no dierence in treatment acceptability when comparing
behavioural activation to CBT (RR 1.04, 95% CI 0.85 to 1.28),
third-wave CBT (RR 0.86, 95% CI 0.54 to 1.36), or psychodynamic,
humanist, or integrative therapies (RR 0.77, 95% CI 0.44 to 1.33).
Comparison 17. Other control groups
There was no dierence in treatment eicacy when comparing
behavioural activation to treatment as usual (RR 1.17, 95% CI 0.95
to 1.45), waiting list (RR 1.17, 95% CI 0.70 to 1.93), no treatment (RR
2.97, 95% CI 1.42 to 6.24), medication (RR 1.77, 95% CI 1.14 to 2.76),
or another comparator (RR 1.59, 95% CI 1.38 to 1.83).
There was no dierence in treatment acceptability when comparing
behavioural activation to treatment as usual (RR 1.50, 95% CI 0.56
to 3.99), waiting list (RR 1.17, 95% CI 0.70 to 1.93), no treatment (RR
0.97, 95% CI 0.45 to 2.09), placebo (RR 0.72, 95% CI 0.31 to 1.67),
medication (RR 0.37, 95% CI 0.18 to 0.75), or another comparator
(RR 2.17, 95% CI 1.04 to 4.53).
Sensitivity analyses
Comparisons 18 and 19. Study quality
Sensitivity analyses were carried out removing studies which
scored 'unclear' or 'high' risk of bias for allocation concealment for
the primary outcomes (Analysis 18.1; Analysis 18.2; Analysis 19.1;
Analysis 19.2).
Behavioural activation was no more or less eective than other
psychological therapies (RR 1.20, 95% CI 0.95 to 1.51) and there was
no dierence in treatment acceptability (RR 1.04, 95% CI 0.84 to
1.29).
Behavioural activation was more eective than comparators other
than psychological therapies (RR 1.49, 95% CI 1.16 to 1.90) and
had lower treatment acceptability than other comparators (RR 2.22,
95% CI 1.00 to 4.95).
Comparisons 20 and 21. Mode of delivery
We analysed studies which were predominantly delivered face-to-
face, removing 10 studies which evaluated interventions mostly
delivered online, over the phone, or email (Analysis 20.1; Analysis
20.2; Analysis 21.1; Analysis 21.2).
There was no dierence in treatment eicacy (RR 1.09, 95% CI 0.92
to 1.29) or acceptability (RR 1.00, 95% CI 0.83 to 1.20) between
behavioural activation and other psychological therapies.
Behavioural activation was more eective than other comparators
(RR 1.76, 95% CI 1.50 to 2.05) and there was no dierence in
treatment acceptability (RR 0.85, 95% CI 0.67 to 1.08).
Severity of depression
We did not perform sensitivity analyses excluding studies with
participants with subthreshold depression, because these analyses
would have included the same study as those in the subgroup
analyses for participants diagnosed with major depressive disorder
or moderate to severe symptoms of depression (Analysis 14.1;
Analysis 14.2).
Comparisons 22 and 23. Individual therapy
We performed sensitivity analyses for the primary outcomes
excluding nine studies delivered in a group format and three
studies delivered in a mixed individual/ group format (Analysis 22.1;
Analysis 22.2; Analysis 23.1; Analysis 23.2).
There was no dierence in treatment eicacy (RR 1.17, 95% CI 1.00
to 1.37) or acceptability (RR 1.05, 95% CI 0.91 to 1.22) between
behavioural activation and other psychological therapies.
Behavioural activation was more eective than other comparators
(RR 1.61, 95% CI 1.26 to 2.05) and there was no dierence in
treatment acceptability (RR 1.55, 95% CI 0.85 to 2.79).
Missing data
The impact of missing data on treatment eicacy was explored
in three scenarios: intention-to-treat analysis, best-case scenario,
and worst-case scenario. Not all studies contributed data to these
analyses, as dropout rates were not consistently reported across
trials.
Comparison 24. Intention-to-treat
In this scenario, we assumed that treatment was not eective for
participants who dropped out aLer randomisation (Analysis 26.1).
There was no dierence in treatment eicacy between behavioural
activation and CBT (RR 0.93, 95% CI 0.83 to 1.05), behavioural
activation and third-wave CBT (RR 1.17, 95% CI 0.91 to 1.52), and
behavioural activation and treatment as usual (RR 1.29, 95% CI 0.99
to 1.68).
Behavioural activation was more eective than humanistic therapy
(RR 2.33, 95% CI 1.09 to 5.00).
Comparison 25. Best-case scenario
In this scenario we assumed that treatment was eective for
participants who dropped out of the behavioural activation study
arm and that treatment was not eective for participants who
dropped out of the comparator study arm (Analysis 27.1).
There was no dierence in treatment eicacy between behavioural
activation and CBT (RR 1.17, 95% CI 0.90 to 1.52). Behavioural
activation was more eective than third-wave CBT (RR 1.41, 95% CI
1.12 to 1.76), humanistic therapy (RR 3.67, 95% CI 1.83 to 7.34), and
treatment as usual (RR 1.63, 95% CI 1.29 to 2.04).
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Comparison 26. Worst-case scenario
In this scenario we assumed that treatment was not eective for
participants who dropped out of the behavioural activation study
arm and that treatment was eective for participants who dropped
out of the comparator study arm (Analysis 28.1).
There was no dierence in treatment eicacy between behavioural
activation and CBT (RR 0.82, 95% CI 0.58 to 1.17), third-wave CBT
(RR 0.89, 95% CI 0.73 to 1.09), humanistic therapy (RR 0.78, 95% CI
0.53 to 1.15), and treatment as usual (RR 1.14, 95% CI 0.89 to 1.46).
D I S C U S S I O N
Summary of main results
Results for each of the 10 comparisons are summarised in the
'Summary of findings' tables.
This review comprised 53 studies, including 26 studies published
aLer previous reviews on this topic were conducted (Churchill 2013;
Ekers 2014; Hunot 2013).
The objectives of this reveiw were to examine the eects of
behavioural activation for depression in adults compared with
1) all other psychological therapies, 2) medication, and 3)
other comparators (treatment as usual, waiting list, placebo, no
treatment).
Behavioural activation versus psychological therapies
Trials included in this review compared behavioural activation with
cognitive-behavioural therapy (CBT), third-wave CBT, humanistic
therapy, psychodynamic therapy, and interpersonal/ cognitive
analytic/ integrative therapy for the treatment of depression. Most
trials reported data on short-term outcomes only.
Primary outcomes
Moderate- to very low-certainty evidence showed no dierence
in treatment eicacy and acceptability (dropouts) between
behavioural activation and other psychological therapies, except
that behavioural activation may be more eective than humanistic
therapy (low-certainty evidence).
Subgroup and sensitivity analyses
Subgroup analyses showed no dierence in eicacy and
acceptability when comparing behavioural activation to
other psychological therapies by participant and treatment
characteristics. Eicacy of behavioural activation was greater
compared with psychodynamic, humanistic, and integrative
therapies than it was for CBT. No dierence by type of comparator
therapy was found for treatment acceptability.
When considering high-quality studies only, behavioural activation
was no more or less eective or acceptable than other
psychological therapies.
When considering only face-to-face and only individual therapies,
there was no dierence between behavioural activation and
other therapies in terms of treatment eicacy and treatment
acceptability.
When using an intention-to-treat approach to missing data,
treatment eicacy remained higher for behavioural activation
than for humanistic therapy. This was no longer the case when
a worst-case scenario was used. In a, more realistic, intention-
to-treat analysis, behavioural activation showed no dierence in
eectiveness compared with CBT and third-wave CBT.
We performed an unplanned sensitivity analysis removing one
small study with a large weighting from comparison 1.1. This
reduced the precision of the estimate, but did not change the
finding that CBT is no more eective than behavioural activation in
the treatment of depression.
Secondary outcomes
There was no evidence of a dierence in our secondary outcomes
between behavioural activation and other psychological therapies
(moderate- to very low-certainty evidence), except for depression
symptoms being reduced to a greater extent with behavioural
activation compared with humanistic therapy (moderate-certainty
evidence).
Adverse events were reported in various studies for participants
receiving behavioural activation, CBT, general counselling,
medication placebo, medication, and treatment as usual. These
events included serious adverse events such as hospitalisation,
suicide attempt, and suicide. Authors of various trials reported that
adverse events were not thought to be related to the treatment
received.
Behavioural activation versus medication
Two trials compared behavioural activation with medication for
depression.
Primary outcomes
Moderate-certainty evidence from one study suggests that
behavioural activation is probably more eicacious than
medication. There was moderate-certainty evidence that
behavioural activation and medication probably do not dier in
terms of treatment acceptability.
Secondary outcomes
Low-certainty evidence suggests reduction in depression
symptoms did not dier between behavioural activation and
medication in the short term, but favoured behavioural activation
in the medium term.
Behavioural activation versus other comparators
Included trials compared behavioural activation with waiting list,
placebo, no treatment, or treatment as usual.
Primary outcomes
Moderate-certainty evidence showed better treatment eicacy for
behavioural activation compared with treatment as usual in the
short term and medium term. Low-certainty evidence on the
treatment eicacy of behavioural activation compared with waiting
list favours behavioural activation but lacks precision.
Moderate- to low-certainty evidence showed no dierence in
treatment acceptability between behavioural activation and
comparison groups in the short term (waiting list, placebo, no
treatment, treatment as usual). Treatment acceptability was higher
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for treatment as usual than for behavioural activation, although the
short- and medium term estimates lacked precision.
Planned subgroup and sensitivity analyses
Subgroup analyses for participant age, length of therapy, and type
of comparator showed no dierences in treatment eicacy and
acceptability (dropouts).
Treatment eicacy was greater for behavioural activation versus
other comparators for participants with moderate to severe
depression compared with those with mild or subthreshold
depression. No dierence by severity of depression was found for
treatment acceptability.
Treatment acceptability was higher for behavioural activation than
for other comparators for interventions delivered by a specialist,
but lower for interventions delivered by a non-specialist. This
finding was driven by three trials of non-specialist interventions, for
which the comparator group consisted of treatment as usual by a
general practitioner or minimal psychoeducation.
Sensitivity analyses of high-quality studies, face-to-face therapy,
and individual therapy showed benefits of behavioural activation
versus other comparators for treatment eicacy, but not for
treatment acceptability. When considering high-quality studies
only, behavioural activation had a lower treatment acceptability
than comparators.
When re-analysing data using three dierent approaches for
missing data, behavioural activation was more eective than
treatment as usual only when a best-case-scenario was used.
Secondary outcomes
Moderate- to low-certainty evidence suggested that depression
symptoms were reduced more for behavioural activation when
compared with waiting list, treatment as usual (short and medium
term but not long term), and no treatment (short and medium
term), but not when compared with a placebo.
Very low- to high-certainty evidence showed benefits of
behavioural activation for short-term quality of life when compared
with treatment as usual and no treatment, but not when compared
with waiting list. Anxiety symptoms were reduced more for
behavioural activation than waiting list, treatment as usual, and no
treatment (low- to moderate-certainty evidence).
Low-certainty evidence showed a benefit of behavioural activation
compared with treatment as usual for short-term social adjustment
and functioning.
Unplanned sensitivity analyses
We removed one outlier in analyses of behavioural activation
versus treatment as usual for depression symptoms and quality of
life. The estimates for depression symptoms and quality of life were
reduced as a result of this, but still showed a benefit of behavioural
activation.
Analyses of behavioural activation versus waiting list and versus
treatment as usual showed large beneficial eects of behavioural
activation, based on a mix of studies including those with small
sample sizes. We conducted fixed-eect analyses in addition to
random-eects analyses to investigate the impact of small studies
on the results of two comparisons. The estimates of behavioural
activation versus waiting list for depression symptoms (Analysis
24.1) and anxiety symptoms (Analysis 24.2) were reduced, but
still favoured behavioural activation. The estimates of depression
symptoms (Analysis 25.1), and quality of life (Analysis 25.2) for
behavioural activation versus waiting list were reduced, but still
showed a benefit of behavioural activation.
Overall completeness and applicability of evidence
Most of the evidence came from studies conducted in high-
income countries, and from the USA in particular. This may make
evidence from this review less applicable to Low and Middle Income
Countries, where the majority of people with depression live.
In settings with less resources to deliver mental health
interventions, behavioural activation may be delivered in a format
which does not require a specialist, for example using lay
health workers or community workers. Our subgroup analyses
did not show a dierence in treatment eicacy between
behavioural activation delivered by specialists, specialists-in-
training, or non-specialists. When comparing behaviour activation
with other comparators, comparisons in which behavioural
activation was delivered by specialists favoured behavioural
activation, while in comparisons with behavioural activation
delivered by non-specialists treatment acceptability was higher for
other comparators.
We included studies of participants with moderate and severe
depression, as well as subthreshold or mild symptoms of
depression, to reflect variation in severity of symptoms found in
clinical practice and in the general population. Subgroup analyses
suggested that behavioural activation may be more eective than
non-therapy comparators for people with moderate to severe
depression rather than subthreshold or mild depression.
Trial participants were not necessarily representative of the
population of people with depression. This makes it diicult to
apply evidence from this review to clinical practice. People with
mental health problems in addition to depression, such as anxiety
disorder or substance abuse, were excluded from participating
in some trials. This is problematic if trial participants are more
amenable to treatment than people with depression not included
in these trials. As for other participant characteristics, several
population groups may be overrepresented. For example, some
studies included only young adults attending college or university,
while others included only women. Ethnicity of trial participants
was not usually reported, and for most studies in which it was
reported, the majority of participants were White American or White
British. Socioeconomic characteristics were also poorly reported.
For trials conducted in high-income countries there was mostly a
mix of participants with dierent socioeconomic status, although it
is diicult to assess to what extent these participant characteristics
are representative of the population eligible for inclusion in trials of
behavioural activation for depression.
Included trials were published between 1977 and 2020. Eligibility
for inclusion was not based on date of publication in our review, in
order to capture the entire evidence base. However, there may be
dierences in the way behavioural activation would be evaluated
and oered in practice nowadays and in the past. Whereas
behavioural therapy was initially based on the extraction of the
behavioural component from CBT, more recently, behavioural
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activation has been integrated into multidisciplinary treatments
or collaborative care. In our review, we only included such
trials if behavioural activation was clearly specified as the main
component of the intervention (Bosanquet 2017; Gilbody 2017),
rather than being only one of several elements of the treatment
(Richards 2013). In a future update of this review, it would be worth
reconsidering selection criteria, including the publication date and
scope of the intervention.
Most studies reported short-term outcomes, within six months
of starting treatment. We cannot be sure that any benefits of
behavioural activation reported shortly aLer the treatment ends
would continue over time.
Quality of the evidence
The certainty of the evidence was mostly low to moderate. This
means that the eect sizes calculated in our review may deviate
from the true eects of behavioural activation for depression in
adults. For several comparisons, evidence for some outcomes
was based on data from one trial only. This means we could
not assess inconsistencies in the results between trials. For the
comparison 'behavioural activation versus medication', this means
the evidence for treatment eicacy was based on only one study
but judged to be of moderate certainty.
The quality of the trials was limited by risk of bias relating to lack of
blinding of participants and personnel, no published study protocol
or trial report, missing information on incomplete outcome data,
and potential conflicts of interest relating to the study authors
being involved in the development of the intervention. We judged
some of the estimates to be imprecise due to the limited availability
of data for these outcomes.
Incomplete outcome data may have resulted in overestimation of
the eicacy of behavioural activation compared with treatment
as usual. In sensitivity analyses using a worst-case scenario
or intention-to-treat scenario, the benefit eect of behavioural
activation over treatment as usual was no longer clearly observed.
Sensitivity analyses of high-quality studies suggested that there
was no dierence in treatment eicacy and acceptability between
behavioural activation and other psychological therapies. In these
analyses, behavioural activation was more eective than non-
therapy comparators and had lower treatment acceptability.
However, we used allocation concealment as a crude proxy for
quality in these analyses, and all studies included in the sensitivity
analyses as 'high quality' had other domains for which risk of bias
was assessed to be high.
Findings were frequently found to be imprecise due to a small
number of studies per comparison, particularly for the primary
outcomes, and a small number of participants per study. The
majority of studies had less than 20 participants per study arm.
This makes it diicult to determine whether behavioural activation
performs as well as other psychological therapies.
Searches
Although we are confident that our search of the literature included
the most important databases and sources of clinical trials on
behavioural activation for depression, we cannot rule out the
possibility that relevant data were missed. For example, our search
did not include databases from low- and middle-income countries.
In years to come, behavioural activation may be rolled out in these
countries as a feasible intervention to treat depression and other
mental health conditions in settings where resources are limited,
and an update of this review should therefore consider a broader
search including such databases.
Missing data
We contacted authors of 44 included studies for information
required to complete the extraction of key data and the 'Risk of
bias' assessment. Authors of 23 studies could not be contacted
and authors of two studies replied, but could no longer provide
the requested information. Many of these studies were published
more than 20 years ago; some nearly 40 years ago. This hindered
our ability to retrieve all missing data, and as a consequence
many 'Risk of bias' domains remained 'unclear'. For nine studies
standard deviations or sample sizes required for meta-analyses
were missing, and for four studies published between 1979 and
1983 this information could not be estimated or obtained.
Publication bias
The small number of studies for most comparisons made it diicult
to assess the possibility of publication bias. There was an indication
of publication bias in the comparison of behavioural activation
versus waiting list for depressive symptoms, with small studies
favouring waiting list missing from the review (Figure 4). This
information was taken into account when assessing the certainty
of the evidence, as summarised in Summary of findings 6. Funnel
plots did not indicate publication bias for treatment acceptability
or depression symptoms in the behavioural activation versus
CBT comparison, nor for the treatment eicacy, acceptability,
and depression symptoms in the behavioural activation versus
treatment as usual comparison.
Primary outcome
Our primary outcome was treatment eicacy measured by the
number of people who responded to treatment. We accepted
trial authors' definitions of 'treatment response'. For some of the
included trials a 50% or greater reduction in symptom severity
measured on a validated depressions scale was defined as response
or clinically significant improvement, while other trials used
recovery or remission (symptom level below the cut-o for clinically
diagnosed depression). This may have led to heterogeneity in
the results. However, because eect estimates are based on
comparisons between intervention and control groups in each trial,
we do not expect this to substantially bias the results.
Conflict of interest
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potential conflict of interest in the 'Risk of bias' assessments
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Agreements and disagreements with other studies or
reviews
Conclusions regarding the eectiveness of behavioural activation
have been limited in previous systematic reviews by the
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absence of substantive, high-certainty evidence (Churchill 2013;
Hunot 2013; Shinohara 2013). No dierence had previously
been found in eectiveness between behavioural activation
and other psychological therapies (Shinohara 2013). Our review
suggested similar eicacy between behavioural activation and
other psychological therapies, although our confidence in these
findings is limited due to concerns about the certainty of the
evidence. Moderate- to low-certainty evidence suggested that
behavioural activation was more eective than humanistic therapy,
both in terms of depression as a binary outcome and symptoms of
depression.
The most recent systematic review of behavioural activation for
depression versus comparators other than psychological therapy
found mostly low-quality evidence indicating that behavioural
activation was superior to a wide range of control treatments,
including medication (Ekers 2014). Our review also suggests a
benefit of behavioural activation in terms of treatment eicacy
or depression symptoms when compared with treatment as usual
or no treatment. Our review also suggested that, compared with
being on a waiting list, behavioural activation improved depression
symptoms, but was not necessarily better in terms of treatment
eicacy (although we found only one trial that looked at this). We
found no dierence between behavioural activation and placebo
in terms of depression symptoms, although no data were available
on treatment eicacy for this comparison. Behavioural activation
performed better than medication in terms of treatment eicacy,
but this was based on only one trial, and we found no dierence
between the two interventions in relation to decreasing symptoms
of depression. Any dierences between reviews are most likely due
to the addition of new studies, minor dierences in the selection
criteria, and the choice of comparisons and outcomes.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
In the UK, NICE guidance recommends behavioural activation
for the treatment of subthreshold, mild, or moderate depression
in adults, whilst recognising that the evidence for behavioural
activation is less robust than for cognitive-behavioural therapy
(CBT) and interpersonal therapy (NICE 2009). This systematic
review suggests that behavioural activation may be more eective
than humanistic therapy, medication, and treatment as usual, and
that it may be no less eective than CBT, psychodynamic therapy,
or being on a waiting list. However, our confidence in these findings
is limited due to concerns about the certainty of the evidence.
Policy makers and practitioners may be able to use this evidence
to inform decisions about whether or not to recommend or provide
behavioural activation for the treatment of depression in adults,
giving people with depression greater treatment choice. Other
more established psychological therapies for depression rely on
the availability of mental health professionals, oLen over a more
extended period of time. Behavioural activation may oer an
additional option, extending the range of available treatments in
terms of type of therapist, format of delivery, and length of therapy,
possibly within the context of a multidisciplinary collaborative care
model.
Although sensitivity analyses of high-quality studies confirmed
findings of no dierence in eectiveness between therapies, the
majority of the evidence on the eicacy of behavioural activation
was of limited quality and/or certainty. There may be dierences
between therapies we have not been able to demonstrate due to a
lack of high-certainty evidence. There was more evidence available
for improvement in symptoms of depression than for treatment
eicacy (which was based on a clinical assessment of significant
improvement, remission, or recovery).
Subgroup analyses suggested that behavioural activation may
be more eective for moderate to severe depression than for
subthreshold or mild depression when compared to control groups
other than psychological therapies. Although this finding was
based on data from only six studies, it is interesting given that
behavioural activation is not currently recommended for moderate
to severe depression in the UK (NICE 2009).
The choice between behavioural activation and another treatment
for depression, for both people with depression and health care
providers, will be influenced by factors other than evidence of
short-term eectiveness. Evidence which was mostly moderate
to low certainty did not suggest a dierence in treatment
acceptability, as indicated by dropout rates, between behavioural
activation and other psychological therapies. People with
depression may consider other aspects of treatment acceptability
in their decision-making, such as the likelihood of side eects
or acceptability of the format, or time commitment required. No
adverse eects were identified for behavioural activation other
than those unlikely to be related to the treatment. However, only
seven out of 53 included studies collected and explicitly mentioned
adverse events, and we therefore know relatively little about any
potential negative impacts of this intervention.
Implications for research
This review has synthesised evidence from 53 studies, spanning
four decades of research on behavioural activation for depression
from a range of countries and settings. Despite this substantial
amount of research, the evidence was mostly not of high certainty
and for psychotherapy comparators in particular, a limited amount
of data were available per comparator. More of the same research
with the same populations is not likely to substantially improve
the evidence base around behavioural activation. Considering the
literature identified by this review, we see clear opportunities
to improve the evidence base, including: enhancing the quality
of trial methodology and reporting, using relevant comparators,
measuring treatment acceptability as well as as well as adverse
events, and better understanding which people with depression are
most likely to benefit.
Strengthening the evidence base
Firstly, we have been limited in the conclusions that can be
drawn from this review by the certainty of the evidence. Some
issues are harder to overcome than others. For example, studies
of psychological therapies are likely to be at risk of performance
bias, because of the lack of a true placebo. However, an
appropriate sample size, a longer follow-up, and transparency
in the randomisation and allocation process would significantly
improve the certainty of the evidence. We note that recent clinical
trials are more likely to have achieved this than some of the
older trials included in this review. In addition, involvement in
the evaluation of interventions by researchers who developed the
intervention caused a potential conflict of interest for several of the
included trials.
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Secondly, comparators should be selected based on their relevance
for clinical practice. In the UK, NICE guidance recommends
behavioural activation as one option for mild to moderate
depression, alongside CBT, interpersonal therapy, couples therapy,
counselling, or psychodynamic therapy (NICE 2009). In this setting,
'behavioural activation versus other therapies' may therefore be
the most informative comparison to clinicians and patients. In
settings where most people with depression remain untreated, the
comparison between behavioural activation and no or minimal
treatment may be of interest.
Thirdly, we used drop out from the study as a crude indicator
of treatment acceptability, while treatment acceptability may
be measured more comprehensively in other ways, for example
through satisfaction surveys. The synthesis of existing evidence
and the incorporation of such measures into trials could aid the
implementation of behavioural activation in practice.
What works for whom
Evaluations of behavioural activation, as for most interventions in
mental health, have generally focused on estimating an average
eect of the intervention for the trial sample. Many questions on the
most eective format or delivery of behavioural activation remain
unanswered. Our review did not find any dierence between
interventions conducted face-to-face or online/over the phone, in
an individual or group format, and with dierent durations. Studies
explicitly investigating any such dierences, whether through
statistically powered clinical trials or qualitative evaluations, would
be better placed to conclusively answer these questions and
to determine what the most eective elements and formats of
behavioural activation therapy are.
We aimed to explore dierences in the eectiveness and
acceptability of behavioural activation for various groups of the
population, such as by participant age and severity of depression.
These subgroup analyses were limited by the lack of relevant
data reported in the included studies. To answer any questions
on treatment eicacy and acceptability for dierent groups of the
population, detailed information on key participant characteristics
should be collected and reported. This would allow researchers
carrying out systematic reviews of the literature to assess what
works for whom, and to better judge the applicability of the
evidence for the diverse population of people with mental health
problems.
Evidence from Low and Middle Income Countries, where resources
to provide mental health support may be limited and behavioural
activation may therefore oer a potential treatment option, is
sparse. Well-conducted trials in Low and Middle Income Countries
including diverse samples of participants may indicate whether
behavioural activation could be an eective, acceptable, and
feasible treatment for depression in these settings.
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C H A R A C T E R I S T I C S   O F   S T U D I E S
Characteristics of included studies [ordered by study ID]
 
Study characteristics
Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: participants were recruited from the Indonesian community through mass media adver-
tisements (banners placed in various websites and places throughout the country), social media (on-
line communities, forums, and pages about mental health), and referral from mental health institutions
or mental health professionals (both flyers and word of mouth). Potential participants could access
extensive information on the trial website, and, if they were interested, could complete the screening
assessment (PHQ-9) via a linked Qualtrics online survey platform. No face-to-face screening methods
were used.
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 31 male (19%), 128 female (81%)
• Ethnic group: Java 69 (43%), Tionghoa 30 (19%), Sunda 21 (13%), Batak 8 (5%), Minangkabau 8 (5%),
Other (19 ethnicities) 23 (14%)
• Household income: -
• Occupation/ employment: unemployed 18 (11%), professional3 (2%), private employee 56 (35%), civil
employee 6 (4%), entrepreneur 4 (3%), freelancer 13 (8%), student 57 (36%), housewife 2 (1%)
• Education level: junior high 3 (2%), senior high 61 (38%), vocational 6 (4%), Bachelor's degree 76 (48%),
Master's degree 13 (8%)
• Comorbid anxiety: N = 67 (42%)
• Depression severity: 29% mild, 28% moderate, 43% severe
• Age: 24.45 (SD 4.93)
Psychoeducation
• Gender (N male, % male, N female, % female): 29 male (19%), 125 female (81%)
• Ethnic group: Java 64 (42%), Tionghoa 18 (12%), Sunda 22 (14%), Batak 15 (10%), Minangkabau 6 (4%),
Other (19 ethnicities) 29 (19%)
• Household income: -
• Occupation/ employment: unemployed 6 (4%), professional 7 (5%), private employee 48 (31%), civil
employee 3 (2%), entrepreneur 4 (3%), freelancer 17 (11%), student 63 (41%), housewife 6 (4%)
• Education level: junior high 2 (1%), senior high 59 (38%), vocational 12 (8%), Bachelor's degree 73
(47%), Master's degree 8 (5%)
• Comorbid anxiety: N = 75 (49%)
• Depression severity: 25% mild, 36% moderate, 39% severe
• Age: 24.52 (SD 5.22)
Overall
• Gender (N male, % male, N female, % female): -
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• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Included criteria: aged 16 or older, scored 10 or above on PHQ 9, met criteria for major or persistent
depressive disorders on DSM-5, were proficient in Bahasa Indonesia, and could use the internet.
Excluded criteria: current substance use disorders, current or previous manic or hypomanic episodes
or psychotic disorder, attending psychological intervention at least weekly, and acute suicidality.
Pretreatment: baseline characteristics of enrolled participants were similar in both intervention
groups.
Current medication: current medication treatment for mental health problems was allowed, and was
checked at enrolment and again during the final interview. No participants were taking medications for
mental health problems at enrolment or at their final interviews.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: online behavioural activation including counsellor support and psychoeducation
• dose: 30 to 45 minutes per module
• frequency: weekly
• duration: 8 weeks
• level of therapist: non-specialist
• individual or group therapy: individual
• mode of delivery: online with support from lay counsellor on the phone
• modifications: reduced text, replaced videos with illustrations, adapted to Indonesian context from
original Dutch intervention
Psychoeducation
• type of intervention: comparator
• specific intervention: minimal psychoeducation; online psychoeducation without support
• dose: -
• frequency: -
• duration: 8 weeks
• level of therapist: -
• individual or group therapy: individual
• mode of delivery: online
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: PHQ-9
• Direction: lower is better
• Data value: endpoint
Quality of life
Arjadi 2018  (Continued)
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• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: WHOQOL-brief
• Direction: higher is better
• Data value: endpoint
Depression remission
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Scale: SCID-5 (DSM-5)
• Direction: higher is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Identification Sponsorship source: this study is funded by the Indonesia Endowment Fund for Education (Lembaga
Pengelola Dana Pendidikan), Ministry of Finance, Republic of Indonesia which provided a PhD schol-





Authors name: Prof Claudi L H Bockting
Institution: University of Amsterdam
Email: c.l.bockting@amc.uva.nl
Address: Amsterdam University Medical Centres,Academic Medical Centre,Department of Psychia-
try,University of Amsterdam,Meibergdreef 9,1105 AZ Amsterdam, the Netherlands
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Participants were randomly allocated (1:1) by a research assistant
to GAF-ID or online psychoeducation via a web-based randomisation pro-
gram built by an independent developer for this trial. Randomisation was
done within a random permuted block design stratified by sex and depression
severity (score 10–14 vs score ≥15 on PHQ-9)."




Low risk Judgement comment: used different research assistants for randomisation
and other aspects of the study. They were not aware of random block design.
Web-based
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High risk Judgement comment: no blinding for participants. Although researchers tried
to conceal which was the 'intervention of interest', the psychoeducation in-
tervention was minimal in terms of support provided and substance of the in-
tervention. This could have influenced participants' outcomes and chance of
dropout.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Quote: "The research assistants who did the clinical interviews after randomi-
sation were not involved in the intervention process and were masked to par-
ticipants’ treatment condition (participants were also asked not to reveal their
treatment condition during the interviews). At the end of the final interview (10
weeks after baseline), research assistants were asked to guess the treatment
allocation of each participant they interviewed, and were then no longer blind-
ed to allocation."
Judgement comment: Efforts were made to conceal treatment allocation from
research assistants who performed interviews, and outcomes were self-com-
pleted online. At the end of the trial, research assistants did correctly identify
68% of allocations, indicating blinding did not work completely, but this is un-




High risk Judgement comment: missing data were imputed but unclear how. People
with milder symptoms more likely to drop out, which may have affected es-
timates. More dropouts in more intensive BA group than psychoeducation
group, which may have led to a final sample of participants who responded
well to treatment, and may have led to overestimation of positive results.
Selective reporting (re-
porting bias)
Low risk Quote: "The trial protocol is publicly available, 6 and the trial was prereg-
istered. The Tarumanagara University Human Research Ethics Committee
(PPZ20152002), and the Research Ethics Committee at the Institute of Re-
search and Community Service, Atma Jaya Catholic University of Indonesia
(942/III/LPPM-PM.10.05/09/2016) provided ethical approval for the study."
Judgement comment: all of the study's pre-specified outcomes have been re-
ported. Outcomes and time points in protocol match study manuscript.
Other bias Low risk Treatment fidelity: Judgement comment: No assessment of treatment fidelity,
but given that the intervention was mostly done on a computer there was lim-
ited potential for deviation from the intended treatments.
Researcher allegiance/ conflict of interest:
Quote: "Participants in the GAF-ID group received an internet- based behav-
ioural activation intervention supported by lay counsellors. The intervention
was made available via a secure online platform, which was built by an inde-
pendent professional intervention website developer in the Netherlands."
Judgement comment: last author C Bockting may have been involved in devel-
opment of Dutch version of this intervention, but this is unlikely to be of great
importance to the study results.
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Study grouping: parallel group
Recruitment:
Type of RCT (blind, double-blind, open-label): open-label
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: 16.3 (9.0 SD)
• Depression severity: -
• Age: -
Supportive treatment
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: 11.6 (6.3 SD)
• Depression severity: -
• Age: -
Overall
• Gender (N male, % male, N female, % female): 19 male (38%), 31 female (62%)
• Ethnic group: 44 Caucasian (88%), 4 African American (8%), 1 Latino (2%), 1 American Indian/ Alaskan
Native (2%)
• Household income: -
• Occupation/ employment: 100% students
• Education level: 14 years (SD 1.38)
• Comorbid anxiety: -
• Depression severity: 29 major depression (58%), 10 dysthymia (20%)
• Age: 20.0 (SD 2.75)
Included criteria: age 18 or older and BDI-II greater than or equal to 14, no medication or stabilised on
medication for at least 8 weeks
Excluded criteria: active suicidal intent, psychosis
Pretreatment: more participants in the ST group had a partner (N = 4 versus N = 0). Anxiety and de-
pression scores seem slightly higher at baseline in BA compared to ST group.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: single session behavioural activation of religious behaviours
• dose: 60 minutes therapy session
• frequency: one session, telephone check in a week after intervention
• duration: one therapy session, 2-week interval given for activities
Armento 2012  (Continued)
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• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: homework form, initial session face-to-face then telephone check in
• modifications: focus on religious activities
Supportive treatment
• type of intervention: comparator
• specific intervention: single session supportive treatment
• dose: 60 minutes
• frequency: one session, telephone check in a week later
• duration: one session
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: initial session face-to-face then telephone check in
• modifications: expressed depressive thoughts in a supportive environment but no therapy interven-
tion used
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: BDI-II
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
• Notes: unclear whether dropouts were included in ITT analysis or as-treated analysis
Anxiety symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: BAI
• Direction: lower is better
• Data value: endpoint
• Notes: Both BAI and STAI reported; chosen Becks Anxiety Inventory because Becks Depression Inven-
tory was used as depression measure.
Quality of life
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: Quality of Life Inventory (QOLI)
• Direction: higher is better
• Data value: endpoint




Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
Comments: -
Authors name: Derek Hopko
Institution: Department of Pyschology, University of Tennessee
Email: dhopko@utk.edu




Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Judgement comment: not mentioned how they were randomised. Author
could not be contacted.
Allocation concealment
(selection bias)





High risk Judgement comment: participants not blinded, may have impacted if dis-
agreed with intervention
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk Judgement comment: unclear who was collecting data from questionnaires.




Low risk Judgement comment: two people dropped out, one for logistical issues and
the other for illness. Both in BA group but no significant difference in attrition
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: protocol reference in dissertation is for different study.
Other bias Unclear risk Judgement comment: group participating were more educated and less likely
to be married compared to those who declined. This may indicate randomisa-
tion was unsuccessful and lead to biased estimates.
Treatment fidelity:
Quote: "All components of therapy were demarcated within the protocol and
checked o by the therapist to indicate protocol adherence."
Judgement comment: BARB group checked but ST group was told to continue
as usual, unclear what this would have involved. Author could not be contact-
ed.
Researcher allegiance/ conflict of interest: Judgement comment: study ap-
pears to have been conducted, treatment provided, and results analysed, by
one person as part of a dissertation. This reduces objectivity. However, no con-
flicts of interest reported.
Therapist allegiance/ conflict of interest: Judgement comment: performed by
one doctoral student in clinical psychology trained in BARB - may have an in-
terest in showing effectiveness.
Armento 2012  (Continued)
Behavioural activation therapy for depression in adults (Review)













Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: May 2009 to June 2010 through referrals by doctors and nurses and through collabora-
tion with former prisoner organisations who notified their members.
Type of RCT (blind, double-blind, open-label): partly blind outcome assessments (85%)
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 49 Male (43%) 65 female (57%)
• Ethnic group:-
• Household income: -
• Occupation/employment: 57 (50%) not employed, 25 (22%) in regular work, 32 (28%) self-employed/in
irregular work
• Education level: 59 (52%) none, 26 (23%) primary, 24 (21%) secondary, 5 (4%) bachelors/institutional
degree or certificate
• Comorbid anxiety: 1.25 mean (0.07 SE)
• Depression severity: 1.6 (SD 0.5)
• Age: 36.9 (SD 12.4)
Cognitive procession therapy (CPT)
• Gender (N male, % male, N female, % female): 59 female (58%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: 47 not working (48%), 32 regular work (33%), 18 self-employed/ irregular
(19%)
• Education level: 44 (44%) none, 30 (30%) primary, 13 (13%) secondary, 14 (14%) bachelors/institution-
al degree or certificate
• Comorbid anxiety: 1.34 mean (0.06 SE)
• Depression severity: 1.7 (SD 0.4)
• Age: 41.5 (SD 13.7)
Waiting-list control
• Gender (N male, % male, N female, % female): 27 Male (41%) 39 Female (59%)
• Ethnic group: -
• Household income: -
• Occupation/employment: 37 not working (56%), 20 regular work (30%), 9 self-employed/irregular
(14%)
• Education level: 38 (58%) none, 18 (27%) primary, 8 (12%) secondary, 2 (3%) bachelors/institutional
degree or certificate
• Comorbid anxiety: 1.18 mean (0.06 SE)
• Depression severity: 1.5 (SD 0.3)
• Age: 42.3 (SD 12.5)
Overall
• Gender (N male, % male, N female, % female): 118 Male (42%), 163 Female (58%)
• Ethnic group: -
Bolton 2014 
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• Household income: -
• Occupation/ employment: 141 (50%) not employed, 77 (27%) in regular work, 59 (21%) self-em-
ployed/in irregular work
• Education level: 141 (50%) none, 74 (26%) primary, 45 (16%) secondary, 21 (7%) bachelors/institution-
al degree or certificate
• Comorbid anxiety: mean 1.26
• Depression severity: mean 1.6
• Age: mean 40.2
Included criteria: eligible persons were survivors of systematic violence living in the governorates of
Erbil or Sulaimaniyah, aged 18 or over, fluent in Sorani Kurdish, reported significant depression symp-
toms on the adapted HSCL-25, had no current psychotic symptoms or active suicidality, and appeared
mentally competent to consent.
Excluded criteria: inability to be interviewed due to a cognitive or physical disability, or severe suicidal
ideation or behavior.
Pretreatment: mental health symptoms on several scales slightly higher in CPT group. Some other dif-
ferences such as proportion of females, partnership status, and employment.
Interventions Intervention characteristics
Behavioural activation





• level of therapist: non-specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: adapted for low literacy/extreme poverty and administration by paraprofessionals +
culturally adapted to consider societal expectations and collective perspective
Cognitive procession therapy (CPT)
• type of intervention: comparator
• specific intervention: CPT
• dose: -
• frequency: 9 sessions
• duration: -
• level of therapist: non-specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: adapted explanations to examples relevant to Kurdistan. Changed themes from es-
teem/intimacy to respect/caring. Reduced complexity of written material and included pictures. Used
mobile phones to record homework and family members as scribe
Waiting-list control
• type of intervention: comparator
• specific intervention: waiting-list control
• dose: -
• frequency: -
• duration: approx 5 months
• level of therapist: non-specialist
Bolton 2014  (Continued)
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• individual or group therapy: individual
• mode of delivery: -
• modifications: offered treatment after 5 months. contacted monthly for symptom check
Outcomes Depression
• Outcome type: Continuous outcome
• Reporting: fully reported
• Scale: adapted HSCL-25
• Range: 0-3
• Direction: lower is better
• Data value: endpoint
• Notes: qualitative study data were used to adapt the Hopkins Symptom Checklist for Depression and
Anxiety (HSCL-25), the Harvard Trauma Questionnaire (HTQ), and the Inventory of Traumatic Grief
to measure symptoms of depression, anxiety, posttraumatic stress and traumatic grief. Adaptation
included adding 13 locally relevant symptoms. Instrument reliability and validity were tested for all
outcomes among local survivors of systematic violence (N = 128).
Anxiety
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: adapted HSCL-25
• Range: 0-3
• Direction: lower is better
• Data value: change from baseline
• Notes: qualitative study data were used to adapt the Hopkins Symptom Checklist for Depression and
Anxiety (HSCL-25), the Harvard Trauma Questionnaire (HTQ), and the Inventory of Traumatic Grief
to measure symptoms of depression, anxiety, posttraumatic stress and traumatic grief. Adaptation
included adding 13 locally relevant symptoms. Instrument reliability and validity were tested for all
outcomes among local survivors of systematic violence (N = 128).
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Identification Sponsorship source: This study was solely funded by the USAID Victims of Torture Fund (VOT).
Country: Northern Iraq
Setting: government primary healthcare clinics
Comments: -
Authors name: Paul Bolton
Institution: John Hopkins Bloomberg School of Public Health
Email: pbolton1@jhu.edu
Address: Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E8646, Balti-
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Randomization of CMHWs and participant IDs was done by JB using
Stata’s randomization function. Investigators kept a master list of each study
ID’s assignment for checking randomization fidelity."
Judgement comment: Use of Stata's randomisation function
Allocation concealment
(selection bias)
Low risk Quote: "If a person consented the CMHW opened a sealed envelope attached
to the consent form containing the participant’s assign- ment."





High risk Quote: "Participants were not blinded to their own treatment/control status."
Judgement comment: no blinding of participants. This might influence out-
comes.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk Judgement comment: outcome assessments were blinded in 85% of cas-
es. 15% of unblinded interviews may have influenced results, as this was the
group of patients that did not want further treatment, which may be related to




Low risk Quote: "Multiple imputation by chained equations accounted for missing scale
items and follow up scores among those lost to follow up [49]."
Judgement comment: dropout reasons reported, and no obvious differences
between groups. Slightly more people in BA group (28%) than CPT group
(21%) started but did not complete treatment.
Selective reporting (re-
porting bias)
Low risk Judgement comment: outcomes as reported in protocol (NCT00925262). Tim-
ing of follow-up assessment was different from proposed timing (3-6 months),
but explained in the paper this is due to time taken to complete intervention
and logistical challenges.
Other bias Low risk Judgement comment: none identified.
Quote: "The authors declare that they have no competing interests."
Judgement comment: therapists were community mental health workers; no
reason to believe there would be conflicts of interest, although therapists may
have preferred one treatment over another.
Correspondence with author: "Providers received weekly supervision during
which supervisors reviewed what actions providers took with each client that





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: from GP practices in the North of England: York, Leeds, Durham, Newcastle, and their
surrounding areas. To start 15 Sept 2012.
Bosanquet 2017 
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Type of RCT (blind, double blind, open label):
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 98 male (39.4%), 150 female (60.2%)
• Ethnic group: 241 (96.8%) white. 1 (0.4%) Asian, 1 (0.04%) black, 3(1.2%) other
• Household income: -
• Occupation/ employment: -
• Education level: 108 (43.4%) educated past 16y. 57 (22.9%) with degree/equivalent
• Comorbid anxiety: GAD-7 9.4 (5.03 SD)
• Depression severity: 1% none, 24% mild, 31% moderate, 28% moderate severe, 16% severe
• Age: 72.5 (SD 6.57)
Usual care
• Gender (N male, % male, N female, % female): 85 male (36.0%), 151 female (64.0%)
• Ethnic group: 233 White (99%), 2 other (1%)
• Household income: -
• Occupation/ employment: -
• Education level: 101 (42.8%) educated past 16y. 68 (28.8%) with degree/equivalent
• Comorbid anxiety: GAD-7 9.3 (4.92 SD)
• Depression severity: 2% none, 19% mild, 33% moderate, 32% moderate severe, 14% severe
• Age: 71.8 (SD 6.07)
Overall
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Included criteria: aged 65 years and over, screen-positive to at least one of the Whooley questions,
and major depressive disorder (DSM IV) on further assessment with the MINI diagnostic tool and PHQ- 9
questionnaire
Excluded criteria: known alcohol dependency (as recorded on GP records). Any known co-morbidity
that would in the GP’s opinion make entry to the trial inadvisable (for example, recent evidence of self-
harm, known current thoughts of self-harm, significant cognitive impairment). Other factors that would
make an invitation to participate in the trial inappropriate (for example, recent bereavement, terminal
illness). Known to be experiencing psychotic symptoms (as recorded on GP records)
Pretreatment: people in the collaborative care group seemed more likely to answer feeling down/de-
pressed/ hopeless and having little or no interest or pleasure in doing things in Whooley questions. No
differences in PHQ-9 scores.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
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• frequency: average 6 sessions
• duration: 8-9 weeks
• level of therapist: non-specialist
• individual or group therapy: individual
• mode of delivery: face-to-face, telephone
• modifications: collaborative care elements: telephone support, medication management, symptom
monitoring, active surveillance. Designed specifically for adults > 65 with depression.
Usual care
• type of intervention: comparator




• level of therapist: non-specialist
• individual or group therapy: individual
• mode of delivery: -
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: PHQ-9
• Range: 0-27
• Direction: lower is better
• Data value: endpoint
Anxiety symptoms
• Outcome type: ContinuousOutcome
• Reporting: Fully reported
• Scale: GAD-7
• Range: 0-21
• Direction: Lower is better
• Data value: Endpoint
Quality of life
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: SF-12 PCS score
• Direction: higher is better
• Data value: endpoint
Suspected adverse events
• Outcome type: adverse event
• Reporting: fully reported
• Data value: change from baseline
• Notes: all but 2 out of 81 suspected adverse events were found to be unrelated to the intervention,
with the other 2 unlikely to be related. None of the 13 deaths were due to suicide. 47/196 suspected
adverse events in BA arm, compared to 34/211 in usual care arm.
Dropouts
Bosanquet 2017  (Continued)
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• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Identification Sponsorship source: this project was funded by the National Institute for Health Research HTA pro-
gramme (project number 10/57/43)
Country: UK
Setting: primary care; 69 GP practices in North of England
Comments: four centres: (1) York centre (the core study centre) covering the York, Harrogate, Hull and
the surrounding areas; (2) Leeds centre and the surrounding area; (3) Durham centre and the surround-
ing area; and (4) Newcastle upon Tyne centre, including Northumberland and North Tyneside
Authors name: Simon Gilbody
Institution: Department of health sciences, University of York
Email: simon.gilbody@york.ac.uk
Address: Department of Health Sciences, University of York, Seebohm Rowntree building, Heslington,
York YO10 5DD, UK
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Randomisation was carried out by the York Trials Unit Randomisation
Service [www.yorkrand.com (accessed 23 June 2016)], accessed by a trained
researcher from the study team. Participants were automatically randomised
by a computer on a 1: 1 basis by simple unstratified randomisation to either
the intervention group or control group, following the completion of a diag-
nostic interview. All</b> diagnostic interviews were conducted over"
Judgement comment: participants automatically randomised by computer, by
the York Trials Unit Randomisation Service, on a 1:1 basis using simple unstrat-




Low risk Judgement comment: central allocation concealed from PI and participating





High risk Judgement comment: not possible to blind, may affect outcomes if patients
know they are just receiving usual care. Mental health workers in GP practices
may have had a preference for BA, particularly given that the alternative was
treatment as usual.
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Judgement comment: outcomes completed by participants, mostly at home
without interference from a researcher. This reduces risk of bias for re-




Low risk Judgement comment: higher percentage of people in the intervention group
dropped out, and more had dropped out because they did not want to engage
compared to usual care. However, dropout low overall.
Bosanquet 2017  (Continued)
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Selective reporting (re-
porting bias)
Low risk Judgement comment: slight differences in outcomes reported in trial registra-
tion, protocol, and trial report, but no change in primary outcomes.
Other bias High risk Judgement comment: a purposive sample of sessions was audio-recorded
from a range of case managers. However, no information on the outcome of
this quality assurance process was reported. Case worker liaised with GP and
recommended changes to patient care - unsure what changes were made by
case workers.
Judgement comment: several authors have been involved in multiple studies
of BA. It can be assumed it is in their interest (status, funding) for findings of





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: the study team used ancillary recruitment strategies such as posting fliers at church-
es, other nursing centres and other resource centres in the African Americancommunity. In addition,
study personnel actively recruited at the BOH one day per week during free-meal services by making
announcements and talking about the group with individuals receiving food from the food line.
Type of RCT (blind, double-blind, open-label):
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 3 male, 4 female
• Ethnic group: African-American
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: 50.86 (SD 6.54), range 44-63
Waiting list
• Gender (N male, % male, N female, % female): -
• Ethnic group: African-American
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: 44.71 (SD 9.07)
Overall
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
Bowe 2014 
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• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Included criteria: African-American, ages of 18 and 65 inclusive, at least a fiLh grade education level,
ability to read and write in English, diagnosis of Major Depressive Disorder during the screen according
to the Mini International Neuropsychiatric Interview and score 14 or greater on HADS at time of screen-
ing
Excluded criteria: current suicidal ideation, meet criteria for Bipolar Disorder, Schizophrenia accord-
ing to the MINI during the screen, alcohol or substance dependence according to the MINI during the
screen, currently receiving psychotherapy or medication for depression, already participated in Phase




• type of intervention: BA
• specific intervention: culturally enhanced behavioural activation (CEBA)
• dose: 2 hours
• frequency: Weekly
• duration: 12 weeks
• level of therapist: specialist
• individual or group therapy: individual + group
• mode of delivery: Face-to-face, phone
• modifications: Adapted to African-American culture
Waiting list
• type of intervention: comparator
• specific intervention: waiting list
• dose: -
• frequency: -
• duration: 12 weeks
• level of therapist: -
• individual or group therapy: individual + group
• mode of delivery: -
• modifications: -
Outcomes Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Depression symptoms
• Outcome type: continuous outcome
• Scale: HAM-D
• Direction: lower is better
• Data value: endpoint
Bowe 2014  (Continued)
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• Notes: only individual data is reported, for three patients who completed mid-treatment data collec-
tion, and one patient who completed endpoint data collection.
Identification Sponsorship source: Research Growth Initiative Grant awarded to J Kanter to fund this dissertation.
Country: USA
Setting: neighbourhood community health centre
Comments: participants in BA group (no information on other group) were extremely disadvantaged
(homelessness, shelter accomodation) and had a multitude of personal issues and comorbidities (dia-
betes, housing needs, suicide attempt, paranoia, alcoholism, gang violence).
Authors name: William Michael Bowe
Institution: University of wisconsin-Milwaukee
Email: -
Address: -
Notes Noortje Uphoff on 02/04/2019 19:19
Select
Can not include data for this study. It doesn't have any analysis of outcomes.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "Following screening procedures described in more detail below, eight
participants were randomized to the waitlist control group, and seven partici-
pants were randomized to the active group. The"
Judgement comment: no information. Author could not be contacted.
Allocation concealment
(selection bias)





High risk Judgement comment: blinding not possible due to nature of intervention.
Blinding of outcome as-
sessment (detection bias)
All outcomes





High risk Judgement comment: large number of dropouts: 6/8 from waiting list and 6/7
from active condition. At least 1 dropout related to not receiving intervention.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no protocol. Author could not be contacted.
Other bias High risk Judgement comment: participants in BA group were extremely disadvantaged
(homelessness, shelter accommodation) and many comorbidities (diabetes,
housing needs, suicide attempt, paranoia, alcoholism, gang violence). No in-
formation on other group. Extremely small sample sizes; randomisation un-
likely to create balanced groups.
Bowe 2014  (Continued)
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
Judgement comment: researcher developed the treatment and may therefore






Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: participants were recruited from the general public by means of a10 x 8 cm advertise-
ment, published on a Sunday in January 2011, in a Swedish newspaper (Dagens Nyheter) with wide cir-
culation.
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Bbehavioural activation
• Gender (N male, % male, N female, % female): 9 male (22%), 31 female (77%)
• Ethnic group: -
• Household income: -
• Occupation/employment: armed forces 0, legislators/senior/managers 5 (12.5%), professionals 8
(20%), technicians/associate profs 8 (20%), clerks 2 (5%), service/shop sales workers 3 (7.5%), skilled
agric/fish 0, craL/related trades 1 (2.5%), plant/machine operators 0, elementary 2 (5%), self-em-
ployed 1 (2.5%), other 1 (2.5%), retired 4 (10%), unemployed/sick 2 (5%), student 3 (7.5%)
• Education level: elementary school 1 (2.5%), upper secondary 11 (27.5%), vocational training 0, uni-
versity ongoing 4 (10%), university completed 24 (60%)
• Comorbid anxiety: -
• Depression severity: -
• Age: 43.6 (SD 13.7)
Waiting list
• Gender (N male, % male, N female, % female): 5 male (12%), 35 female (87%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: armed forces 0, legislators/senior/managers 6 (15%), professionals 0, tech-
nicians/associate profs 10 (25%), clerks 2 (5%), service/shop sales workers 2 (5%), skilled agric/fish
0, craL/related trades 2 (5%), plant/machine operators 0, elementary 1 (2.5%), self-employed 2 (5%),
other 0, retired 5 (12.5%), unemployed/sick 4 (10%), student 6 (15%)
• Education level: elementary school 2 (5%), upper secondary 2 (5%), vocational training 3 (7.5%), uni-
versity ongoing 6 (15%), university completed 27 (67.5%)
• Comorbid anxiety: -
• Depression severity: -
• Age: 45.3 (SD 13.4)
Overall
• Gender (N male, % male, N female, % female): M 14 (17.5%), F 66 (82.5%)
• Ethnic group: -
• Household income: -
• Occupation/employment: armed forces 0, legislators/senior/managers 11 (13.8%), professionals 8
(10%), technicians/associate profs 18 (22.5%), clerks 4 (5%), service/shop sales workers 5 (6.3%),
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skilled agric/fish 0, craL/related trades 3 (3.8%), plant/machine operators 0, elementary 3 (3.8%), self-
employed 2 (2.5%), other 1 (1.3%), retired 9 (11.3%), unemployed/sick 6 (7.5%), student 9 (11.3%)
• Education level: elementary school 3 (3.8%), upper secondary 13 (16.3%), vocational training 3 (3.8%),
university ongoing 10 (12.5%), university completed 51 (63.8%)
• Comorbid anxiety: -
• Depression severity: -
• Age: 44.4 (SD 13.5)
Included criteria: (a) be at least 18 years of age; (b) live in Sweden; and (c) have a MADRS-S score in the
range of 15 to 30. If the participant was on medication the dosage had to be kept constant for the past 3
months.
Excluded criteria: ongoing therapy, other primary diagnosis, just changed medication
Pretreatment: more men in BA group, higher educated in waiting list group
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: online programme 'Depressionshjälpen' with limited therapist interaction
• dose: -
• frequency: -
• duration: 8 weeks
• level of therapist: -
• individual or group therapy: individual
• mode of delivery: online
• modifications: BA with components of Acceptance and Commitment Therapy (ACT)
Waiting list
• type of intervention: comparator
• specific intervention: waiting list
• dose: -
• frequency: -
• duration: 8 weeks
• level of therapist: -
• individual or group therapy: individual
• mode of delivery: online
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: MADRS-S
• Direction: lower is better
• Data value: endpoint
• Notes: self-rated MADRS
Quality of life
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: quality of life inventory
• Direction: higher is better
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• Data value: endpoint
Identification Sponsorship source: this study was sponsored in part by grants from the Swedish Science Foundation,
the Swedish Council for Social Research and the Swedish Council for Work Life Research.
Country: Sweden
Setting: online/ at home
Comments: -
Authors name: Per Carlbring
Institution: Stockholm University
Email: per@carlbring.se
Address: Department of Psychology, Stockholm University, Stockholm, Sweden
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Judgement comment: the participants were divided into two groups – treat-
ment or control – by an online true random-number service independent of
the investigators and therapists
Allocation concealment
(selection bias)
Low risk Judgement comment: online random number service was used which was in-





High risk Judgement comment: no blinding possible. It is possible that self-reported
outcomes were influenced by participants knowing whether they were receiv-
ing treatment or not.
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk Judgement comment: relatively low dropout rates; for post-intervention mea-
surement at 8 weeks 40/40 and 38/40 participants in each group provided da-
ta. Missing data inputed.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no reference to protocol. No response from author.
Other bias High risk Quote: "Mats Dahlin and Kristofer Vernmark are employed by Psykologpart-
ners, which is a company developing and selling products related to the re-
search described in this paper. The other five authors have no conflict of inter-
est."
Judgement Comment: The practice by which two authors are employed of-
fers online support programs for depression. This clinic also owns, developed,
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Study characteristics
Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: participants from Sweden were recruited between January 2013 and May 2014 through
advertisements in newspapers, on various websites and through social media
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Physical exercise without treatment rationale
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: GAD-7 8.97
• Depression severity: PHQ-9: 12.01
• Age: -
Physical exercise with treatment rationale
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: GAD-7 8.97
• Depression severity: PHQ-9: 12
• Age: -
Behavioural activation Lewinshon's model
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: GAD-7 9.29
• Depression severity: PHQ-9: 12.5
• Age: -
Bbehavioural activation Martell's model
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: GAD-7 9.39
• Depression severity: PHQ-9: 13
• Age: -
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Waiting list
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: PHQ-9: 11.5
• Age: -
Overall
• Gender (N male, % male, N female, % female): 76% women, 24% men
• Ethnic group: -
• Household income: -
• Occupation/ employment: 54% working full time, 20% part-time, 11% student, 6% retired, 9% unem-
ployed
• Education level: 3% elementary, 35% high school, 59% graduate school, 3% postgraduate
• Comorbid anxiety: GAD-7 9.28
• Depression severity: PHQ-9: 12.5
• Age: 42 (SD 13.5), range 20-80
Included criteria: mild to moderate depression (DSM-IV-TR), score between 15 to 35 on MADRS-S, be
aged > 18 years, have a computer with access to the internet, be a resident in Sweden, and be able to
read and write in Swedish.
Excluded criteria: individuals were excluded if they were regarded as suicidal or severely depressed
(according to MADRS-S), presently participating in any other psychological treatment, had made
changes in their anti-depressant medications (or other medications that may affect mood) during the
last three months, were active exercisers (exercised more than once a week) or met criteria for another
primary psychiatric diagnosis
Pretreatment: no baseline characteristics reported by group.
Interventions Intervention characteristics
Physical exercise without treatment rationale
• type of intervention: comparator
• specific intervention: physical exercise programme without treatment rationale
• dose: 12 sessions
• frequency: once a week
• duration: 12 weeks
• level of therapist: professional (in training)
• individual or group therapy: individual
• mode of delivery: online interface with some therapist support
• modifications: -
Physical exercise with treatment rationale
• type of intervention: comparator
• specific intervention: physical exercise programme with rationale
• dose: 12 sessions
• frequency: once a week
• duration: 12 weeks
• level of therapist: professional (in training)
• individual or group therapy: individual
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• mode of delivery: online interface with some therapist support
• modifications: -
Behavioural activation Lewinshon's model
• type of intervention: BA
• specific intervention: behavioural activation (Lewinsohn)
• dose: 12 sessions
• frequency: once a week
• duration: 12 weeks
• level of therapist: professional (in training)
• individual or group therapy: individual
• mode of delivery: online interface with some therapist support
• modifications: -
Behavioural activation Martell's model
• type of intervention: BA
• specific intervention: behavioural activation (Martell)
• dose: 12 sessions
• frequency: once a week
• duration: 12 weeks
• level of therapist: professional (in training)
• individual or group therapy: individual
• mode of delivery: online interface with some therapist support
• modifications: -
Waiting list
• type of intervention: comparator
• specific intervention: waiting list
• dose: -
• frequency: -
• duration: 12 weeks
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: partially reported
• Scale: PHQ-9
• Range: 0-27
• Direction: lower is better
• Data value: endpoint
• Notes:
Anxiety symptoms
• Outcome type: continuous outcome
• Reporting: partially reported
• Scale: GAD-7
• Direction: lower is better
• Data value: endpoint
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• Notes:




Authors name: Markus BT Nyström
Institution: Umeå University
Email: markus.nystrom@umu.se
Address: Department of Psychology, Umeå University, SE-901 87 Umeå, Sweden
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)









High risk Judgement comment: no blinding possible in this kind of intervention but still
highly likely to interfere with outcomes.
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Judgement comment: questionnaires were self-completed at home through
an online interface, so influence by researchers is less likely but patient prefer-




High risk Judgement comment: group differences in number of participants dropping
out or with no follow-up data. For example, in BAL group 6% dropped out
and for 11% there were no follow-up data, compared to 18% and 3% for BAM
group. This may be related to differences in how effective treatment was per-
ceived to be. No information reported on reasons for dropout.
Selective reporting (re-
porting bias)
High risk Judgement comment: secondary outcomes on physical activity, quality of life,
and general health are mentioned in the protocol but no data are reported.
Other bias High risk Judgement comment: the interventions specified in the protocol do not match
those in the report. The protocol specifies BA with treatment rationale versus
BA without treatment rationale, instead of BAL versus BAM. This is worrying
because it is unclear how interventions were developed and why this change
was made. The analysis plan also differs substantially from the analyses re-
ported. The sample size was substantially smaller from the proposed sample
size (N = 286 versus 500).
Judgement comment: In the protocol, one author reported a conflict of inter-
est: "CM has written a self-help book similar to the treatment that will be in
one of the treatment arms (BA). Consequently, CM will not be involved in any
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of the informed consent procedures or analyses of outcome data." In the re-





Methods Study design: Randomised controlled trial
Study grouping: parallel group
Recruitment: the study was conducted from August 2015 to January 2016 for adults with depression in
geriatric community mental health centres located at Suwon and Gwangju, Republic of Korea
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 4 (8.5%) male
• Ethnic group: 100% Korean
• Household income: -
• Occupation/ employment: -
• Education level: mean 4.2 yrs (SD 3.8)
• Comorbid anxiety: -
• Depression severity: 12.5 (SD 2.2) baseline GDS
• Age: 78 (SD 6.0)
Usual care management
• Gender (N male, % male, N female, % female): 8 (17.4%) male
• Ethnic group: 100% Korean
• Household income: -
• Occupation/ employment: -
• Education level: mean 4.5 yrs (SD 4.1)
• Comorbid anxiety: -
• Depression severity: 12.2 (SD 2.2) baseline GDS
• Age: 77 (SD 7.2)
Overall
• Gender (N male, % male, N female, % female): 12 male (13%), 81 (87%) female
• Ethnic group: 100% Korean
• Household income: -
• Occupation/ employment: -
• Education level: mean 4.4 yrs (SD 3.9)
• Comorbid anxiety: -
• Depression severity: 12.3 (SD 2.2)
• Age: 78 (SD 6.6)
Included criteria: 1) those with non-psychotic, unipolar MDD DSM-IV diagnosis (Mini-International
Neuropsychiatric Interview)13; 2) those with Montgomery Asberg Depression Rating Scale (MADRS)
score of 17 or higher 14; and 3) those who were taking antidepressants at stable dosage for at least 6
weeks prior to study entry without any medical recommendation for medication change for the next 3
months.
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Excluded criteria: 1) those with other Axis I psychiatric disorder; 2) those with acute or severe medical
illness (e.g., metastatic cancer, liver failure); 3) those who were taking drugs known to cause depres-
sion; 4) those with advanced dementia; and 5) those with aphasia or inability to speak Korean.
Pretreatment: slightly more males in UCM
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: multi-domain prize based contingency management for lifestyle modification
• dose: -
• frequency: one phone call a week + 1 session of therapy a month
• duration: 12 weeks
• level of therapist: non-specialist
• individual or group therapy: individual
• mode of delivery: telephone and face-to-face
• modifications: Prizes for positive reinforcement in this study were symbolic gold medal stickers
Usual care management
• type of intervention: comparator
• specific intervention: Usual care management - supportive psychotherapy
• dose: -
• frequency: one phone call a week + 1 session of therapy a month
• duration: 12 weeks
• level of therapist: non-specialist
• individual or group therapy: individual
• mode of delivery: face-to-face plus phone
• modifications: Focused on non-specific therapeutic factors such as facilitating expression of effect,
conveying empathy, and imparting optimism.
Outcomes Geriatric depression scale
• Outcome type: continuous outcome
• Reporting: partially reported
• Scale: Geriatric Depression Scale (GDS)
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Identification Sponsorship source: this study was supported by a grant (HI15C1032) funded by a R&D Project of Ko-
rea Mental Health Technology.
Country: South Korea
Setting: geriatric community mental health centres located at Suwon and Gwangju, Republic of Korea.
Comments: -
Authors name: Ki Jung Chang
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Institution: Ajou Good Hospital
Email: sjsonpsy@ajou.ac.kr
Address: Department of Psychiatry, Ajou University School of Medicine, 164 World cupro, Yeong-
tong-gu, Suwon 16499, Republic of Korea
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "informed consent. Randomization and masking <b>Randomization
was designed in blocks of four participants using SAS. The</b> study coordina-
tor sequentially allocated par-"
Allocation concealment
(selection bias)
Low risk Quote: "The study coordinator sequentially allocated participants to either
usual care management (UCM) or lifestyle modification with contingency man-
agement"
Judgement comment: sequentially allocated participants in block of four after





High risk Judgement comment: group allocation not divulged to participants, although
nurses were not blinded and feelings about treatment may affect outcome
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Quote: "Raters were independent evaluators who were unaware of randomiza-




Low risk Judgement comment: only a few dropped out during treatment, similar num-
bers in both groups
Selective reporting (re-
porting bias)
High risk Quote: "(NCT03095820)."
Judgement comment: study protocol states MADRS is primary outcome, but
GDS is reported instead. Report did not include measurement at 8 weeks as
mentioned in protocol.
Other bias Unclear risk Quote: "The intervention was carried out by trained health worker in men-
tal health community center. For treatment fidelity, they received training
on brief advising process, assessing activity level using a simple self-assess-
ment tool, providing how to in- crease the activity level, and selecting ade-
quate lifestyle modification goals. A manual was also provided to health work-
ers with systematic introductions. Health workers followed the study’s written
protocols when making any intervention-related recommendations."





Methods Study design: randomised controlled trial
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Study grouping: parallel group
Recruitment: participants were primary health centre attendees recruited between August 2013 and
October 2013
Type of RCT (blind, double-blind, open-label):
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 11 male (35%), 20 female (64%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: Unemployed 19 (61.3%), manual 8 (25.8%), professional 3 (9.7%) no data
1 (3.2%)
• Education level: None 6 (19.3%), primary 17 (54.8%), secondary or higher 8 (25.8%)
• Comorbid anxiety: -
• Depression severity: -
• Age: 42.8 (SD 13.0)
Enhanced usual care
• Gender (N male, % male, N female, % female): 6 male (25%), 18 female (75%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: Unemployed 12 (50.0%), manual 9 (37.5%), professional 2 (8.3%), no data
1 (4.2%)
• Education level: 5 none (21%), 11 primary (46%), 8 higher than primary (33%)
• Comorbid anxiety: -
• Depression severity: -
• Age: 37.6 (SD 10.2)
Overall
• Gender (N male, % male, N female, % female): 17 male, 38 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -






• type of intervention: BA
• specific intervention: healthy Activity Program: brief psychological therapy based on behavioural ac-
tivation for depression
• dose: 30- to 40-minute session
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• frequency: weekly or fortnightly
• duration: 6 to 8 weeks
• level of therapist: non-specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: modification of behavioural activation for depression to simplify language, improve
cultural relevance and acceptability, and enhance feasibility for delivery by lay counsellors
Enhanced usual care
• type of intervention: comparator




• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: partially reported
• Scale: BDI-II
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Remission
• Outcome type: dichotomous outcome
• Reporting: partially reported
• Direction: higher is better
• Data value: endpoint
• Notes: participants with PHQ<5
Identification Sponsorship source: This research has been entirely funded by a Wellcome Trust Senior Research Fel-
lowship to V.P. (Grant no. 091834/Z/10/Z).
Country: India
Setting: primary health centres
Comments: -
Authors name: Vikram Patel
Institution: Centre for Chronic Conditions and Injuries, Public Health Foundation of India, New Delhi
Email: vikram.patel@lshtm.ac.uk
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Address: H No 451 (168), Bhatkar Waddo, Succour, Porvorim, Bardez, Goa 403501, India
Notes Only adjusted risk ratios reported.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Those who consented were randomly allocated in a 1:1 ratio to receive
either enhanced usual care (EUC) or EUC plus HAP using a computer-generat-
ed allocation sequence, stratified by primary health centre and gender."
Allocation concealment
(selection bias)
Low risk Quote: "Those who consented were randomly allocated in a 1:1 ratio to receive
either enhanced usual care (EUC) or EUC plus HAP using a computer-generat-





Unclear risk Judgement comment: no blinding. Dropout may have been influenced by will-
ingness of researchers to engage with participants, and by participants' prefer-
ence for treatment arms.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk Judgement comment: unclear who assessed outcomes. Presumably same as








Unclear risk Judgement comment: protocol not available
Other bias High risk Judgement comment: authors were responsible for the development of this
intervention. Even if not financially, they would benefit from its success (sta-
tus, recognition).
Quote: "The quality of the delivery was enhanced by provision of checklists
for use by counsellors during sessions. Examples were step-by-step guidelines
in dealing with difficult situations (especially high suicide risk) and o-the-
shelf solutions derived from experiences in the clinical case series for dealing
with social problems. Finally, simplification of therapeutic tools was empha-
sised, such as doing activity monitoring in blocks of time (morning, afternoon,
night) rather than hourly and the use of icons to represent specific activities
and emotions for patients with limited literacy to track activities."
Judgement comment: strategies to improve fidelity, but no monitoring or





Methods Study design: randomised controlled trial
Study grouping: parallel group
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Recruitment: a sample of Latinos with a Spanish-speaking preference was recruited from July 2013 to
June 2014 primarily through community organisations and radio stations serving the Spanish-speaking
community.
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 83% female
• Ethnic group: country of origin: 22% El Salvador, 17% Guatemala, 17% Honduras
• Household income: 45% ≤ USD 14999, 20% 15000-29999, 25% 30000-44999, 10% 45000 or higher
• Occupation/ employment: 48% full-time, 9% part-time
• Education level: mean grade 11 (SD 3.7)
• Comorbid anxiety: 74%
• Depression severity: BDI 29.9 (SD 9.26)
• Age: 34 (SD 12.2)
Supportive counselling (SC)
• Gender (N male, % male, N female, % female): 87% female
• Ethnic group: 35% El Salvador, 17% Mexico, 13% Guatemala
• Household income: 47% ≤ USD 149,99, 35% 150,00 to 29,999, 18% 30,000 to 44,999, 0% 45,000 or higher
• Occupation/ employment: 35% full-time, 14% part-time
• Education level: mean grade 10 (SD 3.8)
• Comorbid anxiety: 56%
• Depression severity: BDI 29.5 (SD 11.5)
• Age: 38 (SD 15.2)
Overall
• Gender (N male, % male, N female, % female): 85% female
• Ethnic group: 28% El Salvador, 15% Guatemala, 13% Honduras, 13% Mexico
• Household income: 46% ≤ USD 149,99, 27% 150,00 to 299,99, 22% 300,00 to 449,99, 5% 450,00 or higher
• Occupation/ employment: 41% full-time, 11% part-time
• Education level: mean grade 11 (SD 3.7)
• Comorbid anxiety: 65%
• Depression severity: -
• Age: 36 (SD 13.8)
Included criteria: 1) be a minimum of 18 years of age, 2) Latino/a, 3) report Spanish-language prefer-
ence, 4) meet MDD criteria, 5) not meet criteria for substance abuse or dependence, bipolar or psychot-
ic disorders, 6) not be receiving psychotherapy, and 7) if taking antidepressants, demonstrate three or
more consecutive months of use
Excluded criteria: -
Pretreatment: no statistically significant differences, but BATD group seems to have more previous
treatment for depression and higher rates of comorbid anxiety disorder and PTSD, than SC group.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
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• duration: 10 weeks
• level of therapist: non-specialist (students)
• individual or group therapy: individual
• mode of delivery: face to face, homework assignments
• modifications: manual translated into Spanish
Supportive counselling (SC)
• type of intervention: comparator
• specific intervention: supportive counselling
• dose: -
• frequency: weekly
• duration: 10 weeks
• level of therapist: non-specialist (students)
• individual or group therapy: individual
• mode of delivery: face to face, homework assignments
• modifications: manual translated into Spanish
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: BDI
• Direction: lower is better
• Data value: endpoint
• Notes: follow-up at 1 month seems to be 1 month from end of treatment (10 weeks).
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Depression remission
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Scale: SCID-IV
• Direction: higher is better
• Data value: endpoint
Identification Sponsorship source: the work was supported in part by the National Institute of Mental Health
F31MH098512-02 awarded to Anahi Collado.
Country: USA
Setting: community
Comments: participants were paid $125 throughout the course of the study for completing assess-
ments and for travel.
Authors name: Anahí Collado
Institution: Center for Addictions, Personality, and Emotion Research (CAPER)
Email: acollado@umd.edu
Collado 2016  (Continued)
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
Address: Center for Addictions, Personality, and Emotion Research (CAPER), 2103 ColeField House,
University of Maryland, College Park, MD 20742, USA
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "the assessments, participants receive compensation. <b>At the first
meeting, a sta member not involved in the study conducts the randomization
using a computerized random number generator</b> and informs the partici-
pant’s therapist"
Judgement comment: independent sta member conducts the randomisation
using a computerised random number generator
Allocation concealment
(selection bias)





High risk Judgement comment: blinding not possible. This may affect outcomes if re-
searchers, therapists, or sta have a preference for the treatment versus con-
trol intervention.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Judgement comment: the research assistant conducting assessments for a




High risk Judgement comment: 20/46 did not complete follow-up. Small number
dropped out because of the intervention
Selective reporting (re-
porting bias)
High risk Judgement comment: protocol mentions Hamilton Rating Scale for Depres-
sion to be measured in each session, but no results reported. Results for 1
month follow-up depression remission (SCID-IV) also not reported. Stigma
checklist questionnaire not reported.





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: referred by local community agencies for treatment of depression
Type of RCT (blind, double-blind, open-label):
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
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• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Cognitive therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Waiting list
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Overall
• Gender (N male, % male, N female, % female): 100% female
• Ethnic group: 100% Puerto Rican
• Household income: 100% low income
• Occupation/employment: 100% unemployed
• Education level: average 6 years
• Comorbid anxiety: -
• Depression severity: -
• Age: mean 38
Included criteria: depressed (classified by BDI and HAM-D) low socio-economic status, unemployed,
Puerto Rican women who were recipients of government financial aid
Excluded criteria: women thought to be psychotic, addicted to drugs, organic, or severely suicidal
were not considered for the investigation.
Pretreatment: no significant differences reported.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behaviour therapy; activity schedules, verbal contracts, and behavioral rehearsal
techniques for training social skills and self-reinforcement
• dose: 1.5 hours per session
• frequency: 5 sessions
Comas Díaz 1981  (Continued)
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• duration: 4 weeks
• level of therapist: -
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Cognitive therapy
• type of intervention: comparator
• specific intervention: cognitive therapy (Beck's)
• dose: 1.5 hours per session
• frequency: 5 sessions
• duration: 4 weeks
• level of therapist: -
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: added elements of learned helplessness strategies (assertiveness and experience with
success and failure)
Waiting list
• type of intervention: comparator
• specific intervention: waiting list
• dose: -
• frequency: -
• duration: 4 weeks
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: partially reported
• Scale: HRSD
• Direction: lower is better
• Data value: endpoint
Identification Sponsorship source: none reported. Research completed as part of a PhD.
Country: USA
Setting: local community agencies
Comments: -
Authors name: Lillian Comas-Diaz
Institution: Yale University
Email: -
Address: Yale University School of Medicine, 464 Congress Avenue, New Haven, Connecticut 06519
Notes Data not included in meta-analysis; not possible to estimate SD.
Risk of bias
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "After matching the clients in age and severity of depression as mea-
sured by the Beck pretreatment scores, 8 women were randomly assigned to a
cognitive therapy group, 8 lo a behavior therapy group, and 10 to a waiting list/
assessment group."
Judgement comment: no further information on how randomisation was
achieved. Author could not be contacted.
Allocation concealment
(selection bias)
Unclear risk Judgement comment: no information on allocation concealment. Author





High risk Judgement comment: no blinding. All treatment provided by one therapist.
Experience of therapy was found to be similar in the two treatment groups.
Lack of blinding may influence outcomes.
Blinding of outcome as-
sessment (detection bias)
All outcomes





Unclear risk Judgement comment: no information provided re dropouts and missing data.
Author could not be contacted.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no protocol available. Author could not be contacted.
Other bias Low risk Judgement comment: no other sources of bias identified. No evidence of con-





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: adults seeking mental health services for Unipolar Depression recruited through public
service announcements, newspaper advertisement, solicitations from community professionals, and
other healthcare agencies
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation






• Depression severity: BDI score 32.78 (SD 6.3)
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• Age:
Waiting list






• Depression severity: BDI score 29.75 (SD 5.6)
• Age:
Overall
• Gender (N male, % male, N female, % female): 19 M (61.3%) , 12 F (38.7%)
• Ethnic group: 1 African American, 1 Hispanic, 1, 1 Inernational, 1 Alsakan American, 26 Caucasian, 1
did not report
• Household income: Under $10,000 per year = 8, $10-$20K per year = 7, $20-$30K per year = 7, over $30k
per year = 7, did not report = 2
• Occupation/employment:
• Education level: < 12 years = 2, 12 years or GED = 5, >12 <16 years = 13, 16 years = 3, 16 + years = 8
• Comorbid anxiety:
• Depression severity:
• Age: mean 37.9
Included criteria: MDD according to DSM-IV, at least 20 on BDI-II and 14 or greater on revised HRSD.
Excluded criteria: coexistent psychiatric disorders including bipolar or psychotic subtypes of depres-
sion, panic disorder, current alcohol or other substance abuse, past or present schizophrenia or schizo-
phreniform disorder, organic brain syndrome, obsessive compulsive disorder and mental retardation.
Participants who were in some concurrent form of psychotherapy or who needed to be hospitalised be-
cause of imminent suicide potential or psychosis were deemed ineligible for the study
Pretreatment: baseline differences not reported by treatment arm
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural activation (Beck)
• dose: 1-hour sessions
• frequency: weekly
• duration: 10 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications:
Waiting list
• type of intervention: comparator
• specific intervention: waiting list
• dose: one-hour sessions
• frequency: weekly
• duration: 6 weeks
• level of therapist: specialist
Cullen 2003  (Continued)
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• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications:
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: BDI-II
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
depression
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Scale: MDD according to DSM-IV
• Direction: lower is better
• Data value: endpoint
Identification Sponsorship source: none reported. PhD thesis.
Country: United States
Setting: University Psychology Clinic
Comments: PhD dissertation
Authors name: Jennifer M Cullen
Institution: Western Michigan University
Email: -
Address: Western Michigan University, Kalamazoo, Michigan
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Judgement comment: "If they chose to participate, each person was assigned
a research code number to be used on all subsequent forms and randomly as-
signed into an immediate treatment or waitlist control condition." Unclear
how randomisation was achieved.
Allocation concealment
(selection bias)




Unclear risk Judgement comment: no information. Presumably not blinded.
Cullen 2003  (Continued)
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All outcomes
Blinding of outcome as-
sessment (detection bias)
All outcomes




High risk Judgement comment: data on dropouts are unclear and inconsistent: in the
text; it is suggested that 5 participants dropped out after randomisation. In the
tables it only shows 3 dropouts (in the treatment group). Further on in the text
it is reported that only 3 participants finished treatment. Outcome data are al-
so reported where none were collected (Table 3, follow-up WL group), and in-
appropriate imputation is performed; it appears missing outcome data from
14/17 participants were imputed using the mean score of the 3 remaining par-
ticipants. Dropout rate appears high (14/27).
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: data on HRSD were inconsistently reported. No proto-
col available.
Other bias Unclear risk Judgement comment: data on dropouts and outcomes are unclear and incon-





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: recruitment occurred between 1998 and 2001; the majority of participants were recruit-
ed from media advertisements, a substantial minority by referral from local agencies, and the rest by
word of mouth or other referral sources.




• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Cognitive therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
Dimidjian 2006 
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• Depression severity: -
• Age: -
Antidepressant medication
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Placebo
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Overall
• Gender (N male, % male, N female, % female): 159 female (66%)
• Ethnic group: 197 White (82%)
• Household income: -
• Occupation/ employment: 171 (71%) employed outside the home
• Education level: 121 (50%) college graduate
• Comorbid anxiety: 57 (24%)
• Depression severity: 103 (43%) low (HRSD 14-19), 138 (57%) high (HRSD >=20)
• Age: 39.9 (SD 10.97)
Included criteria: age 18 to 60, met criteria for major depression (DSM-IV) and scored 20 or higher on
the BDI-II and 14 or greater on the HRSD.
Excluded criteria: lifetime diagnosis of psychosis or bipolar disorder, organic brain syndrome, or men-
tal retardation. Suicide risk, alcohol or drug abuse/dependence, panic disorder, OCD, psychogenic pain
disorder, anorexia, or bulimia, antisocial/borderline/schizotypal personality disorder, participants who
had not responded favourably within the preceding year to an adequate trial of either CT or paroxetine
also were excluded. Unstable medical condition, using any medication that would complicate the ad-
ministration of paroxetine, allergy to paroxetine. Pregnant/breastfeeding
Pretreatment: people in the CT group seemed to have slightly lower levels of depression symptoms
than people in the BA group at baseline, although any differences were small. There were fewer women
in the BA group.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural activation
• dose: 50 minute sessions
• frequency: maximum 24 sessions. twice weekly for first 8 weeks, then once weekly for next 8 weeks
Dimidjian 2006  (Continued)
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• duration: 16 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Cognitive therapy
• type of intervention: comparator
• specific intervention: CT
• dose: 50 minute sessions
• frequency: maximum 24 sessions. twice weekly for first 8 weeks, then once weekly for next 8 weeks
• duration: 16 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Antidepressant medication
• type of intervention: comparator
• specific intervention: paroxetine (SSRI)
• dose: 10 mg to 50 mg
• frequency: daily
• duration: 8 to 16 weeks
• level of therapist: -
• individual or group therapy: individual
• mode of delivery: self-administered, with weekly/biweekly check ups
• modifications: dose increased from 10 mg to 50 mg over course of follow-up. After 8 weeks place-
bo/medication groups were allowed to switch.
Placebo
• type of intervention: comparator
• specific intervention: placebo
• dose: -
• frequency: seen weekly for first 4 weeks then bi-weekly after that
• duration: 8-16 weeks
• level of therapist: -
• individual or group therapy: individual
• mode of delivery: self-administered, with weekly/ biweekly check ups
• modifications: After 8 weeks blinding was broken and placebo/ medication groups were allowed to
switch.
Outcomes HRSD posttreatment - low-severity group
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: HRSD
• Direction: lower is better
• Data value: endpoint
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• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Side effects
• Outcome type: continuous outcome
• Reporting: fully reported
HRSD posttreatment - high-severity group
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: HRSD
• Direction: lower is better
• Data value: endpoint
• Notes: data presented separately for people with low severity (HRSD 14-19) and high severity (HRSD
>=20) depression
Identification Sponsorship source: GlaxoSmithKline provided medications and pill placebos for the trial. The re-
search was supported by National Institute of Mental Health Grant MH55502 (R01) first to Neil S. Jacob-




Authors name: Sona Dimidjian
Institution: University of Colorado
Email: sona.dimidjian@colorado.edu
Address: Department of Psychology, University of Colorado,Boulder, CO 80309-0345.
Notes Cross-over was allowed in medication and placebo groups after 8 weeks. Only data up to 8 weeks are
included in meta-analyses.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Once eligibility was determined, participants were assigned by the
participant coordinator to one of four acute treatment conditions using a com-
puter- generated randomization list:"
Judgement comment: unclear how randomisation was achieved; antidepres-
sant medication group was twice the size of the other groups, which would not




Low risk Judgement comment: participant co-ordinator used a list to randomise partic-
ipants. It appears the coordinator was therefore not blinded to the allocation.




High risk Quote: "Pharmacotherapists, evaluators, and patients were blind to medica-
tion status, meaning that the pharmacological portion of the trial was con-
ducted triple blind."
Dimidjian 2006  (Continued)
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All outcomes Judgement comment: blinding of participants and personnel for medica-
tion/placebo arms but not for therapy arms. Possible that therapists had a
preference for either CT or BA. High number of dropouts after randomisation
in medication groups, possibly because participants did want medication.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Quote: "Participants completed standard comprehensive outcome assess-






High risk Quote: "The rate of attrition for ADM (44%; n 44) was significantly higher than
for either CT (13.3%; n 6), 2 (1, N 145) 12.92, p .001, or BA (16.3%; n 7), 2 (1, N
143) 10.07, p.002."
Judgement comment: rate of attrition higher in ADM than in other groups, par-
ticularly in the first 8 weeks. Last observation carried forward for missing data.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no reference to published protocol.
Other bias High risk Quote: "GlaxoSmithKline provided medications and pill placebos for the trial."
Judgement comment: one of the authors, who managed the funding for this
research in the later stages of the study, received funding from GlaxoSmithK-





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: recruited potential participants aged 18 or over from either general practices directly or
from primary care mental health services over a 9-month period. Practices were based in a mix of rural
and urban settings.
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Bbehavioural activation
• Gender (N male, % male, N female, % female): 8 male (35%), 15 female (65%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: full time 13 (56.5%), part time 1 (4.3%), housewife 1 (4.3%), retired 3 (13%),
unemployed 4 (17.4%), incapacity benefit 1 (4.3%)
• Education level:
• Depression severity: 35.57 (9.60) mild 1 (4.3%), moderate 13 (56.5%), severe 8 (34.8)
• Age: 46.43 (24 to 63)
Usual care
• Gender (N male, % male, N female, % female): 10 male (42%), 14 female (58%)
• Ethnic group: -
Ekers 2011 
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• Household income: -
• Occupation/ employment: full time 8 (33.3%), part time 7 (29.2%), housewife 1 (4.2%), carer 1 (4.2%)
retired 3 (12.5%), unemployed 2 (8.3%), incapacity benefit 2 (8.3%)
• Education level:
• Depression severity: 35.08 (9.60), mild 2 (8.3%), moderate 9 (37.5%), severe 13 (54.2%)
• Age: 43.08 (28 to 63)
Overall
• Gender (N male, % male, N female, % female): 18 male, 29 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: 21 full-time, 8 part-time, 6 unemployed
• Education level: -
• Comorbid anxiety: 1 (2.1%)
• Depression severity: 35.32 (9.50), mild 3 (6.4%, moderate 22 (46.8%), severe 21 (44.7%)
• Age: 44.72 (24 to 63)
Included criteria: aged 18 or over, depression (ICD-10), stable or no dose of antidepressants for 6
weeks prior
Excluded criteria: suicidal risk, psychotic symptoms, diagnosis of bipolar disorder, organic brain dis-
ease or the use of alcohol/non-prescription drugs requiring clinical intervention.
Pretreatment: BA group more likely to be employed full-time, usual care group more likely to be em-
ployed part-time. 65% in BA group prescribed antidepressants, compared to 71% in usual care group.
Prescribed antidepressants BA 15 (65%), usual care 17 (71%): -
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural activation
• dose: 1 hour sessions
• frequency: 12 sessions
• duration: 3 months
• level of therapist: non-specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Usual care
• type of intervention: comparator
• specific intervention: usual care
• dose: -
• frequency: -
• duration: 3 months
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: participants were allowed to take part in interventions offered as per normal practice.
Outcomes Depression symptoms
• Outcome type: continuous outcome
Ekers 2011  (Continued)
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• Reporting: fully reported
• Scale: BDI-II
• Range: 0 to 63
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Functioning
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: Work and Social Adjustment Scale (WSAS)
• Range: 0 to 40
• Direction: lower is better
• Data value: endpoint
Clinically significant improvement
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Scale: BDI-II
• Direction: higher is better
• Data value: endpoint
• Notes: Jacobson & Truax procedures used for calculating reliable and clinically significant change
to quantify clinical improvement in depressive symptoms on the BDI-II. Calculated for whole sample
using last observation carried forward (LOCF) for missing data.




Authors name: David Ekers
Institution: Durham University
Email: david.ekers@tewv.nhs.uk
Address: Mental Health Research Centre, Durham University, Health Centre, Chester Le Street, Co
Durham, DH3 3UR, UK.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Judgement comment: "Following assessment, participants were randomised
to two arms through an allocation concealment process independent of the
study team using a block randomisation system in blocks of four."
Ekers 2011  (Continued)
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Allocation concealment
(selection bias)
Low risk Quote: "Following assessment, participants were randomised to two arms
through an allocation concealment process independent of the study team us-
ing a block randomisation system in blocks of four. Taking"
Judgement comment: not entirely clear how randomisation was performed,






High risk Quote: "participants were informed of allocation automatically by letter."
Judgement comment: no blinding given nature of treatments. Evaluation of
adherence of personnel mitigates risk of bias, but patients may have been in-
fluenced by knowing they were receiving the active treatment or usual care.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Quote: "Assessments were collected by a research worker masked to treat-
ment allocation at baseline, 1-, 2- and 3-month follow-up. To reduce the risk of
bias further we used self-completed assessments of depression symptom lev-
el, functioning and satisfaction."









Low risk Judgement comment: all outcomes stated in the protocol are reported in the
study results.
Other bias High risk Judgement comment: first author is also author of the present review. Several
of the authors of this study have benefited in their career from evidence show-





Methods Study design: cluster-randomised controlled trial
Study grouping: parallel group
Recruitment: volunteer participants were recruited from the community through the mass media.
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI 24.15
• Age: -
Fleming 1980 
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Cognitive therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI 23.46
• Age: -
Non-directive therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI 26.44
• Age: -
Overall
• Gender (N male, % male, N female, % female): 8 male, 25 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: mean 38 (SD 13.7)
Included criteria: at least 3 weeks of reported depression, no current involvement in psychotherapy,
score >= 17 on BDI, score >= 14 on D-30 scale, and clinical judgment that depression was the major pre-
senting problem.
Excluded criteria: psychotic symptoms




• type of intervention: BA
• specific intervention: behavioural therapy (self-control therapy manual Fuchs and Rehm)
• dose: 2 hours a session
• frequency: twice a week
• duration: 4 weeks
• level of therapist: non-specialist
• individual or group therapy: group
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• type of intervention: comparator
• specific intervention: cognitive therapy (cognitive modification manual Shaw)
• dose: 2 hours a session
• frequency: twice a week
• duration: 4 weeks
• level of therapist: non-specialist
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Non-directive therapy
• type of intervention: comparator
• specific intervention: unstructured, non-directive therapy
• dose: 2 hours a session
• frequency: twice a week
• duration: 4 weeks
• level of therapist: non-specialist
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: partially reported
• Scale: BDI
• Direction: lower is better
• Data value: endpoint




Authors name: Barbara M Fleming
Institution: Michigan State University
Email: -
Address: Department of Psychology, Michigan State University, East Lansing, Michigan 48824
Notes Data not included in meta-analysis; not possible to estimate SD.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Judgement comment: no information. Author could not be contacted.
Allocation concealment
(selection bias)
Unclear risk Quote: "To minimize the waiting period, groups were formed as soon as a suf-
ficient number of subjects had been screened, and each group was randomly
assigned to a treatment condition."
Fleming 1980  (Continued)
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Judgement comment: unclear whether and how allocation was concealed. Au-





High risk Judgement comment: blinding not possible due to nature of treatments. It is
likely that being aware of the therapy provided could influence outcomes.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk Judgement comment: it appears participants completed questionnaires; un-
clear who processed them. As they were aware of the intervention they re-




Unclear risk Judgement comment: 5/40 participants dropped out. Unclear in which arm.
Author could not be contacted.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no protocol available. Author could not be contacted.
Other bias High risk Judgement comment: methods are not described in detail. No information on
baseline characteristics and potential differences between study arms. Author
could not be contacted.
Issues specific to cluster RCTs:
Quote: "To minimize the waiting period, groups were formed as soon as a suf-
ficient number of subjects had been screened, and each group was randomly
assigned to a treatment condition."
Judgement comment: only 6 groups for 3 interventions. Groups were formed






Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: depressed women were sought as volunteer participant clients for an experimental ther-
apy program through announcements in the mass media.
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 100% female
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: baseline BDI 21.38
• Age: 26
Fuchs 1977 
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Non-specific therapy
• Gender (N male, % male, N female, % female): 100% female
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: baseline BDI 23.60
• Age: 28.5
Waiting list
• Gender (N male, % male, N female, % female): 100% female
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: baseline BDI 23.20
• Age: 31.1
Overall
• Gender (N male, % male, N female, % female): 100% female
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: 28.8, range 18 to 48
Included criteria: female, depressed, 18 to 60 years old. Depression based on criteria on the Minnesota
Multiphasic Personality Inventory
Excluded criteria: no history of psychiatric hospitalisation, no serious suicidal ideation or attempt, no
involvement in any other therapy for problems relating to psychological functioning within the past
month, not suicidal or psychotic.
Pretreatment: authors report no statistically significant differences.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: self-control therapy with 3 phases placing emphasis on training, self-monitoring,
self-evaluation and self-reinforcement skills
• dose: 2 hours a session
• frequency: once a week
• duration: 6 weeks
• level of therapist: specialist (in training)
• individual or group therapy: group
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• type of intervention: comparator
• specific intervention: non-directive
• dose: 2 hours a session
• frequency: once a week
• duration: 6 weeks
• level of therapist: specialist (in training)
• individual or group therapy: group
• mode of delivery: face-to-face, homework assignments
• modifications: -
Waiting list
• type of intervention: comparator




• level of therapist: -
• individual or group therapy: -
• mode of delivery: informed by telephone
• modifications: told that they would retake some of the screening tests just before therapy; were as-
sured of being seen. Follow-up data not collected as in therapy
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: partially reported
• Scale: BDI
• Direction: lower is better
• Data value: endpoint




Authors name: Carilyn Z Fuchs
Institution: University of Pittsburgh
Email: -




Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "Except where necessary to balance experimental conditions for mean
age and severity of depression, subjects were randomly assigned to one of two
therapists and one of three treatment conditions—self-control therapy, non-
specific therapy, or waiting list control."
Fuchs 1977  (Continued)
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Judgement comment: unclear how they were randomised, participants were
balanced within groups. Author could not be contacted.
Allocation concealment
(selection bias)
High risk Judgement comment: no mention of concealing allocation. It seems likely re-






High risk Judgement comment: not possible to blind, allocation especially to waiting
list may affect outcome
Blinding of outcome as-
sessment (detection bias)
All outcomes





Unclear risk Quote: "Drop-out rate did not differ significantly between conditions, x 2 ( 2 )
= .29, p < .80. Dropouts did not differ from remainders on age, Depression In-
ventory, MMPl D, or MMPI total elevation scores."
Judgement comment: authors report dropouts were not different from partici-
pants who continued on some characteristics, but no information is available
on the dropout rate per study arm. Author could not be contacted.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no protocol available. Author could not be contacted.
Other bias High risk Quote: "All therapy subjects were required to make a $10 deposit, which was to
be returned upon completion of the last session."
Judgement comment: participants had to pay a deposit to take part. This may
influence outcomes, for example if participants felt the need to respond in a
more positive way. Not clear from the report how many participants started
and finished in each group. Author could not be contacted. Baseline character-
istics of participants by study arm not reported; there may have been impor-
tant differences between the groups. Intervention was developed by the au-






Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: through advertisements in the local newspapers
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
Gardner 1981 
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• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI 24.5
• Age: 19-65
Cognitive therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI 23
• Age: 19-65
Overall
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: 19 to 65
Included criteria: men and women aged 19 to 65 with depression.
Excluded criteria: no depression according to BDI criteria.
Pretreatment: no differences reported.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural therapy
• dose: -
• frequency: -
• duration: 6 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Cognitive therapy
• type of intervention: comparator
• specific intervention: cognitive therapy using a rational emotive therapeutic approach
• dose: 6 sessions
• frequency: -
• duration: 6 weeks
• level of therapist: specialist
• individual or group therapy: individual
Gardner 1981  (Continued)
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• mode of delivery: face-to-face
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: partially reported
• Scale: BDI
• Direction: lower is better
• Data value: endpoint
• Notes: data extracted from figure with WebPlotDigitizer




Authors name: P Gardner
Institution: La Trobe University, Bundoora, Australia
Email: -
Address: Department of Psychology, La Trobe University, Bundoors, Australia 3083
Notes Noortje Uphoff on 25/09/2019 18:51
Included
Author contacted to ask for clarifications about RoB assessment.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "Based on the Beck Depressive Inventory, Ss were assigned to light,
moderate and severe depressive levels and then were matched on these levels
and on sex and allocated randomly after matching to the behavioral treatment
group (BT) or the cognitive treatment group (CT)."
Judgement comment: no information on randomisation method reported.










High risk Judgement comment: it is not reported if there were any attempts to blind
participants or personnel but unlikely given nature of trial.
Blinding of outcome as-
sessment (detection bias)
All outcomes




High risk Quote: "Thirteen Ss withdrew at the end of the first baseline period."
Gardner 1981  (Continued)
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Judgement comment: 13 participants withdrew during baseline measurement




Unclear risk Judgement comment: no reference to protocol.
Other bias Unclear risk Judgement comment: no information on participant characteristics by study
arm. No information on who therapists were or how therapist allegiance





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: introductory psychology students recruited from a public Southeastern university who
received credit for participation
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: BAI 13.4
• Depression severity: BDI 21.0
• Age: -
No treatment
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: BAI 16.1
• Depression severity: BDI 19.8
• Age: -
Overall
• Gender (N male, % male, N female, % female): 6 men (20%), 24 women (80%)
• Ethnic group: 21 Caucasian (70%) 4 African American (13%), 5 other (17%)
• Household income: -
• Occupation/ employment: 100% university students
• Education level: currently at university first year (100%)
• Comorbid anxiety: -
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• Depression severity: -
• Age: mean 18.4 (SD 0.81)
Included criteria: participants 18 years and older who scored 14 or higher on the BDI–II and were not
presently undergoing pharmacological or psychological treatment for depression were included in the
study.
Excluded criteria: involved with psychotherapy within the past 2 years, active suicidal intent, current
psychosis, bipolar disorder.
Pretreatment: no information on participant characteristics by study arm.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural activation treatment for depression (BATD)
• dose: 90-minute session
• frequency: 1 session + homework
• duration: 2 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: one session treatment
No treatment
• type of intervention: comparator




• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Outcomes Clinically significant improvement
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Scale: BDI-II
• Direction: higher is better
• Data value: endpoint
• Notes: clinically significant improvement on BDI-II using reliable chance indices (RCI).
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
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• Scale: BDI-II
• Direction: lower is better
• Data value: endpoint
Anxiety symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: BAI
• Direction: lower is better
• Data value: endpoint
Identification Sponsorship source: none reported; study part of a thesis
Country: USA
Setting: University of Tennessee psychology clinic
Comments: -
Authors name: Derek R Hopko
Institution: University of Tennessee
Email: dhopko@utk.edu
Address: University of Tennessee, Knoxville, Department of Psychology,Room 301D, Austin Peay Build-
ing, Knoxville, TN 37996-0900
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Judgement comment: no information about how randomisation was
achieved. Author could not be contacted.
Allocation concealment
(selection bias)
Unclear risk Judgement comment: no information about efforts to conceal allocation. Au-





High risk Judgement comment: patients knew whether they were received an interven-
tion or not, as did personnel. It is likely that this influences outcomes.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk Judgement comment: unclear whether outcome assessors were blinded. It ap-
pears patients completed questionnaires, which may cause bias due to experi-




Low risk Judgement comment: researchers report there was no attrition.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no reference to protocol. Author could not be contact-
ed.
Other bias High risk Judgement comment: no information on participant characteristics by study
arm, making it hard to establish whether randomisation was successful. Au-
thor could not be contacted.
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Quote: "Behavioral Activation Treatment for Depression (BATD; Lejuez, Hopko,
& Hopko, 2001; Hopko & Lejuez, 2007)."
Judgement comment: author Hopko developed the intervention tested (BATD)





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: participants aged 65 years or older from 32 primary care practices in the North of Eng-
land gave written informed consent between March 2011 and July 2013. Potential participants were
identified by postal questionnaire and were eligible if they reported depressive symptoms on a stan-
dardized brief 2-item case-finding tool
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 159 male (46%), 185 female (54%)
• Ethnic group: 340 (98.8%) white, 2 (0.6%) Asian, 1 (0.3%) other
• Household income: -
• Occupation/ employment: -
• Education level: 52% education beyond 16 years, 33% degree or equivalent professional
• Comorbid anxiety: mean GAD-7 score 5.7 (SD 4.8)
• Depression severity: mean PHQ-9 score 7.8 (SD 4.7)
• Age: mean 77.1 (SD 7.09)
Usual GP care
• Gender (N male, % male, N female, % female): 139 male (38%), 222 female (61%)
• Ethnic group: 358 (99.2%) white, 2 (0.6%) black
• Household income: -
• Occupation/ employment: -
• Education level: 51% education beyond 16 years, 29% degree or equivalent professional
• Comorbid anxiety: mean GAD-7 score 5.7 (SD 4.4)
• Depression severity: mean PHQ-9 score 7.8 (SD 4.6)
• Age: mean 77.5 (SD 7.18)
Overall
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Gilbody 2017 
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
Included criteria: aged ≥ 75 years during the pilot phase or ≥ 65 years during the main trial identified
by a GP practice as being able to take part in collaborative care, subthreshold depression according to
DSM-IV (MINI 5.0)
Excluded criteria: known alcohol dependency, psychotic symptoms, comorbidity making entry into
trial inadvisable, other factors that would make an invitation to participate in a trial inappropriate.
Pretreatment: No important differences found between the groups.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: collaborative care using behavioural activation
• dose: half an hour sessions
• frequency: weekly sessions, 6 on average
• duration: 8 to 10 weeks
• level of therapist: non-specialist (mental health/ IAPT worker)
• individual or group therapy: individual
• mode of delivery: 1st session face-to-face, then telephone
• modifications: programme designed for those aged ≥ 65 years with subthreshold depression and to
accommodate long-term physical health problems
Usual GP care
• type of intervention: comparator




• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: initiate medication only in response to increasing depressive symptoms
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: PHQ-9
• Range: 0-27
• Direction: lower is better
• Data value: endpoint
• Notes: data for unadjusted analysis; other analyses were reported.
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Cases of depression
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Scale: PHQ-9
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• Direction: lower is better
• Data value: endpoint
• Notes: PHQ-9 score of >= 10 indicating moderate to severe depression.
Quality of life - SF12 PCS
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: SF-12 PCS
• Range: 0 to 100
• Direction: higher is better
• Data value: endpoint
Quality of life - SF12 MCS
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: SF-12 MCS
• Range: 0 to 100
• Direction: higher is better
• Data value: endpoint
Anxiety symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: GAD-7
• Range: 0-21
• Direction: lower is better
• Data value: endpoint
Adverse events
• Outcome type: adverse event
• Reporting: fully reported
• Data value: endpoint
• Notes: 81 suspected adverse events; 37 in 33 patients in the collaborative care arm and 44 in 43 pa-
tients in the usual care arm. None of the adverse events were possibly, probably, or definitely related
to the study. None of the deaths were suicides.
Identification Sponsorship source: this project was funded by the NIHR Health Technology Assessment programme
(reference: 08/19/04
Country: UK
Setting: 32 primary care centres in the UK
Comments: -
Authors name: Simon Gilbody
Institution: Department of health sciences, University of York
Email: simon.gilbody@york.ac.uk
Address: Department of Health Sciences, Seebohm Rowntree Building, University of York, Heslington,
York, YO10 5DD, UK
Notes  
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Judgement comment: randomisation through computer programme at York
trials unit. Participants were allocated in a 1:1 ratio by simple randomisation
without blocking or stratification.
Allocation concealment
(selection bias)
Low risk Judgement comment: use of computer programme ensured automatic ran-
domisation without intervention by a researcher. Treatment allocation was
concealed from study researchers at the point of recruitment using an auto-
mated computer data entry system, administered remotely by the York Trials





High risk Judgement comment: due to the nature of the intervention this was an open
trial. Participants in particular may have been influenced by knowing whether
they were in the intervention or usual care group.
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Judgement comment: most participants completed self-reported question-
naires and those who did not respond were asked to complete the PHQ-9 over




High risk Judgement comment: similar rates of non-response across arms, but in the
collaborative care arm participants were more likely to withdraw from the trial
or follow-up at either 4 or 12 months. Many of those states 'no time', 'too busy'
or 'does not wish to engage', which may be related to the intervention and par-
ticipants leL in the trial may therefore be better responders than those who
did not complete the study. Authors did perform analysis adjusting for factors
associated with non-response, but other factors may not have been measured.
Four-month retention was 83%, with higher loss to follow-up in collaborative
care (82/344 [24%]) vs usual care (37/361 [10%]).
Selective reporting (re-
porting bias)
Low risk Judgement comment: reason for changing to 65 years justified, outcomes the
same in protocol
Other bias High risk Judgement comment: trial is meant to include patients with subthreshold de-
pression only (based on MINI), but a substantial proportion of participants re-
port either severe/moderately severe depression or no depression at baseline
based on the PHQ-9.
Judgement comment: some of the authors have published extensively on the
topic of behavioural activation, and it would be in their interest for the trial to
show effectiveness of the intervention. The author team also developed the in-





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: students enrolled in psychology classes at University
Type of RCT (blind, double-blind, open-label): Open
Hammen 1975 
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Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Expectancy control
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Self-monitoring
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age:
No treatment
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Overall
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
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Included criteria: student in introductory psychology class, consistent signs of mild to moderate de-
pression
Excluded criteria: -




• type of intervention: BA
• specific intervention: increase pleasant events
• dose: -
• frequency: -
• duration: 2 weeks
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Expectancy control
• type of intervention: comparator
• specific intervention: dietary change; attention placebo
• dose: -
• frequency: -
• duration: 2 weeks
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Self-monitoring
• type of intervention: comparator
• specific intervention: no changes from normal activities
• dose: -
• frequency: -
• duration: 2 weeks
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
No treatment
• type of intervention: comparator
• specific intervention: no treatment
• dose: -
• frequency: -
• duration: 2 weeks
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
Hammen 1975  (Continued)
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• modifications: retesting at end of study
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: Partially reported
• Scale: Depression Adjective Checklist
• Direction: lower is better
• Data value: endpoint




Authors name: Constance L. Hammen
Institution: University of California
Email: -
Address: Department of Psychology, University of California, Los Angeles, California
Notes Data reported for Depression Adjective Checklist is daily average over treatment period rather than
endpoint.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Judgement comment: no information on randomisation. Author contacted;
was not able to provide information.
Allocation concealment
(selection bias)
Unclear risk Judgement comment: no information on how allocation was performed or





Unclear risk Quote: "The study was depicted as an investi- gation of mood changes in col-
lege students; sub- jects were not told that they had been selected on the ba-
sis of depressed mood. Ten subjects were randomly assigned to each of four
groups."
Judgement comment: no blinding reported. Unclear whether participants
were aware of study arms. Author contacted; was not able to provide informa-
tion.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk Judgement comment: no information on how performed outcome assess-




Unclear risk Judgement comment: dropouts and missing data not reported. Author con-
tacted; was not able to provide information.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no reference to protocol. Author contacted; was not
able to provide information.
Hammen 1975  (Continued)
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Other bias Unclear risk Judgement comment: no description of baseline characteristics of partici-
pants. Baseline depression scores not reported. No outcomes reported for no-





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment:
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender: 87% female
• Ethnic group: 29% White, 33% Brown, 38% Black
• Household income: -
• Occupation/ employment: 63% employed
• Education level: 38% high school, 62% higher education
• Comorbid anxiety: 25%
• Depression severity: HAM-D: 22.38 (SD 5.8), BDI: 32.38 (SD 8.6)
• Age: mean 40.9 (SD 11.0)
Trial-based cognitive therapy (TBCT)
• Gender: 88% female
• Ethnic group: 27% White, 54% Brown, 19% Black
• Household income: -
• Occupation/ employment: 73% employed
• Education level: 27% high school, 73% higher education
• Comorbid anxiety: 54%
• Depression severity: HAM-D: 20.62 (SD 5.3), BDI: 31.38 (SD 7.1)
• Age: mean 39.6 (SD 10.4)
Inclusion criteria: on antidepressant medication for at least 2 months, 18 to 60 years old, met MDD cri-
teria (DSM-IV/ICD-10) assessed with MINI, >15 HDRS score/ >20 BDI.
Exclusion criteria: mood stabilising drugs, bipolar disorder, psychotic disorders, current abuse or de-
pendence on psychoactive substances.
Pretreatment: more recurrent depression, GAD, and comorbidities in TBCT group. Also more likely to
be an employee. TAU group lower baseline scores of anxiety and related measure (BAI, CD-Quest).
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
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• duration: 12 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: adapted for 12 sessions
Trial based cognitive therapy (TBCT)
• type of intervention: comparator
• specific intervention: trial based cognitive therapy (+ antidepressants)
• dose: -
• frequency: weekly
• duration: 12 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Treatment as usual
• type of intervention: comparator
• specific intervention: treatment as usual (+ antidepressants)
• dose: -
• frequency: N/A
• duration: 12 weeks
• level of therapist: N/A
• individual or group therapy: N/A
• mode of delivery: N/A
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: HRSD
• Direction: lower is better
• Data value: mean, SD
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Scale: -
• Direction: lower is better
• Data value: n/N
Anxiety symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: BAI
• Direction: lower is better
• Data value: mean, SD
Quality of life (physical domain)
• Outcome type: continuous outcome
Hemanny 2019  (Continued)
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• Reporting: fully reported
• Scale: WHOQOL-BREF
• Direction: higher is better
• Data value: mean, SD
Social functioning
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: CD-Quest
• Direction: lower is better
• Data value: mean, SD
Identification Sponsorship source: not reported in paper or protocol.
Country: Brazil
Setting: not reported
Comments: all participants received antidepressants throughout study.
Authors name: Curt Hemanny
Institution: Health Sciences Institute, Federal University of Bahia
Email: hemanny@gmail.com
Address: Postgraduate Program of Interactive Processes of Organs and Systems, Health Sciences Insti-
tute, Federal University of Bahia, Brazil
Notes All participants also received antidepressants
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "When eligible, participants were assigned by the research coordinator,
through a randomization list, to 1 of 3 intervention groups".
Judgement comment: randomisation list used but not clear how generated
Allocation concealment
(selection bias)
Unclear risk Judgement comment: research co-ordinator performed randomisation using






Unclear risk Judgement comment: unclear if attempts made to blind participants (de-
scribed as 'single blind' but this may refer to outcome assessors) but unlikely
that participants were blinded given nature of intervention.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Quote: "All assessments were performed by a trained and blind evaluator."




High risk Judgement comment: dropout rates were relatively high (16/26 in TAU group)
and more patients dropped out of TAU than other groups. Some reasons for
drop out (not wanting to take part after being randomised to TAU group) are
likely to be related to the interventions. Missing data were imputed and as-
sumed to be missing at random; this might not be justified.
Hemanny 2019  (Continued)
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Selective reporting (re-
porting bias)
High risk JJudgement comment: primary outcome measure was BDI in protocol and
HAM-D in paper. One-year measurements specified in protocol but not report-
ed. Beck Anxiety Inventory not specified in protocol.
Other bias High risk JJudgement comment: potential conflict of interest; one of the authors devel-





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: potential clients were referred by a Seattle area health maintenance organization (HMO)
or self-referred through a newspaper advertisement soliciting participation in a depression treatment
program.
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): N = 16 male (28%), N = 41 female (72%)
• Ethnic group: African American 1 (1.9%), Hispanic 2 (3.7%), Caucasian 50 (92.6%), Native American 1
(1.9%), Asian 0 (0%)
• Household income: -
• Occupation/ employment: -
• Education level: N = 18 post college (32%), N = 36 college graduate (63%)
• Comorbid anxiety: -
• Depression severity: BDI 29.3 (SD 6.9), HRSD 17.4 (SD 3.8)
• Age: mean 36.6
Cognitive therapy
• Gender (N male, % male, N female, % female): N = 12 male (24%), N = 38 female (76%)
• Ethnic group: African American 3 (6%), Hispanic 0(%), Caucasian 38 (76%), Native American 3 (6%),
Asian 2 (4%)
• Household income: -
• Occupation/ employment: -
• Education level: N = 12 post college (24%), N = 27 college graduate (54%)
• Comorbid anxiety: -
• Depression severity: BDI 29.8 (SD 6.3), HRSD 19.1 (SD 4.4)
• Age: mean 39.2
Automatic thoughts
• Gender (N male, % male, N female, % female): 34 female (77%), 10 male (23%)
• Ethnic group: 1 Hispanic (2%), 40 Caucasian (91%), 2 Native American (4%), 1 Asian (2%)
• Household income: -
• Occupation/ employment: -
• Education level: 22 college graduate (50%), 8 post college (18%)
• Comorbid anxiety: -
Jacobson 1996 
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• Depression severity: BDI 29.2 (SD 6.6), HRSD 19.3 (SD 4.0)
• Age: mean 38.3
Overall
• Gender (N male, % male, N female, % female): N = 28 male, N = 79 female
• Ethnic group: N = 88 Caucasian, N = 12 other
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Included criteria: all clients met the following inclusion criteria: a diagnosis of current major depres-
sion based on DSM-III-R, a score of 20 or higher on the BDI, a score of 14 or higher on the HAM-D, agree-
ment to random assignment to one of three treatment conditions, and agreement to having therapy
sessions audiotaped and to completing questionnaires and participating in follow-up interviews.
Excluded criteria: at imminent risk of suicide, within the previous 6 months they met criteria for an Ax-
is I disorder of alcohol or drug abuse or dependence, anorexia, bulimia, or panic disorder; or they had
ever met criteria for obsessive compulsive disorder, bipolar disorder, or schizophrenia.
Pretreatment: baseline HAM-D score higher in CT group. No other baseline characteristics reported in
this paper. Used baseline characteristics from original paper (numbers slightly different).
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural activation
• dose: -
• frequency: -
• duration: 20 sessions in total
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Cognitive therapy
• type of intervention: comparator
• specific intervention: cognitive therapy
• dose: -
• frequency: -
• duration: 20 sessions in total
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Automatic thoughts
• type of intervention: comparator
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• duration: 20 sessions in total
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: elements of BA
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: HRSD
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint





Authors name: NS Jacobson
Institution: University of Washington
Email: -




Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk Judgement comment: no information. Contacted author: concealed from re-





High risk Judgement comment: no blinding; outcome may be influenced by therapist
and patient preference.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Contacted author: outcome assessors blinded.
Jacobson 1996  (Continued)
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Low risk Judgement comment: N = 1 in each group did not complete post-treatment




Unclear risk Judgement comment: no protocol.
Other bias Unclear risk Judgement comment: numbers of participants in two papers of same trial do





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: participants were low-income, monolingual Spanish-speaking Latinos who were re-
ferred for psychological services at the behavioral health clinic of the SSCHC over a 9-month period
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 16 female (76%)
• Ethnic group: 14 (66.7%) Mexico, 6 (28.6%) Puerto Rico, 1 (4.8%) other
• Household income: 9 ≤ $10,000 (43%), 6 10,000 to 20,000 (29%), 3 >20,000 to 30,000 (14%)
• Occupation/employment: 11 unemployed (52%)
• Education level: -
• Comorbid anxiety: -
• Depression severity: 6 low (29%), 15 high (71%)
• Age: 38.7 (SD 11.7)
Treatment as usual
• Gender (N male, % male, N female, % female): 18 female (82%)
• Ethnic group: 15 (68.2%) Mexico, 3 (13.6%) Puerto Rico, 3 (13.6%) other
• Household income: 11 ≤ $10,000 (50%), 5 10,000-20 to 000 (23%), 5 >20,000 to 30,000 (23%)
• Occupation/ employment: 12 unemployed (54%)
• Education level: -
• Comorbid anxiety: -
• Depression severity: 11 low (50%), 11 high (50%)
• Age: 37.5 (SD 10.1)
Overall
• Gender (N male, % male, N female, % female): 34 female (79%)
• Ethnic group: 29 (67.4%) Mexico. 9 (20.9%) Puerto Rico. 4 (9.3%) other
• Household income: 20 ≤ $10,000 (46%), 11 10,000 to 20,000 (26%), 8 >20,000 to 30,000 (19%
• Occupation/ employment: 23 unemployed (53%)
• Education level: -
• Comorbid anxiety: -
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• Depression severity: 17 low (39%), 26 high (60%)
• Age: 38.1 (SD 10.8)
Included criteria: Latino, age 18 to 65, score 16 or higher on modified 17 item HRSD, meeting criteria
for major depressive disorder (DSM-IV-TR).
Excluded criteria: any problem requiring immediate inpatient hospitalisation, organic brain syndrome
or an intellectual or developmental disability according to medical records, probable alcohol abuse, a
lifetime diagnosis of psychosis or bipolar disorder as indicated by the MINI, a current diagnosis of panic
disorder as indicated by the MINI, or being on an antidepressant medication at the time of eligibility as-
sessment.




• type of intervention: BA
• specific intervention: Behavioural Activation for Latinos (BAL)
• dose: 50-minute sessions
• frequency: weekly
• duration: up to 12 sessions
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: Adapted from Martell original BA model
Treatment as usual
• type of intervention: comparator
• specific intervention: treatment as usual; non-specified therapy
• dose: 50 minute sessions
• frequency: weekly
• duration: up to 12 sessions
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Outcomes Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Depression symptoms
• Outcome type: continuous outcome
• Reporting: partially reported
• Scale: HRSD
• Direction: lower is better
• Data value: endpoint
• Notes: outcomes only reported by number of sessions completed; no data for two arms by treatment
group.
Kanter 2015  (Continued)
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Quality of life - SF12 PCS
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: SF12 PCS
• Direction: higher is better
• Data value: endpoint
Quality of life SF-12 MCS
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: SF-12 MCS
• Direction: higher is better
• Data value: endpoint
Identification Sponsorship source: this study was supported by NIMH Grant (R34) MH085109-01A1 awarded to
Jonathan W. Kanter and Azara L. Santiago-Rivera.
Country: USA
Setting: community health centre
Comments: -
Authors name: Jonathan W. Kanter
Institution: University of Washington
Email: jonkan@uw.edu
Address: Department of Psychology, University of Washington, Box 351525, Seattle, Washington, 98105
Notes Noortje Uphoff on 26/07/2019 18:13
Included
No outcomes by treatment arm; only by number of sessions.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Participants then were randomly assigned by the project coordinator
to one of two acute treatment conditions, BAL or TAU, using a computerized
adaptive biased-coin randomization procedure that uses the urn design (Wei &
Lachin, 1988) balancing on gender, marital status, and depression severity, in









High risk Judgement comment: blinding not possible due to nature of interventions.
This may have led to bias for participants in particular.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Judgement comment: outcome assessor was blinded.
Kanter 2015  (Continued)
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High risk Quote: "BAL clients attended significantly more sessions over the course of
therapy (M = 8.21, SD = 3.95) compared to TAU clients (M = 4.95, SD = 3.41),"
Judgement comment: Dropout was higher in TAU group. Dropout in BAL group
was more likely for those with higher baseline depression symptoms, and




Unclear risk Judgement comment: author contacted; no pre-registration or protocol avail-
able.
Other bias High risk Judgement comment: TAU was a non-specified therapy, which shared ele-
ments of treatment with the behavioural activation therapy. Given that TAU
was not specified and therapists were aware of the treatment they provided,
the 'TAU' treatment may have been different from what it would have been
outside the trial. For example, purposefully less focused on behavioural activa-
tion.
Intervention developed by one of the authors (Kanter), who has published a
book on behavioural activation. It is therefore likely he has an interest in the
intervention being successful.
Quote: "Both BAL and TAU therapists followed equivalent standard clinic pro-
cedures with respect to the scheduling of sessions and phone follow-ups with
clients in the case of missed sessions"
Quote: "Although both BAL and TAU therapists followed the same clinic proto-
cols between sessions with respect to calling clients who missed sessions or to
remind clients to attend sessions, BAL therapists likely worked harder in ses-
sion to encourage session attendance."
Judgement comment: BAL protocol specifically encouraged therapists to





Methods Study design: randomised controlled trial
Study grouping: cross-over
Recruitment: newspaper advertisement
Type of RCT (blind, double-blind, open-label): 10-week intervention; active treatment started in
week 3 and in week 7 cross-over was used.
Participants Baseline characteristics
Behavioural activation






• Depression severity: Mean BDI: 24 (from graph)
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• Age:
Cognitive intervention approach






• Depression severity: Mean BDI: 23.5 (from graph)
• Age:
Overall






• Depression severity: BDI 10 to 40
• Age:
Included criteria: score between 10 and 40 on BD. ICommitment to attend 10 consecutive treatment
sessions, commitment to complete all research forms requested
Excluded criteria: severe depression (40 to 60 on BDI). Very mild depressive symptoms (0 to 9 on BDI),
unable to commit to full participation
Pretreatment: No information. Baseline depression level similar between groups.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural treatment programme
• dose: one hour sessions
• frequency: weekly
• duration: 10 weeks (active treatment 4 weeks)
• level of therapist: specialist in training (doctoral students with training in specific approach)
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: Exploratory sessions for first 2 weeks with no specific attempt to improve symptoms.
Cognitive intervention from week 7.
Cognitive intervention approach
• type of intervention: comparator
• specific intervention: cognitive treatment
• dose: 1-hour sessions
• frequency: weekly
• duration: 10 weeks (active treatment 4 weeks)
• level of therapist: specialist in training (doctoral students with training in specific approach)
• individual or group therapy: individual
• mode of delivery: face-to-face
Kelly 1983  (Continued)
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• modifications: Exploratory sessions for first 2 weeks with no specific attempt to improve symptoms.
Behavioural intervention from week 7.
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: partially reported
• Scale: BDI
• Direction: lower is better
• Data value: endpoint
• Notes: data extraction from graph using WebPlotDigitizer.
Identification Sponsorship source: none reported.
Country: USA
Setting: training and research centre at a university
Comments:
Authors name: E. Thomas Dowd
Institution: University of Nebraska
Email:
Address: Department of Educational Psychology and Social Foundations, Educational Psychology Clin-
ic, University of Nebraska, 130 Bancroft Hall, Lincoln, Nebraska 68588, USA
Notes Noortje Uphoff on 18/07/2019 19:38
Included
Submitted and received inte-rlending request through library.
Data not included in meta-analysis; not possible to estimate SD.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Judgement comment: no information on randomisation method provided. Au-
thor could not be contacted.
Allocation concealment
(selection bias)
Unclear risk Judgement comment: no information on randomisation method provided. Au-





High risk Judgement comment: no attempts to blind participants or personnel reported
and unlikely due to nature of trial.
Blinding of outcome as-
sessment (detection bias)
All outcomes




Unclear risk Judgement comment: no information regarding dropout rates; presumably all
participants completed the interventions. Author could not be contacted.
Kelly 1983  (Continued)
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Selective reporting (re-
porting bias)
Unclear risk Judgement comment: measures reported in methods section are not present-
ed in results section. Result section does not fully report results of all analyses.
No reference to protocol. Author could not be contacted.
Other bias Unclear risk Judgement comment: study design: first inactive treatment, then active treat-
ment, then treatments are swapped. Results show that decline in depression
symptoms in both groups start during inactive treatment. - No information re-
garding baseline characteristics of participants.- Participants may have been
pressured to complete the study (inclusion criteria include commitment to





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment:
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Comprehensive self-control (behavioural activation)
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Self-monitoring plus self-evaluation (behavioural activation)
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Principles-only (behavioural activation)
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
Kornblith 1980 
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
• Depression severity: -
• Age: -
Psychotherapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Overall
• Gender (N male, % male, N female, % female): 100% women (N = 49)
• Ethnic group: -
• Household income: average USD 15,000 to 20,000
• Occupation/ employment: 44.9% employed
• Education level: median 13.9 years of school. 98% high school graduates
• Comorbid anxiety: -
• Depression severity: mean BDI score 27.6
• Age: mean 37.9, range 19 to 59
Included criteria: women, 18to 60 years old, not currently or in last 30 days in psychotherapy for de-
pression, not taking antidepressants or major tranquillisers, no life-threatening illness, =>20 on BDI and
met Research Diagnostic Criteria for Major Affective Disorder.
Excluded criteria: current suicidal crisis, mania, hypomania, or schizophrenia; organic brain syn-
drome; mental retardation; borderline syndrome; antisocial personality; anorexia nervosa; or, during
the last 12 months: alcohol abuse, anxiety disorder, Briquet's syndrome, drug abuse, obsessive-com-
pulsive disorder, panic disorder, or phobic disorder.
Pretreatment: psychotherapy group seemed to have lower baseline depression scores
Interventions Intervention characteristics
Comprehensive self-control (behavioural activation)
• type of intervention: BA
• specific intervention: behavioural activation with principles, exercises, and homework based on Rehm
principles
• dose: 1.5 hours a session
• frequency: weekly
• duration: 12 weeks
• level of therapist: specialist
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Self-monitoring plus self-evaluation (behavioural activation)
• type of intervention: BA
• specific intervention: behavioural activation with focus on self-reinforcement
• dose: 1.5 hours a session
• frequency: weekly
• duration: 12 weeks
Kornblith 1980  (Continued)
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• level of therapist: specialist
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Principles-only (behavioural activation)
• type of intervention: comparator
• specific intervention: behavioural activation without homework (principles only)
• dose: 1.5 hours a session
• frequency: weekly
• duration: 12 weeks
• level of therapist: specialist
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Psychotherapy
• type of intervention: comparator
• specific intervention: general psychotherapy without homework
• dose: 1.5 hours a session
• frequency: weekly
• duration: 12 weeks
• level of therapist: specialist
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: HDRS - interviewer rates
• Direction: lower is better
• Data value: endpoint
• Notes: reporting BA and comparator groups only due to review inclusion criteria. Reporting interview-
er rates instead of clinician rates.
Functioning
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: Global Assessment Scale
• Direction: higher is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Identification Sponsorship source: the study was supported by NIMH grant R01 MH27822 to the second author, who
also chaired the dissertation committee.
Kornblith 1980  (Continued)
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Authors name: Lynn Rehm
Institution: University of Houston
Email: -
Address: Department of Psychology, University of Houston, Houston, Texas 77004.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Judgement comment: author contacted; allocation based on when participant
was screened; not completely at random.
Allocation concealment
(selection bias)
High risk Judgement comment: author contacted; allocation based on when participant





High risk Judgement comment: no blinding possible due to nature of interventions. This
may influence outcomes, particularly because patients were aware of treat-
ment and may favour one treatment over another.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Quote: "All clinicians were blind as to treatment condition, and the second
raters were blind as to the pre/post status of the subject's videotape."




High risk Quote: "Of the 10 withdrawals who failed to continue in the program past ses-
sion 9, 5 dropped from the 16 who began the Comprehensive Self-Control
condition (31%0), 0 dropped from the 12 who began the Self-Monitoring plus
Self- Evaluation condition (0%0), 4 dropped from the 15 who began the Prin-
ciples-Only condition (27%0), and 1 dropped from the 6 who began the Psy-
chotherapy condition (17%)."
Judgement comment: Dropout seemed higher in comprehensive self-control
(BA) group than in psychotherapy group. This may be due to chance (small
numbers) or because the psychotherapy was seen as more favourable.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: contacted author; no protocol or online registration
available.
Other bias High risk Judgement comment: contacted author; no baseline characteristics of partici-
pants published but groups balanced on age and severity of depression symp-
toms according to author. One of the authors (Rehm) developed the model of
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Methods Study design: cluster-randomised controlled trial
Study grouping: parallel group
Recruitment: seven long-term care facilities managed by a single non government organisation were
randomly assigned as experimental and control sites. Participants recruited from the experimental
sites were invited to take part in the PMAL intervention, whereas participants from the control sites re-
ceived care as usual. A list of potential participants who may benefit from PMAL intervention was gen-
erated from the most up-to-date record of the Minimum Data Set (MDS) 2.0
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 27 female (84%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: 13 (43.3%) no formal education, 12 (40%) primary school, 5 (16.7%) middle school or
higher
• Comorbid anxiety: -
• Depression severity: -
• Age: 85.9 (SD 7.14)
Usual care
• Gender (N male, % male, N female, % female): 23 female (77%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: 18 (56.3%) no formal education, 12 (37.5%) primary school, 2 (6.3%) middle school
or higher
• Comorbid anxiety: -
• Depression severity: -
• Age: 84.4 (SD 9.5)
Overall
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Included criteria: presence of a mood problem indicated by the Resident Assessment Protocol (RAP),
where one or more symptoms from 17 listed symptoms indicates a mood problem, a Cognitive Perfor-
mance Scale (CPS) score of 0 or 1 (intact or borderline intact), no other acute clinical variations; and
voluntary participation.
Excluded criteria: low cognitive performance
Pretreatment: no obvious differences.
Interventions Intervention characteristics
Luo 2020  (Continued)
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Behavioural activation
• type of intervention: BA
• specific intervention: Positive Mood and Active Life (PMAL) behavioural activation based on BE-ACTIV
intervention
• dose: -
• frequency: 36 sessions in total
• duration: 12 weeks
• level of therapist: non-specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: social workers instead of specialists
Usual care
• type of intervention: comparator
• specific intervention: usual care
• dose: -
• frequency: -
• duration: 12 weeks
• level of therapist: non-specialist
• individual or group therapy: individual
• mode of delivery: -
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: Geriatric Depression Scale (GDS)
• Direction: lower is better
• Data value: endpoint
• Notes: estimates from three-level linear mixed model to account for clustering of time points within
patients within nursing homes.
Dropouts
• Outcome type: dichotomous outcome
• Direction: lower is better
• Data value: endpoint
• Notes: baseline characteristics are presented for those who completed the study only.
Quality of life
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: WHOQoL
• Direction: higher is better
• Data value: endpoint
Identification Sponsorship source: none reported
Country: Hong Kong, China
Setting: long-term care facilities
Comments: -
Luo 2020  (Continued)
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
Authors name: Vivian Lou
Institution: University of Hong Kong
Email: wlou@hku.hk
Address: Department of Social Work and Social Administration, Rm522, The Jockey Club Tower, Cen-
tennial Campus, The University of Hong Kong, Pokfulam Road, Hong Kong, China
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Judgement comment: unclear how sites were randomised.
Allocation concealment
(selection bias)





High risk Judgement comment: participants and personnel were likely not blinded due
to the nature of the intervention. It is possible that the active intervention was
seen as favourable compared to 'care as usual', which may cause bias.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk Quote: "The items of the project-tailored assess- ment were read to the res-
idents by an experienced research assistant who was trained on the GDS-15
and WHOQoL- BREF by the principal investigator."
Judgement comment: unlikely that outcome assessors who administered




Low risk Judgement comment: dropout rates were low and for reasons unlikely to be
related to the treatment (cognitive impairment, frailty, mortality).
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no reference to protocol
Other bias High risk Researchers developed the intervention, which means they have an interest in
the intervention being successful.Issues specific to cluster RCTs:
Judgemen comment: 7 sites; unclear how randomised. Sites were all part of
the same organisation. No large differences between samples in control and





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: mass media and advertisements in large Swedish newspapers. Those who were interest-
ed were directed to a web page with information about the study
Ly 2014 
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Type of RCT (blind, double blind, open label):
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): N = 12 male (30%), N = 28 female (70%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: 35 (87.5%) employed/student, 3 (7.5%) unemployed, 0 retired, 2 (6.3%) oth-
er
• Education level: 1 (2.5%) 9-year compulsory school, 11 (27.5%) secondary school, 27 (67.5%) col-
lege/university, 1 (2.5%) other
• Comorbid anxiety: N = 19 (47%)
• Depression severity: BDI-II 23.50 (7.85 SD)
• Age: mean 36.6 (10.5 SD). range 20 to 59 years
Mindfulness
• Gender (N male, % male, N female, % female): N = 12 male (29%), N = 29 female (71%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: 30 (73.2%) employed/student, 3 (7.3%) unemployed, 1 (2.4%) retired, 7
(17.1%) other
• Education level: 2 (4.9%) 9-year compulsory school, 14 (34.1%) secondary school, 24 (58.5%) col-
lege/university, 1 (2.4%) other
• Comorbid anxiety: N=10 (24%)
• Depression severity: BDI-II mean 24.68, SD 9.47
• Age: mean 35.6 (11.3 SD), range 21 to 61 years
Overall
• Gender (N male, % male, N female, % female): N = 24 male, N = 57 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: N = 65 employed, N = 6 unemployed, N = 10 other
• Education level: 3 (3.8%) 9-year compulsory school, 25 (30.9%) secondary school, 51 (63%) college/uni-
versity, 2 (2.5%) other
• Comorbid anxiety: N = 29 (36%)
• Depression severity: -
• Age: mean 36.1 (10.8 SD), range 20 to 61 years
Included criteria: 18 years old, > 5 on PHQ-9, depressive symptoms according to DSM-IV, access to the
internet and a smartphone, good knowledge of Swedish language.
Excluded criteria: change in psychiatric medication in the last month, any other current psychological
treatment, severe comorbid psychiatric condition which could interfere with treatment e.g. bipolar or
schizophrenia, primary medical problems that would need other treatment, severe alcohol problems,
severe depression, suicidal ideation.
Pretreatment: BA group seems to have a slightly higher level of education, is less likely to be on med-




• type of intervention: BA
Ly 2014  (Continued)
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• specific intervention: smartphone delivered BA with minimal therapist contact
• dose: max 20 min per participant per week of therapist contact
• frequency: personal encouraging messages every other or every third day, weekly general educational
messages, weekly reflections from participants
• duration: 8 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: smartphone + email
• modifications: app was not designed for depression but to register behaviours to increase everyday
activation. BA treatment manual adapted for this intervention.
Mindfulness
• type of intervention: comparator
• specific intervention: smartphone delivered psychoeducation and mindfulness with minimal therapist
contact
• dose: max 20-minutes per participant per week of therapist contact. 3 to 30 minutes guided audio
tracks
• frequency: personal encouraging emails every other or every third day, weekly general educational
emails, weekly reflections from participants
• duration: 8 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: smartphone + email
• modifications: emails rather than messages via the app, mindfulness adapted for this intervention
Outcomes Recovery rates
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: higher is better
• Data value: endpoint
• Notes: recovery rates were defined as no longer fulfilling the criteria for depression according to the
MINI
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Data value: endpoint
Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: BDI-II
• Direction: lower is better
• Data value: endpoint
Anxiety symptoms
• Outcome type:cContinuous outcome
• Reporting: fully reported
• Scale: Becks Anxiety Inventory
• Direction: lower is better
• Data value: endpoint
Ly 2014  (Continued)
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Quality of life
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: QOLI
• Direction: higher is better
• Data value: endpoint
Identification Sponsorship source: the Swedish Research Council sponsored this study with funding 2011–2476.
Country: Sweden
Setting: community/ at home
Comments: -
Authors name: Kien Hoa Ly
Institution: Department of Behavioural Sciences and Learning, Linkoeping University
Email: kien.hoa.ly@liu.se
Address: Department of BehaviouralSciences and Learning, Linköping University, Linköping, Sweden
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Judgement comment: allocated using an online randomisation tool, done by
an independent person separate from sta conducting the study
Allocation concealment
(selection bias)
Low risk Judgement comment: randomisation done by independent person. Not





High risk Judgement comment: participants and therapists providing support via email
were not blinded. Their preference may have influenced outcomes.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Quote: "At the 6-month follow-up, the interviews were conducted by other
clinical psychology students who were blind to the participant’s condition and
the treatment they had been given."





Low risk Judgement comment: similar numbers lost to post-assessment and 6-month
follow-up in both groups, and included in ITTanalysis.
Selective reporting (re-
porting bias)
High risk Judgement comment: protocol states outcomes will be reported at 1 year in-
stead of 6 months. Primary outcome measures same as protocol, didn't in-
clude TIC-P secondary outcome which was in protocol.
Other bias High risk Judgement comment: the research group developed the behavioural activa-
tion smartphone app, so it in their interest for the app to be successful.
Ly 2014  (Continued)
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Study characteristics
Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: flyers around university campus
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Bbehavioural activation
• Gender (N male, % male, N female, % female): 76% female, 24% male
• Ethnic group: 90% White, 5% Black, 5% Asian
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI-II 18.75, SD 8.08
• Age: 19.6, SD 1.27
No treatment
• Gender (N male, % male, N female, % female): 83% female, 17% male
• Ethnic group: 78% White, 11% Black, 6% Hispanic, 6% Asian
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI-II 21.56, SD 6.05
• Age: 19.6, SD 1.46
Overall
• Gender (N male, % male, N female, % female): 81% female, 19% male
• Ethnic group: 90% White, 3% Black, 2% Hispanic, 4% Asian
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI-II 18.67, SD 3.01
• Age: 19.61 (1.35)
Included criteria: aged 18 years of over with BDI 13-28 (mild-moderate depression). Individuals taking
antidepressant medication were required to be stabilized for a period of 8 weeks prior to beginning the
study
Excluded criteria: under 18, not fluent in English, not meeting depression score criteria, significant his-
tories of suicidal thoughts, psychosis, substance abuse, or bipolar disorder. Participants taking antide-
pressants had to be stabilised for a minimum of 8 weeks prior to the study.
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• type of intervention: BA
• specific intervention: brief behavioural activation treatment for depression (BATD-R) with homework
• dose: 90-minute BATD-R based intervention session with assigned homework plus 2 follow-up ses-
sions every 2 weeks
• frequency: -
• duration: 1 month
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: Small changes to BATD protocol by Gawrysiak et al, 2009
No treatment
• type of intervention: comparator




• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: partially reported
• Direction: lower is better
• Data value: endpoint
• Notes: extracted data for ITT analysis (last observation carried forward for missing data). Data extract-
ed from figure.
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Identification Sponsorship source: none reported. PhD dissertation.
Country: USA
Setting: psychological centre at University
Comments: -
Authors name: D Lee McCluskey
Institution: West Virginia University
Email: -
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "computer-based random number generator."
Allocation concealment
(selection bias)






High risk Judgement comment: no blinding due to nature of intervention. This may
have influenced scores, for example leading to lower scores in no treatment
arm.
Blinding of outcome as-
sessment (detection bias)
All outcomes





Unclear risk Judgement comment: attrition did not differ between groups. Missing data
were imputed (last observation carried forward). It is unclear whether this is a
valid method in this case, given that scores tended to go down at the first time
point but up before follow-up.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: protocol not available. Author could not be contacted.





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: recruited through general psychology courses using a research participation website
(96%) and fliers posted on campus (4%). Recruitment took place between August 2013 and January
2014.
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 11 females (69%)
• Ethnic group: 88% White, 6% Asian American, 6% Indian/ Middle Eastern
• Household income: 3 (19%) < 20,000. 2 (12%) 20,000 to 40,000. 3 (19%) 40,000 to 60,000. 4 (25%) 60,000
to 80,000. 3 (19%) 80,000 to 100,000. 1 (6%) >100,000
• Occupation/ employment: 100% students
• Education level: 100% college students
• Comorbid anxiety: -
• Depression severity: 63% major depressive disorder
• Age: 19.3 (SD 1.5)
Mindfulness-based therapy
McIndoo 2016 
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• Gender (N male, % male, N female, % female): 12 females (60%)
• Ethnic group: 80% White, 5% African American, 5% Hispanic, 10% mixed
• Household income: 4 (20%) <$20,000, 2 (10%) 20,000 to 40,000, 1 (5%) 40,000 to 60,000. 4 (20%) 60,000
to 80,000. 2 (10%) 80,000 to 100,000. 7 (35%) >100,000
• Occupation/ employment: 100% students
• Education level: 100% college students
• Comorbid anxiety: -
• Depression severity: 70% major depressive disorder
• Age: 19.3 (SD 1.9)
Waiting list
• Gender (N male, % male, N female, % female): 8 females (57%)
• Ethnic group: 57% White, 7% African American, 7% Indian/Middle Eastern, 7% HIspanic, 22% mixed
• Household income: 2 (14%) <20,000. 2 (14%) 20,000 to 40,000. 2 (14%) 40,000 to 60,000. 4 (29%) 60,000
to 80,000. 3 (22%) 80,000 to 100,000. 1 (7%) >100,000
• Occupation/ employment: 100% students
• Education level: 100% college students
• Comorbid anxiety: -
• Depression severity: 64% major depressive disorder
• Age: 19.0 (SD 1.5)
Overall
• Gender (N male, % male, N female, % female): 19 male (38%), 31 female (62%)
• Ethnic group: 76% White, 10% mixed race, 4% African American, 4% Asian American, 4% Indian/Middle
Eastern, 2% HIspanic
• Household income: -
• Occupation/ employment: 100% students
• Education level: 100% college students
• Comorbid anxiety: -
• Depression severity: 66% major depressive disorder
• Age: 19.2 (SD 1.67)
Included criteria: college students with depression (BDI-II >=14), non-medicated or stabilised for 8
weeks, not receiving other psychotherapy or counselling.
Excluded criteria: psychosis, alcohol or substance dependence.
Pretreatment: depression severity slightly higher in mindfulness group
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural activation
• dose: 1 hour sessions
• frequency: weekly
• duration: 4 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: minor modifications to suit population and reduction to 4 sessions
Mindfulness-based therapy
• type of intervention: comparator
McIndoo 2016  (Continued)
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• specific intervention: mindfulness-based therapy modelled on MBSR (Kabat-Zinn, 1982)
• dose: 1 hour sessions
• frequency: weekly
• duration: 4 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: reduced length of programme from 8 to 4 weeks; individual rather than group based
Waiting list
• type of intervention: comparator




• level of therapist:
• individual or group therapy:
• mode of delivery:
• modifications: offered BA or mindfulness at end of treatment
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: HRSD
• Direction: lower is better
• Data value: endpoint
Dopouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Anxiety symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: BAI
• Direction: lower is better
• Data value: endpoint
Response
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Scale: HRSD
• Direction: higher is better
• Data value: endpoint
• Notes: response defined as at least 50% reduction on HRSD
Remission
• Outcome type: dichotomousOutcome
• Reporting: Fully reported
McIndoo 2016  (Continued)
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• Scale: HRSD
• Direction: Higher is better
• Data value: Endpoint
• Notes: Remission defined as no longer meeting criteria for depression according to HRSD.
Clinically significant improvement
• Outcome type: Dichotomous outcome
• Reporting: fully reported
• Scale: HRSD
• Direction: higher is better
• Data value: endpoint
• Notes: reliable change index (RCI) calculated with HRSD scores
Identification Sponsorship source:
Country: USA
Setting: Students at University of Tennessee
Comments: -
Authors name: Derek Hopko
Institution: University of Tennessee
Email: dhopko@utk.edu
Address: The University of Tennessee Knoxville, Department of Psychology, 307 Austin Peay Building,
Knoxville, TN 37996-0900, USA.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "As indicated on the CONSORT Figure, if included following the com-
prehensive assessment, based on a randomization table, participants were as-
signed to BA (n ¼ 16), MBT (n ¼ 20), or the WLC"
Judgement comment: randomisation table used.
Allocation concealment
(selection bias)
High risk Quote: "The principal investigator (DH) generated and concealed the random-
ization table and stored it in a secure area. When participants were officially in-
cluded in the trial, respective therapists were then informed (by the PI) which
therapy they would provide."
Judgement comment: therapists were not involved in allocation procedure,





High risk Judgement comment: no blinding due to nature of interventions. This could
have influenced study outcomes.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk Judgement comment: outcome assessors not specified; presumably thera-
pists supervised patient-completed questionnaires as outcome questionnaires
were completed following therapy sessions. Author could not be contacted.
McIndoo 2016  (Continued)
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High risk Judgement comment: for remission/response and clinically relevant change,
only post-treatment data were reported and not follow-up. Since these out-
comes are based on HRSD scores collected at each time point, they could have
been calculated and reported. Three fewer weeks of intervention compared to
protocol so did not do behavioural contracting strategies.
Other bias High risk Judgement comment: one of the authors (Hopko) was involved in the develop-






Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: participants were invited from those seeking services at the counselling centre.
Type of RCT (blind, double-blind, open-label): not reported
Participants Baseline characteristics
Cognitive therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI mean (SD): 24.80 (5.29)
• Age: -
Behavioural activation
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI mean (SD): 25.90 (4.04)
• Age: -
Combined therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
McNamara 1986 
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• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI mean (SD): 22.11 (4.28 )
• Age: -
High demand control
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI mean (SD): 25.55 (8.35)
• Age: -
Overall
• Gender (N male, % male, N female, % female): 11 male (27%), 29 female (73%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: mean 23, range 19-31
Included criteria: seeking services at counselling centre, reported depressive episode of at least 2
weeks, BDI => 18 at intake, BDI =>16 at baseline, HRSD =>20, consented to participation
Excluded criteria: suicidal behaviour, psychosis, drug addiction, sociopathy, organicity, major medical
illness
Pretreatment: no information on patient characteristics by study arm. BDI at screening seemed higher




• type of intervention: comparator
• specific intervention: cognitive therapy
• dose: 50 minute sessions
• frequency: weekly
• duration: 8 weeks
• level of therapist: specialist (in training)
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: No attempts made to modify participants' behaviours or environments
Behavioural activation
• type of intervention: BA
• specific intervention: behaviour therapy (Lewinsohn)
• dose: 50-minute sessions
• frequency: weekly
• duration: 8 weeks
McNamara 1986  (Continued)
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• level of therapist: professional (in training)
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: No references made to cognitions as possible sources of depression
Combined therapy
• type of intervention: comparator
• specific intervention: CBT
• dose: 50-minute sessions
• frequency: weekly
• duration: 10 weeks
• level of therapist: specialist (in training)
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
High demand control
• type of intervention: comparator
• specific intervention: Rogerian person-centred humanistic therapy
• dose: 50-minute sessions
• frequency: weekly
• duration: 8 weeks
• level of therapist: specialist (in training)
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Outcomes Clinically significant improvement
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: higher is better
• Data value: endpoint
• Notes: BDI 9 or below was classed as 'normal'
Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: BDI
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
• Reporting: partially reported
• Direction: lower is better
• Data value: endpoint
Identification Sponsorship source: None reported
Country: United States
Setting: University counselling centre
McNamara 1986  (Continued)
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Comments: -
Authors name: Kathleen McNamara
Institution: Colorado State University
Email: -
Address: Department of Psychology, Colorado State University, Fort Collins, Colorado 80523
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "Whenever 4 clients met the screening criteria, they were randomly as-
signed without exception to one of the four treatment conditions."
Judgement comment: unclear how sequence was generated. Allocation was in
blocks of four. Author could not be contacted.
Allocation concealment
(selection bias)
Unclear risk Judgement comment: unclear how sequence was generated or concealed. Au-





High risk Judgement comment: no information, but it seems unlikely participants and
personnel were blinded. This may have influenced outcomes and dropout
rates.
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Judgement comment: no information on outcome assessors. Risk of bias for
follow-up, as questionnaires were completed at home by participants them-




High risk Judgement comment: dropout seemed to be higher in some groups than oth-
ers, particularly in control group, but information on number of participants in
each arm at each time point is missing. It appears that, at follow-up, the num-
ber of participants in each arm is very small (< N = 10).
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no reference to protocol. Author could not be contact-
ed.
Other bias High risk Judgement comment: no information on participant baseline characteristics.
At baseline, depression symptoms seemed lower in the combined treatment
group, but no formal assessment of differences and extremely small sample
sizes.
Judgement comment: fidelity was monitored but no evaluation of fidelity was
reported. Authors speculate that therapists may not have been delivering BA
therapy to sufficient standard.
Quote: "At the time of recruitment, seven counselors were self-described as
"cognitive-behavioral" in orientation; the eighth preferred the term "interper-
sonal" (cf. Strong, 1968). All counsellors had expressed complete willingness to
follow the exact procedures required by this study, despite any idiosyncratic
preferences that might occur."
Judgement comment: 7/8 counsellors described themselves as 'cognitive-be-
havioural' in orientation, and may therefore have been biased towards this
particular treatment.
McNamara 1986  (Continued)
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Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: from six nursing homes in Louisville, Kentucky, metropolitan area.
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation




• Education level: 9.3 (SD 1.8)
• Comorbid anxiety:
• Depression severity: HRSD 18.0 (SD 7.9
• Age: 76.9 (SD 11.5)
Treatment as usual




• Education level: 13.0 (SD 2.6)
• Comorbid anxiety:
• Depression severity: HRSD 15.9 (SD 5.8)
• Age: 79.4 (SD 4.3)
Overall
• Gender (N male, % male, N female, % female):
• Ethnic group:
• Household income:
• Occupation/ employment: retired
• Education level: 10.6 (SD 2.5)
• Comorbid anxiety:
• Depression severity: HRSD 17.2 (SD 7.1)
• Age: 75.4 (SD 10.1)
Included criteria: nursing home residents in long-term care beds with an expected stay of 3 months or
more, Geriatric Depression Scale score of at least 11, meets DSM-IV criteria for major depressive disor-
der or research diagnostic criteria for minor depressive disorder
Excluded criteria: Mini Mental State Exam score below 14 , referred to hospice care for a terminal con-
dition , current unstable or terminal medical condition , suicidal, meets DSM-IV criteria for bipolar dis-
order
Meeks 2008 
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Pretreatment: Depression seemed more severe in treatment than treatment as usual group for HRSD
and GDS, but very small sample sizes.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: Behavioral Activities Intervention (BE-ACTIV)
• dose: 30-40 minutes
• frequency: weekly
• duration: 10 weeks
• level of therapist: specialist and non-specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications:
Treatment as usual
• type of intervention: comparator
• specific intervention: treatment as usual
• dose:
• frequency:
• duration: 10 weeks
• level of therapist:
• individual or group therapy:
• mode of delivery:
• modifications:
Outcomes Depression symptoms
• Outcome type: continuous outcome
Dropouts
• Outcome type: dichotomous outcome





Authors name: Suzanne Meeks
Institution: University of Louisville
Email: smeeks@louisville.edu
Address: Department of Psychological & Brain Sciences, University of Louisville, Louisville, KY 40292.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Meeks 2008  (Continued)
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Random sequence genera-
tion (selection bias)
Low risk Quote: "randomly assigned"




High risk Judgement comment: no information. Contacted author: Random numbers





High risk Judgement comment: no blinding possible due to nature of interventions.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Quote: "A doctoral student blind to treatment condition and trained to be re-
liable on the SADS with the principal investigator and criterion training tapes
conducted posttreatment interviews."




High risk Judgement comment: dropout was 3/13 and 3/7 for treatment and control
groups, respectively, Proportionate to small sample size, this is a high dropout
rate. Morbidity and assessment burden cited as reasons for drop-out.
Selective reporting (re-
porting bias)
High risk Judgement comment: outcomes specified in online trial registration include
Darthmouth COOP scales, which was not reported, and does not include Glob-
al Assessment Scale and HDRS, which were reported.
Other bias High risk Judgement comment: extremely small sample sizes may have hindered ran-
domisation creating balance across groups. BA intervention was developed
by study author. The researcher who developed the intervention was also the





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: participants were recruited through the media and poster advertisements, word of
mouth, and referral from other mental health clinics and general practitioners
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 45 female (90%)
• Ethnic group:
• Household income:
• Occupation/ employment: employed outside home 16
• Education level: 13 college student (26%), 21 college graduate (42%)
• Comorbid anxiety: 7 (14%)
• Depression severity: HRSD 21.12 (SD 5.26)
• Age: 30.12 (SD 7.47)
Moradveisi 2015 
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Sertaline (treatment as usual)
• Gender (N male, % male, N female, % female): 40 female (80%)
• Ethnic group:
• Household income:
• Occupation/ employment: employed outside home 19
• Education level: 10 college student (20%), 19 college graduate (38%)
• Comorbid anxiety: 4 (8%)
• Depression severity: HRSD 21.62 (SD 5.42)
• Age: 32.63 (SD 10.17)
Overall




• Education level: 23 college student (23%), 50 college graduate (40%)
• Comorbid anxiety: 11 (11%)
• Depression severity: HRSD 21.37 (SD 5.32)
• Age: 31.37 (SD 8.97)
Included criteria: depressed female patients from Sanandaj, Iran, between the ages of 18 to 60 years,
with a primary diagnosis of MDD according to the DSM-IV-TR. Score of >=19 on BDI-II and >=14 on HRSD.
Excluded criteria: a lifetime diagnosis of bipolar disorder or psychosis; organic brain syndrome; intel-
lectual disability; substantial and imminent suicide risk; a current (within the past 6 months) diagno-
sis of alcohol or drug misuse or dependence, or a positive toxicology screen; a primary diagnosis other
than major depressive disorder; unfavourable antidepressant medication response within the preced-
ing year; unstable medical condition; medication use that would complicate antidepressant adminis-
tration; known allergy to antidepressant medication/sertraline; pregnancy or a plan to become preg-
nant; and inability to read and understand the study's instruments
Pretreatment: no statistically significant differences.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural activation (Martell)
• dose: 50 minutes a session, 16 sessions in total
• frequency: 1 to 2 sessions a week
• duration: 12 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications:
Sertaline (treatment as usual)
• type of intervention: comparator
• specific intervention: antidepressant Sertraline (SSRI)
• dose: 25 mg to100 mg (25 mg daily week 1, 50 mg daily week 2, 75 mg daily week 4, 100 mg daily weeks
6 to 12)
• frequency: daily
• duration: 12 weeks
• level of therapist:
Moradveisi 2015  (Continued)
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• individual or group therapy: individual
• mode of delivery:
• modifications:
Outcomes Dropouts
• Outcome type: dichotomous outcome
Depression remission
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: higher is better
• Data value: endpoint
• Notes: remission was defined as scores of <=7 on the HRSD and <=10 on the BDI.
Response
• Outcome type: dichotomous outcome
• Direction: higher is better
• Data value: endpoint
• Notes: at least a 50% reduction from baseline on both HRSD and BDI-II
Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: HRSD
• Direction: lower is better
• Data value: change from baseline
• Notes: data imputed for missing values; last observation carried forward.




Authors name: Latif Moradveisi
Institution: Maastricht University
Email: latif.moradveisi@maastrichtuniversity.nl
Address: Department of Clinical Psychological Science, Faculty ofPsychology and Neuroscience, Maas-
tricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Judgement comment: "randomised by an independent coordinator using a
computer-generated list based on blocks of four"
Allocation concealment
(selection bias)
Low risk Quote: "Participants were randomized by an independent coordinator."
Moradveisi 2015  (Continued)
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Judgement comment: allocation probably concealed adequately as the proce-





High risk Judgement comment: no blinding due to nature of interventions. This may in-
fluence treatment outcomes.
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Quote: "HRSD assessments were done by evaluators blind to treatment condi-
tions. Independent assessors assessed the HRSD for TAU patients and the BDI
for BA patients before every treatment session and supplied results to psychia-
trists and therapists."
Judgement comment: outcome assessors were independent, but clinicians




High risk Quote: "For participants who dropped out of treat- ment, we used the last ob-
servation with the associated time, and estimated missing HRSD scores (for
those in the behavioural activation group) from changes on the BDI, and miss-
ing BDI scores (for those in the TAU group) from changes on the HRSD, using
regression-derived equations (1 BDI unit = 1.3 HRSD unit). All treatment drop-
out took place before the mid-treatment assessment. We repeated the analy-
ses without these estimates as a sensitivity analysis.</b> For the test of mod-
eration"
Judgement comment: patients were more likely to drop out of the medica-
tion (N = 15) rather than the behavioural activation (N = 5) group, and reasons
for dropping out were related to dissatisfaction with treatments or side ef-
fects. Data were imputed by last observation carried forward, but patients who




Unclear risk Judgement comment: no reference to protocol
Other bias Unclear risk Judgement comment: follow-up for a year, but after 3 months participants had
to pay for medication, which may explain higher dropout rate in medication
group. Unclear how many participants continued medication after 3 months.





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: participants were recruited from two primary care psychological therapies services in
South London.
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 13 female (65%)
Nasrin 2017 
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• Ethnic group: 11 White (55%), 3 Black African (15%), 2 Black Caribbean (10%), 4 other (20%)
• Household income: -
• Occupation/employment: full time 5 (25%), part-time 5 (25%), self-employed 1 (5%), unemployed 6
(30%), in education 3 (15%)
• Education level: high school 3 (15%), NVQs 2 (10%), A levels 6 (30%), diploma 1 (5%), undergraduate
5 (25%), postgraduate 3 (15%)
• Comorbid anxiety: -
• Depression severity: 7 moderate (35%), 5 moderate-severe (25%), 8 severe (40%)
• Age: 34.90 (SD 10.9)
Waiting list
• Gender (N male, % male, N female, % female): 14 female (70%)
• Ethnic group: White 12 (60%), Black 3 (15%), Pakistani 1 (5%), Other 4 (20%)
• Household income: -
• Occupation/employment: full time 8 (40%), part-time 1 (5%), self-employed 2 (10%), unemployed 5
(25%), in education 4 (20%)
• Education level: high school 3 (15%), NVQs 6 (30%), A levels 0 (0%), diploma 2 (10%), undergraduate
5 (25%), postgraduate 4 (20%)
• Comorbid anxiety: -
• Depression severity: 5 moderate (25%), 12 moderate-severe (60%), 3 severe (15%)
• Age: 37.60 (SD 8.4)
Overall
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Included criteria: met diagnostic criteria for major depressive disorder, age 18 to 60, speaking fluent
English, 10 or above on PHQ-9
Excluded criteria: history of psychosis or mania, recent self-harm (within the last 4 weeks), current di-
agnosis of eating disorder, obsessive compulsive disorder, current drug/alcohol/medication abuse or
dependence, history of traumatic brain injury or epileptic seizures, unable to refrain from taking benzo-
diazepines 48 hours before completing the experimental tasks, and psychotherapy or counselling at a
frequency of more than once a month
Pretreatment: no notable differences.
Participants currently taking antidepressants were included in the study, with the caveat that
medication had not been changed during the 4 weeks before starting the study: -
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: brief behavioural activation
• dose: 1 session of 60 to 90 minutes
• frequency: 1
• duration: 1 week
• level of therapist: professional (in training)
Nasrin 2017  (Continued)
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• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: Based on BATD manual, reduced to 1 session
Waiting list
• type of intervention: comparator




• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: PHQ-9
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
Identification Sponsorship source: This research received no specific grant from any funding agency, commercial or
not-for-profit sectors.
Country: UK
Setting: two primary care psychological therapy services
Comments: -
Authors name: Thorsten Barnhofer
Institution: University of Exeter
Email: t.barnhofer@exeter.ac.uk
Address: University of Exeter, Sir Henry Wellcome Building for Mood Disorders Research, Perry Road,
Exeter EX4 4QG, UK
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Randomization was conducted following a simple randomization
protocol using sealed envelopes and a manually generated randomization
sequence (permuted blocked randomization with blocks of size 4) achieved
through shuffling of the envelopes that remained concealed until assignment
to the groups. The sequence was generated by an independent statistician."
Nasrin 2017  (Continued)
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Allocation concealment
(selection bias)
Unclear risk Judgement comment: sequence generated by independent statistician, but






High risk Judgement comment: assumed that no blinding was possible due to nature of
intervention. This may have led to bias in drop out of participants and depres-
sion scores.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk Judgement comment: unclear who performed outcome assessments; possibly




Unclear risk Judgement comment: missing data N = 4 in each arm, no indication this is re-
lated to the intervention.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no reference to protocol.
Other bias Unclear risk Judgement comment: it appears the first author was both therapist and out-
come assessor. If the first author was convinced of the benefit of the treat-
ment, this might have biased results both through the delivery of the treat-





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: recruited from welfare, schools, physicians and newspapers.
Type of RCT (blind, double-blind, open=label): open
Participants Baseline characteristics
Relationship model
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Behavioural activation
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
Padfield 1976 
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• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Overall
• Gender (N male, % male, N female, % female): 100% female
• Ethnic group: -
• Household income: N=12 $400 or less per month, N=11 > $400 a month
• Occupation/ employment: -
• Education level: 54% not finished high school
• Comorbid anxiety: -
• Depression severity: moderately depressed
• Age: 21 to 65
Included criteria: women of low socioeconomic status, moderately depressed (Zung self-rating de-
pression scale > 1.5, interview), living in rural area, age 18 to 64.
Excluded criteria: depression not the major problem but attributable to alcoholism, drugs, organic
causes, or temporary situational distress. In first 6 months postpartum.
Pretreatment: depression symptoms on Zung scale similar between groups at baseline. No other in-
formation on baseline characteristics by study arm.
Interventions Intervention characteristics
Relationship model
• type of intervention: comparator
• specific intervention: general counselling
• dose: 50 minute sessions
• frequency: once a week
• duration: 12 weeks (+2 week diagnostic period)
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Behavioural activation
• type of intervention: BA
• specific intervention: general counselling + BA (Lewinsohn)
• dose: 50 minute sessions
• frequency: once a week
• duration: 12 weeks (+ 2 weeks diagnostic period)
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: Zung Self-Rating Depression Scale
• Direction: lower is better
Padfield 1976  (Continued)
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• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
Adverse events
• Outcome type: dichotomous outcome
• Reporting: partially reported
• Direction: lower is better
• Data value: endpoint




Authors name: Marianne Nina Carter Padfield





Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "a period of 12 weeks. After the women had volunteered for partici-
pation, had taken part in a two-week diagnostic phase, and met the criteria,
every two clients in order of appearance were randomly assigned to counsel-
ing with the relationship model (Group A) or the relationship model plus the
behavioral model (Group B) by flipping a coin.The two-week diagnostic period
allowed"
Judgement comment: coin tossing is an acceptable method of randomisation,
but unclear whether the 'order of appearance' would have been random.
Allocation concealment
(selection bias)






High risk Judgement comment: no blinding possible due to nature of interventions; this
may have caused bias in the outcome estimates.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Judgement comment: the interviews were recorded and a second rater, a psy-
chiatric nurse, after listening to the tapes without knowing which counselling





Unclear risk Judgement comment: 1 dropout but no other information provided. Author
could not be contacted.
Padfield 1976  (Continued)
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Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no reference to protocol. Author could not be contact-
ed.
Other bias Unclear risk Judgement comment: no baseline characteristics presented by study arm; un-
clear whether arms were balanced on main characteristics. - Two week diag-
nostic phase before randomisation. Unclear whether any participants dropped
out. Not specified who therapist was. Assumed to be first author. No evidence





Methods Study design: randomised controlled trial
Study grouping: parallel
Recruitment: From senior centres
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation








Referral to mental health services









• Gender (N male, % male, N female, % female): 83% female
• Ethnic group: 11% non-Hispanic Black, 11% Black
• Household income:
• Occupation/ employment:
• Education level: Mean 15 (2.5) years
• Comorbid anxiety:
• Depression severity: 73% major depression, 14% minor depression, 13% subtreshold depression
• Age: mean 76 (SD 8.3)
Raue 2019 
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Included criteria: attending one of two senior centres, age => 60, English speaking, PHQ => 10, MMSE
=> 24.
Excluded criteria: passive or active suicidal ideation and diagnoses of bipolar depression, psychosis,
or current alcohol or substance abuse.




• type of intervention: BA
• specific intervention: Programme including activity scheduling and focus on pleasant events.
• dose:
• frequency: once a week
• duration: 12 weeks
• level of therapist: non-specialist
• individual or group therapy:
• mode of delivery: face-to-face
• modifications:
Referral to mental health services
• type of intervention: comparator
• specific intervention: referral to mental health services
• dose:
• frequency:
• duration: 12 weeks
• level of therapist:
• individual or group therapy:
• mode of delivery:
• modifications:
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: HRSD
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
Identification Sponsorship source: National Institute of Mental Health, Grant/ Award Numbers: P30 MH085943 and
R34 MH111849
Country: USA
Setting: Two age service settings in NYC
Comments:
Authors name: Patrick J Raue
Institution: University of Washington
Raue 2019  (Continued)
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
Email: praue@uw.edu
Address: Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Wash-
ington, 110 Campus Parkway, Box 358017, Seattle, WA 98195
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "We randomized 18 depressed clients to receive the “Do More, Feel Bet-
ter” intervention or referral to mental health services. Study"
Judgement comment: no information. Contacted author: study coordinator




High risk Judgement comment: no information. Contacted author: study coordinator





High risk Judgement comment: no blinding due to nature of intervention. Research as-
sistants were not aware of study aims.
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Quote: "The RAs assessed depressive symptom severity with the HAM-D at
baseline and week 12. We"





High risk Judgement comment: although dropouts small (only 2 in each group), the
sample size was small (18) so represents a significant dropout rate. Also rea-
sons for dropout unknown as unable to contact participants.
Selective reporting (re-
porting bias)
Low risk Judgement comment: outcomes match trial registration.
Other bias High risk Judgement comment: very small sample size; randomisation not likely to
achieve balanced groups (higher baseline mean depression scores in interven-
tion group although not statistically significant. The intervention was devel-





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: participants were solicited from the general community with media announcements
seeking women between the ages of 18 and 60 who felt they had a significant problem with depression
and who were interested in volunteering for a 10-week therapy program as part of a research project.
Type of RCT (blind, double-blind, open-label): open-label
Rehm 1982 
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Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Cognitive therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Cognitive-behavioural therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Overall
• Gender (N male, % male, N female, % female): 100% female
• Ethnic group: -
• Household income: median $25,000
• Occupation/ employment: 67.3% employed
• Education level: mean 14.8 years
• Comorbid anxiety: -
• Depression severity: 16.3% single-episode, 27.6% episodic, 29.6% intermittent, and 26.5% chronic
• Age: mean 38.6
Included criteria: women aged 18 to 60, BDI > 20, T score =>70 on MMPI Depression Scale, non-psy-
chotic, non-bipolar major affective disorder diagnosed in interview
Excluded criteria: psychotherapy for depression in last 30 days, antidepressant or major tranquilliser
use, mania, hypomania, schizophrenia, organic brain syndrome, mental retardation, antisocial person-
ality, anorexia nervosa, or (during the last 12 months) alcohol abuse, anxiety disorder, Briquet's syn-
drome, drug abuse, obsessive--compulsive disorder, panic disorder, or phobic disorder
Pretreatment: similar scores for depression severity at baseline. Baseline characteristics not reported
by research arm.
Rehm 1982  (Continued)
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Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural therapy
• dose: 1.5 hour sessions
• frequency: weekly
• duration: 10 weeks
• level of therapist: professional
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Cognitive therapy
• type of intervention: comparator
• specific intervention: cognitive therapy
• dose: 1.5 hour sessions
• frequency: weekly
• duration: 10 weeks
• level of therapist: professional
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Cognitive-behavioural therapy
• type of intervention: comparator
• specific intervention: cognitive-behavioural therapy
• dose: 1.5 hour sessions
• frequency: weekly
• duration: 10 weeks
• level of therapist: professional
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: HRSD-interviewer rating
• Direction: lower is better
• Data value: endpoint
• Notes: interviewer rating and clinician rating was provided; reporting interviewer rating here as this
may be less biased.
Dropouts
• Outcome type: dichotomous outcome
Identification Sponsorship source: this study was supported by National Institute of Mental Health Grant 2R01
MH27822 to the first author
Country: USA
Rehm 1982  (Continued)
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Setting: general community
Comments: -
Authors name: Lynn P Rehm
Institution: University of Houston
Email: -
Address: Psychology Department, University of Houston, Houston, Texas 77004
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Judgement comment: no information. Author could not be contacted.
Allocation concealment
(selection bias)





High risk Judgement comment: blinding impossible due to nature of treatments; this
may have affected results.
Blinding of outcome as-
sessment (detection bias)
All outcomes





High risk Judgement comment: 34 participants withdrew prior to completion but rea-
sons not stated.HRSD not presented at 6 months.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no reference to protocol. Author could not be contact-
ed.
Other bias Low risk Judgement comment: no other sources of bias identified. Although researcher
published extensively on the topic a clear preference for one treatment does





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: adults aged≥18 years who met DSM-IV criteria for a major depressive disorder recruited
from primary care and psychological therapy services in Devon, Durham and Leeds between Sept 2012
to April 2014.
Type of RCT (blind, double-blind, open-label): open
Richards 2017 
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Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 79 male (36%), 142 female (64%)
• Ethnic group: 204 White British (92%)
• Household income: -
• Occupation/employment: -
• Education level: 25 (11%) none, 36 (16%) GCSE, 28 (13%) A levels, 54 (24%) NVQ, 44 (20%) undergrad-
uate, 28 (13%) postgraduate, 2 (1%) doctoral, 4 (2%) professional degree
• Comorbid anxiety: 131 (59%)
• Depression severity: PHQ < 19 118 (54%), PHQ>= 19 103 (46%)
• Age: 43.9 (SD 14.1)
Cognitive behavioural therapy (CBT)
• Gender (N male, % male, N female, % female): 71 male (32%), 148 female (68%)
• Ethnic group: 197 White British (90%)
• Household income: -
• Occupation/ employment: -
• Education level: 30 (14%) none, 3 (20%) GCSE, 22 (10%) A levels, 71 (32%) NVQ, 35 (16%) undergradu-
ate, 14 (6%) postgraduate, 1 doctoral, 3 (1%) professional degree
• Comorbid anxiety: 141 (64%)
• Depression severity: PHQ < 19 118 (54%), PHQ>=19 101 (46%)
• Age: 43.0 (SD 14.1)
Overall
• Gender (N male, % male, N female, % female): 150 (34%) male, 290 (66%) female
• Ethnic group: 401 White British (91%)
• Household income: -
• Occupation/ employment: -
• Education level: 55 (13%) none, 79 (18%) GCSE, 50 (11%) A levels, 125 (28%) NVQ, 79 (18%) undergrad-
uate, 42 (10%) postgraduate, 3 (1%) doctoral, 7 (2%) professional degree
• Comorbid anxiety: 272 (62%)
• Depression severity: PHQ<19 236 (54%), PHQ>=19 204 (46%
• Age: 43.5 (SD 14.1)
Included criteria: adults 18 or over who met DSM IV criteria for major depressive disorder
Excluded criteria: receiving psychological therapy, alcohol or drug dependent, acutely suicidal or at-
tempted suicide in previous 2 months, cognitively impaired, bipolar disorder, or psychosis or psychotic
symptoms.




• type of intervention: BA
• specific intervention: behavioural activation
• dose: 1 hour sessions
• frequency: weekly. max 20 sessions. twice weekly for the first 2 months, then weekly
• duration: 16 weeks
• level of therapist: non-specialist
Richards 2017  (Continued)
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• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: optional 4 booster sessions
Cognitive behavioural therapy (CBT)
• type of intervention: comparator
• specific intervention: cognitive behavioural therapy
• dose: 1 hour sessions
• frequency: weekly. max 20 sessions
• duration: 16 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: optional 4 booster sessions
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: PHQ-9
• Range: 0-27
• Direction: lower is better
• Data value: endpoint
• Notes: reporting data for intention-to-treat analysis
Anxiety symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: GAD-7
• Direction: lower is better
• Data value: endpoint
Recovery
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Scale: PHQ-9
• Direction: higher is better
• Data value: endpoint
• Notes: recovery defined as follow-up score of <=9 on the PHQ-9.There seems to be a typo in Table 9;
recovery for BA group 6% of 221 is not 208.
Response
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Scale: PHQ-9
• Direction: higher is better
• Data value: endpoint
• Notes: 50% or greater reduction in PHQ-9 score compared to baseline.
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
Richards 2017  (Continued)
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• Direction: lower is better
• Data value: endpoint
Quality of life SF-36 PCS
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: SF-36 V2 PCS
• Direction: higher is better
• Data value: endpoint
Quality of life SF-36 MCS
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: SF-36
• Direction: higher is better
• Data value: endpoint
Adverse events
• Outcome type: adverse event
• Reporting: fully reported
• Data value: endpoint
Identification Sponsorship source: National Institute for Health Research (NIHR) Health Technology Assessment pro-
gramme
CountryUK
Setting: three community mental health services
Comments: -
Authors name: Dave A Richards
Institution: University of Exeter Medical School
Email: d.a.richards@exeter.ac.uk
Address: University of Exeter Medical School, St Luke’s Campus, Exeter, UK
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "The registered Peninsula Clinical Trials Unit (PenCTU) allocated par-
ticipants remotely after the researchers had collected and entered baseline
data into a computer database to ensure researcher blinding and allocation
concealment. Investigators were not informed of participants’ allocations. The
computer-based system allocated the first 20 participants to each arm on a
truly random basis. For subsequent participants, allocation was minimised to
maximise the likelihood of balance in stratification variables across the two
study arms. Concealment was ensured by the use."
Judgement comment: sequence generated at random for first 20 patients in
each arm, and non-random after that. However, given that a computer pro-
gramme was used bias is less likely.
Richards 2017  (Continued)
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Allocation concealment
(selection bias)
Low risk Quote: "and recruitment site. Allocation concealment <b>The registered
Peninsula Clinical Trials Unit allocated participants remotely using a pass-
word-protected website after the researchers had collected and entered base-
line data into a computer database.</b> DOI: 10.3310/hta21460 HEALTH TECH-
NOLOGY ASSESSMENT"






High risk Judgement comment: blinding of patients and therapists was not possible due
to nature of intervention.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Quote: "We ensured that research assessors were blind to participant alloca-
tion and we protected against assessment bias by using self-reported mea-
sures. We recorded instances where researchers were unblinded."
Judgement comment: outcome assessors were blinded, except in instances





High risk Judgement comment:uUndertook both ITT and per protocol analysis. More




Low risk Judgement comment: all outcomes in protocol were reported.
Other bias High risk Several researchers are also authors of the current review, and have received






Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: participants were recruited for the study by announcements made in undergraduate
psychology classes and placed on student information boards and by referral from the Student Health
Service
Type of RCT (blind, double-blind, open-label): open-label
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 2 male, 6 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: 100% at university
• Comorbid anxiety: -
Shaw 1977 
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• Depression severity: BDI 25.6 (18 to 38)
• Age: 20.1 (range 19 to 24)
Cognitive modification
• Gender (N male, % male, N female, % female): 3 male, 5 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: 100% at university
• Comorbid anxiety: -
• Depression severity: BDI 30.1 (18 to 45)
• Age: 19.8 (range 17 to 26)
Non-directive control
• Gender (N male, % male, N female, % female): 3 male, 5 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: 100% at university
• Comorbid anxiety: -
• Depression severity: BDI 26.4 (18-42)
• Age: 20.5 (range 19-26)
Waiting list
• Gender (N male, % male, N female, % female): 2 male, 6 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: 100% at university
• Comorbid anxiety: -
• Depression severity: BDI 26.6 (19 to 43)
• Age: 19.9 (range 18 to 25)
Overall
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Included criteria: 18 to 26 year old students at University of Western Ontario, self-reported current de-
pression of at least 3 weeks, interest in intervention, BDI 18 or more, depression major presenting psy-
chopathology, symptoms not severe enough to warrant hospitalisation or risk of suicide, HRSD 20 or
over, VAS 40 or higher.
Excluded criteria: psychotic symptoms, drug addiction, sociopathy, organicity, major medical prob-
lems.
Pretreatment: mean ages and BDI are not significantly different but groups were not successfully
matched on the sex variables - more females in BA and waiting list group.
Shaw 1977  (Continued)
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Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural therapy (Lewinsohn)
• dose: 2 hours per sessions
• frequency: twice per week
• duration: 4 weeks
• level of therapist: specialist (in training)
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Cognitive modification
• type of intervention: comparator
• specific intervention: cognitive therapy (Beck)
• dose: 2 hours per sessions
• frequency: twice per week
• duration: 4 weeks
• level of therapist: specialist (in training)
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Non-directive control
• type of intervention: comparator
• specific intervention: non-directive therapy (attention control)
• dose: 2 hours per sessions
• frequency: twice a week
• duration: 4 weeks
• level of therapist: specialist (in training)
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Waiting list
• type of intervention: comparator
• specific intervention: waiting list
• dose: -
• frequency: -
• duration: 4 weeks
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: partially reported
• Scale: HRSD
Shaw 1977  (Continued)
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• Direction: lower is better
• Data value: endpoint
• Notes: no SDs reported.
Identification Sponsorship source: None reported
Country: Canada
Setting: University of Western Ontario
Comments: -
Authors name: Brian F Shaw
Institution: University of Western Ontario
Email: -
Address: Department of Psychology, University Hospital, London, Ontario, Canada N6G 2K3.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Judgement comment: "Assignment was done randomly". No more informa-
tion. Author could not be contacted.
Allocation concealment
(selection bias)





High risk Judgement comment: open-trial; this may lead to biased results if patients or
therapist favour one treatment over another.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Judgement comment: ratings were done by clinical psychologists who were




Unclear risk Judgement comment: no SDs reported. Follow-up only for two treatment
groups. Unclear how many participants were included in follow-up data. Au-
thor could not be contacted.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no reference to protocol. Author could not be contact-
ed.
Other bias Unclear risk Judgement comment: some differences at baseline (BDI highest in cognitive






Methods Study design: randomised controlled trial
Skinner 1984 
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Study grouping: parallel group
Recruitment: ads in local newspapers throughout San Diego
Type of RCT (blind, double-blind, open-label):
Participants Baseline characteristics
Cognitive-behaviour therapy




• Education level: range 12 to 16 years
• Comorbid anxiety:
• Depression severity:
• Age: range 24 to 40
Behavioural activation




• Education level: range 10 to 16 years
• Comorbid anxiety:
• Depression severity:
• Age: range 20 to 61
Control




• Education level: range 11 to 16 years
• Comorbid anxiety:
• Depression severity:
• Age: range 19 to 47
Self-intervention
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• Occupation/ employment:
• Education level: Mean 14 years (range 10 to 18)
• Comorbid anxiety:
• Depression severity: BDI score 13 to 41
• Age: Mean 34 years (range 20 to 61)
Included criteria: BDI 13 or higher, depressive episode of at least 8 weeks, age 18 or older
Excluded criteria:
Pretreatment: not able to assess; no summary statistics by study arm.
Interventions Intervention characteristics
Cognitive-behaviour therapy
• type of intervention: comparator
• specific intervention: Beck cognitive behaviour self-therapy
• dose: 60 minute meetings
• frequency: weekly meetings, daily self-intervention
• duration: 5 weeks
• level of therapist:
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications:
Behavioural activation
• type of intervention: BA
• specific intervention: Lewinsohn behavioural self-therapy
• dose: 60 minute meetings
• frequency: weekly meetings, daily self-intervention
• duration: 5 weeks
• level of therapist:
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications:
Control
• type of intervention: comparator
• specific intervention: no intervention
• dose: 60 minute meetings
• frequency: weekly meetings, daily self-intervention
• duration: 2 weeks
• level of therapist:
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications:
Self-intervention
• type of intervention: comparator
• specific intervention: self-selected behavioural or cognitive self-therapy
• dose: 60 minute meetings
• frequency: weekly meetings, daily self-intervention
• duration: 5 weeks
Skinner 1984  (Continued)
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• level of therapist:
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications:
Outcomes  




Authors name: Donald Alan Skinner
Institution: United States International University
Email:
Address:
Notes Noortje Uphoff on 06/08/2019 20:20
Included
No results by study arm; individual results only.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)









High risk Judgement comment: blinding not possible due to nature of interventions.
Blinding of outcome as-
sessment (detection bias)
All outcomes








Unclear risk Judgement comment: no protocol.
Other bias High risk Judgement comment: author states that groups were not matched on key
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Study characteristics
Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: recruitment of participants occurred from September 2015 to January 2016 from online
ads posted on Craigslist in major American cities.
Type of RCT (blind, double blind, open label): -
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: PHQ-9: 15.20 (SD 5.49)
• Age: -
Cognitive therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: PHQ-9: 17.00 (SD 4.62)
• Age: -
Waiting list
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: PHQ-9: 16.10 (SD 3.76)
• Age: -
Overall
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Stiles-Shields 2019 
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Included criteria: PHQ-9 score 10 or higher, QIDS score 11 or higher, able to speak and read English,
at least 18 years old, owned an Android, no visual, hearing, voice, or motor impairment, not diagnosed
with a comorbid diagnosis for which participation in the trial was inappropriate or dangerous, not se-
verely suicidal, not receiving psychotherapy, not on antidepressant medication or on stable dose.
Excluded criteria: -
Pretreatment: no participant characteristics reported. Similar baseline depression scores.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: app based on behavioural activation with coaching
• dose: coaching session max 5 minUTES
• frequency: weekly coaching sessions
• duration: 6 weeks
• level of therapist: professional
• individual or group therapy: individual
• mode of delivery: Computer (smartphone) & telephone or email
• modifications: based on activity scheduling component of BA only
Cognitive therapy
• type of intervention: comparator
• specific intervention: app based on cognitive therapy with coaching
• dose: coaching session max 5 minutes
• frequency: weekly coaching sessions
• duration: 6 weeks
• level of therapist: professional
• individual or group therapy: individual
• mode of delivery: Computer (smartphone) & telephone or email
• modifications: based on restructuring component of cognitive therapy only
Waiting list
• type of intervention: comparator
• specific intervention: waiting list
• dose: -
• frequency: -
• duration: 10 weeks
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: PHQ-9
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
Stiles-Shields 2019  (Continued)
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• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Adverse events
• Outcome type: adverse event
• Reporting: fully reported
• Data value: endpoint
Identification Sponsorship source: this research was supported by National Institute of Mental Health Grants R01
MH100482 (principal investigator [PI]: David C. Mohr) and F31 MH106321 (PI: Colleen Stiles-Shields).
This project was also supported by National Institutes of Health (NIH)/National Center for Research Re-
sources Colorado Clinical and Translational Sciences Institute Grant UL1 RR025780.
Country: USA
Setting: Smartphone app & phone
Comments: -
Authors name: Colleen Stiles-Shields
Institution: Loyola University Chicago
Email: estilesshields@luc.edu




Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Randomization was created using PROC PLAN in SAS Version 9.2, with
participants randomly assigned in randomization blocks of six to either Boost
Me (n 10) or Thought Challenger (n 10) or to wait-list control (n 10). The ran-
domized block design was used to ensure equal numbers were randomized to
each group at a given time, should the study end early or if there were season-
al effects."
Judgement comment: computer-generated randomisation, block sizes of 6
Allocation concealment
(selection bias)
Low risk Quote: "Once generated, this list was uploaded to Research Electronic Data
Capture (REDCap), where study personnel were blinded to allocation prior to
randomization, and participants would be randomized once eligibility was de-
termined."
Judgement comment: limited detail on how allocation concealment was





High risk Judgement comment: no blinding due to nature of interventions; this may
have led to bias in the results.
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Quote: "To maximize blinding, we administered only self-report measures
beyond the baseline assessment. Self-report assessments occurred at base-
line, at Weeks 3 and 6 (midtreatment and end of treatment), and at Week 10
Stiles-Shields 2019  (Continued)
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(1 month posttreatment follow-up) via REDCap, electronic data capture tools
hosted at the university (Harris et al., 2009)."




High risk Quote: "All Boost Me participants received the intervention. Three Thought
Challenger participants did not receive the intervention; one reported not hav-
ing enough device memory to download the app, and two were unresponsive
to contact following randomization."
Judgement comment: all 3 dropouts were in the Thought Challenger interven-
tion; unclear whether this was related to the intervention.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no reference to protocol. Author could not be contact-
ed.
Other bias High risk Judgement comment: participant characteristics are not reported. The au-
thors state there were no differences at baseline, but no information is provid-
ed. Author could not be contacted.
Quote: "David C. Mohr also receives honoraria from Optum Behavioral Health
and has an ownership interest in Actualize Therapy Ltd."
Judgement comment: all authors work for centre that developed the two
apps. A study by the same authors evaluating the usability of the CBT app is
cited, suggesting they may have been involved in development. One of the au-
thors has ownership interest in Actualize Therapy Ltd (mobile technology for
depression/anxiety). Therapist delivering coaching to both groups was also





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: the participants were recruited over a 2-year period between 2013 and 2014 at Hiroshi-
ma University via email on a public information sharing platform
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 24 female, 38 male
• Ethnic group: -
• Household income: -
• Occupation/ employment: 100% university students
• Education level: attending university
• Comorbid anxiety: N = 7
• Depression severity: BDI 12.76 (SD 6.66)
• Age: 18.23 (SD 0.42)
No treatment
• Gender (N male, % male, N female, % female): 21 female, 35 male
Takagaki 2016 
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• Ethnic group: -
• Household income: -
• Occupation/ employment: 100% university students
• Education level: attending university
• Comorbid anxiety: N = 14
• Depression severity: BDI 13.30 (SD 5.95)
• Age: 18.20 (SD 0.40)
Overall
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Included criteria: 18 to 19-year-old first-year university student at Hiroshima University, BDI-II score
>=10 according to earlier studies, no major depressive episode (CIDI interview), and not undergoing
psychopharmacological or psychological treatment.
Excluded criteria: a diagnosis of major depressive disorder (MDD) during the past year, a lifetime histo-
ry of bipolar disorder, currently taking psychiatric medications or undergoing psychotherapy, possibil-
ity of acute suicide attempts, difficulty in understanding the purpose of the study, difficulty in complet-
ing the self-report scales due to a serious mental condition, or severe physical illness
Pretreatment: more participants with recent history of anxiety in control group, but depressions
severity similar between groups.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural activation
• dose: 60 minute sessions
• frequency: weekly
• duration: 5 weeks
• level of therapist: specialist
• individual or group therapy: individual + group
• mode of delivery: face-to-face
• modifications: based on CBT programme
No treatment
• type of intervention: comparator
• specific intervention: no treatment
• dose: -
• frequency: -
• duration: 5 weeks
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Takagaki 2016  (Continued)
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Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: BDI
• Direction: lower is better
• Data value: endpoint
• Notes: both ITT and complete case analysis are reported. Results reported here are from ITT analysis.
Dropouts
• Outcome type: dichotomous outcome
Quality of life
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: HRQOL
• Direction: higher is better
• Data value: endpoint
Identification Sponsorship source: Supported by a Grant-in-Aid for Scientific Research on Innovative Areas from
Japan Society for the Promotion of Science, JSPS (grants 16H06395 and 16H06399), and grant
23118004 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.This work
was partially supported by the programme for Brain Mapping by Integrated Neurotechnologies for
Disease Studies (Brain/MINDS) by Japan Agency for Medical Researchand Development, AMED (grant





Authors name: Yasumasa Okamoto
Institution: Hiroshima University
Email: oy@hiroshima-u-ac.jp
Address: Department of Psychiatry and Neurosciences, Hiroshima University, 1-2-3 Kasumi, Mina-
mi-ku, Hiroshima 734-8551, Japan.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Microsoft Excel randomization function."
Judgement comment: random numbers table used.
Allocation concealment
(selection bias)
Low risk Quote: "An expert of the Department of Clinical Research, who was indepen-
dent of the research team that conducted this study, developed a sequential
assignment list using computer-generated random numbers to allocate the
participants to a treatment or a control group randomly at a 1:1 ratio. The ran-
dom sequence was stratified by sex and depression severity during screening
Takagaki 2016  (Continued)
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
(BDI-II score #13, BDI-II score $14). The group allocation was masked in the en-





High risk Judgement comment: blinding not possible in this trial due to the nature of
the intervention. This may have caused bias in the outcome estimates.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Quote: "Participants received telephone interviews by CIDI and completed
self-report scales via the Internet 1 year after the assessment by blind testers
who did not know the allocation. In CIDI assessment of 1-year follow-up, allo-
cation to the treatment group or control group was masked."





Low risk Judgement comment: dropout slightly higher in treatment group. ITT analy-
sis (imputation) and completers only presented separately. These results were
compared in sensitivity analyses.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: trial registration provided. Secondary outcomes report-
ed post-treatment only. Unclear whether study authors had planned to report
secondary outcomes at 1 year follow-up.





Methods Study design: Randomised controlled trial
Study grouping: parallel group
Recruitment:
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Cognitive therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Behavioural activation
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
Taylor 1977 
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• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Cognitive and behavioural therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Waiting list
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Overall
• Gender (N male, % male, N female, % female): 8 male, 20 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: undergraduate or graduate students
• Comorbid anxiety: -
• Depression severity: BDI 21.2 (mild-moderate)
• Age: 22.4 (SD 2.6, range 18 to 26)
Included criteria: 1. Self-reported depression of not less than two weeks duration. 2. Beck Depression
Inventory (BDI) scores of not less than 13; the figure suggested by Beck (1967) as the cut-o point be-
tween de- pressed and non-depressed patients. 3. D-30 Scale (Dempsey, 1964), T scores of not less than






• type of intervention: comparator
• specific intervention: cognitive therapy based on Beck and Ellis
• dose: 40 minute sessions
• frequency: 6 sessions
• duration: 5 weeks
• level of therapist: specialist
Taylor 1977  (Continued)
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• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural therapy based on Lewinsohn, Ferster, and Lazarus
• dose: 40 minute sessions
• frequency: 6 sessions
• duration: 5 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Cognitive and behavioural therapy
• type of intervention: comparator
• specific intervention: combined cognitive-behavioural treatment
• dose: 40-minute sessions
• frequency: 6 sessions
• duration: 5 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Waiting list
• type of intervention: comparator
• specific intervention: waiting list
• dose: -
• frequency: -
• duration: 5 weeks
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: BDI
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
• Notes: in the waiting list group, 2 patients did receive treatment. The other 5 were then given the
combined treatment.
Taylor 1977  (Continued)
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Authors name: Frederick G Taylor
Institution: Queen's University
Email: -
Address: Queen's University, Kingston, Ontario, Canada
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Quote: "Subjects were randomly assigned in order of acceptance to one of four
groups:"
Judgement comment: it seems that allocation was in order of appearance,
which is not completely random.
Allocation concealment
(selection bias)
High risk Judgement comment:iIt seems that allocation was in order of appearance,
which is not thought to be random. This also means allocation was not likely





High risk Judgement comment: no blinding due to nature of interventions; this may
lead to bias.
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Judgement comment: self-assessment of outcome measures, which may lead





Unclear risk Judgement comment: no dropouts reported in active treatment groups; it has
to be assumed that all participants randomised completed the study. In the
waiting list group, 2 participants did receive treatment and therefore the other
5 were provided with the combined treatment. Unclear why this decision was
made. Author could not be contacted.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no reference to protocol. Author could not be contact-
ed.
Other bias Unclear risk Judgement comment: very small sample sizes (N = 7 per arm) and no descrip-
tion of patient characteristics by study arm, making it impossible to ascertain
whether randomisation was successful. Unclear at which times post-treatment
and follow-up measures were completed. Author could not be contacted.
Quote: "All treatments (six 40-min. sessions) were administered individually by
a single therapist (the senior author),"
Judgement comment: no evidence of therapist allegiance.
Taylor 1977  (Continued)
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Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: mass media
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI 25.09 (SD 2.38)
• Age: -
Cognitive therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI 20.40 (SD 2.11)
• Age: -
Overall
• Gender (N male, % male, N female, % female): N = 30 (100%) female
• Ethnic group: predominantly White
• Household income: -
• Occupation/employment: predominantly middle-class, 50% unemployed
• Education level: mode: high school graduate, range: 10th grade to college graduate
• Comorbid anxiety: -
• Depression severity: -
• Age: mean 35, range 18 to 60
Included criteria: women, MMPI score F-K <11 and D > 69, BDI 11 or more, no history of psychiatric hos-
pitalisation, serious suicidal ideation or attempts, and no involvement in any other psychological ther-
apy in the past month, clinical judgement of depression as major psychopathology, depression of at
least 4 months duration, not psychotic or suicidal.
Excluded criteria: -
Pretreatment: patients in the self-control group had a higher pretest BDI score at baseline, although
authors say this was not statistically significant. No other baseline characteristics reported by study
arm.
Thomas 1987 
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Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural therapy according to Fuchs & Rehm 1977
• dose: -
• frequency: weekly
• duration: 6 weeks
• level of therapist: specialist (in training)
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Cognitive therapy
• type of intervention: comparator
• specific intervention: cognitive therapy (Beck)
• dose: -
• frequency: weekly
• duration: 6 weeks
• level of therapist: specialist (in training)
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: BDI
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
• Reporting: partially reported
• Direction: lower is better
• Data value: endpoint




Authors name: J Randy Thomas
Institution: Medical College of Virginia
Email: -
Address: PO Box 253, MCV Station, Richmond, Virginia 23298.
Notes  
Thomas 1987  (Continued)
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "The 30 subjects were randomly assigned to one of six groups, with the
re- straint that five subjects were in each group."
Judgement comment: no information. Author could not be contacted.
Allocation concealment
(selection bias)





High risk Quote: "Therapists were told chat subjects were selected on the basis of locus
of control scores and matched to treatment. The purpose of this was to dis-
tract - - the therapist from the obvious cognitive versus self-control treatment
comparison and to limit any personal bias that may have resulted, intention-
al or not. The misdirection appeared effective, as on debriefing the therapists
said they felt they had identified the different locus of control groups and the
matching that had occurred."
Judgement comment: no blinding due to nature of interventions. This may
have led to bias. Therapists were told that matching had occurred, when in re-
ality it had not. It is unlikely this is an effective way to prevent bias.
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Judgement comment: questionnaires were completed by patients themselves;
possibly in the presence of the therapist. This may have led to bias if patients





High risk Judgement comment: almost half of all participants dropped out before the
study finished (4 in one group, 5 in the other group). It is unclear why this was
the case, and at what point in the study participants dropped out. Authors
state there were no significant differences between drop-outs and completers,
but it would have been hard to find differences for such small sample sizes.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no reference to protocol. Author could not be contact-
ed.
Other bias Unclear risk Judgement comment: sample sizes at follow-up are extremely small (N = 6
and N = 5), and any differences in outcomes may therefore have occurred by
chance. Randomisation unlikely to have been effective. No information on





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: participants were 725 elderly individuals who telephoned our research center between
January 1, 1982, and January 1, 1984, to inquire about participation in the psychotherapy outcome
study (Breckenridge 1985)
Type of RCT (blind, double-blind, open-label): open
Thompson 1987 
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Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 8 male, 17 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: 7 employed, 18 not employed
• Education level: mean 14.16 years (SD 2.37)
• Comorbid anxiety: -
• Depression severity: -
• Age: 66.88 (SD 5.17)
Cognitive therapy
• Gender (N male, % male, N female, % female): 11 male, 16 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: 3 employed, 24 not employed
• Education level: 13.96 (SD 2.17)
• Comorbid anxiety: -
• Depression severity: -
• Age: 67.07 (SD 6.48)
Brief psychodynamic therapy
• Gender (N male, % male, N female, % female): 8 male, 16 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: 3 employed, 21 not employed
• Education level: 14.62 (SD 2.12)
• Comorbid anxiety: -
• Depression severity: -
• Age: 66.71 (SD 6.16)
Delayed treatment
• Gender (N male, % male, N female, % female): 4 male, 15 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: 4 employed, 15 not employed
• Education level: 15.31 (SD 1.34)
• Comorbid anxiety: -
• Depression severity: -
• Age: 67.63 (SD 5.56)
Overall
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Thompson 1987  (Continued)
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Included criteria: 60 or older, diagnosed with major depressive disorder (RDC), no or stable medica-
tion for minimum of 3 months, not concurrently in psychotherapy, no evidence of psychosis, alco-
holism, immediate suicidal risk, or bipolar disorder, not exhibiting evidence of significant cognitive im-
pairment, minimum score 17 on BDI and 14 on HRSD.
Excluded criteria: -




• type of intervention: BA
• specific intervention: behavioural therapy (Lewinsohn)
• dose: 16 to 20 sessions
• frequency: twice a week for first 4 weeks and once a week thereafter
• duration: -
• level of therapist: specialist (in training)
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Cognitive therapy
• type of intervention: comparator
• specific intervention: cognitive therapy (Beck)
• dose: 16 to 20 sessions
• frequency: twice a week for first 4 weeks and once a week thereafter
• duration: -
• level of therapist: specialist (in training)
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Brief psychodynamic therapy
• type of intervention: comparator
• specific intervention: brief psychodynamic therapy (Horowitz)
• dose: 16 to 20 sessions
• frequency: twice a week for first 4 weeks and once a week thereafter
• duration: -
• level of therapist: specialist (in training)
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: Prescribed outline with some variations depending on patient progress
Delayed treatment
• type of intervention: comparator
• specific intervention: waiting list
• dose: -
• frequency: -
• duration: 6 weeks
• level of therapist: -
• individual or group therapy: -
Thompson 1987  (Continued)
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• mode of delivery: -
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: HRSD
• Direction: lower is better
• Data value: endpoint
Functioning
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: Global Assessment Scale
• Direction: higher is better
• Data value: endpoint
Social adjustment
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: Social Adjustment Scale
• Direction: lower is better
• Data value: endpoint
Depression remission
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: higher is better
• Data value: endpoint
• Notes: Remission according to 1) reliable change index and 2) deviation from normative elderly sam-
ple
Identification Sponsorship source: this research was supported by Grant R01-MH37196 from the National Institute of
Mental Health to the first author.
Country: USA
Setting: -
Comments: this study refers to Breckenridge 1985, which is not an RCT. It appears this is not the same
study, but similar recruitment methods were used, and the funding source is the same.
Authors name: Larry W Thompson
Institution: Veterans Administration Medical Center
Email: -
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Judgement comment: no information. Author could not be contacted.
Allocation concealment
(selection bias)





High risk Judgement Comment: no blinding due to nature of interventions. This may
have biased estimates.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk Judgement comment: unclear who performed outcome assessments. Author




High risk Judgement comment: patients were dropped from analyses if treatment fi-
delity was found to be insufficient (N = 5). More patients were reported to have
dropped out in the cognitive (N = 10) than other groups (N = 4 each), and more
patients in the cognitive group dropped out because of dissatisfaction with
treatment. Data on dropouts are inconsistent throughout text and tables.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: not all prespecified outcomes are reported at the pre-
specified time points. No reference to protocol. Author could not be contacted.
Other bias High risk Judgement comment:
• patients on the waiting list were re-randomised to one of three treatments
halfway through the study, and these participants were analysed as belong-
ing to one of the treatment groups at the end of the study, even though they
had received no treatment at first.
• this study seems partly based on Breckenridge 1985, with the same source
of funding.
• unclear treatment duration, and unclear when post-treatment follow-up
was.
• it seems that 5 participants were dropped from the analysis due to issues with
patient adherence, although this is not entirely clear from the text.





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: patients were recruited from psychological services centres.
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• Gender: 100% female
• Ethnic group: -
• Household income: -
• Occupation/ employment: 25% employed, 25% student, 50% housewife
• Education level: 50% high school, 50% university degree
• Comorbid anxiety: excluded
• Depression severity: BDI mean 30.17 (SD 9.60)
• Age: mean 33.4 (SD 8.73)
ILPI
• Gender: 100% female
• Ethnic group: -
• Household income: -
• Occupation/ employment: 33% student, 67% house wife
• Education level: 33% primary school, 9% secondary school, 33% high school, 25% university degree
• Comorbid anxiety: excluded
• Depression severity: BDI mean 25.37 (SD 11.46)
• Age: mean 35.8 (SD 9.57)
Inclusion criteria: 20 to 50 years old, diagnosis of MDD (DSM-V), mild to moderate symptoms (BDI),
physical and cognitive ability to write and give consent.
Exclusion criteria: suffering from any other psychological disorders, under psychotherapy or medicine
for major depressive disorder.
Pretreatment: significantly higher levels of education and employment in BA group. Depression, hope-
lessness and worry higher in BA group at baseline (statistical significant not reported).
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural activation
• dose: 90 minutes
• frequency: weekly
• duration: 8 weeks
• level of therapist: specialist
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: group therapy
ILPI
• type of intervention: comparator
• specific intervention: Islamic lifestyle psychoeducational intervention (ILPI)
• dose: 90-minute sessions
• frequency: weekly
• duration: 10 weeks
• level of therapist: not reported
• individual or group therapy: group
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• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: BDI-II
• Direction: lower is better
• Data value: mean, SD
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Scale: -
• Direction: lower is better
• Data value: n/N
Identification Sponsorship source: this work was supported by the Center of Excellence for Spirituality and Happi-
ness in the University of Isfahan [grant number 5863].
Country: Iran
Setting: Recruitment from psychological services centres
Comments:
Authors name: Mojtaba Toghyani
Institution: University of Isfahan
Email: m.b.kaj@edu.ui.ac.ir




Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "Patients were equally and randomly assigned to the Islamic lifestyle
psychoeducational intervention (ILPI) or behavioural activation (BA) treat-
ment group"
Judgement comment: no information on sequence generation.
Allocation concealment
(selection bias)





High risk Judgement comment: assumed to be not blinding due to nature of interven-
tions.
Blinding of outcome as-
sessment (detection bias)
All outcomes




High risk Judgement comment: 3 participants did not complete treatment and were ex-
cluded from analysis in each group and not included in table of baseline char-
acteristics. Reasons not given.
Toghyani 2018  (Continued)
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Selective reporting (re-
porting bias)
Unclear risk Judgement comment: protocol mentioned but no link to protocol or trial reg-
istration.
Other bias High risk Judgement comment: the researcher who delivered ILPI is also the first au-
thor and may have favoured this approach. This therapist and researcher alle-





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: patients receiving treatment at outpatient centre
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 6 males (39%), 9 females (62%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: 54% major depression; 31% major depression superimposed on dysthymia
• Age: 33.8 years (SD 10.2)
Treatment as usual
• Gender (N male, % male, N female, % female): 6 males (42%), 8 females (59%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: 0
• Depression severity: 42% major depression; 50% major depression superimposed on dysthymia
• Age: 34.2 years (SD 8.8)
Overall
• Gender (N male, % male, N female, % female): 10 males (40%), 15 females (60%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: 0% (anxiety disorder was exclusion criteria
• Depression severity: 11 (38%) major depression superimposed on pre-existing dysthymia; 15 (52%)
major depression; 3 (10%) dysthymia
• Age: 34 years
van den Hout 1995 
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Included criteria: major depression and/or dysthymia on SCID-III-R≥ 50 on Zung’s Self-rating Depres-
sion Scale
Excluded criteria: bipolar mood disorderPsychotic disorderAlcohol or drug dependenceAnxiety disor-
der or post-traumatic stress disorder when clearly preceding the depressive episodeIlliteracy
Pretreatment: participants in the experimental group were more likely to have major depression,
whereas participants in the control group were more likely to have a diagnosis of dysthymia.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: self-control therapy/ behavioural therapy (Rehm) + standard treatment
• dose: 90-minute sessions (+5-day treatment as usual programme)
• frequency: weekly
• duration: 12 weeks
• level of therapist: -
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Treatment as usual
• type of intervention: comparator
• specific intervention: treatment as usual (including social skills training etc.)
• dose: -
• frequency: -
• duration: 5 days
• level of therapist: -
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Scale: Zung Self-rating Depression Scale
• Direction: higher is better
• Data value: endpoint
Identification Sponsorship source: not reported
Country: the Netherlands
Setting: psychiatric outpatient centre
Comments: -
Authors name: JHC van den Hout
Institution: University of Limburg
Email: -
Address: Department of Medical Psychology, University of Limburg, P.O. Box 616, NL-6200 MD Maas-
tricht, the Netherlands
van den Hout 1995  (Continued)
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Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "According to the randomized pre- and posttest control group design,
29 selected subjects were randomly assigned to either standard treatment
(control condition, n = 14), or standard treatment plus self-control therapy (ex-
perimental condition, n = 15). Standard treatment (ST)."









High risk Quote: "Although patients in both conditions were treated with care and at-
tention, patients in the SCT condition could have been affected by the knowl-
edge of being participants of a new therapy that focused especially on their
depressive complaints. Because of the absence of an attention placebo con-
trol, this study fails to control for such effects. Furthermore, though both con-
ditions participated"
Judgement comment: Presumably no blinding; this may have led to bias in the
estimates if patients or therapists had a preference for one treatment.
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Judgement Comment: self-rating scales were completed; this may have led to





Unclear risk Quote: "Three subjects dropped out be- tween pre- and posttest. The remain-
ing sample consisted of 25 subjects, 10 males and 15 females. The mean age
of all subjects was 34 years (range 20-59). One subject dropped out between
posttest and follow-up."
Judgement comment: it is unclear how many participants dropped out in
each study arm; 4 participants dropped out during treatment and 1 during fol-
low-up. Author could not be contacted.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no reference to protocol. Author could not be contact-
ed.
Other bias Unclear risk Quote: "To control for possible bias caused by medication, the number of
weeks medication was administered from pre- to posttest and from pretest to
follow-up was included as a covariate in posttest and follow-up ANCOVAs, re-
spectively. Univariate analysis outcomes at posttest and follow-up were com-
parable to those acquired when medication was not added as a covariate. For
this reason, medication was not included in the analyses presented in this ar-
ticle. Furthermore, at pre-test, patients who received antidepressant medica-
tion did not have higher depression scores than those who did not."
Quote: "There were no significant differences between the two groups in num-
ber of antidepressant medication-using patients (Table 1)."
Judgement comment: some participants took antidepressants during trial. Al-
though there was no significant difference between group and taking medica-
tion was not found to make a difference in analyses, rates of medication use
van den Hout 1995  (Continued)
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
were higher in the BA group than the control during the intervention and fol-
low-up period.




Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment:
Type of RCT (blind, double-blind, open-label): open
Participants Baseline characteristics
Cognitive-behavioural therapy
• Gender (N male, % male, N female, % female): 18 female (90%), 2 male (10%)
• Ethnic group:
• Household income:
• Occupation/ employment: 12 housework (60%), 8 other (40%)
• Education level: 13 less than high school (65%), 7 high school or university (35%)
• Comorbid anxiety:
• Depression severity: subthreshold
• Age: 59.3 (SD 9.7)
Behavioural activation
• Gender (N male, % male, N female, % female): 22 female (100%), 0 male
• Ethnic group:
• Household income:
• Occupation/ employment: 15 housework (68%), 7 other (32%)
• Education level: 13 less than high school (59%), 9 high school or university (41%)
• Comorbid anxiety:
• Depression severity: subthreshold
• Age: 59.7 (SD 8.1)
Usual care
• Gender (N male, % male, N female, % female): 17 female (89%), 2 male (10%)
• Ethnic group:
• Household income:
• Occupation/ employment: 12 housework (63%), 7 other (37%)
• Education level: 14 less than high school (74%), 5 high school or higher (26%)
• Comorbid anxiety:
• Depression severity: subthreshold
• Age: 55.9 (SD 5.4)
Overall
• Gender (N male, % male, N female, % female): 57 female (93%), 4 male (7%)
• Ethnic group:
• Household income:
• Occupation/ employment: 39 housework (64%), 22 other (36%)
Vázquez 2014 
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• Education level: 40 less than high school (66%), 21 high school or university (34%)
• Comorbid anxiety:
• Depression severity: subthreshold
• Age: 58.4 (SD 8.0)
Included criteria: (1) be a non-professional primary caregiver of a person whose dependence was offi-
cially recognised, (2) have a telephone, (3) pre-treatment score of at least 16 on the Spanish CES-D, 4)
not meet the diagnostic criteria for a major depressive episode, (5) have no history of major depression
and (6) give informed consent.
Excluded criteria: (1) had received psychological or psycho-pharmacological treatment within the
last two months, (2) had mental or medical conditions that could act as confounders in the study (e.g.
symptoms due to the direct physiological effects of a substance or a medical, metabolic or psychiatric
condition in women participants), (3) presented medical or mental problems of such gravity that they
either required immediate intervention (e.g. suicidal ideation) or precluded participation in the study
(e.g. severe hearing impairment), (4) were caring for a person with a grave or terminal prognosis or (5)
planned to change their domicile or institutionalise the person for whom they were caring.
Pretreatment: there were no remarkable or clinically relevant baseline differences
Interventions Intervention characteristics
Cognitive-behavioural therapy
• type of intervention: control
• specific intervention: cognitive-behavioural therapy (Lewinsohn)
• dose: 90-minute sessions
• frequency: once a week
• duration: 5 weeks
• level of therapist: specialist
• individual or group therapy: group
• mode of delivery: conference call
• modifications:
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural activation (Lewinsohn/ Vazquez)
• dose: 90-minute sessions
• frequency: once a week
• duration: 5 weeks
• level of therapist: specialist
• individual or group therapy: group
• mode of delivery: conference call
• modifications:
Usual care
• type of intervention: control
• specific intervention: usual care; no intervention or educational materials
• dose:
• frequency:
• duration: 5 weeks
• level of therapist:
• individual or group therapy:
• mode of delivery:
• modifications:
Vázquez 2014  (Continued)
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Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: CES-D
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
• Direction: lower is better
• Data value: endpoint
Depression
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Scale: DSM-IV
• Direction: lower is better
• Data value: endpoint





Authors name: Fernando Vazquez
Institution: University of Santiago de Compostela
Email: fernandolino.vazquez@usc.es
Address: Department of Clinical Psychology and Psychobiology, University of Santiago de Compostela,
Santiago de Compostela, Spain
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "An independent statistician randomly assigned participants to groups
using a table of random numbers."




Unclear risk Judgement comment: unclear who performed allocation based on random
numbers table. Contacted author who states 'allocation concealment tech-





High risk Judgement comment: blinding not possible due to nature of interventions.
Vázquez 2014  (Continued)
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Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Quote: "All pre- and post-treatment assessments were conducted face-to-face
by trained interviewers not directly involved in the research study and who
were blind to the group to which each participant had been assigned."









Unclear risk Judgement comment: protocol reported for full trial but not for this feasibility
trial.
Other bias Unclear risk Quote: "The BAC intervention was also adapted from Vazquez et al. (2014) but
in this case the intervention focused solely on the behavioral activation com-
ponent."






Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: from introductory psychology courses at college
Type of RCT (blind, double-blind, open-label): open-label
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Cognitive therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Weinberg 1978 
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Emotional Awareness Training
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Waiting List
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Overall
• Gender (N male, % male, N female, % female): 35 female, 5 male
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: University
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Included criteria: at least moderate depression (score >=8 BDI)
Excluded criteria: -




• type of intervention: BA
• specific intervention: behavioural therapy (Lewinsohn)
• dose: 1-hour sessions
• frequency: weekly
• duration: 4 weeks
• level of therapist: specialist (in training)
• individual or group therapy: group
• mode of delivery: face-to-face + homework
• modifications: -
Cognitive therapy
• type of intervention: comparator
• specific intervention: cognitive therapy (Goldfried)
Weinberg 1978  (Continued)
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• dose: 1 hour sessions
• frequency: weekly
• duration: 4 weeks
• level of therapist: specialist (in training)
• individual or group therapy: group
• mode of delivery: face-to-face + homework
• modifications: -
Emotional Awareness Training
• type of intervention: comparator
• specific intervention: sensitivity treatment focused on awareness of emotions
• dose: 1-hour sessions
• frequency: weekly
• duration: 4 weeks
• level of therapist: specialist (in training)
• individual or group therapy: group
• mode of delivery: face-to-face + homework
• modifications: -
Waiting list
• type of intervention: comparator
• specific intervention: waiting list
• dose: -
• frequency: -
• duration: 4 weeks
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: BDI
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
Anxiety symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: Trait Anxiety Scale
• Direction: lower is better
• Data value: endpoint
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Comments: -
Authors name: Leslie Weinberg





Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Judgement comment: no information on sequence generation. One partic-
ipant who dropped out after randomisation was replaced by a participant
from the waiting list group; unclear to which group. Allocation was altered 'for




High risk Judgement comment: very probably not concealed to researcher because





High risk Judgement comment: blinding not possible due to nature of interventions; it
is likely that knowledge of the intervention affects the estimates.
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Judgement comment: BDI was self-reported; unclear who was present at the
time of completion. This may lead to bias as patients were aware of interven-




Unclear risk Judgement comment: one person dropped out before treatment and was re-
placed by a person from the waiting list group; unclear why and how this de-
cision was made. A further 3 participants dropped out; unclear why. Author
could not be contacted.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no link to protocol. Author could not be contacted.
Other bias Unclear risk Judgement comment: no information on baseline characteristics of partici-
pants; given small sample sizes it is likely that there would have been differ-
ences at baseline, that may also correlate with effect of interventions. No in-





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: from primary health centre
Type of RCT (blind, double-blind, open-label): open
Weobong 2017 
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Participants Baseline characteristics
Enhanced usual care
• Gender (N male, % male, N female, % female): 191 female (77%)
• Ethnic group: -
• Household income: -
• Occupation/employment: unemployed 140 (56%), unskilled manual 97 (39%) skilled manual 4 (2%,
clerical and professional 7 (3%)
• Education level: 55 none (22%), 135 primary (54%), 40 secondary (16%), 11 higher secondary (4%), 7
graduate or above (3%)
• Comorbid anxiety: -
• Depression severity: 187 moderately-severe (75%), 61 severe (25%)
• Age: 42.6 (SD 12.0)
Behavioural activation
• Gender (N male, % male, N female, % female): 188 female (76%)
• Ethnic group: -
• Household income: -
• Occupation/employment: unemployed 152 (62%), unskilled manual 77 (31%), skilled manual 3 (1%),
clerical and professional 13 (5%)
• Education level: 75 none (31%), 114 primary (46%), 38 secondary (16%), 13 higher secondary (5%), 5
graduate or above (2%)
• Comorbid anxiety: -
• Depression severity: 185 moderately-severe (76%), 60 severe (24%)
• Age: 42.4 (SD 12.1)
Overall
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Included criteria: 18 to 65, probably diagnosis of moderately severe to severe depression (PHQ>14),
gave informed consent





• type of intervention: comparator




• level of therapist: -
Weobong 2017  (Continued)
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Behavioural activation
• type of intervention: BA
• specific intervention: Healthy Activity Programme (HAP): brief psychological therapy based on behav-
ioural activation
• dose: 30- to 40-minute sessions
• frequency: weekly
• duration: 8 weeks
• level of therapist: non-professional
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: adapted for local context
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: partially reported
• Scale: BDI-II
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
Adverse events
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Depression remission
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Scale: PHQ-9
• Direction: higher is better
• Data value: endpoint
• Notes: remission as defined by a PHQ-9 score < 10
Identification Sponsorship source: Wellcome Trust Senior Research Fellowship grant to VP (091834)
Country: India
Setting: primary care rural and peri-urban settings
Comments: -
Authors name: Vikram Patel
Institution: Harvard Medical School
Email: vikram.patel@hms.harvard.edu
Weobong 2017  (Continued)
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "An independent statistician generated a randomisation list in random-
ly sized blocks (block size four to six [two to four for men because we anticipat-
ed relatively fewer men on the basis of the epidemiology of the prevalence of
depression and did not want imbalance between groups]), stratified by PHC
and sex. Assignments were sealed in sequential numbered opaque envelopes
by independent support sta that were opened as each consenting eligible pa-
tient was enrolled 21 by trained health assistants."
Allocation concealment
(selection bias)
Low risk Quote: "Physicians providing EUC were masked to allocation status, as were
the independent assessors who did outcome assessments, and these people
had no contact with the PHCs or other team members. All authors, apart from
the data manager (BB), were masked until the trial results were unmasked in
the presence of the Trial Steering Committee and Data Safety and Monitoring





High risk Judgement comment: blinding of those who delivered the intervention and
participants was not possible, but those who provided enhanced usual care
were blinded, and had no contact with researchers.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Quote: "Instances of unmasking of outcome assessors in the HAP group will be
summarised on the basis of overall prevalence and the exact point during the
interview that the interviewer was unmasked."
Judgement comment: outcome assessors were blinded in most circum-




Unclear risk Judgement comment: N = 5 refused follow-up in the control group, compared
to N = 12 in the treatment (HAP) group. Unclear why this was the case, but this
may be related to how the intervention was perceived. In this case, even multi-
ple imputation of these missing data may have led to biased estimates.
Selective reporting (re-
porting bias)
Low risk Judgement comment: protocol matches study reports.
Other bias Unclear risk Judgement comment: depression remission figures do not match up: a small-
er sample is reported at 3 months than at 12 months. Numbers and percent-
ages for 12 months don't match total sample size. Small differences; unclear





Methods Study design: randomised controlled trial
Study grouping: parallel group
Wilson 1983 
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Recruitment: participants were obtained from the general population of Sydney through announce-
ments of a depression treatment-research program in the media.
Type of RCT (blind, double-blind, open-label): -
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 2 males (25%), 6 females (75%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: HAM-D: 13.89 (SD 3.22)
• Age: -
Cognitive therapy
• Gender (N male, % male, N female, % female): 1 male (12%), 7 females (88%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: HAM-D: 13.62 (SD 2.40)
• Age: -
Waiting list
• Gender (N male, % male, N female, % female): 2 males (22%), 7 females (78%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: HAM-D: 13.22 (SD 4.08)
• Age: -
Overall
• Gender (N male, % male, N female, % female): 5 males (20%), 20 females (80%)
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: N = 19 completed at least secondary school
• Comorbid anxiety: -
• Depression severity: -
• Age: 39.5, range 20 to 58
Included criteria: 20 to 60 years Score ≥ 17 on BDI self-reported duration of depression of ≥ 3 months
Excluded criteria: previous or concurrent treatment with major tranquillisers or lithium. Major physi-
cal or psychiatric disorders (including bipolar affective disorders). Suicidal intention or ideation.
Wilson 1983  (Continued)
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Pretreatment: pre-treatment depression scores were similar for HRSD, but not for BDI: highest in cog-
nitive therapy and lowest in behaviour therapy group.
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural therapy (Lewinsohn)
• dose: 1-hour sessions
• frequency: 8 sessions
• duration: 8 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Cognitive therapy
• type of intervention: comparator
• specific intervention: cognitive therapy (Beck)
• dose: 1-hour sessions
• frequency: 8 sessions
• duration: 8 weeks
• level of therapist: specialist
• individual or group therapy: individual
• mode of delivery: face-to-face
• modifications: -
Waiting list
• type of intervention: comparator
• specific intervention: waiting list
• dose: -
• frequency: -
• duration: 8 weeks
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: HRSD
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
• Notes: dropouts were replaced.
Wilson 1983  (Continued)
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Identification Sponsorship source: not reported
Country: Australia
Setting: University psychology clinic
Comments: -
Authors name: Peter H Wilson
Institution: University of Sydney
Email: -
Address: Department of Psychology, University of Sydney, N.S.W., Australia 2006
Notes Noortje Uphoff on 12/08/2019 22:07
Outcomes
No data extracted for BDI as HRSD was our preferred measure.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "Twenty-five subjects were randomly allocated to one of three experi-
mental conditions"
Judgement comment: no details on randomisation method reported. Author
could not be contacted.
Allocation concealment
(selection bias)





High risk Judgement Comment: No blinding possible due to nature of intervention; this
may cause bias, for example if participants or researchers/therapists have a
preference for one treatment over another.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Quote: "Interviews were tape-recorded and independently assessed by one
rater who was blind to both treatment condition and assessment occasion."
Judgement comment: it appears that the therapist administered the HRSD,




High risk Judgement comment: 4/25 participants were replaced without randomisa-
tion. Most dropouts (N = 3) occurred in the cognitive therapy group.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no link to protocol. Author could not be contacted.
Other bias Low risk Quote: "it is possible that the therapists in the present study failed to admin-
ister the treatments in a sufficiently distinct manner. Although every effort
was made to distinguish clearly between the two approaches, no independent
checks were made on the adherence of therapists to the treatment manuals."
Judgement comment: fidelity not monitored. Authors speculate treatments
may not have been adhered to correctly. Author could not be contacted.
Wilson 1983  (Continued)
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Study characteristics
Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: 317 leL-behind older adults from 17 villages in Yankou Town were asked to complete the
Geriatric Depression Scale (GDS) by the local health service centre.
Type of RCT (blind, double-blind, open-label): open-label
Participants Baseline characteristics
Behavioural activation
• Gender (N male, % male, N female, % female): 17 male, 23 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: 35 no schooling (97%), 5 elementary school (12%)
• Comorbid anxiety: -
• Depression severity: mean GDS 16.1 (SD 1.8)
• Age: 71.9 (SD 3.9)
Regular care
• Gender (N male, % male, N female, % female): 16 male, 24 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: 40 no schooling (100%)
• Comorbid anxiety: -
• Depression severity: mean GDS 15.8 (SD 1.6)
• Age: 71.8 (SD 3.7)
Overall
• Gender (N male, % male, N female, % female): 33 male, 47 female
• Ethnic group: -
• Household income: -
• Occupation/ employment: -
• Education level: 75 no schooling (94%), 5 some schooling (6%)
• Comorbid anxiety: -
• Depression severity: mean GDS 16.0 (SD 1.7)
• Age: 71.9 (SD 3.8)
Included criteria: GDS scores 11 to 25, over 65 years of age, only one participant from each family, leL-
behind for longer than 6 months
Excluded criteria: psychiatric and medical co-morbidities that are potentially life threatening or ex-
pected to severely limit client participation or adherence, currently seeing a cognitive–behavioral ther-
apist, psychotherapist or counsellor or currently receiving antidepressant drug treatment.
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Behavioural activation
• type of intervention: BA
• specific intervention: modified BA + regular care
• dose: 2-hour sessions
• frequency: weekly
• duration: 8 weeks
• level of therapist: non-professional
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: modified to suit population
Regular care
• type of intervention: comparator
• specific intervention: regular care with some education and physical checks
• dose: -
• frequency: weekly
• duration: 8 weeks
• level of therapist: non-professional
• individual or group therapy: -
• mode of delivery: face-to-face
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: Geriatric Depression Scale
• Direction: lower is better
Dropouts
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Anxiety symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: Becks Anxiety Inventory
• Direction: lower is better
• Data value: endpoint
Depression remission
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Scale: GDS
• Direction: higher is better
• Data value: endpoint
• Notes: remission defined as score < 11 on GDS ('normal' range).
Identification Sponsorship source: this study was supported by the China Family Foundation Health Fellowship Pro-
gram of Yale-China Association and the National Natural Science Foundation of China (NO.81502701).
Xie 2019  (Continued)
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Country: China
Setting: 17 villages in Yanuka Town recruited through local health service centres
Comments: -
Authors name: Jianda Zhou
Institution: Central South University
Email: doctorzhoujianda@163.com
Address: Department of Orthopedic, The Third Xiangya Hospital, Central South University, Changsha,
People’s Republic of China.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Eighty participants were randomly numbered using a random number
table and then divided into two groups randomly with 40 in the experimental
group receiving MBAT intervention plus regular care, and 40 cases in the con-
trol group receiving regular care only."
Judgement comment: random numbers table used.
Allocation concealment
(selection bias)






High risk Quote: "Based on randomization procedures, each facilitator worked with one
of the four groups of participants in the intervention period in close collabora-
tion with the investigator. To ensure competent provision of intervention, all
facilitators met for weekly individual supervision sessions with the investiga-
tor."
Judgement comment: only one active treatment group, and investigator was
aware of who was receiving treatment. Blinding not possible due to nature of
intervention; this may have influenced outcomes.
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Quote: "These scales were administered by trained investigators."
Judgement comment: it appears assessments were not blinded. Unclear




Unclear risk Judgement comment: 5/40 participants dropped out in each group; reasons
for discontinuing not all related to intervention (N = 4 lack of interest/ too
busy). These participants were dropped from the analysis.
Selective reporting (re-
porting bias)
Low risk Judgement comment: trial registration (http://www.chictr.org.cn/com/25/
showprojen.aspx?proj=19204) lists depression as primary objective, and anxi-
ety as secondary. In trial report, anxiety is listed as a primary outcome. Howev-
er, all outcomes mentioned in trial registration have been reported.
Other bias Unclear risk Judgement comment: unclear whether regular care is truly 'regular'; patients
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Study characteristics
Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: through announcement offering therapy for depression as part of a research project.
This announcement was widely disseminated at the University of Oregon and in the surrounding met-
ropolitan area.
Type of RCT (blind, double-blind, open-label): open-label
Participants Baseline characteristics
Interpersonal behaviour therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Behavioural activation
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Cognitive therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
IPT waiting list
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
Zeiss 1979 
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• Age: -
BA waiting list
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
CT waiting list
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: -
• Age: -
Overall
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: 33% employed, 13% unemployed, 21% homemaker, 28% student, 4% re-
tired
• Education level: mean 14.3 years
• Comorbid anxiety: -
• Depression severity: Moderate to severe
• Age: mean 33.9, range 19 TO 68
Included criteria: D equal to or greater than 70 and D > all other clinical scales (not Lie, Test-Taking At-
titude, Masculinity and Femininity, Hypomania, or Social Introversion) on MMPI and one or more factor
scores > 1.0 or mean factor score > 0.7 on Grinker interview rating
Excluded criteria: individuals who appeared to have a manic-depressive cycle were excluded from this
study. Individuals currently in psychotherapy elsewhere were also excluded unless they chose to termi-
nate the other therapy.
Pretreatment: no participant characteristics reported by study arm. Depression scores at baseline
seem higher in the pleasant events group and lower in the cognitive group.
Interventions Intervention characteristics
Interpersonal behaviour therapy
• type of intervention: comparator
• specific intervention: interpersonal therapy
• dose: -
• frequency: 12 sessions
• duration: 1 month
• level of therapist: professional (in training)
• individual or group therapy: individual
Zeiss 1979  (Continued)
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• mode of delivery: face-to-face + homework
• modifications: -
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural activation through increasing (enjoyment of) pleasant activities
(Lewinsohn)
• dose: -
• frequency: 12 sessions
• duration: 1 month
• level of therapist: professional (in training)
• individual or group therapy: individual
• mode of delivery: face-to-face + homework
• modifications: -
Cognitive therapy
• type of intervention: comparator
• specific intervention: cognitive therapy
• dose: -
• frequency: 12 sessions
• duration: 1 month
• level of therapist: professional (in training)
• individual or group therapy: individual
• mode of delivery: face-to-face + homework
• modifications: -
IPT waiting list
• type of intervention: comparator
• specific intervention: waiting list
• dose: -
• frequency: -
• duration: 1 month
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
BA waiting list
• type of intervention: comparator
• specific intervention: waiting list
• dose: -
• frequency: -
• duration: 1 month
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
CT waiting list
• type of intervention: comparator
• specific intervention: waiting list
Zeiss 1979  (Continued)
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• dose: -
• frequency: -
• duration: 1 month
• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Outcomes Depression symptoms
• Outcome type: continuous outcome
• Reporting: partially reported
• Scale: MMPI Depression Scale
• Direction: lower is better
• Data value: endpoint
Dropouts
• Outcome type: dichotomous outcome
• Reporting: partially reported
• Direction: lower is better
• Data value: endpoint
Identification Sponsorship source: supported in part by National Institute of Mental Health Grant MH24477
Country: USA
Setting: Outpatient, university of Oregon
Comments: -
Authors name: Antonette M Zeis
Institution: Arizona State University
Email: -
Address: Department of Psychology, Arizona State University, Tempe, Arizona 85281
Notes Data not included in meta-analysis; not possible to estimate SD.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "Depressed partici- pants were randomly assigned to one of the three
treatment projects, and they were randomly assigned to begin therapy either
immediately or after a 1-month waiting period."
Judgement comment: no information. Author could not be contacted.
Allocation concealment
(selection bias)





High risk Judgement comment: no blinding possible due to nature of interventions. This
may lead to bias in estimates.
Zeiss 1979  (Continued)
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Blinding of outcome as-
sessment (detection bias)
All outcomes





High risk Judgement comment: dropouts per study arm not clearly described. Five par-
ticipants dropped out of waiting list groups; authors state this might be due to
them seeking treatment elsewhere. This may mean that those who were less
motivated to receive therapy remained in the study, which may bias results.
22/66 participants dropped out in total.
Selective reporting (re-
porting bias)
Unclear risk Judgement comment: no reference to protocol. Author could not be contact-
ed.
Other bias High risk Judgement comment:
• participant characteristics are not reported by study arm.
• number of participants is small (66 across 6 study arms) and randomisa-
tion has resulted in differences in depression symptoms at baseline between
study arms.
• Peter Lewinsohn developed behavioural therapy as a standalone therapy; he





Methods Study design: randomised controlled trial
Study grouping: parallel group
Recruitment: at university
Type of RCT (blind, double-blind, open-label): -
Participants Baseline cCharacteristics
Behavioural activation
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI-II: 28.77 (SD 3.37)
• Age: -
Metacognitive therapy
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI-II: 29.28 (SD 3.24)
Zemestani 2016 
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• Age: -
Waiting list
• Gender (N male, % male, N female, % female): -
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: -
• Comorbid anxiety: -
• Depression severity: BDI-II: 29.35 (SD 3.56)
• Age: -
Overall
• Gender (N male, % male, N female, % female): 16 male (39%), 25 female (61%)
• Ethnic group: -
• Household income: -
• Occupation/employment: -
• Education level: 100% university students
• Comorbid anxiety: 4 panic disorder, 6 social phobia, 9 GAD
• Depression severity: all major depressive disorder
• Age: mean 24.2, range 18 to 30
Included criteria: Bachelor students at university, DSM-IV diagnosis of major depression (clinical inter-
view), BDI-II > 19.
Excluded criteria: lifetime or current bipolar I or II disorder, schizophrenia, delusional disorder, brain
injuries, OCD, PTSD, or Axis II disorders (SCID-II), alcohol or drug abuse or dependence within last six
months, imminent risk of suicide or homicide, having a medical condition underlying depression, and
use of psychotropic medications or involvement in concurrent psychotherapy.
Pretreatment: slightly lower depression score (BDI-II) for BA group than other groups and shorter du-
ration of depressive episode for MCT group than other groups (statistical significance not reported)
Interventions Intervention characteristics
Behavioural activation
• type of intervention: BA
• specific intervention: behavioural activation (Dimidjian/ Martell manual)
• dose: 90-minute sessions
• frequency: weekly
• duration: 8 sessions
• level of therapist: professional (in training)
• individual or group therapy: group
• mode of delivery: face-to-face
• modifications: -
Metacognitive therapy
• type of intervention: comparator
• specific intervention: metacognitive therapy (third-wave CBT, Wells manual)
• dose: 90 minute sessions
• frequency: weekly
• duration: 8 sessions
• level of therapist: professional (in training)
• individual or group therapy: group
Zemestani 2016  (Continued)
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• mode of delivery: face-to-face
• modifications: -
Waiting list
• type of intervention: comparator




• level of therapist: -
• individual or group therapy: -
• mode of delivery: -
• modifications: -
Outcomes Depression symptoms
• Outcome type: Continuous outcome
• Reporting: fully reported
• Scale: BDI-II
• Direction: lower is better
• Data value: endpoint
Droputs
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Direction: lower is better
• Data value: endpoint
Anxiety symptoms
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: BAI
• Direction: lower is better
• Data value: endpoint
Identification Sponsorship source: none reported
Country: Assumed to be Iran
Setting: university
Comments: -
Authors name: Medhi Zemestani
Institution: University of Kurdistan
Email: m.zemestan@gmail.com
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Fifteen individuals were randomly allocated to each group (MCT, BA,
and control). Random allocation was achieved by the use of a computer gener-
ated randomisation list without any attempt to match the groups."
Judgement comment: computer-generated randomisation
Allocation concealment
(selection bias)
High risk Judgement comment: no information in study. Contact with author: re-





High risk Quote: "treatments were delivered by a member of the research team, who
was not blind to the hypotheses."
Judgement comment: blinding not possible due to nature of interventions.
This may lead to biased estimates.
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Judgement comment: BDI-II and BAI self-reported. No attempt to blind out-




Low risk Quote: "There were no dropouts,"
Judgement comment: no dropouts during treatment. 4 participants missed
sessions, but were included in the ITT analysis.
Selective reporting (re-
porting bias)
Unclear risk Quote: "The trial was not pre-registered in a clinical trial registry."
Judgement comment: contact with author: retrospective trial registration
(IRCT2013030912753N1), no protocol.
Other bias Unclear risk Quote: "Interventions were conducted by a PhD student in psychology who
concluded a 2-year training in CBT and a 6-month training in MCT for depres-
sion."
Judgement comment: therapist was first author and was reported to receive
more training for one treatment than the other.
Zemestani 2016  (Continued)
BA: Behavioural activation; BA: Behavioural activation; BAL: Behavioural Activation for Latinos; BATD: Behavioural Activation Treatment
for Depression; BDI: Becks Depression Inventory; CT: cognitive therapy; DSM: Diagnostic and Statistical Manual of Mental Disorders; GAD:
Generalised Anxiety Disorder; GDS: Geriatric Depression Scale; HADS: Hospital Anxiety and Depression Scale; HAM: Hamilton Anxiety
Scale; HRSD: Hamilton Rating Scale for Depression; ILPI: Islamic lifestyle psychoeducational intervention; ITT: intention-to-treat; MADRS:
Montgomery Asberg Depression Rating Scale; MDD: Major Depressive Disorder; MMSE: Mini-Mental State Examination; OCD: obsessive--
compulsive disorder; PHQ_9: Patient Health Questionnaire; SD: standard deviation; SE: standard error; SSRI: serotonin reuptake inhibitor;
STAI: State-Trait Anxiety Inventory; VAS: visual analogue scale; WHOQL: World Health Organization Quality of Life.
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Almeida 2018 Inpatient population
Arjadi 2018a Population < 18
Bagnall 2014 Postnatal/perinatal depression
Barrera 1979 Wrong comparator
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Study Reason for exclusion
Cernin 2009 No (subthreshold) depression
Clignet 2012 Inpatient population
Dimidjian 2017 Postnatal/perinatal depression
Egede 2018 Wrong comparator
Farrand 2014 Wrong comparator
Gallagher 1983 >20% of dropouts replaced
Lambert 2018 Online only - no interaction with therapist
Luxton 2012 Wrong comparator
Ly 2015 Wrong comparator
Mausbach 2018 Online only - no interaction with therapist
McKendree Smith 2000 Online only - no interaction with therapist
McLean 1973 Couple therapy
McLean 1979 > 20% of dropouts replaced
Moss 2012 Online only - no interaction with therapist
Pentecost 2015 Wrong comparator
Rehm 1981 Wrong comparator
Shapiro 1974 Inpatient population
Soucy 2018 Online only - no interaction with therapist
Stein 2017 Wrong comparator
Turner 1979 Wrong comparator
Watkins 2016 Wrong comparator
 




Interventions Unclear; behaviour modification techniques.
Outcomes Unclear; relating to mental health.
Bolin 1974 
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Participants Self-referred depressed students (experiment 1)
Interventions Unclear; possibly only the cognitive components of CBT
Outcomes Depression symptoms (experiment 1)





Participants Rural leL behind elderly with GDS score between 11 and 25
Interventions Behavioural activation and control (enhanced usual care)
Outcomes Primary: depression (GDS)





Participants University students with depressive symptoms
Interventions Behavioural activation and control
Outcomes Depressive symptoms, dysfunctional attitudes





Participants Adults with depression
Interventions ACE-4 behavioural activation + treatment as usual and treatment as usual
Outcomes Primary: anxiety and depression (HADS). Secondary: Clinical Outcome in Routine Evaluation
(CORE), Brief Disability Questionnaire (BDQ).
Naeem 2015 
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Participants Primary unipolar depressed females (study 2/3)
Interventions Unclear; Sensory Awareness Training, Relaxation Training, control (study 2) and Relaxation Train-
ing versus Task Assignment (study 3) and possibly waiting list and Client-Oriented Therapy.
Outcomes Depression
Notes Dissertation. ProQuest Dissertations and Theses Global: “This graduate work is not available to





Participants Women with major depressive disorder
Interventions Pleasant events class or problem-solving skills
Outcomes Diagnosis, emotional distress.




Methods Unclear; possibly RCT.
Participants Adults with depression
Interventions Behavioural activation + medication and medication
Outcomes Primary: PHQ-9. Secondary: anxiety symptoms (GAD-7), physical health (SF-12), mental health
(SF-12), BADS, substantial improvement PHQ-9, depression remission (PHQ-9).
Notes Contacted author to enquire whether results have been published.
Weiss 2010 
BA: Behavioural activation; GAD-7: Generalised Anxiety Disorder; GDS: Geriatric Depression Scale; HADS: Hospital Anxiety and Depression
Scale; PHQ_9: Patient Health Questionnaire; RCT: randomised controlled trial; SF-12: Short Form.
 
Characteristics of ongoing studies [ordered by study ID]
 
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
Study name Randomised controlled trial to determine whether a greater proportion of older people with major
depression living in remote and regional Western Australia who receive a behavioural activation in-
tervention experience remission of the depressive episode, compared with usual care.
Methods RCT
Participants Depressed older adults living in regional and remote areas in Western Australia
Interventions Behavioural activation and usual care
Outcomes Remission of symptoms at 12 weeks
Starting date Unclear
Contact information Professor Osvaldo Almeida: osvaldo.almeida@uwa.edu.au




Study name Cognitive control training for depression
Methods RCT
Participants Adults with major depressive disorder
Interventions Cognitive control training and behavioural activation
Outcomes BDI, CGI, Spatial Span, Digit Span
Starting date October 2017
Contact information Ms Meenakshi Banerjee; meenakshi.banerjee@gmail.com




Study name Efficacy of two internet delivered intervention programs for depression: behavioral activation vs
physical activity (PROMETEOII)
Methods RCT
Participants Adults with major depressive disorder and adjustment disorder with depressive symptomatology
Interventions Behavioural activation, physical activity, and waiting list
Outcomes Primary: PHQ-9 and BDI. Secondary: EQ-5D-5L, QLI, OASIS, PANAS, Happiness Scale, Satisfaction
with Life Scale, Ry Scale of Psychological Wellbeing, BADS-SF, EROS, BDI-II
Starting date April 2018
Botella 2015 
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Contact information Christina Botella: botalla@uji.es




Study name Development and testing of a behavioral activation mobile therapy for elevated depressive sys-
tems
Methods RCT
Participants Adults with elevated depressive symptoms
Interventions Moodivate (behavioural activation), CBT, and treatment as usual
Outcomes Primary: BDI. Secondary: client treatment adherence, user feasibility and acceptability, PANAS,
EROS, POMS, BADS, SHAPS, BAI, ASI, FTND, timeline follow back (drug/tobacco use), contempla-
tion ladder (tobacco use).
Starting date 1 June 2016





Study name Reducing depressive symptoms among rural African Americans (REJOICE)
Methods Cross-over RCT
Participants African-American adults with mild to moderate depression
Interventions REJOICE (behavioural activation) and usual care (educational materials)
Outcomes Primary: depression symptoms (BDI)
Starting date May 2016
Contact information Tiany F Haynes, tfhaynes@uams.edu




Study name Effectiveness of add-on group behavioral activation treatment for depression in psychiatric care
Methods RCT
Participants Adults with major depressive disorder
Isometsä 2016 
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Interventions Behavioural activation, usual care (talking therapy and antidepressant medication), and peer sup-
port
Outcomes Primary: depression symptoms (PHQ-9) at 8 weeks. Secondary: response, remission, functional im-
pairment, depression score at 6 months.
Starting date 18/01/2016
Contact information Professor Erkki Isometsä: erkki.isometsa@helsinki.fi




Study name Behavioural activation delivered by mental health nurses versus treatment as usual for late-life de-
pression in primary care.
Methods RCT
Participants Older adults with PHQ-9 score > 9
Interventions Behavioural activation and treatment as usual
Outcomes Primary: depression severity (Q-IDS). Secondary: EQ-5D-5L and TiC-P (cost-effectiveness)
Starting date 7 January 2016
Contact information GJ Hendriks: ghendriks@ggznijmegen.nl




Study name BLENDING: Blended care vs. usual care in the treatment of depressive symptoms and disorders in
general practice
Methods RCT
Participants Adults with depressive disorder or symptoms of depression
Interventions Online + face-to-face self-management through behavioural activation and care as usual
Outcomes Primary: depression symptoms at 3 months. Secondary: depression symptoms at 12 months, re-
sponse, remission, antidepressant use, use of other psychotropics, functional impairment, health
care utilisation, general health status, treatment satisfaction, Ecological Momentary Assessment.
Starting date September 2014
Contact information Dr H Burger: H.Burger@rug.nl
Notes  
Massoudi 2017 
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Study name Effects of behavioural activation on emotional cognition and mood
Methods RCT
Participants Low mood
Interventions Behavioural activation, active monitoring, and waiting list
Outcomes Emotional attention and memory, depression severity, environmental rewards, social support
Starting date -





Study name Randomised controlled trial of behavioral activation group therapy for depression in undergradu-
ate students
Methods RCT
Participants Undergraduate students with depression
Interventions Behavioural activation group therapy and no treatment
Outcomes Primary: PHQ-9. Secondary: BDI, BADS, Reward Probability Index, Work and Social Adjustment
Scale, WHO Quality of Life 26
Starting date April 2018





Study name A pilot study to assess the effectiveness of BehaviouRal ActiVation group program in patients with
dEpression: BRAVE (BRAVE)
Methods Pilot study including RCT
Participants Adults with a diagnosis of major depressive disorder.
Interventions Behavioural activation and support group (enhanced usual care)
Outcomes Primary: recruitment and retention, data completion, resource utilisation. Secondary: qualitative
study feedback, EQ-5D-5L feasibility.
Samaan 2014 
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Starting date March 2014





Study name Metacognitive therapy vs. behavioral activation a single-center randomized clinical trial
(PRO*MDD)
Methods RCT
Participants People with major depressive disorder
Interventions Behavioural activation and metacognitive therapy
Outcomes Primary: depression severity (HRSD). Secondary: quality of life, psychosocial functioning and par-
ticipation, comorbidity.
Starting date September 2016





Study name Feasibility of a behavioral activation trial
Methods RCT
Participants Adults with major depressive disorder
Interventions Behavioural activation and treatment as usual (psychotherapy and medication)
Outcomes Primary: patients refusing randomisation, patients completing 9 sessions, homework completed,
monthly assessments obtained, opinions about treatment, Brief Alliance Inventory. Secondary out-
comes available in trial registration.
Starting date March 2016
Contact information University of Penssylvania, Philadelphia, Pennsylvania, United States, 19104
Notes Estimated completion date April 2020 (trial registry)
University of Pennsylvania 2016 
 
 
Study name Improving mood in veterans in primary care
VA O:ice of Research and Development 2014 
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Methods RCT
Participants Veterans with depressive symptoms
Interventions Brief behavioural activation and usual care
Outcomes Primary: depression symptoms at 12 weeks. Secondary: quality of life, sleep disturbances, EROS,
suicidal ideation.
Starting date March 2015
Contact information Jennifer Schum Funderburk, PhD
Notes Data have added to online trial registration record after data extraction for this review finished.
VA O:ice of Research and Development 2014  (Continued)
 
 
Study name Behavioural activation in nursing homes to treat depression (BAN-Dep)
Methods Cluster-RCT
Participants Nursing home residents with depressive symptoms
Interventions Behavioural activation + Beyondblue Professional Education to aged care and Beyondblue Profes-
sional Education to Aged Care
Outcomes PHQ-9, GAD-7, Montreal Cognitive Assessment, SF-12, DeJong Gierveld Loneliness Scale, LSNS-6,
KLLD-R
Starting date -
Contact information Professor Osvaldo P Almeida; osvaldo. almeida@ uwa. edu. au
Notes Estimated to be completed in 2022
Velasquez Reyes 2019 
BA: Behavioural activation; BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory; CBT: cognitive-behavioural therapy; GAD-7:
Generalised Anxiety Disorder; PANAS: Positive and Negative Aect Schedule; PHQ_9: Patient Health Questionnaire; RCT: randomised
controlled trial; WHO: World Health Organization.
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   behavioural activation vs CBT





Statistical method Effect size
1.1 treatment efficacy 5   Risk Ratio (IV, Random, 95% CI) Subtotals only
1.1.1 Short-term (up to 6 months) 5 601 Risk Ratio (IV, Random, 95% CI) 0.99 [0.92, 1.07]
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Statistical method Effect size
1.1.2 Medium-term (7-12 months) 1 364 Risk Ratio (IV, Random, 95% CI) 1.00 [0.86, 1.16]
1.1.3 Long-term (>12 months) 1 356 Risk Ratio (IV, Random, 95% CI) 0.93 [0.81, 1.08]
1.2 treatment acceptability (dropouts) 12   Risk Ratio (IV, Random, 95% CI) Subtotals only
1.2.1 Short-term (up to 6 months) 12 1195 Risk Ratio (IV, Random, 95% CI) 1.03 [0.85, 1.25]
1.2.2 Medium-term (7-12 months) 1 440 Risk Ratio (IV, Random, 95% CI) 1.25 [0.97, 1.62]
1.2.3 Long-term (>12 months) 1 440 Risk Ratio (IV, Random, 95% CI) 1.16 [0.90, 1.49]
1.3 depression symptoms 16   Std. Mean Difference (IV, Random,
95% CI)
Subtotals only
1.3.1 Short-term (up to 6 months) 16 1205 Std. Mean Difference (IV, Random,
95% CI)
0.12 [-0.08, 0.32]
1.3.2 Medium-term (7-12 months) 1 380 Std. Mean Difference (IV, Random,
95% CI)
-0.18 [-0.38, 0.02]
1.3.3 Long-term (>12 months) 1 364 Std. Mean Difference (IV, Random,
95% CI)
0.00 [-0.21, 0.21]
1.4 quality of life 2   Std. Mean Difference (IV, Random,
95% CI)
Subtotals only
1.4.1 Short-term (up to 6 months) 2 268 Std. Mean Difference (IV, Random,
95% CI)
0.04 [-0.20, 0.28]
1.4.2 Medium-term (7-12 months) 1 318 Std. Mean Difference (IV, Random,
95% CI)
0.15 [-0.07, 0.37]
1.4.3 Long-term (>12 months) 1 327 Std. Mean Difference (IV, Random,
95% CI)
0.06 [-0.15, 0.28]
1.5 social adjustment and functioning 2   Std. Mean Difference (IV, Random,
95% CI)
Subtotals only
1.5.1 Short-term (up to 6 months) 2 111 Std. Mean Difference (IV, Random,
95% CI)
-0.13 [-0.50, 0.24]
1.6 anxiety symptoms 4   Std. Mean Difference (IV, Random,
95% CI)
Subtotals only
1.6.1 Short-term (up to 6 months) 4 646 Std. Mean Difference (IV, Random,
95% CI)
-0.03 [-0.18, 0.13]
1.6.2 Medium-term (7-12 months) 1 337 Std. Mean Difference (IV, Random,
95% CI)
0.02 [-0.20, 0.23]
1.6.3 Long-term (>12 months) 1 332 Std. Mean Difference (IV, Random,
95% CI)
-0.10 [-0.31, 0.12]
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Analysis 1.1.   Comparison 1: behavioural activation vs CBT, Outcome 1: treatment e:icacy
Study or Subgroup








Heterogeneity: Tau² = 0.00; Chi² = 1.35, df = 4 (P = 0.85); I² = 0%
Test for overall effect: Z = 0.27 (P = 0.79)





Test for overall effect: Z = 0.02 (P = 0.98)
































































IV, Random, 95% CI
0.92 [0.77 , 1.11]
0.94 [0.66 , 1.35]
1.00 [0.91 , 1.09]
1.10 [0.69 , 1.74]
1.16 [0.73 , 1.83]
0.99 [0.92 , 1.07]
1.00 [0.86 , 1.16]
1.00 [0.86 , 1.16]
0.93 [0.81 , 1.08]
0.93 [0.81 , 1.08]
Risk Ratio
IV, Random, 95% CI
0.5 0.7 1 1.5 2
Favours CBT Favours BA
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Analysis 1.2.   Comparison 1: behavioural activation vs CBT, Outcome 2: treatment acceptability (dropouts)
Study or Subgroup















Heterogeneity: Tau² = 0.00; Chi² = 5.97, df = 10 (P = 0.82); I² = 0%
Test for overall effect: Z = 0.29 (P = 0.77)





Test for overall effect: Z = 1.72 (P = 0.09)





Test for overall effect: Z = 1.12 (P = 0.26)





























































































IV, Random, 95% CI
Not estimable
0.20 [0.01 , 3.70]
0.33 [0.04 , 2.56]
0.79 [0.43 , 1.45]
0.80 [0.27 , 2.41]
0.83 [0.45 , 1.53]
1.05 [0.63 , 1.76]
1.12 [0.86 , 1.47]
1.22 [0.45 , 3.34]
1.82 [0.18 , 18.55]
2.49 [0.43 , 14.45]
3.00 [0.14 , 65.90]
1.03 [0.85 , 1.25]
1.25 [0.97 , 1.62]
1.25 [0.97 , 1.62]
1.16 [0.90 , 1.49]
1.16 [0.90 , 1.49]
Risk Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
Favours BA Favours CBT
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Analysis 1.3.   Comparison 1: behavioural activation vs CBT, Outcome 3: depression symptoms
Study or Subgroup


















Heterogeneity: Tau² = 0.07; Chi² = 31.26, df = 15 (P = 0.008); I² = 52%
Test for overall effect: Z = 1.20 (P = 0.23)




Test for overall effect: Z = 1.76 (P = 0.08)




Test for overall effect: Z = 0.00 (P = 1.00)


















































































































































IV, Random, 95% CI
-0.63 [-1.56 , 0.30]
-0.22 [-0.72 , 0.29]
-0.14 [-1.12 , 0.84]
-0.11 [-0.67 , 0.45]
-0.07 [-0.42 , 0.28]
-0.04 [-0.80 , 0.72]
-0.03 [-0.23 , 0.18]
-0.01 [-0.28 , 0.26]
0.12 [-0.29 , 0.52]
0.16 [-0.45 , 0.76]
0.16 [-0.29 , 0.61]
0.63 [-0.39 , 1.64]
0.65 [-0.31 , 1.61]
0.69 [-0.33 , 1.70]
0.97 [0.01 , 1.94]
2.83 [1.55 , 4.11]
0.12 [-0.08 , 0.32]
-0.18 [-0.38 , 0.02]
-0.18 [-0.38 , 0.02]
0.00 [-0.21 , 0.21]
0.00 [-0.21 , 0.21]
Std. Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours BA Favours CBT
 
 
Analysis 1.4.   Comparison 1: behavioural activation vs CBT, Outcome 4: quality of life
Study or Subgroup




Heterogeneity: Tau² = 0.00; Chi² = 0.51, df = 1 (P = 0.48); I² = 0%
Test for overall effect: Z = 0.34 (P = 0.73)




Test for overall effect: Z = 1.34 (P = 0.18)




Test for overall effect: Z = 0.58 (P = 0.56)
















































IV, Random, 95% CI
-0.14 [-0.70 , 0.42]
0.08 [-0.18 , 0.35]
0.04 [-0.20 , 0.28]
0.15 [-0.07 , 0.37]
0.15 [-0.07 , 0.37]
0.06 [-0.15 , 0.28]
0.06 [-0.15 , 0.28]
Std. Mean Difference
IV, Random, 95% CI
-0.5 -0.25 0 0.25 0.5
Favours CBT Favours BA
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Analysis 1.5.   Comparison 1: behavioural activation vs CBT, Outcome 5: social adjustment and functioning
Study or Subgroup




Heterogeneity: Tau² = 0.00; Chi² = 0.78, df = 1 (P = 0.38); I² = 0%
Test for overall effect: Z = 0.68 (P = 0.50)




























IV, Random, 95% CI
-0.32 [-0.88 , 0.24]
0.02 [-0.48 , 0.52]
-0.13 [-0.50 , 0.24]
Std. Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Favours BA Favours CBT
 
 
Analysis 1.6.   Comparison 1: behavioural activation vs CBT, Outcome 6: anxiety symptoms
Study or Subgroup






Heterogeneity: Tau² = 0.00; Chi² = 1.18, df = 3 (P = 0.76); I² = 0%
Test for overall effect: Z = 0.32 (P = 0.75)




Test for overall effect: Z = 0.15 (P = 0.88)




Test for overall effect: Z = 0.90 (P = 0.37)






























































IV, Random, 95% CI
-0.46 [-1.38 , 0.45]
-0.16 [-0.71 , 0.40]
0.00 [-0.21 , 0.21]
0.00 [-0.27 , 0.27]
-0.03 [-0.18 , 0.13]
0.02 [-0.20 , 0.23]
0.02 [-0.20 , 0.23]
-0.10 [-0.31 , 0.12]
-0.10 [-0.31 , 0.12]
Std. Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
Favours BA Favours CBT
 
 
Comparison 2.   behavioural activation vs third-wave CBT





Statistical method Effect size
2.1 treatment efficacy 2   Risk Ratio (IV, Random, 95% CI) Subtotals only
2.1.1 Short-term (up to 6 months) 2 98 Risk Ratio (IV, Random, 95% CI) 1.10 [0.91, 1.33]
2.2 treatment acceptability (dropouts) 3   Risk Ratio (IV, Random, 95% CI) Subtotals only
2.2.1 Short-term (up to 6 months) 3 147 Risk Ratio (IV, Random, 95% CI) 0.84 [0.33, 2.10]
2.3 depression symptoms 3   Std. Mean Difference (IV, Random,
95% CI)
Subtotals only
2.3.1 Short-term (up to 6 months) 3 147 Std. Mean Difference (IV, Random,
95% CI)
-0.14 [-0.47, 0.18]
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Statistical method Effect size
2.4 quality of life 1   Mean Difference (IV, Random, 95% CI) Subtotals only
2.4.1 Short-term (up to 6 months) 1 81 Mean Difference (IV, Random, 95% CI) 0.02 [-0.96, 1.00]
2.5 anxiety symptoms 3   Mean Difference (IV, Random, 95% CI) Subtotals only
2.5.1 Short-term (up to 6 months) 3 147 Mean Difference (IV, Random, 95% CI) 0.69 [-0.68, 2.06]
 
 
Analysis 2.1.   Comparison 2: behavioural activation vs third-wave CBT, Outcome 1: treatment e:icacy
Study or Subgroup





Heterogeneity: Tau² = 0.00; Chi² = 0.07, df = 1 (P = 0.79); I² = 0%
Test for overall effect: Z = 0.96 (P = 0.34)
























IV, Random, 95% CI
1.09 [0.88 , 1.34]
1.17 [0.71 , 1.92]
1.10 [0.91 , 1.33]
Risk Ratio
IV, Random, 95% CI
0.5 0.7 1 1.5 2
favours third-wave CBT favours BA
 
 
Analysis 2.2.   Comparison 2: behavioural activation vs third-
wave CBT, Outcome 2: treatment acceptability (dropouts)
Study or Subgroup






Heterogeneity: Tau² = 0.00; Chi² = 0.24, df = 1 (P = 0.62); I² = 0%
Test for overall effect: Z = 0.38 (P = 0.70)




























IV, Random, 95% CI
Not estimable
0.73 [0.25 , 2.12]
1.25 [0.20 , 7.92]
0.84 [0.33 , 2.10]
Risk Ratio
IV, Random, 95% CI
0.02 0.1 1 10 50
favours BA favours third-wave CBT
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Analysis 2.3.   Comparison 2: behavioural activation vs third-wave CBT, Outcome 3: depression symptoms
Study or Subgroup





Heterogeneity: Tau² = 0.00; Chi² = 1.22, df = 2 (P = 0.54); I² = 0%
Test for overall effect: Z = 0.85 (P = 0.40)



































IV, Random, 95% CI
-0.47 [-1.14 , 0.20]
-0.05 [-0.77 , 0.66]
-0.03 [-0.47 , 0.40]
-0.14 [-0.47 , 0.18]
Std. Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
favours BA favours third-wave CBT
 
 
Analysis 2.4.   Comparison 2: behavioural activation vs third-wave CBT, Outcome 4: quality of life
Study or Subgroup




Test for overall effect: Z = 0.04 (P = 0.97)





















IV, Random, 95% CI
0.02 [-0.96 , 1.00]
0.02 [-0.96 , 1.00]
Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Favours BA Favours third-wave CBT
 
 
Analysis 2.5.   Comparison 2: behavioural activation vs third-wave CBT, Outcome 5: anxiety symptoms
Study or Subgroup





Heterogeneity: Tau² = 0.00; Chi² = 0.39, df = 2 (P = 0.82); I² = 0%
Test for overall effect: Z = 0.99 (P = 0.32)



































IV, Random, 95% CI
-0.96 [-6.90 , 4.98]
0.70 [-0.84 , 2.24]
1.24 [-2.25 , 4.73]
0.69 [-0.68 , 2.06]
Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
favours BA favours third-wave CBT
 
 
Comparison 3.   behavioural activation vs humanistic therapy





Statistical method Effect size
3.1 treatment efficacy 2   Risk Ratio (IV, Random, 95% CI) Subtotals only
3.1.1 Short-term (up to 6 months) 2 46 Risk Ratio (IV, Random, 95% CI) 1.84 [1.15, 2.95]
3.2 treatment acceptability (dropouts) 2 96 Risk Ratio (IV, Random, 95% CI) 1.06 [0.20, 5.55]
3.2.1 Short-term (up to 6 months) 2 96 Risk Ratio (IV, Random, 95% CI) 1.06 [0.20, 5.55]
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Statistical method Effect size
3.3 depression symptoms 3   Mean Difference (IV, Random, 95%
CI)
Subtotals only
3.3.1 Short-term (up to 6 months) 3 93 Mean Difference (IV, Random, 95%
CI)
-3.75 [-6.72, -0.78]
3.4 quality of life 1   Mean Difference (IV, Random, 95%
CI)
Subtotals only
3.4.1 Short-term (up to 6 months) 1 50 Mean Difference (IV, Random, 95%
CI)
0.80 [-0.12, 1.72]
3.5 anxiety symptoms 1   Mean Difference (IV, Random, 95%
CI)
Subtotals only





Analysis 3.1.   Comparison 3: behavioural activation vs humanistic therapy, Outcome 1: treatment e:icacy
Study or Subgroup





Heterogeneity: Tau² = 0.00; Chi² = 0.01, df = 1 (P = 0.94); I² = 0%
Test for overall effect: Z = 2.55 (P = 0.01)
























IV, Random, 95% CI
1.80 [0.81 , 3.98]
1.87 [1.04 , 3.34]
1.84 [1.15 , 2.95]
Risk Ratio
IV, Random, 95% CI
0.2 0.5 1 2 5
favours humanistic favours BA
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Analysis 3.2.   Comparison 3: behavioural activation vs humanistic
therapy, Outcome 2: treatment acceptability (dropouts)
Study or Subgroup





Heterogeneity: Tau² = 0.81; Chi² = 1.66, df = 1 (P = 0.20); I² = 40%
Test for overall effect: Z = 0.07 (P = 0.95)
Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.81; Chi² = 1.66, df = 1 (P = 0.20); I² = 40%
Test for overall effect: Z = 0.07 (P = 0.95)





























IV, Random, 95% CI
0.67 [0.34 , 1.32]
5.00 [0.25 , 99.16]
1.06 [0.20 , 5.55]
1.06 [0.20 , 5.55]
Risk Ratio
IV, Random, 95% CI
0.002 0.1 1 10 500
favours BA favours humanistic
 
 
Analysis 3.3.   Comparison 3: behavioural activation vs humanistic therapy, Outcome 3: depression symptoms
Study or Subgroup





Heterogeneity: Tau² = 0.00; Chi² = 0.10, df = 2 (P = 0.95); I² = 0%
Test for overall effect: Z = 2.47 (P = 0.01)



































IV, Random, 95% CI
-4.17 [-8.53 , 0.19]
-3.92 [-10.79 , 2.95]
-3.10 [-8.14 , 1.94]
-3.75 [-6.72 , -0.78]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
favours BA favours humanistic
 
 
Analysis 3.4.   Comparison 3: behavioural activation vs humanistic therapy, Outcome 4: quality of life
Study or Subgroup




Test for overall effect: Z = 1.71 (P = 0.09)





















IV, Random, 95% CI
0.80 [-0.12 , 1.72]
0.80 [-0.12 , 1.72]
Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Favours humanistic Favours BA
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Analysis 3.5.   Comparison 3: behavioural activation vs humanistic therapy, Outcome 5: anxiety symptoms
Study or Subgroup




Test for overall effect: Z = 0.53 (P = 0.60)





















IV, Random, 95% CI
-1.30 [-6.10 , 3.50]
-1.30 [-6.10 , 3.50]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
favours BA favours humanistic
 
 
Comparison 4.   behavioural activation vs psychodynamic





Statistical method Effect size
4.1 treatment efficacy 1   Risk Ratio (IV, Random, 95% CI) Subtotals only
4.1.1 Short-term (up to 6 months) 1 60 Risk Ratio (IV, Random, 95% CI) 1.21 [0.74, 1.99]
4.2 depression symptoms 1   Mean Difference (IV, Random, 95% CI) Subtotals only
4.2.1 Short-term (up to 6 months) 1 60 Mean Difference (IV, Random, 95% CI) -1.10 [-4.35, 2.15]
4.3 social adjustment and functioning 1   Mean Difference (IV, Random, 95% CI) Subtotals only
4.3.1 Short-term (up to 6 months) 1 60 Mean Difference (IV, Random, 95% CI) 2.10 [-4.92, 9.12]
 
 
Analysis 4.1.   Comparison 4: behavioural activation vs psychodynamic, Outcome 1: treatment e:icacy
Study or Subgroup





Test for overall effect: Z = 0.77 (P = 0.44)



















IV, Random, 95% CI
1.21 [0.74 , 1.99]
1.21 [0.74 , 1.99]
Risk Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
Favours psychodynamic Favours BA
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Analysis 4.2.   Comparison 4: behavioural activation vs psychodynamic, Outcome 2: depression symptoms
Study or Subgroup




Test for overall effect: Z = 0.66 (P = 0.51)





















IV, Random, 95% CI
-1.10 [-4.35 , 2.15]
-1.10 [-4.35 , 2.15]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours BA Favours psychodynamic
 
 
Analysis 4.3.   Comparison 4: behavioural activation vs
psychodynamic, Outcome 3: social adjustment and functioning
Study or Subgroup




Test for overall effect: Z = 0.59 (P = 0.56)





















IV, Random, 95% CI
2.10 [-4.92 , 9.12]
2.10 [-4.92 , 9.12]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours psychodynamic Favours BA
 
 
Comparison 5.   behavioural activation vs interpersonal, cognitive analytic, integrative





Statistical method Effect size
5.1 treatment acceptability (dropouts) 4   Risk Ratio (IV, Random, 95% CI) Subtotals only
5.1.1 Short-term (up to 6 months) 4 123 Risk Ratio (IV, Random, 95% CI) 0.84 [0.32, 2.20]
5.2 depression symptoms 4   Std. Mean Difference (IV, Random,
95% CI)
Subtotals only
5.2.1 Short-term (up to 6 months) 4 103 Std. Mean Difference (IV, Random,
95% CI)
-0.16 [-0.59, 0.28]
5.3 social adjustment and functioning 1 39 Mean Difference (IV, Random, 95%
CI)
-3.92 [-16.78, 8.93]
5.3.1 Short-term (up to 6 months) 1 39 Mean Difference (IV, Random, 95%
CI)
-3.92 [-16.78, 8.93]
5.4 anxiety symptoms 1 15 Mean Difference (IV, Fixed, 95% CI) -0.39 [-11.78, 11.00]
5.4.1 Short-term (up to 6 months) 1 15 Mean Difference (IV, Fixed, 95% CI) -0.39 [-11.78, 11.00]
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Analysis 5.1.   Comparison 5: behavioural activation vs interpersonal,
cognitive analytic, integrative, Outcome 1: treatment acceptability (dropouts)
Study or Subgroup







Heterogeneity: Tau² = 0.00; Chi² = 0.78, df = 3 (P = 0.85); I² = 0%
Test for overall effect: Z = 0.36 (P = 0.72)


































IV, Random, 95% CI
0.33 [0.01 , 7.45]
0.50 [0.05 , 4.67]
1.00 [0.24 , 4.18]
1.26 [0.19 , 8.24]
0.84 [0.32 , 2.20]
Risk Ratio
IV, Random, 95% CI
0.005 0.1 1 10 200
favours BA favours control
 
 
Analysis 5.2.   Comparison 5: behavioural activation vs interpersonal,
cognitive analytic, integrative, Outcome 2: depression symptoms
Study or Subgroup






Heterogeneity: Tau² = 0.00; Chi² = 2.86, df = 3 (P = 0.41); I² = 0%
Test for overall effect: Z = 0.69 (P = 0.49)










































IV, Random, 95% CI
-0.67 [-1.66 , 0.32]
-0.35 [-1.18 , 0.47]
-0.06 [-0.86 , 0.74]
0.44 [-0.50 , 1.39]
-0.16 [-0.59 , 0.28]
Std. Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
favours BA favours control
 
 
Analysis 5.3.   Comparison 5: behavioural activation vs interpersonal,
cognitive analytic, integrative, Outcome 3: social adjustment and functioning
Study or Subgroup




Test for overall effect: Z = 0.60 (P = 0.55)
Total (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.60 (P = 0.55)
























IV, Random, 95% CI
-3.92 [-16.78 , 8.93]
-3.92 [-16.78 , 8.93]
-3.92 [-16.78 , 8.93]
Mean Difference
IV, Random, 95% CI
-20 -10 0 10 20
Favours interpersonal etc Favours BA
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Analysis 5.4.   Comparison 5: behavioural activation vs interpersonal,
cognitive analytic, integrative, Outcome 4: anxiety symptoms
Study or Subgroup




Test for overall effect: Z = 0.07 (P = 0.95)
Total (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.07 (P = 0.95)
























IV, Fixed, 95% CI
-0.39 [-11.78 , 11.00]
-0.39 [-11.78 , 11.00]
-0.39 [-11.78 , 11.00]
Mean Difference
IV, Fixed, 95% CI
-20 -10 0 10 20
Favours BA Favours comparator
 
 
Comparison 6.   behavioural activation vs waiting list





Statistical method Effect size
6.1 treatment efficacy 1   Risk Ratio (IV, Random, 95% CI) Subtotals only
6.1.1 Short-term (up to 6 months) 1 26 Risk Ratio (IV, Random, 95% CI) 2.14 [0.90, 5.09]
6.2 treatment acceptability (dropouts) 8   Risk Ratio (IV, Random, 95% CI) Subtotals only
6.2.1 Short-term (up to 6 months) 8 359 Risk Ratio (IV, Random, 95% CI) 1.17 [0.70, 1.93]
6.3 depression symptoms 12   Std. Mean Difference (IV, Random,
95% CI)
Subtotals only
6.3.1 Short-term (up to 6 months) 12 619 Std. Mean Difference (IV, Random,
95% CI)
-1.04 [-1.44, -0.63]
6.4 quality of life 1 80 Mean Difference (IV, Random, 95% CI) 0.03 [-0.70, 0.76]
6.4.1 Short-term (up to 6 months) 1 80 Mean Difference (IV, Random, 95% CI) 0.03 [-0.70, 0.76]
6.5 anxiety symptoms 5   Std. Mean Difference (IV, Random,
95% CI)
Subtotals only
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Analysis 6.1.   Comparison 6: behavioural activation vs waiting list, Outcome 1: treatment e:icacy
Study or Subgroup





Test for overall effect: Z = 1.72 (P = 0.08)



















IV, Random, 95% CI
2.14 [0.90 , 5.09]
2.14 [0.90 , 5.09]
Risk Ratio
IV, Random, 95% CI
0.2 0.5 1 2 5
Favours waiting list Favours BA
 
 
Analysis 6.2.   Comparison 6: behavioural activation vs waiting list, Outcome 2: treatment acceptability (dropouts)
Study or Subgroup











Heterogeneity: Tau² = 0.00; Chi² = 0.93, df = 4 (P = 0.92); I² = 0%
Test for overall effect: Z = 0.60 (P = 0.55)























































0.88 [0.14 , 5.42]
1.11 [0.61 , 2.02]
1.18 [0.33 , 4.18]
3.00 [0.14 , 65.90]
3.33 [0.15 , 71.90]
1.17 [0.70 , 1.93]
Risk Ratio
IV, Random, 95% CI
0.005 0.1 1 10 200
favours BA favours waiting list
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Analysis 6.3.   Comparison 6: behavioural activation vs waiting list, Outcome 3: depression symptoms
Study or Subgroup














Heterogeneity: Tau² = 0.32; Chi² = 44.26, df = 11 (P < 0.00001); I² = 75%
Test for overall effect: Z = 5.03 (P < 0.00001)


































































































IV, Random, 95% CI
-3.93 [-5.21 , -2.64]
-1.83 [-3.01 , -0.64]
-1.81 [-3.13 , -0.49]
-1.63 [-2.89 , -0.36]
-1.40 [-2.21 , -0.59]
-0.85 [-1.19 , -0.51]
-0.76 [-1.79 , 0.26]
-0.63 [-1.08 , -0.18]
-0.62 [-1.55 , 0.31]
-0.49 [-1.38 , 0.41]
-0.36 [-1.06 , 0.34]
-0.29 [-0.60 , 0.01]
-1.04 [-1.44 , -0.63]
Std. Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
favours BA favours waiting list
 
 
Analysis 6.4.   Comparison 6: behavioural activation vs waiting list, Outcome 4: quality of life
Study or Subgroup




Test for overall effect: Z = 0.08 (P = 0.94)
Total (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.08 (P = 0.94)
























IV, Random, 95% CI
0.03 [-0.70 , 0.76]
0.03 [-0.70 , 0.76]
0.03 [-0.70 , 0.76]
Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours waiting list Favours BA
 
 
Analysis 6.5.   Comparison 6: behavioural activation vs waiting list, Outcome 5: anxiety symptoms
Study or Subgroup







Heterogeneity: Tau² = 0.47; Chi² = 30.87, df = 4 (P < 0.00001); I² = 87%
Test for overall effect: Z = 2.61 (P = 0.009)

















































IV, Random, 95% CI
-3.67 [-4.90 , -2.44]
-0.73 [-1.07 , -0.39]
-0.55 [-1.47 , 0.37]
-0.35 [-1.07 , 0.37]
-0.22 [-0.52 , 0.09]
-0.91 [-1.59 , -0.23]
Std. Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
favours BA favours waiting list
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Comparison 7.   behavioural activation vs placebo





Statistical method Effect size
7.1 treatment acceptability (dropouts) 1 96 Risk Ratio (M-H, Random, 95% CI) 0.72 [0.31, 1.67]
7.1.1 Short-term (up to 6 months) 1 96 Risk Ratio (M-H, Random, 95% CI) 0.72 [0.31, 1.67]
7.2 depression symptoms 2 108 Std. Mean Difference (IV, Random,
95% CI)
-0.18 [-0.57, 0.20]





Analysis 7.1.   Comparison 7: behavioural activation vs placebo, Outcome 1: treatment acceptability (dropouts)
Study or Subgroup









Test for overall effect: Z = 0.77 (P = 0.44)
























M-H, Random, 95% CI
0.72 [0.31 , 1.67]
0.72 [0.31 , 1.67]
0.72 [0.31 , 1.67]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours BA Favours placebo
 
 
Analysis 7.2.   Comparison 7: behavioural activation vs placebo, Outcome 2: depression symptoms
Study or Subgroup




Heterogeneity: Tau² = 0.00; Chi² = 0.13, df = 1 (P = 0.71); I² = 0%
Test for overall effect: Z = 0.93 (P = 0.35)
Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.13, df = 1 (P = 0.71); I² = 0%
Test for overall effect: Z = 0.93 (P = 0.35)































IV, Random, 95% CI
-0.22 [-0.67 , 0.22]
-0.06 [-0.82 , 0.70]
-0.18 [-0.57 , 0.20]
-0.18 [-0.57 , 0.20]
Std. Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
favours BA favours placebo
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Comparison 8.   behavioural activation vs medication





Statistical method Effect size
8.1 treatment efficacy 1   Risk Ratio (IV, Random, 95% CI) Subtotals only
8.1.1 Short-term (up to 6 months) 1 141 Risk Ratio (IV, Random, 95% CI) 1.77 [1.14, 2.76]
8.2 treatment acceptability
(dropouts)
2   Risk Ratio (IV, Random, 95% CI) Subtotals only
8.2.1 Short-term (up to 6 months) 2 243 Risk Ratio (IV, Random, 95% CI) 0.52 [0.23, 1.16]
8.2.2 Medium-term (7-12 months) 1 100 Risk Ratio (IV, Random, 95% CI) 0.86 [0.31, 2.37]
8.3 depression symptoms 2   Mean Difference (IV, Random, 95% CI) Subtotals only
8.3.1 Short-term change from base-
line (up to 6 months)
2 180 Mean Difference (IV, Random, 95% CI) -1.42 [-4.80, 1.96]
8.3.2 Medium-term change from
baseline (7-12 months)
1 100 Mean Difference (IV, Random, 95% CI) -2.34 [-3.84, -0.84]
 
 
Analysis 8.1.   Comparison 8: behavioural activation vs medication, Outcome 1: treatment e:icacy
Study or Subgroup
























IV, Random, 95% CI
1.77 [1.14 , 2.76]
1.77 [1.14 , 2.76]
Risk Ratio
IV, Random, 95% CI
0.5 0.7 1 1.5 2
Favours medication Favours BA
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Analysis 8.2.   Comparison 8: behavioural activation vs medication, Outcome 2: treatment acceptability (dropouts)
Study or Subgroup





Heterogeneity: Tau² = 0.15; Chi² = 1.76, df = 1 (P = 0.19); I² = 43%
Test for overall effect: Z = 1.59 (P = 0.11)





Test for overall effect: Z = 0.30 (P = 0.77)


































IV, Random, 95% CI
0.37 [0.18 , 0.75]
0.86 [0.31 , 2.37]
0.52 [0.23 , 1.16]
0.86 [0.31 , 2.37]
0.86 [0.31 , 2.37]
Risk Ratio
IV, Random, 95% CI
0.02 0.1 1 10 50
favours BA favours medication
 
 
Analysis 8.3.   Comparison 8: behavioural activation vs medication, Outcome 3: depression symptoms
Study or Subgroup




Heterogeneity: Tau² = 4.96; Chi² = 6.01, df = 1 (P = 0.01); I² = 83%
Test for overall effect: Z = 0.82 (P = 0.41)




Test for overall effect: Z = 3.05 (P = 0.002)






































IV, Random, 95% CI
-3.09 [-4.86 , -1.32]
0.36 [-1.76 , 2.48]
-1.42 [-4.80 , 1.96]
-2.34 [-3.84 , -0.84]
-2.34 [-3.84 , -0.84]
Mean Difference
IV, Random, 95% CI
-20 -10 0 10 20
favours BA favours medication
 
 
Comparison 9.   behavioural activation vs no treatment





Statistical method Effect size
9.1 treatment acceptability (dropouts) 3   Risk Ratio (IV, Random, 95% CI) Subtotals only
9.1.1 Short-term (up to 6 months) 3 187 Risk Ratio (IV, Random, 95% CI) 0.97 [0.45, 2.09]
9.1.2 Medium-term (7-12 months) 1 124 Risk Ratio (IV, Random, 95% CI) 1.57 [0.65, 3.79]
9.2 depression symptoms 3   Mean Difference (IV, Random, 95%
CI)
Subtotals only
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Statistical method Effect size
9.2.1 Short-term (up to 6 months) 3 187 Mean Difference (IV, Random, 95%
CI)
-6.10 [-7.87, -4.33]
9.2.2 Medium-term (7-12 months) 1 118 Mean Difference (IV, Random, 95%
CI)
-2.83 [-5.32, -0.34]
9.3 quality of life 1   Mean Difference (IV, Random, 95%
CI)
Subtotals only
9.3.1 Short-term (up to 6 months) 1 118 Mean Difference (IV, Random, 95%
CI)
0.07 [0.03, 0.11]
9.4 anxiety symptoms 1   Mean Difference (IV, Random, 95%
CI)
Subtotals only





Analysis 9.1.   Comparison 9: behavioural activation vs no treatment, Outcome 1: treatment acceptability (dropouts)
Study or Subgroup






Heterogeneity: Tau² = 0.00; Chi² = 0.00, df = 1 (P = 0.96); I² = 0%
Test for overall effect: Z = 0.07 (P = 0.94)





Test for overall effect: Z = 1.01 (P = 0.31)






































IV, Random, 95% CI
Not estimable
0.90 [0.06 , 14.10]
0.98 [0.44 , 2.17]
0.97 [0.45 , 2.09]
1.57 [0.65 , 3.79]
1.57 [0.65 , 3.79]
Risk Ratio
IV, Random, 95% CI
0.05 0.2 1 5 20
favours BA favours no treatment
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Analysis 9.2.   Comparison 9: behavioural activation vs no treatment, Outcome 2: depression symptoms
Study or Subgroup





Heterogeneity: Tau² = 0.00; Chi² = 0.23, df = 2 (P = 0.89); I² = 0%
Test for overall effect: Z = 6.75 (P < 0.00001)




Test for overall effect: Z = 2.22 (P = 0.03)













































IV, Random, 95% CI
-6.60 [-9.31 , -3.89]
-5.74 [-8.12 , -3.36]
-5.39 [-18.06 , 7.28]
-6.10 [-7.87 , -4.33]
-2.83 [-5.32 , -0.34]
-2.83 [-5.32 , -0.34]
Mean Difference
IV, Random, 95% CI
-20 -10 0 10 20
favours BA favours no treatment
 
 
Analysis 9.3.   Comparison 9: behavioural activation vs no treatment, Outcome 3: quality of life
Study or Subgroup




Test for overall effect: Z = 3.14 (P = 0.002)





















IV, Random, 95% CI
0.07 [0.03 , 0.11]
0.07 [0.03 , 0.11]
Mean Difference
IV, Random, 95% CI
-0.2 -0.1 0 0.1 0.2
Favours BA Favours no treatment
 
 
Analysis 9.4.   Comparison 9: behavioural activation vs no treatment, Outcome 4: anxiety symptoms
Study or Subgroup




Test for overall effect: Z = 2.39 (P = 0.02)





















IV, Random, 95% CI
-5.50 [-10.01 , -0.99]
-5.50 [-10.01 , -0.99]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours BA Favours no treatment
 
 
Comparison 10.   behavioural activation vs treatment as usual





Statistical method Effect size
10.1 treatment efficacy 7   Risk Ratio (M-H, Random, 95% CI) Subtotals only
10.1.1 Short-term (up to 6 months) 7 1533 Risk Ratio (M-H, Random, 95% CI) 1.40 [1.10, 1.78]
10.1.2 Medium-term (7-12 months) 2 1012 Risk Ratio (M-H, Random, 95% CI) 1.23 [1.07, 1.42]
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Statistical method Effect size
10.2 treatment acceptability (dropouts) 14   Risk Ratio (IV, Random, 95% CI) Subtotals only
10.2.1 Short-term (up to 6 months) 14 2518 Risk Ratio (IV, Random, 95% CI) 1.64 [0.81, 3.31]
10.2.2 Medium-term (7-12 months) 4 1726 Risk Ratio (IV, Random, 95% CI) 2.84 [0.92, 8.75]
10.2.3 Long-term (>12 months) 1 485 Risk Ratio (IV, Random, 95% CI) 2.17 [1.39, 3.39]
10.3 depression symptoms 15   Std. Mean Difference (IV, Random,
95% CI)
Subtotals only
10.3.1 Short-term (up to 6 months) 15 2208 Std. Mean Difference (IV, Random,
95% CI)
-0.78 [-1.05, -0.51]
10.3.2 Medium-term (7-12 months) 4 1381 Std. Mean Difference (IV, Random,
95% CI)
-0.23 [-0.38, -0.08]
10.3.3 Long-term (>12 months) 1 343 Std. Mean Difference (IV, Random,
95% CI)
0.02 [-0.19, 0.23]
10.4 quality of life 6   Std. Mean Difference (IV, Random,
95% CI)
Subtotals only
10.4.1 short-term (up to 6 months) 6 1299 Std. Mean Difference (IV, Random,
95% CI)
0.97 [0.38, 1.57]
10.4.2 medium-term (7-12 months) 2 879 Std. Mean Difference (IV, Random,
95% CI)
0.14 [-0.12, 0.40]
10.4.3 long-term (>12 months) 1 325 Std. Mean Difference (IV, Random,
95% CI)
-0.09 [-0.30, 0.13]
10.5 social adjustment and functioning 2   Std. Mean Difference (IV, Random,
95% CI)
Subtotals only
10.5.1 Short-term (up to 6 months) 2 88 Std. Mean Difference (IV, Random,
95% CI)
-1.27 [-1.74, -0.81]
10.6 anxiety symptoms 4   Std. Mean Difference (IV, Random,
95% CI)
Subtotals only
10.6.1 Short-term (up to 6 months) 4 1063 Std. Mean Difference (IV, Random,
95% CI)
-0.33 [-0.45, -0.21]
10.6.2 Medium-term (7-12 months) 2 851 Std. Mean Difference (IV, Random,
95% CI)
-0.27 [-0.41, -0.12]
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Analysis 10.1.   Comparison 10: behavioural activation vs treatment as usual, Outcome 1: treatment e:icacy
Study or Subgroup










Heterogeneity: Tau² = 0.07; Chi² = 38.50, df = 6 (P < 0.00001); I² = 84%
Test for overall effect: Z = 2.74 (P = 0.006)





Heterogeneity: Tau² = 0.01; Chi² = 2.45, df = 1 (P = 0.12); I² = 59%
Test for overall effect: Z = 2.88 (P = 0.004)
































































M-H, Random, 95% CI
1.08 [1.00 , 1.17]
1.12 [0.94 , 1.33]
1.50 [1.19 , 1.88]
1.58 [0.78 , 3.18]
1.66 [1.37 , 2.00]
1.96 [1.03 , 3.71]
20.45 [1.24 , 336.48]
1.40 [1.10 , 1.78]
1.17 [1.07 , 1.28]
1.34 [1.14 , 1.58]
1.23 [1.07 , 1.42]
Risk Ratio
M-H, Random, 95% CI
0.5 0.7 1 1.5 2
favours treatm. as usual favours BA
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Analysis 10.2.   Comparison 10: behavioural activation vs
treatment as usual, Outcome 2: treatment acceptability (dropouts)
Study or Subgroup

















Heterogeneity: Tau² = 1.39; Chi² = 84.19, df = 13 (P < 0.00001); I² = 85%
Test for overall effect: Z = 1.38 (P = 0.17)







Heterogeneity: Tau² = 1.24; Chi² = 53.00, df = 3 (P < 0.00001); I² = 94%
Test for overall effect: Z = 1.81 (P = 0.07)





Test for overall effect: Z = 3.41 (P = 0.0006)























































































































IV, Random, 95% CI
0.50 [0.10 , 2.55]
0.52 [0.21 , 1.28]
0.54 [0.23 , 1.24]
0.65 [0.11 , 3.73]
0.68 [0.39 , 1.19]
0.75 [0.18 , 3.14]
1.25 [0.22 , 7.02]
1.43 [0.70 , 2.94]
1.62 [0.39 , 6.64]
1.73 [0.17 , 17.59]
3.65 [0.85 , 15.78]
4.55 [2.39 , 8.68]
7.58 [2.31 , 24.85]
22.04 [9.85 , 49.32]
1.64 [0.81 , 3.31]
1.18 [0.56 , 2.47]
1.55 [0.89 , 2.68]
2.91 [1.64 , 5.18]
11.19 [7.76 , 16.14]
2.84 [0.92 , 8.75]
2.17 [1.39 , 3.39]
2.17 [1.39 , 3.39]
Risk Ratio
IV, Random, 95% CI
0.02 0.1 1 10 50
favours BA favours treatm. as usual
 
 
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
Analysis 10.3.   Comparison 10: behavioural activation vs treatment as usual, Outcome 3: depression symptoms
Study or Subgroup

















Heterogeneity: Tau² = 0.19; Chi² = 92.99, df = 14 (P < 0.00001); I² = 85%
Test for overall effect: Z = 5.72 (P < 0.00001)
10.3.2 Medium-term (7-12 months)





Heterogeneity: Tau² = 0.01; Chi² = 5.00, df = 3 (P = 0.17); I² = 40%
Test for overall effect: Z = 2.97 (P = 0.003)




Test for overall effect: Z = 0.16 (P = 0.87)
































































































































































IV, Random, 95% CI
-3.83 [-4.68 , -2.97]
-2.03 [-2.80 , -1.26]
-1.29 [-1.90 , -0.67]
-1.15 [-1.85 , -0.45]
-0.79 [-1.91 , 0.32]
-0.69 [-1.12 , -0.26]
-0.56 [-1.03 , -0.09]
-0.52 [-0.70 , -0.34]
-0.45 [-0.99 , 0.09]
-0.43 [-1.27 , 0.42]
-0.37 [-0.53 , -0.20]
-0.35 [-0.55 , -0.15]
-0.31 [-0.56 , -0.06]
-0.16 [-0.91 , 0.59]
0.36 [-1.20 , 1.92]
-0.78 [-1.05 , -0.51]
-0.55 [-1.71 , 0.62]
-0.31 [-0.49 , -0.14]
-0.29 [-0.47 , -0.11]
-0.03 [-0.24 , 0.17]
-0.23 [-0.38 , -0.08]
0.02 [-0.19 , 0.23]
0.02 [-0.19 , 0.23]
Std. Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
favours BA favours treatm. as usual
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Analysis 10.4.   Comparison 10: behavioural activation vs treatment as usual, Outcome 4: quality of life
Study or Subgroup








Heterogeneity: Tau² = 0.48; Chi² = 103.00, df = 5 (P < 0.00001); I² = 95%
Test for overall effect: Z = 3.20 (P = 0.001)




Heterogeneity: Tau² = 0.02; Chi² = 3.58, df = 1 (P = 0.06); I² = 72%
Test for overall effect: Z = 1.07 (P = 0.29)




Test for overall effect: Z = 0.77 (P = 0.44)



















































































IV, Random, 95% CI
-0.05 [-0.25 , 0.16]
0.17 [-0.10 , 0.43]
0.33 [-0.43 , 1.08]
0.36 [0.19 , 0.53]
1.36 [0.74 , 1.98]
5.04 [3.99 , 6.08]
0.97 [0.38 , 1.57]
0.00 [-0.21 , 0.21]
0.26 [0.09 , 0.43]
0.14 [-0.12 , 0.40]
-0.09 [-0.30 , 0.13]
-0.09 [-0.30 , 0.13]
Std. Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
favours treatm. as usual favours BA
 
 
Analysis 10.5.   Comparison 10: behavioural activation vs
treatment as usual, Outcome 5: social adjustment and functioning
Study or Subgroup




Heterogeneity: Tau² = 0.00; Chi² = 0.23, df = 1 (P = 0.63); I² = 0%
Test for overall effect: Z = 5.37 (P < 0.00001)




























IV, Random, 95% CI
-1.38 [-2.00 , -0.75]
-1.14 [-1.84 , -0.45]
-1.27 [-1.74 , -0.81]
Std. Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Favours BA Favours treatm. as usual
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Analysis 10.6.   Comparison 10: behavioural activation vs treatment as usual, Outcome 6: anxiety symptoms
Study or Subgroup






Heterogeneity: Tau² = 0.00; Chi² = 1.23, df = 3 (P = 0.74); I² = 0%
Test for overall effect: Z = 5.30 (P < 0.00001)




Heterogeneity: Tau² = 0.00; Chi² = 1.12, df = 1 (P = 0.29); I² = 11%
Test for overall effect: Z = 3.64 (P = 0.0003)




Test for overall effect: Z = 0.72 (P = 0.47)





































































IV, Random, 95% CI
-0.58 [-1.05 , -0.11]
-0.35 [-0.91 , 0.21]
-0.31 [-0.51 , -0.10]
-0.31 [-0.47 , -0.14]
-0.33 [-0.45 , -0.21]
-0.33 [-0.50 , -0.15]
-0.18 [-0.39 , 0.03]
-0.27 [-0.41 , -0.12]
-0.08 [-0.29 , 0.14]
-0.08 [-0.29 , 0.14]
Std. Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
favours BA favours treatm. as usual
 
 
Comparison 11.   SUBGROUP 1 AGE behavioural activation vs other controls (up to 6 months)





Statistical method Effect size
11.1 treatment efficacy 6 903 Risk Ratio (IV, Random, 95% CI) 1.87 [1.18, 2.95]
11.1.1 under 65 4 244 Risk Ratio (IV, Random, 95% CI) 2.03 [1.49, 2.75]
11.1.2 65 and over 2 659 Risk Ratio (IV, Random, 95% CI) 3.32 [0.20, 54.59]
11.2 treatment acceptability
(dropouts)
15 1550 Risk Ratio (IV, Random, 95% CI) 1.20 [0.54, 2.67]
11.2.1 under 65 9 566 Risk Ratio (IV, Random, 95% CI) 0.83 [0.49, 1.40]
11.2.2 65 and over 6 984 Risk Ratio (IV, Random, 95% CI) 1.30 [0.26, 6.38]
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Analysis 11.1.   Comparison 11: SUBGROUP 1 AGE behavioural activation









Heterogeneity: Tau² = 0.00; Chi² = 1.40, df = 3 (P = 0.71); I² = 0%
Test for overall effect: Z = 4.53 (P < 0.00001)





Heterogeneity: Tau² = 3.30; Chi² = 4.23, df = 1 (P = 0.04); I² = 76%
Test for overall effect: Z = 0.84 (P = 0.40)
Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.20; Chi² = 20.61, df = 5 (P = 0.0010); I² = 76%
Test for overall effect: Z = 2.67 (P = 0.008)






















































IV, Random, 95% CI
1.77 [1.14 , 2.76]
1.96 [1.03 , 3.71]
2.14 [0.90 , 5.09]
2.97 [1.42 , 6.24]
2.03 [1.49 , 2.75]
1.08 [1.00 , 1.17]
20.45 [1.24 , 336.48]
3.32 [0.20 , 54.59]
1.87 [1.18 , 2.95]
Risk Ratio
IV, Random, 95% CI
0.02 0.1 1 10 50
favours control favours BA
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Analysis 11.2.   Comparison 11: SUBGROUP 1 AGE behavioural activation vs














Heterogeneity: Tau² = 0.12; Chi² = 8.15, df = 6 (P = 0.23); I² = 26%
Test for overall effect: Z = 0.70 (P = 0.48)









Heterogeneity: Tau² = 3.45; Chi² = 50.03, df = 5 (P < 0.00001); I² = 90%
Test for overall effect: Z = 0.32 (P = 0.75)
Total (95% CI)
Total events:
Heterogeneity: Tau² = 1.58; Chi² = 69.83, df = 12 (P < 0.00001); I² = 83%
Test for overall effect: Z = 0.44 (P = 0.66)

































































































IV, Random, 95% CI
Not estimable
Not estimable
0.44 [0.22 , 0.90]
0.68 [0.39 , 1.19]
0.88 [0.14 , 5.42]
0.90 [0.06 , 14.10]
1.18 [0.33 , 4.18]
3.33 [0.15 , 71.90]
3.65 [0.85 , 15.78]
0.83 [0.49 , 1.40]
0.50 [0.10 , 2.55]
0.54 [0.23 , 1.24]
0.65 [0.11 , 3.73]
0.75 [0.18 , 3.14]
1.25 [0.22 , 7.02]
22.04 [9.85 , 49.32]
1.30 [0.26 , 6.38]
1.20 [0.54 , 2.67]
Risk Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
favours BA favours control
 
 
Comparison 12.   SUBGROUP 2 THERAPIST behavioural activation vs other psychological therapies (up to 6 months)





Statistical method Effect size
12.1 treatment efficacy 8   Risk Ratio (IV, Random, 95% CI) Subtotals only
12.1.1 specialist 3 186 Risk Ratio (IV, Random, 95% CI) 1.11 [0.93, 1.32]
12.1.2 specialist in training 2 130 Risk Ratio (IV, Random, 95% CI) 1.13 [0.85, 1.49]
12.1.3 non-specialist 3 672 Risk Ratio (IV, Random, 95% CI) 1.30 [0.86, 1.98]
12.2 treatment acceptability
(dropouts)
17   Risk Ratio (IV, Random, 95% CI) Subtotals only
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Statistical method Effect size
12.2.1 specialist 11 593 Risk Ratio (IV, Random, 95% CI) 0.88 [0.62, 1.25]
12.2.2 specialist in training 3 90 Risk Ratio (IV, Random, 95% CI) 0.83 [0.31, 2.25]
12.2.3 non-specialist 3 701 Risk Ratio (IV, Random, 95% CI) 1.05 [0.84, 1.31]
 
 
Analysis 12.1.   Comparison 12: SUBGROUP 2 THERAPIST behavioural activation








Heterogeneity: Tau² = 0.00; Chi² = 0.11, df = 2 (P = 0.94); I² = 0%
Test for overall effect: Z = 1.12 (P = 0.26)





Heterogeneity: Tau² = 0.00; Chi² = 0.02, df = 1 (P = 0.88); I² = 0%







Heterogeneity: Tau² = 0.11; Chi² = 13.41, df = 2 (P = 0.001); I² = 85%
Test for overall effect: Z = 1.24 (P = 0.21)
































































IV, Random, 95% CI
1.09 [0.88 , 1.34]
1.16 [0.73 , 1.83]
1.17 [0.71 , 1.92]
1.11 [0.93 , 1.32]
1.10 [0.75 , 1.62]
1.15 [0.77 , 1.73]
1.13 [0.85 , 1.49]
0.92 [0.77 , 1.11]
1.50 [1.19 , 1.88]
1.87 [1.04 , 3.34]
1.30 [0.86 , 1.98]
Risk Ratio
IV, Random, 95% CI
0.850.9 1 1.1 1.2
favours other therapy favours BA
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Analysis 12.2.   Comparison 12: SUBGROUP 2 THERAPIST behavioural activation vs other
















Heterogeneity: Tau² = 0.00; Chi² = 4.68, df = 9 (P = 0.86); I² = 0%
Test for overall effect: Z = 0.71 (P = 0.48)






Heterogeneity: Tau² = 0.00; Chi² = 0.03, df = 1 (P = 0.86); I² = 0%







Heterogeneity: Tau² = 0.00; Chi² = 1.94, df = 2 (P = 0.38); I² = 0%
Test for overall effect: Z = 0.41 (P = 0.68)











































































































IV, Random, 95% CI
Not estimable
0.20 [0.01 , 3.70]
0.33 [0.01 , 7.45]
0.33 [0.04 , 2.56]
0.79 [0.43 , 1.45]
0.83 [0.45 , 1.53]
1.00 [0.24 , 4.18]
1.22 [0.45 , 3.34]
1.26 [0.19 , 8.24]
1.82 [0.18 , 18.55]
2.49 [0.43 , 14.45]
0.88 [0.62 , 1.25]
Not estimable
0.80 [0.27 , 2.41]
1.00 [0.10 , 9.75]
0.83 [0.31 , 2.25]
0.67 [0.34 , 1.32]
1.05 [0.63 , 1.76]
1.12 [0.86 , 1.47]
1.05 [0.84 , 1.31]
Risk Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
favours BA favours control
 
 
Comparison 13.   SUBGROUP 2 THERAPIST behavioural activation vs other controls (up to 6 months)





Statistical method Effect size
13.1 treatment efficacy 10 1730 Risk Ratio (IV, Random, 95% CI) 1.51 [1.24, 1.85]
13.1.1 specialist 4 238 Risk Ratio (IV, Random, 95% CI) 1.71 [1.08, 2.70]
13.1.2 non-specialist 6 1492 Risk Ratio (IV, Random, 95% CI) 1.49 [1.13, 1.97]
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Statistical method Effect size
13.2 treatment acceptability
(dropouts)
26   Risk Ratio (IV, Random, 95% CI) Subtotals only
13.2.1 specialist 12 618 Risk Ratio (IV, Random, 95% CI) 0.65 [0.47, 0.89]
13.2.2 specialist in training 3 98 Risk Ratio (IV, Random, 95% CI) 1.35 [0.42, 4.35]
13.2.3 non-specialist 11 2544 Risk Ratio (IV, Random, 95% CI) 2.20 [1.06, 4.57]
 
 
Analysis 13.1.   Comparison 13: SUBGROUP 2 THERAPIST behavioural









Heterogeneity: Tau² = 0.14; Chi² = 10.63, df = 3 (P = 0.01); I² = 72%










Heterogeneity: Tau² = 0.07; Chi² = 27.87, df = 5 (P < 0.0001); I² = 82%
Test for overall effect: Z = 2.81 (P = 0.005)
Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.06; Chi² = 38.86, df = 9 (P < 0.0001); I² = 77%
Test for overall effect: Z = 4.01 (P < 0.0001)










































































IV, Random, 95% CI
1.12 [0.94 , 1.33]
1.77 [1.14 , 2.76]
2.14 [0.90 , 5.09]
2.97 [1.42 , 6.24]
1.71 [1.08 , 2.70]
1.08 [1.00 , 1.17]
1.50 [1.19 , 1.88]
1.58 [0.78 , 3.18]
1.66 [1.37 , 2.00]
1.96 [1.03 , 3.71]
20.45 [1.24 , 336.48]
1.49 [1.13 , 1.97]
1.51 [1.24 , 1.85]
Risk Ratio
IV, Random, 95% CI
0.05 0.2 1 5 20
favours control favours BA
 
 
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
Analysis 13.2.   Comparison 13: SUBGROUP 2 THERAPIST behavioural activation

















Heterogeneity: Tau² = 0.00; Chi² = 4.49, df = 8 (P = 0.81); I² = 0%
Test for overall effect: Z = 2.71 (P = 0.007)






Heterogeneity: Tau² = 0.00; Chi² = 0.30, df = 1 (P = 0.58); I² = 0%















Heterogeneity: Tau² = 1.13; Chi² = 54.01, df = 10 (P < 0.00001); I² = 81%
Test for overall effect: Z = 2.13 (P = 0.03)






















































































































































IV, Random, 95% CI
Not estimable
0.44 [0.22 , 0.90]
Not estimable
0.68 [0.39 , 1.19]
0.52 [0.21 , 1.28]
0.98 [0.44 , 2.17]
0.88 [0.14 , 5.42]
0.54 [0.23 , 1.24]
Not estimable
0.90 [0.06 , 14.10]
1.73 [0.17 , 17.59]
3.33 [0.15 , 71.90]
0.65 [0.47 , 0.89]
1.18 [0.33 , 4.18]
3.00 [0.14 , 65.90]
Not estimable
1.35 [0.42 , 4.35]
4.55 [2.39 , 8.68]
1.11 [0.61 , 2.02]
7.58 [2.31 , 24.85]
0.65 [0.11 , 3.73]
1.62 [0.39 , 6.64]
3.65 [0.85 , 15.78]
22.04 [9.85 , 49.32]
0.50 [0.10 , 2.55]
1.25 [0.22 , 7.02]
1.43 [0.70 , 2.94]
0.75 [0.18 , 3.14]
2.20 [1.06 , 4.57]
Risk Ratio
IV, Random, 95% CI
0.005 0.1 1 10 200
favours BA favours control
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Comparison 14.   SUBGROUP 3 SEVERITY behavioural activation vs other controls (up to 6 months)





Statistical method Effect size
14.1 treatment efficacy 7 1627 Risk Ratio (IV, Random, 95% CI) 1.38 [1.13, 1.70]
14.1.1 subthreshold depression 2 627 Risk Ratio (IV, Random, 95% CI) 1.09 [1.01, 1.17]
14.1.2 moderate/ severe depression 5 1000 Risk Ratio (IV, Random, 95% CI) 1.62 [1.41, 1.85]
14.2 treatment acceptability
(dropouts)
15 2278 Risk Ratio (IV, Random, 95% CI) 1.45 [0.65, 3.25]
14.2.1 subthreshold depression 3 864 Risk Ratio (IV, Random, 95% CI) 4.30 [0.46, 40.44]
14.2.2 moderate/ severe depression 12 1414 Risk Ratio (IV, Random, 95% CI) 1.04 [0.55, 1.97]
 
 
Analysis 14.1.   Comparison 14: SUBGROUP 3 SEVERITY behavioural







Heterogeneity: Tau² = 0.00; Chi² = 0.11, df = 1 (P = 0.74); I² = 0%
Test for overall effect: Z = 2.24 (P = 0.03)








Heterogeneity: Tau² = 0.00; Chi² = 3.84, df = 4 (P = 0.43); I² = 0%
Test for overall effect: Z = 6.96 (P < 0.00001)
Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.05; Chi² = 29.18, df = 6 (P < 0.0001); I² = 79%
Test for overall effect: Z = 3.11 (P = 0.002)



























































IV, Random, 95% CI
1.08 [1.00 , 1.17]
1.12 [0.94 , 1.33]
1.09 [1.01 , 1.17]
1.50 [1.19 , 1.88]
1.58 [0.78 , 3.18]
1.66 [1.37 , 2.00]
1.77 [1.14 , 2.76]
20.45 [1.24 , 336.48]
1.62 [1.41 , 1.85]
1.38 [1.13 , 1.70]
Risk Ratio
IV, Random, 95% CI
0.5 0.7 1 1.5 2
favours control favours BA
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Analysis 14.2.   Comparison 14: SUBGROUP 3 SEVERITY behavioural activation vs








Heterogeneity: Tau² = 2.89; Chi² = 8.16, df = 2 (P = 0.02); I² = 75%
Test for overall effect: Z = 1.28 (P = 0.20)















Heterogeneity: Tau² = 0.62; Chi² = 32.16, df = 8 (P < 0.0001); I² = 75%
Test for overall effect: Z = 0.12 (P = 0.91)
Total (95% CI)
Total events:
Heterogeneity: Tau² = 1.51; Chi² = 80.57, df = 11 (P < 0.00001); I² = 86%
Test for overall effect: Z = 0.91 (P = 0.36)
































































































IV, Random, 95% CI
0.90 [0.06 , 14.10]
1.73 [0.17 , 17.59]
22.04 [9.85 , 49.32]




0.44 [0.22 , 0.90]
0.52 [0.21 , 1.28]
0.65 [0.11 , 3.73]
0.68 [0.39 , 1.19]
0.75 [0.18 , 3.14]
1.43 [0.70 , 2.94]
1.62 [0.39 , 6.64]
3.00 [0.14 , 65.90]
4.55 [2.39 , 8.68]
1.04 [0.55 , 1.97]
1.45 [0.65 , 3.25]
Risk Ratio
IV, Random, 95% CI
0.05 0.2 1 5 20
favours BA favours control
 
 
Comparison 15.   SUBGROUP 4 LENGTH behavioural activation vs other controls (up to 6 months)





Statistical method Effect size
15.1 treatment acceptability
(dropouts)
25 2947 Risk Ratio (IV, Random, 95% CI) 1.31 [0.79, 2.17]
15.1.1 1-3 sessions 3 117 Risk Ratio (IV, Random, 95% CI) 1.03 [0.53, 2.03]
15.1.2 >3 sessions 22 2830 Risk Ratio (IV, Random, 95% CI) 1.35 [0.76, 2.37]
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Analysis 15.1.   Comparison 15: SUBGROUP 4 LENGTH behavioural activation vs








Heterogeneity: Tau² = 0.00; Chi² = 0.06, df = 1 (P = 0.81); I² = 0%


























Heterogeneity: Tau² = 1.05; Chi² = 80.24, df = 18 (P < 0.00001); I² = 78%
Test for overall effect: Z = 1.02 (P = 0.31)
Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.89; Chi² = 80.60, df = 20 (P < 0.00001); I² = 75%
Test for overall effect: Z = 1.04 (P = 0.30)

















































































































































IV, Random, 95% CI
Not estimable
0.98 [0.44 , 2.17]
1.18 [0.33 , 4.18]




0.42 [0.16 , 1.11]
0.50 [0.10 , 2.55]
0.52 [0.21 , 1.28]
0.54 [0.23 , 1.24]
0.65 [0.11 , 3.73]
0.68 [0.39 , 1.19]
0.75 [0.18 , 3.14]
0.88 [0.14 , 5.42]
0.90 [0.06 , 14.10]
1.11 [0.61 , 2.02]
1.25 [0.22 , 7.02]
1.43 [0.70 , 2.94]
1.62 [0.39 , 6.64]
1.73 [0.17 , 17.59]
3.00 [0.14 , 65.90]
3.33 [0.15 , 71.90]
3.65 [0.85 , 15.78]
7.58 [2.31 , 24.85]
22.04 [9.85 , 49.32]
1.35 [0.76 , 2.37]
1.31 [0.79 , 2.17]
Risk Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
favours BA favours control
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Comparison 16.   SUBGROUP 5 THERAPY behavioural activation vs other psychological therapies (up to 6 months)





Statistical method Effect size
16.1 treatment efficacy 9   Risk Ratio (IV, Random, 95% CI) Subtotals only
16.1.1 CBT comparator 5 591 Risk Ratio (IV, Random, 95% CI) 0.99 [0.91, 1.07]
16.1.2 Third-wave CBT comparator 3 118 Risk Ratio (IV, Random, 95% CI) 1.08 [0.91, 1.29]
16.1.3 Psychodynamic/ humanist/ in-
tegrative comparator
4 371 Risk Ratio (IV, Random, 95% CI) 1.50 [1.24, 1.81]
16.2 treatment acceptability
(dropouts)
20   Risk Ratio (IV, Random, 95% CI) Subtotals only
16.2.1 CBT comparator 8 1017 Risk Ratio (IV, Random, 95% CI) 1.04 [0.85, 1.28]
16.2.2 Third-wave CBT comparator 9 393 Risk Ratio (IV, Random, 95% CI) 0.86 [0.54, 1.36]
16.2.3 Psychodynamic/ humanist/ in-
tegrative comparator
7 249 Risk Ratio (IV, Random, 95% CI) 0.77 [0.44, 1.33]
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Analysis 16.1.   Comparison 16: SUBGROUP 5 THERAPY behavioural activation vs










Heterogeneity: Tau² = 0.00; Chi² = 1.59, df = 4 (P = 0.81); I² = 0%
Test for overall effect: Z = 0.33 (P = 0.74)






Heterogeneity: Tau² = 0.00; Chi² = 0.22, df = 2 (P = 0.90); I² = 0%
Test for overall effect: Z = 0.88 (P = 0.38)







Heterogeneity: Tau² = 0.00; Chi² = 1.45, df = 3 (P = 0.69); I² = 0%
Test for overall effect: Z = 4.21 (P < 0.0001)




















































































IV, Random, 95% CI
0.89 [0.61 , 1.29]
0.92 [0.77 , 1.11]
1.00 [0.91 , 1.09]
1.10 [0.69 , 1.74]
1.16 [0.73 , 1.83]
0.99 [0.91 , 1.07]
1.00 [0.65 , 1.55]
1.09 [0.88 , 1.34]
1.17 [0.71 , 1.92]
1.08 [0.91 , 1.29]
1.21 [0.74 , 1.99]
1.50 [1.19 , 1.88]
1.80 [0.81 , 3.98]
1.87 [1.04 , 3.34]
1.50 [1.24 , 1.81]
Risk Ratio
IV, Random, 95% CI
0.2 0.5 1 2 5
favours other therapy favours BA
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Analysis 16.2.   Comparison 16: SUBGROUP 5 THERAPY behavioural activation vs other













Heterogeneity: Tau² = 0.00; Chi² = 3.08, df = 6 (P = 0.80); I² = 0%
Test for overall effect: Z = 0.38 (P = 0.70)












Heterogeneity: Tau² = 0.00; Chi² = 3.70, df = 7 (P = 0.81); I² = 0%
Test for overall effect: Z = 0.66 (P = 0.51)










Heterogeneity: Tau² = 0.00; Chi² = 2.49, df = 5 (P = 0.78); I² = 0%
Test for overall effect: Z = 0.94 (P = 0.35)













































































































































IV, Random, 95% CI
Not estimable
0.69 [0.36 , 1.34]
0.83 [0.45 , 1.53]
1.05 [0.63 , 1.76]
1.12 [0.86 , 1.47]
1.22 [0.45 , 3.34]
1.82 [0.18 , 18.55]
2.30 [0.25 , 21.38]
1.04 [0.85 , 1.28]
Not estimable
0.20 [0.01 , 3.70]
0.33 [0.04 , 2.56]
0.73 [0.25 , 2.12]
0.80 [0.27 , 2.41]
0.91 [0.44 , 1.86]
1.25 [0.20 , 7.92]
2.68 [0.29 , 24.93]
3.00 [0.14 , 65.90]
0.86 [0.54 , 1.36]
Not estimable
0.33 [0.01 , 7.45]
0.50 [0.05 , 4.67]
0.67 [0.34 , 1.32]
1.00 [0.24 , 4.18]
1.26 [0.19 , 8.24]
5.00 [0.25 , 99.16]
0.77 [0.44 , 1.33]
Risk Ratio
IV, Random, 95% CI
0.005 0.1 1 10 200
favours BA favours other therapy
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Comparison 17.   SUBGROUP 6 CONTROL behavioural activation vs other controls (up to 6 months)





Statistical method Effect size
17.1 treatment efficacy 10   Risk Ratio (IV, Random, 95% CI) Subtotals only
17.1.1 treatment as usual 4 747 Risk Ratio (IV, Random, 95% CI) 1.17 [0.95, 1.45]
17.1.2 waiting list 1 26 Risk Ratio (IV, Random, 95% CI) 2.14 [0.90, 5.09]
17.1.3 no treatment 1 30 Risk Ratio (IV, Random, 95% CI) 2.97 [1.42, 6.24]
17.1.4 medication 1 141 Risk Ratio (IV, Random, 95% CI) 1.77 [1.14, 2.76]
17.1.5 other comparator (en-
hanced usual care, mental health
referral, psychoeducation)
3 786 Risk Ratio (IV, Random, 95% CI) 1.59 [1.38, 1.83]
17.2 treatment acceptability
(dropouts)
26   Risk Ratio (IV, Random, 95% CI) Subtotals only
17.2.1 treatment as usual 10 1632 Risk Ratio (IV, Random, 95% CI) 1.50 [0.56, 3.99]
17.2.2 waiting list 8 359 Risk Ratio (IV, Random, 95% CI) 1.17 [0.70, 1.93]
17.2.3 no treatment 3 187 Risk Ratio (IV, Random, 95% CI) 0.97 [0.45, 2.09]
17.2.4 medication placebo 1 96 Risk Ratio (IV, Random, 95% CI) 0.72 [0.31, 1.67]
17.2.5 medication 1 143 Risk Ratio (IV, Random, 95% CI) 0.37 [0.18, 0.75]
17.2.6 other comparator (en-
hanced usual care, mental health
referral, psychoeducation)
4 886 Risk Ratio (IV, Random, 95% CI) 2.17 [1.04, 4.53]
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Analysis 17.1.   Comparison 17: SUBGROUP 6 CONTROL behavioural
activation vs other controls (up to 6 months), Outcome 1: treatment e:icacy
Study or Subgroup







Heterogeneity: Tau² = 0.02; Chi² = 7.48, df = 3 (P = 0.06); I² = 60%


















Test for overall effect: Z = 2.53 (P = 0.01)






Heterogeneity: Tau² = 0.00; Chi² = 0.46, df = 2 (P = 0.79); I² = 0%
Test for overall effect: Z = 6.40 (P < 0.00001)




















































































IV, Random, 95% CI
1.08 [1.00 , 1.17]
1.12 [0.94 , 1.33]
1.96 [1.03 , 3.71]
20.45 [1.24 , 336.48]
1.17 [0.95 , 1.45]
2.14 [0.90 , 5.09]
2.14 [0.90 , 5.09]
2.97 [1.42 , 6.24]
2.97 [1.42 , 6.24]
1.77 [1.14 , 2.76]
1.77 [1.14 , 2.76]
1.50 [1.19 , 1.88]
1.58 [0.78 , 3.18]
1.66 [1.37 , 2.00]
1.59 [1.38 , 1.83]
Risk Ratio
IV, Random, 95% CI
0.05 0.2 1 5 20
favours control favours BA
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Analysis 17.2.   Comparison 17: SUBGROUP 6 CONTROL behavioural activation vs other controls (up to 6 months),
Outcome 2: treatment acceptability (dropouts)
Study or Subgroup













Heterogeneity: Tau² = 2.04; Chi² = 73.58, df = 9 (P < 0.00001); I² = 88%












Heterogeneity: Tau² = 0.00; Chi² = 0.93, df = 4 (P = 0.92); I² = 0%







Heterogeneity: Tau² = 0.00; Chi² = 0.00, df = 1 (P = 0.96); I² = 0%





























































































































































IV, Random, 95% CI
0.50 [0.10 , 2.55]
0.52 [0.21 , 1.28]
0.54 [0.23 , 1.24]
0.65 [0.11 , 3.73]
0.68 [0.39 , 1.19]
0.75 [0.18 , 3.14]
1.73 [0.17 , 17.59]
3.65 [0.85 , 15.78]
7.58 [2.31 , 24.85]
22.04 [9.85 , 49.32]




0.88 [0.14 , 5.42]
1.11 [0.61 , 2.02]
1.18 [0.33 , 4.18]
3.00 [0.14 , 65.90]
3.33 [0.15 , 71.90]
1.17 [0.70 , 1.93]
Not estimable
0.90 [0.06 , 14.10]
0.98 [0.44 , 2.17]
0.97 [0.45 , 2.09]
0.72 [0.31 , 1.67]
0.72 [0.31 , 1.67]
0.37 [0.18 , 0.75]
0.37 [0.18 , 0.75]
Risk Ratio
IV, Random, 95% CI
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Analysis 17.2.   (Continued)
Heterogeneity: Not applicable
Test for overall effect: Z = 2.73 (P = 0.006)







Heterogeneity: Tau² = 0.29; Chi² = 6.59, df = 3 (P = 0.09); I² = 54%
Test for overall effect: Z = 2.07 (P = 0.04)


























1.25 [0.22 , 7.02]
1.43 [0.70 , 2.94]
1.62 [0.39 , 6.64]
4.55 [2.39 , 8.68]
2.17 [1.04 , 4.53]
0.01 0.1 1 10 100
favours BA favours control
 
 
Comparison 18.   SENSITIVITY 1 HIGH QUALITY STUDIES behavioural activation versus other psychological therapies
(up to 6 months)





Statistical method Effect size
18.1 treatment efficacy 5 826 Risk Ratio (IV, Random, 95% CI) 1.20 [0.95, 1.51]
18.2 treatment acceptability (dropouts) 7 1039 Risk Ratio (IV, Random, 95% CI) 1.04 [0.84, 1.29]
 
 
Analysis 18.1.   Comparison 18: SENSITIVITY 1 HIGH QUALITY STUDIES behavioural activation









Heterogeneity: Tau² = 0.04; Chi² = 13.62, df = 4 (P = 0.009); I² = 71%
Test for overall effect: Z = 1.55 (P = 0.12)







































IV, Random, 95% CI
0.92 [0.77 , 1.11]
1.09 [0.88 , 1.34]
1.16 [0.73 , 1.83]
1.50 [1.19 , 1.88]
1.87 [1.04 , 3.34]
1.20 [0.95 , 1.51]
Risk Ratio
IV, Random, 95% CI
0.2 0.5 1 2 5
favours other therapy favours BA
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Analysis 18.2.   Comparison 18: SENSITIVITY 1 HIGH QUALITY STUDIES behavioural activation versus











Heterogeneity: Tau² = 0.00; Chi² = 4.64, df = 6 (P = 0.59); I² = 0%
Test for overall effect: Z = 0.40 (P = 0.69)

















































IV, Random, 95% CI
0.20 [0.01 , 3.70]
0.67 [0.34 , 1.32]
0.73 [0.25 , 2.12]
1.05 [0.63 , 1.76]
1.12 [0.86 , 1.47]
1.22 [0.45 , 3.34]
2.49 [0.43 , 14.45]
1.04 [0.84 , 1.29]
Risk Ratio
IV, Random, 95% CI
0.05 0.2 1 5 20
favours BA favours other therapy
 
 
Comparison 19.   SENSITIVITY 2 HIGH QUALITY STUDIES behavioural activation versus other controls (up to 6
months)




Statistical method Effect size
19.1 treatment efficacy 6 1560 Risk Ratio (IV, Random, 95% CI) 1.49 [1.16, 1.90]
19.2 treatment acceptability
(dropouts)
12 2753 Risk Ratio (IV, Random, 95% CI) 2.22 [1.00, 4.95]
 
 
Analysis 19.1.   Comparison 19: SENSITIVITY 2 HIGH QUALITY STUDIES behavioural










Heterogeneity: Tau² = 0.06; Chi² = 26.86, df = 5 (P < 0.0001); I² = 81%
Test for overall effect: Z = 3.17 (P = 0.002)












































IV, Random, 95% CI
1.08 [1.00 , 1.17]
1.50 [1.19 , 1.88]
1.58 [0.78 , 3.18]
1.66 [1.37 , 2.00]
1.77 [1.14 , 2.76]
1.96 [1.03 , 3.71]
1.49 [1.16 , 1.90]
Risk Ratio
IV, Random, 95% CI
0.05 0.2 1 5 20
favours other controls favours BA
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Analysis 19.2.   Comparison 19: SENSITIVITY 2 HIGH QUALITY STUDIES behavioural activation
















Heterogeneity: Tau² = 1.39; Chi² = 69.30, df = 10 (P < 0.00001); I² = 86%
Test for overall effect: Z = 1.96 (P = 0.05)









































































IV, Random, 95% CI
Not estimable
0.44 [0.22 , 0.90]
0.65 [0.11 , 3.73]
0.90 [0.06 , 14.10]
1.11 [0.61 , 2.02]
1.43 [0.70 , 2.94]
1.62 [0.39 , 6.64]
1.73 [0.17 , 17.59]
3.65 [0.85 , 15.78]
4.55 [2.39 , 8.68]
7.58 [2.31 , 24.85]
22.04 [9.85 , 49.32]
2.22 [1.00 , 4.95]
Risk Ratio
IV, Random, 95% CI
0.02 0.1 1 10 50
favours BA favours other controls
 
 
Comparison 20.   SENSITIVITY 3 FACE-TO-FACE behavioural activation vs other psychological therapies (up to 6
months)





Statistical method Effect size
20.1 treatment efficacy 6 657 Risk Ratio (IV, Random, 95% CI) 1.09 [0.92, 1.29]
20.2 treatment acceptability (dropouts) 16 1351 Risk Ratio (IV, Random, 95% CI) 1.00 [0.83, 1.20]
 
 
Analysis 20.1.   Comparison 20: SENSITIVITY 3 FACE-TO-FACE behavioural activation










Heterogeneity: Tau² = 0.01; Chi² = 6.32, df = 5 (P = 0.28); I² = 21%
Test for overall effect: Z = 0.96 (P = 0.34)












































IV, Random, 95% CI
0.92 [0.77 , 1.11]
1.10 [0.75 , 1.62]
1.15 [0.77 , 1.73]
1.16 [0.73 , 1.83]
1.17 [0.71 , 1.92]
1.87 [1.04 , 3.34]
1.09 [0.92 , 1.29]
Risk Ratio
IV, Random, 95% CI
0.2 0.5 1 2 5
favours other therapy favours BA
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Analysis 20.2.   Comparison 20: SENSITIVITY 3 FACE-TO-FACE behavioural activation vs other




















Heterogeneity: Tau² = 0.00; Chi² = 6.09, df = 13 (P = 0.94); I² = 0%
Test for overall effect: Z = 0.05 (P = 0.96)




























































































IV, Random, 95% CI
Not estimable
Not estimable
0.33 [0.01 , 7.45]
0.33 [0.04 , 2.56]
0.67 [0.34 , 1.32]
0.79 [0.43 , 1.45]
0.80 [0.27 , 2.41]
0.83 [0.45 , 1.53]
1.00 [0.24 , 4.18]
1.00 [0.10 , 9.75]
1.05 [0.63 , 1.76]
1.12 [0.86 , 1.47]
1.22 [0.45 , 3.34]
1.25 [0.20 , 7.92]
1.26 [0.19 , 8.24]
2.49 [0.43 , 14.45]
1.00 [0.83 , 1.20]
Risk Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
favours BA favours other therapy
 
 
Comparison 21.   SENSITIVITY 4 FACE-TO-FACE behavioural activation vs other controls (up to 6 months)





Statistical method Effect size
21.1 treatment efficacy 7 838 Risk Ratio (IV, Random, 95% CI) 1.76 [1.50, 2.05]
21.2 treatment acceptability (dropouts) 20 1603 Risk Ratio (IV, Random, 95% CI) 0.85 [0.67, 1.08]
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Analysis 21.1.   Comparison 21: SENSITIVITY 4 FACE-TO-FACE behavioural











Heterogeneity: Tau² = 0.00; Chi² = 5.65, df = 6 (P = 0.46); I² = 0%
Test for overall effect: Z = 7.08 (P < 0.00001)

















































IV, Random, 95% CI
1.58 [0.78 , 3.18]
1.66 [1.37 , 2.00]
1.77 [1.14 , 2.76]
1.96 [1.03 , 3.71]
2.14 [0.90 , 5.09]
2.97 [1.42 , 6.24]
20.45 [1.24 , 336.48]
1.76 [1.50 , 2.05]
Risk Ratio
IV, Random, 95% CI
0.02 0.1 1 10 50
favours control favours BA
 
 
Analysis 21.2.   Comparison 21: SENSITIVITY 4 FACE-TO-FACE behavioural activation
























Heterogeneity: Tau² = 0.00; Chi² = 15.97, df = 16 (P = 0.46); I² = 0%
Test for overall effect: Z = 1.29 (P = 0.20)



















































































































0.44 [0.22 , 0.90]
0.50 [0.10 , 2.55]
0.52 [0.21 , 1.28]
0.54 [0.23 , 1.24]
0.68 [0.39 , 1.19]
0.75 [0.18 , 3.14]
0.88 [0.14 , 5.42]
0.90 [0.06 , 14.10]
0.98 [0.44 , 2.17]
1.11 [0.61 , 2.02]
1.18 [0.33 , 4.18]
1.25 [0.22 , 7.02]
1.43 [0.70 , 2.94]
1.62 [0.39 , 6.64]
3.00 [0.14 , 65.90]
3.33 [0.15 , 71.90]
3.65 [0.85 , 15.78]
0.85 [0.67 , 1.08]
Risk Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
favours BA favours control
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Comparison 22.   SENSITIVITY 5 INDIVIDUAL behavioural activation versus other psychological therapies (up to 6
months)





Statistical method Effect size
22.1 treatment efficacy 8 988 Risk Ratio (IV, Random, 95% CI) 1.17 [1.00, 1.37]
22.2 treatment acceptability (dropouts) 14 1251 Risk Ratio (IV, Random, 95% CI) 1.05 [0.91, 1.22]
 
 
Analysis 22.1.   Comparison 22: SENSITIVITY 5 INDIVIDUAL behavioural activation












Heterogeneity: Tau² = 0.02; Chi² = 13.65, df = 7 (P = 0.06); I² = 49%
Test for overall effect: Z = 1.94 (P = 0.05)






















































IV, Random, 95% CI
0.92 [0.77 , 1.11]
1.09 [0.88 , 1.34]
1.10 [0.75 , 1.62]
1.15 [0.77 , 1.73]
1.16 [0.73 , 1.83]
1.17 [0.71 , 1.92]
1.50 [1.19 , 1.88]
1.87 [1.04 , 3.34]
1.17 [1.00 , 1.37]
Risk Ratio
IV, Random, 95% CI
0.2 0.5 1 2 5
favours other therapy favours BA
 
 
Behavioural activation therapy for depression in adults (Review)









Cochrane Database of Systematic Reviews
Analysis 22.2.   Comparison 22: SENSITIVITY 5 INDIVIDUAL behavioural activation versus other


















Heterogeneity: Tau² = 0.00; Chi² = 7.67, df = 12 (P = 0.81); I² = 0%
Test for overall effect: Z = 0.72 (P = 0.47)



















































































IV, Random, 95% CI
Not estimable
0.20 [0.01 , 3.70]
0.33 [0.01 , 7.45]
0.33 [0.04 , 2.56]
0.67 [0.34 , 1.32]
0.83 [0.45 , 1.53]
1.00 [0.10 , 9.75]
1.05 [0.63 , 1.76]
1.09 [0.88 , 1.34]
1.12 [0.86 , 1.47]
1.22 [0.45 , 3.34]
1.25 [0.20 , 7.92]
2.49 [0.43 , 14.45]
5.00 [0.25 , 99.16]
1.05 [0.91 , 1.22]
Risk Ratio
IV, Random, 95% CI
0.02 0.1 1 10 50
favours BA favours other therapy
 
 
Comparison 23.   SENSITIVITY 5 INDIVIDUAL behavioural activation versus other controls (up to 6 months)




Statistical method Effect size
23.1 treatment efficacy 8 1616 Risk Ratio (IV, Random, 95% CI) 1.61 [1.26, 2.05]
23.2 treatment acceptability
(dropouts)
21 2811 Risk Ratio (IV, Random, 95% CI) 1.55 [0.85, 2.79]
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Analysis 23.1.   Comparison 23: SENSITIVITY 5 INDIVIDUAL behavioural












Heterogeneity: Tau² = 0.07; Chi² = 34.08, df = 7 (P < 0.0001); I² = 79%
Test for overall effect: Z = 3.80 (P = 0.0001)






















































IV, Random, 95% CI
1.08 [1.00 , 1.17]
1.50 [1.19 , 1.88]
1.58 [0.78 , 3.18]
1.66 [1.37 , 2.00]
1.77 [1.14 , 2.76]
1.96 [1.03 , 3.71]
2.14 [0.90 , 5.09]
2.97 [1.42 , 6.24]
1.61 [1.26 , 2.05]
Risk Ratio
IV, Random, 95% CI
0.05 0.2 1 5 20
favours control favours BA
 
 
Analysis 23.2.   Comparison 23: SENSITIVITY 5 INDIVIDUAL behavioural activation

























Heterogeneity: Tau² = 1.19; Chi² = 95.88, df = 17 (P < 0.00001); I² = 82%
Test for overall effect: Z = 1.44 (P = 0.15)
























































































































0.44 [0.22 , 0.90]
0.52 [0.21 , 1.28]
0.54 [0.23 , 1.24]
0.65 [0.11 , 3.73]
0.68 [0.39 , 1.19]
0.88 [0.14 , 5.42]
0.98 [0.44 , 2.17]
1.00 [0.15 , 6.70]
1.18 [0.33 , 4.18]
1.25 [0.22 , 7.02]
1.43 [0.70 , 2.94]
1.62 [0.39 , 6.64]
3.00 [0.14 , 65.90]
3.33 [0.15 , 71.90]
3.65 [0.85 , 15.78]
4.55 [2.39 , 8.68]
7.58 [2.31 , 24.85]
22.04 [9.85 , 49.32]
1.55 [0.85 , 2.79]
Risk Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
favours BA favours control
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Comparison 24.   SENSITIVITY 6 fixed e:ects BA vs waiting list





Statistical method Effect size
24.1 depression symptoms 12   Std. Mean Difference (IV, Fixed, 95% CI) Subtotals only
24.1.1 Short-term (up to 6 months) 12 619 Std. Mean Difference (IV, Fixed, 95% CI) -0.72 [-0.89, -0.55]
24.2 anxiety symptoms 5   Std. Mean Difference (IV, Fixed, 95% CI) Subtotals only
24.2.1 Short-term (up to 6 months) 5 424 Std. Mean Difference (IV, Fixed, 95% CI) -0.54 [-0.74, -0.33]
 
 
Analysis 24.1.   Comparison 24: SENSITIVITY 6 fixed e:ects BA vs waiting list, Outcome 1: depression symptoms
Study or Subgroup














Heterogeneity: Chi² = 44.26, df = 11 (P < 0.00001); I² = 75%
Test for overall effect: Z = 8.19 (P < 0.00001)


































































































IV, Fixed, 95% CI
-3.93 [-5.21 , -2.64]
-1.83 [-3.01 , -0.64]
-1.81 [-3.13 , -0.49]
-1.63 [-2.89 , -0.36]
-1.40 [-2.21 , -0.59]
-0.85 [-1.19 , -0.51]
-0.76 [-1.79 , 0.26]
-0.63 [-1.08 , -0.18]
-0.62 [-1.55 , 0.31]
-0.49 [-1.38 , 0.41]
-0.36 [-1.06 , 0.34]
-0.29 [-0.60 , 0.01]
-0.72 [-0.89 , -0.55]
Std. Mean Difference
IV, Fixed, 95% CI
-4 -2 0 2 4
favours BA favours waiting list
 
 
Analysis 24.2.   Comparison 24: SENSITIVITY 6 fixed e:ects BA vs waiting list, Outcome 2: anxiety symptoms
Study or Subgroup







Heterogeneity: Chi² = 30.87, df = 4 (P < 0.00001); I² = 87%
Test for overall effect: Z = 5.08 (P < 0.00001)

















































IV, Fixed, 95% CI
-3.67 [-4.90 , -2.44]
-0.73 [-1.07 , -0.39]
-0.55 [-1.47 , 0.37]
-0.35 [-1.07 , 0.37]
-0.22 [-0.52 , 0.09]
-0.54 [-0.74 , -0.33]
Std. Mean Difference
IV, Fixed, 95% CI
-4 -2 0 2 4
favours BA favours waiting list
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Comparison 25.   SENSITIVITY 7 fixed e:ects BA vs treatment as usual





Statistical method Effect size
25.1 depression symptoms 14   Std. Mean Difference (IV, Fixed, 95% CI) Subtotals only
25.1.1 Short-term (up to 6 months) 14 2158 Std. Mean Difference (IV, Fixed, 95% CI) -0.48 [-0.57, -0.39]
25.1.2 Medium-term (7-12 months) 4 1381 Std. Mean Difference (IV, Fixed, 95% CI) -0.23 [-0.34, -0.13]
25.1.3 Long-term (>12 months) 1 343 Std. Mean Difference (IV, Fixed, 95% CI) 0.02 [-0.19, 0.23]
25.2 quality of life 5   Std. Mean Difference (IV, Fixed, 95% CI) Subtotals only
25.2.1 short-term (up to 6 months) 5 1249 Std. Mean Difference (IV, Fixed, 95% CI) 0.25 [0.14, 0.37]
25.2.2 medium-term (7-12 months) 2 879 Std. Mean Difference (IV, Fixed, 95% CI) 0.16 [0.03, 0.29]
25.2.3 long-term (>12 months) 1 325 Std. Mean Difference (IV, Fixed, 95% CI) -0.09 [-0.30, 0.13]
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Analysis 25.1.   Comparison 25: SENSITIVITY 7 fixed e:ects
BA vs treatment as usual, Outcome 1: depression symptoms
Study or Subgroup
















Heterogeneity: Chi² = 86.52, df = 13 (P < 0.00001); I² = 85%
Test for overall effect: Z = 10.85 (P < 0.00001)
25.1.2 Medium-term (7-12 months)





Heterogeneity: Chi² = 5.00, df = 3 (P = 0.17); I² = 40%
Test for overall effect: Z = 4.30 (P < 0.0001)




Test for overall effect: Z = 0.16 (P = 0.87)

























































































































































IV, Fixed, 95% CI
-3.83 [-4.68 , -2.97]
-2.03 [-2.80 , -1.26]
-1.15 [-1.85 , -0.45]
-0.79 [-1.91 , 0.32]
-0.69 [-1.12 , -0.26]
-0.56 [-1.03 , -0.09]
-0.52 [-0.70 , -0.34]
-0.45 [-0.99 , 0.09]
-0.43 [-1.27 , 0.42]
-0.37 [-0.53 , -0.20]
-0.35 [-0.55 , -0.15]
-0.31 [-0.56 , -0.06]
-0.16 [-0.91 , 0.59]
0.36 [-1.20 , 1.92]
-0.48 [-0.57 , -0.39]
-0.55 [-1.71 , 0.62]
-0.31 [-0.49 , -0.14]
-0.29 [-0.47 , -0.11]
-0.03 [-0.24 , 0.17]
-0.23 [-0.34 , -0.13]
0.02 [-0.19 , 0.23]
0.02 [-0.19 , 0.23]
Std. Mean Difference
IV, Fixed, 95% CI
-4 -2 0 2 4
favours BA favours treatm. as usual
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Analysis 25.2.   Comparison 25: SENSITIVITY 7 fixed e:ects BA vs treatment as usual, Outcome 2: quality of life
Study or Subgroup







Heterogeneity: Chi² = 91.14, df = 4 (P < 0.00001); I² = 96%
Test for overall effect: Z = 4.36 (P < 0.0001)




Heterogeneity: Chi² = 3.58, df = 1 (P = 0.06); I² = 72%
Test for overall effect: Z = 2.39 (P = 0.02)




Test for overall effect: Z = 0.77 (P = 0.44)












































































IV, Fixed, 95% CI
-0.05 [-0.25 , 0.16]
0.17 [-0.10 , 0.43]
0.33 [-0.43 , 1.08]
0.36 [0.19 , 0.53]
5.04 [3.99 , 6.08]
0.25 [0.14 , 0.37]
0.00 [-0.21 , 0.21]
0.26 [0.09 , 0.43]
0.16 [0.03 , 0.29]
-0.09 [-0.30 , 0.13]
-0.09 [-0.30 , 0.13]
Std. Mean Difference
IV, Fixed, 95% CI
-4 -2 0 2 4
favours treatm. as usual favours BA
 
 
Comparison 26.   MISSING DATA ITT (up to 6 months)





Statistical method Effect size
26.1 treatment efficacy 13   Risk Ratio (IV, Random, 95% CI) Subtotals only
26.1.1 CBT 4 573 Risk Ratio (IV, Random, 95% CI) 0.93 [0.83, 1.05]
26.1.2 third-wave CBT 2 117 Risk Ratio (IV, Random, 95% CI) 1.17 [0.91, 1.52]
26.1.3 humanistic 1 46 Risk Ratio (IV, Random, 95% CI) 2.33 [1.09, 5.00]
26.1.4 treatment as usual 7 1743 Risk Ratio (IV, Random, 95% CI) 1.29 [0.99, 1.68]
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Heterogeneity: Tau² = 0.00; Chi² = 1.11, df = 3 (P = 0.77); I² = 0%






Heterogeneity: Tau² = 0.00; Chi² = 0.02, df = 1 (P = 0.90); I² = 0%






Test for overall effect: Z = 2.18 (P = 0.03)










Heterogeneity: Tau² = 0.08; Chi² = 34.94, df = 6 (P < 0.00001); I² = 83%
Test for overall effect: Z = 1.88 (P = 0.06)



































































































IV, Random, 95% CI
0.87 [0.71 , 1.06]
0.94 [0.66 , 1.35]
0.96 [0.81 , 1.13]
1.10 [0.69 , 1.74]
0.93 [0.83 , 1.05]
1.14 [0.66 , 1.97]
1.18 [0.88 , 1.59]
1.17 [0.91 , 1.52]
2.33 [1.09 , 5.00]
2.33 [1.09 , 5.00]
0.92 [0.83 , 1.02]
1.08 [0.85 , 1.37]
1.20 [0.94 , 1.54]
1.48 [0.72 , 3.06]
1.62 [1.34 , 1.97]
1.96 [1.03 , 3.71]
21.00 [1.27 , 346.66]
1.29 [0.99 , 1.68]
Risk Ratio
IV, Random, 95% CI
0.05 0.2 1 5 20
favours comparator favours BA
 
 
Comparison 27.   MISSING DATA BEST CASE (up to 6 months)





Statistical method Effect size
27.1 treatment efficacy 13   Risk Ratio (IV, Random, 95% CI) Subtotals only
27.1.1 CBT 4 573 Risk Ratio (IV, Random, 95% CI) 1.17 [0.90, 1.52]
27.1.2 third-wave CBT 2 117 Risk Ratio (IV, Random, 95% CI) 1.41 [1.12, 1.76]
27.1.3 humanistic 1 46 Risk Ratio (IV, Random, 95% CI) 3.67 [1.83, 7.34]
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Statistical method Effect size
27.1.4 treatment as usual 7 1743 Risk Ratio (IV, Random, 95% CI) 1.63 [1.29, 2.04]
 
 









Heterogeneity: Tau² = 0.05; Chi² = 16.60, df = 3 (P = 0.0009); I² = 82%






Heterogeneity: Tau² = 0.00; Chi² = 0.02, df = 1 (P = 0.89); I² = 0%






Test for overall effect: Z = 3.67 (P = 0.0002)










Heterogeneity: Tau² = 0.06; Chi² = 36.77, df = 6 (P < 0.00001); I² = 84%
Test for overall effect: Z = 4.17 (P < 0.0001)



































































































IV, Random, 95% CI
0.94 [0.66 , 1.35]
1.05 [0.92 , 1.20]
1.10 [0.69 , 1.74]
1.54 [1.33 , 1.79]
1.17 [0.90 , 1.52]
1.36 [0.84 , 2.22]
1.42 [1.10 , 1.83]
1.41 [1.12 , 1.76]
3.67 [1.83 , 7.34]
3.67 [1.83 , 7.34]
1.12 [0.94 , 1.33]
1.27 [1.17 , 1.37]
1.80 [1.46 , 2.22]
1.83 [1.52 , 2.20]
2.02 [1.05 , 3.91]
2.87 [1.62 , 5.09]
27.00 [1.66 , 439.27]
1.63 [1.29 , 2.04]
Risk Ratio
IV, Random, 95% CI
0.002 0.1 1 10 500
favours comparator favours BA
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Comparison 28.   MISSING DATA WORST CASE (up to 6 months)





Statistical method Effect size
28.1 treatment efficacy 13   Risk Ratio (IV, Random, 95% CI) Subtotals only
28.1.1 CBT 4 573 Risk Ratio (IV, Random, 95% CI) 0.82 [0.58, 1.17]
28.1.2 third-wave CBT 2 117 Risk Ratio (IV, Random, 95% CI) 0.89 [0.73, 1.09]
28.1.3 humanistic 1 46 Risk Ratio (IV, Random, 95% CI) 0.78 [0.53, 1.15]
28.1.4 treatment as usual 7 1743 Risk Ratio (IV, Random, 95% CI) 1.14 [0.89, 1.46]
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Heterogeneity: Tau² = 0.11; Chi² = 25.85, df = 3 (P < 0.0001); I² = 88%






Heterogeneity: Tau² = 0.00; Chi² = 0.11, df = 1 (P = 0.74); I² = 0%






Test for overall effect: Z = 1.26 (P = 0.21)










Heterogeneity: Tau² = 0.08; Chi² = 39.85, df = 6 (P < 0.00001); I² = 85%
Test for overall effect: Z = 1.02 (P = 0.31)



































































































IV, Random, 95% CI
0.54 [0.46 , 0.64]
0.91 [0.78 , 1.07]
0.94 [0.66 , 1.35]
1.10 [0.69 , 1.74]
0.82 [0.58 , 1.17]
0.88 [0.71 , 1.09]
0.96 [0.58 , 1.58]
0.89 [0.73 , 1.09]
0.78 [0.53 , 1.15]
0.78 [0.53 , 1.15]
0.80 [0.73 , 0.88]
1.02 [0.83 , 1.24]
1.05 [0.83 , 1.32]
1.11 [0.58 , 2.13]
1.43 [1.20 , 1.72]
1.57 [0.89 , 2.74]
2.50 [0.85 , 7.31]
1.14 [0.89 , 1.46]
Risk Ratio
IV, Random, 95% CI
0.1 0.2 0.5 1 2 5 10
favours comparator favours BA
 
 
A D D I T I O N A L   T A B L E S
 




Description of adverse events (at end of study period)
Bosanquet 2017 Treatment as
usual
BA: 47 suspected adverse events.
Usual care: 34 suspected adverse events. Elderly sample.
Table 1.   Adverse events 
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Dimidjian 2006 CBT, medica-
tion, medical
placebo
various physical side effects from antidepressant medication and placebo. 1
suicide in antidepressant arm.
Gilbody 2017 Treatment as
usual
BA: 37 events; 35 unrelated to intervention and 2 unlikely to be related to in-
tervention.
Usual care: 44 events; 40 unrelated and 4 unlikely to be related to interven-





2 suicide attempts and 1 case of suicidal thoughts in comparator arm; no
adverse events in behavioural activation arm.
Richards 2017 CBT 3 serious adverse events in behavioural activation arm (2 overdose, 1 self-
harm) and 8 serious adverse events in comparator arm (7 overdose, 1 self-
harm).
Stiles-Shields 2018 CBT and wait-
ing list
No adverse events.
Weobong 2017 Treatment as
usual
1 suicide attempt and 18 unplanned hospitalisations in behavioural activa-
tion arm. 1 suicide attempt, 26 unplanned hospitalisations, and 2 deaths in
comparator arm.
Table 1.   Adverse events  (Continued)
BA: Behavioural activation; CBT: cognitive-behavioural therapy;
 
 
A P P E N D I C E S
Appendix 1. Categories of psychological therapies
 
Categories Abbreviation Subcategories Abbreviation
Behavioural therapy (Lewinsohn)  
Behavioural activation (original model) (Jacobson) BA





Other behavioural therapies  
Cognitive therapy  






Coping with depression course  
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Other cognitive-behavioural therapies  
Acceptance and commitment therapy  
Compassionate mind training  
Functional analytic psychotherapy  
Extended behavioural activation eBA
Metacognitive therapy  
Mindfulness-based cognitive therapy  






Other third wave cognitive and behavioural therapies
(other third wave CBT)
 
Drive/structural model (Freud)  
Relational model (Strupp, Luborsky)  




Other psychodynamic therapies  























Other integrative therapy approaches  
  (Continued)
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Appendix 2. Specialised Register: CCMD-CTR
Cochrane Common Mental Disorders Controlled Trials Register (CCMD-CTR)
Cochrane Common Mental Disorders has a specialised register of randomised controlled trials, the CCMD-CTR. This register contains over
40,000 reference records (reports of RCTs) for anxiety disorders, depression, bipolar disorder, eating disorders, self-harm and other mental
disorders within the scope of this Group. The CCMD-CTR is a partially studies-based register with more than 50% of reference records
tagged to around 12,500 individually PICO-coded study records. Reports of trials for inclusion in the register are collated from (weekly)
generic searches of MEDLINE (1950 onwards), Embase (1974 onwards) and PsycINFO (1967 onwards), quarterly searches of the Cochrane
Central Register of Controlled Trials (CENTRAL) and review-specific searches of additional databases. Reports of trials are also sourced
from international trials registries, drug companies, the handsearching of key journals, conference proceedings and other (non-Cochrane)
systematic reviews and meta-analyses. Details of CCMD's core search strategies (used to identify RCTs) can be found on the Group's website,
with an example of the core MEDLINE search displayed below.
The CCMD-CTR will be searched for this review using the following terms:
(("behavioral activation” or "behavior therapy" or “behavior modification” or “self-monitoring" or “self-management therapy” or “self-
control therapy” or “task assignment”):SIN and (depress*):SCO)
N.B. The search of the CCMD-CTR will only retrieve RCTs of 'behavioural activation', or the main elements of behavioural activation in
participants with clinically diagnosed depression, hence additional searches of the main bibliographic databases (all years to date) to
identify trials which also include participants with subthreshold depression.
The search strategy listed below is the weekly OVID Medline search which was used to inform the Group’s specialised register. It is
based on a list of terms for all conditions within the scope of the Cochrane Common Mental Disorders Group plus a sensitive RCT
filter.
1. [MeSH Headings]: eating disorders/ or anorexia nervosa/ or binge-eating disorder/ or bulimia nervosa/ or female athlete triad
syndrome/ or pica/ or hyperphagia/ or bulimia/ or self-injurious behavior/ or self mutilation/ or suicide/ or suicidal ideation/ or suicide,
attempted/ or mood disorders/ or aective disorders, psychotic/ or bipolar disorder/ or cyclothymic disorder/ or depressive disorder/ or
depression, postpartum/ or depressive disorder, major/ or depressive disorder, treatment-resistant/ or dysthymic disorder/ or seasonal
aective disorder/ or neurotic disorders/ or depression/ or adjustment disorders/ or exp antidepressive agents/ or anxiety disorders/
or agoraphobia/ or neurocirculatory asthenia/ or obsessive-compulsive disorder/ or obsessive hoarding/ or panic disorder/ or phobic
disorders/ or stress disorders, traumatic/ or combat disorders/ or stress disorders, post-traumatic/ or stress disorders, traumatic, acute/
or anxiety/ or anxiety, castration/ or koro/ or anxiety, separation/ or panic/ or exp anti-anxiety agents/ or somatoform disorders/ or body
dysmorphic disorders/ or conversion disorder/ or hypochondriasis/ or neurasthenia/ or hysteria/ or munchausen syndrome by proxy/ or
munchausen syndrome/ or fatigue syndrome, chronic/ or obsessive behavior/ or compulsive behavior/ or behavior, addictive/ or impulse
control disorders/ or firesetting behavior/ or gambling/ or trichotillomania/ or stress, psychological/ or burnout, professional/ or sexual
dysfunctions, psychological/ or vaginismus/ or Anhedonia/ or Aective Symptoms/ or *Mental Disorders/
2. [Title/ Author Keywords]: (eating disorder* or anorexia nervosa or bulimi* or binge eat* or (self adj (injur* or mutilat*)) or suicide* or
suicidal or parasuicid* or mood disorder* or aective disorder* or bipolar i or bipolar ii or (bipolar and (aective or disorder*)) or mania or
manic or cyclothymic* or depression or depressive or dysthymi* or neurotic or neurosis or adjustment disorder* or antidepress* or anxiety
disorder* or agoraphobia or obsess* or compulsi* or panic or phobi* or ptsd or posttrauma* or post trauma* or combat or somatoform
or somati#ation or medical* unexplained or body dysmorphi* or conversion disorder or hypochondria* or neurastheni* or hysteria or
munchausen or chronic fatigue* or gambling or trichotillomania or vaginismus or anhedoni* or aective symptoms or mental disorder*
or mental health).ti,kf.
3. [RCT filter]: (controlled clinical trial.pt. or randomised controlled trial.pt. or (randomi#ed or randomi#ation).ab,ti. or randomly.ab. or
(random* adj3 (administ* or allocat* or assign* or class* or control* or determine* or divide* or distribut* or expose* or fashion or number*
or place* or recruit* or subsitut* or treat*)).ab. or placebo*.ab,ti. or drug therapy.fs. or trial.ab,ti. or groups.ab. or (control* adj3 (trial*
or study or studies)).ab,ti. or ((singl* or doubl* or tripl* or trebl*) adj3 (blind* or mask* or dummy*)).mp. or clinical trial, phase ii/ or
clinical trial, phase iii/ or clinical trial, phase iv/ or randomised controlled trial/ or pragmatic clinical trial/ or (quasi adj (experimental or
random*)).ti,ab. or ((waitlist* or wait* list* or treatment as usual or TAU) adj3 (control or group)).ab.)
4. (1 and 2 and 3)
Records are screened for reports of RCTs within the scope of the Cochrane Common Mental Disorders Group. Secondary reports of RCTs
are tagged to the appropriate study record.
The CCMD-CTR is current to June 2016 only.
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Appendix 3. Other database searches
Date of search: 17-January-2019
Ovid PsycINFO (Jan, week 2,2019) n = 1694
CENTRAL (℅ CRS-Web), (18-Jan-2019), n = 1567
CCMDCTR-Sudies Register (current to June 2016), n = 72
Ovid Embase, (2019 Week 02), n = 2237
Ovid MEDLINE all searches to 17-Jan-2019, n = 2036
Theses databases, n = 139
Trial Registries, n = 261
Total = 8006
Duplicates removed n = 2751
Total screen, n = 5255
An update search, 17 Jan 2020 retrieved an addition 594 records to screen.
Ovid PsycINFO <1806 to January Week 2 2019>
Search Strategy:
--------------------------------------------------------------------------------
1 behavioral activation system/ (295)
2 ((behavio* adj1 activ*) or BATD).ti,ab,id. (6198)
3 (behavio* adj3 (reinforce* or re-inforce*)).ti,ab,id. (5249)
4 reinforc*.ti,id. or (((contingent or positive) adj1 reinforc*) or (reinforc* adj3 (environment* or experience*))).ti,ab,id. (29104)
5 exp reinforcement/ (46970)
6 (reinforce or reinforcer or reinforcement or reinforcements or re-inforcement or re-inforcements).ab. /freq=2 (15569)
7 (behavio* adj2 (contracting or modification or modify*)).ti,ab,id. (7960)
8 behavior contracting/ or behavior modification/ (10563)
9 ((activit* or event?) adj2 schedul*).ti,ab,id. (798)
10 planned behavior/ (2518)
11 ((pleas* or enjoyable or rewarding) adj (activit* or event?)).ti,ab,id. (909)
12 (operant conditioning or instrumental learning).ti,ab,id. (4692)
13 exp operant conditioning/ (34771)
14 (positive interaction* or avoidant coping or environmental contingenc* or contigency management).ti,ab,id. (2755)
15 exp contingency management/ (2898)
16 ((gain? or reapprais*) adj2 focus*).ti,ab,id. (120)
17 functional analysis.ti,ab,id,sh. (3984)
18 (behavio* and (self adj (care or eicacy or evaluat* or monitor*))).ti,id,hw. (9576)
19 ((psychoeducat* or psycho-educat*) and (coping behavi* or coping skills or self manag* or (behavi* adj2 chang*))).ti,ab,id,hw. (879)
20 self management/ and behavior change/ (111)
21 or/1-20 (127748)
22 Behavior Therapy/ and depress*.ti,hw,tm. (913)
23 (behavio* therapy adj3 depress*).ti,ab,id. (841)
24 ((behavio* adj (counsel* or intervention or train* or treatment or therapy or psychotherapy)) and depress*).ti. (1255)
25 "depression (emotion)"/ (24732)
26 major depression/ or late life depression/ or reactive depression/ (113534)
27 emotional states/ or distress/ or emotional trauma/ or grief/ or hopelessness/ or sadness/ (83186)
28 depress*.ti,ab,id. (284738)
29 (mood? or mental health or ((emotion* or psychological) adj (distress or trauma*))).ti,id. (129767)
30 or/25-29 (438086)
31 (21 and 30) or 22 or 23 or 24 (9842)
32 clinical trials.sh. (11213)
33 (randomi#ed or randomi#ation or randomi#ing).ti,ab,id. (77179)
34 (RCT or at random or (random* adj3 (administ* or allocat* or assign* or class* or control* or crossover or cross-over or determine* or
divide* or division or distribut* or expose* or fashion or number* or place* or recruit* or split or subsitut* or treat*))).ti,ab,id. (93213)
35 (control* and (trial or study or group) and (placebo or waitlist* or wait* list* or ((treatment or care) adj2 usual))).ti,ab,id,hw. (26859)
36 ((allocat* or assign* or receive*) and (placebo or no-treatment or waitlist or wait* list* or ((treatment or care) adj2 usual)) and (control
or group)).ab. (12516)
37 empirical study.md. and ((placebo or no-treatment or waitlist or wait* list* or ((treatment or care) adj2 usual)) and (control or group
or compared or comparison)).ab. (26670)
38 ((single or double or triple or treble) adj2 (blind* or mask* or dummy)).ti,ab,id. (24826)
39 trial.ti. (27214)
40 treatment eectiveness evaluation.sh. (22581)
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41 (treatment adj5 control).ab. (11883)
42 or/32-41 (172828)
43 31 and 42 (1694)
***************************
Cochrane Central Register of Controlled Trials (CENTRAL) ℅ CRS-Web (18-Jan-2019)
#1 ((behavio* adj1 activ*) or BATD): AB,EH,KW,KY,MC,MH,TI,TO AND CENTRAL:TARGET
#2 (behavio* adj3 (reinforce* or re-inforce*)): AB,EH,KW,KY,MC,MH,TI,TO AND CENTRAL:TARGET
#3 (((contingent or positive) adj1 reinforc*) or (reinforc* adj3 (environment* or experience*))): AB,EH,KW,KY,MC,MH,TI,TO AND
CENTRAL:TARGET
#4 reinforc*:TO,TI AND CENTRAL:TARGET
#5 (behavio* adj2 (contracting or modification or modify*)): AB,EH,KW,KY,MC,MH,TI,TO AND CENTRAL:TARGET
#6 ((activit* or event or events) adj2 schedul*): AB,EH,KW,KY,MC,MH,TI,TO AND CENTRAL:TARGET
#7 ((pleas* or enjoyable or rewarding) adj (activit* or event or events)): AB,EH,KW,KY,MC,MH,TI,TO AND CENTRAL:TARGET
#8 (operant conditioning or instrumental learning): AB,EH,KW,KY,MC,MH,TI,TO AND CENTRAL:TARGET
#9 (positive interaction* or avoidant coping or environmental contingenc* or contigency management): AB,EH,KW,KY,MC,MH,TI,TO AND
CENTRAL:TARGET
#10 functional analysis: AB,EH,KW,KY,MC,MH,TI,TO AND CENTRAL:TARGET
#11 ((psychoeducat* or psycho-educat*) and (coping behavi* or coping skills or self manag* or (behavi* adj2 chang*))):
AB,EH,KW,KY,MC,MH,TI,TO AND CENTRAL:TARGET
#12 MESH DESCRIPTOR Reinforcement (Psychology) EXPLODE ALL AND CENTRAL:TARGET
#13 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12)
#14 depress*: AB,EH,KW,KY,MC,MH,TI,TO AND CENTRAL:TARGET
#15 (grief or hopelessness or sadness):TI,TO AND CENTRAL:TARGET
#16 (mood or moods or mental health or emotion* distress* or emotional trauma or psychological distress or psychological trauma): TI,TO
AND CENTRAL:TARGET
#17 (#14 OR #15 OR #16)
#18 (#13 AND #17)
#19 MESH DESCRIPTOR Behavior Therapy AND CENTRAL:TARGET
#20 depress*: EH,KW,KY,MC,MH,TI,TO AND CENTRAL:TARGET
#21 (#19 AND #20)
#22 (#18 OR #21), n=1567
CCMDCTR-Sudies Register (current to June 2016)
(("behavioral activation” or "behavior therapy" or “behavior modification” or “self-monitoring or “self-management therapy” or “self-
control therapy” or “task assignment”):SIN and (depress*):SCO)
Ovid-MEDLINE-1 (Initial searches November 2018)
Database: Ovid MEDLINE(R) and Epub Ahead of Print, In-Process & Other Non-Indexed Citations and Daily <1946 to November 21, 2018>
Search Strategy:
--------------------------------------------------------------------------------
Search-1 (Search for condition initially tailored to retrieve BATD RCTs for clinical depression/MDD)
1 (behavio* activat* or BATD).ti,ab,kf. (1791)
2 (behavio* adj3 (reinforce* or re-inforce*)).ti,ab,kf. (2727)
3 (behavio* adj2 (contracting or modification or modify*)).ti,ab,kf. (6332)
4 reinforc*.ti,kf. or ((positive adj1 reinforc*) or (reinforc* adj3 (environment* or experience*))).ti,ab,kf. (19953)
5 (reinforce or reinforcer or reinforcement or reinforcements or re-inforcement or re-inforcements).ab. /freq=2 (10487)
6 (activit* adj2 schedul*).ti,ab,kf. (509)
7 (pleas* adj (activit* or event?)).ti,ab,kf. (319)
8 (operant conditioning or instrumental learning).ti,ab,kf. (2522)
9 (positive interaction* or avoidant coping or environmental contingenc* or contigency management).ti,ab,kf. (2716)
10 functional analysis.ti,ab,kf. (21598)
11 behavio*.mp. and (self adj (evaluat* or monitor*)).ti,ab,kf. (3268)
12 or/1-11 (64373)
13 Behavior Therapy/ and depress*.ti,hw. (1382)
14 ((behavio* adj (counsel* or intervention or train* or treatment or therapy or psychotherapy)) and depress*).ti,kf. (1562)
15 Depression/ (104912)
16 Depressive Disorder/ or Depressive Disorder, Major/ (94699)
17 (depress* adj3 (acute or clinical* or diagnos* or disorder* or major or unipolar or illness or scale* or score* or adult* or patient* or
participant* or people or inpatient* or in-patient* or outpatient* or out-patient*)).ab. (135995)
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18 (depress* and (Beck* or BDI* or DSM* or (Statistical Manual adj2 Mental Disorders) or Hamilton or HAM-D or HAMD or MADRS or
(International Classification adj2 Disease?) or ICD-10 or ICD-9)).ab. (39194)
19 "with depressi*".ab. (23474)
20 (depress* or mood or mental health).ti,kf. (216491)
21 or/15-20 (344231)
22 13 or 14 or (12 and 21) (4533)
23 controlled clinical trial.pt. (92759)
24 randomized controlled trial.pt. (471716)
25 (randomi#ed or randomi#ation or randomi#ing).ti,ab,kf. (561767)
26 (RCT or "at random" or (random* adj3 (administ* or allocat* or assign* or class* or cluster or control* or determine* or divide* or division
or distribut* or expose* or fashion or number* or place* or pragmatic or quasi or recruit* or split or subsitut* or treat*))).ti,ab,kf. (473029)
27 placebo*.ab,ti,kf. (200526)
28 trial.ab,ti,kf. (527152)
29 (control* and (trial or study or group*) and (placebo or waitlist* or wait* list* or ((treatment or care) adj2 usual))).ti,ab,kf,hw. (182546)
30 ((single or double or triple or treble) adj2 (blind* or mask* or dummy)).ti,ab,kf. (161075)
31 double-blind method/ or random allocation/ or single-blind method/ (259732)
32 exp animals/ not humans.sh. (4517568)
33 (or/23-31) not 32 (1139578)
34 22 and 33 (1759)
35 (abreaction or assertiveness training or autogenic training or aversion therapy or covert sensiti#ation or biofeedback or conversion
therapy or distraction therapy or eye movement desensiti#ation or EMDR or exposure therapy or guided imagery or implosive therapy
or (problem? adj2 (focus* or solution?)) or psychoeducat* or reciprocal inhibition or (relaxation adj (technique? or training)) or response
cost or sensitivity training or sleep phase chronotherapy or social* eective* or (social skills adj2 train*) or systematic desensiti#ation).mp.
(29817)
36 (relaxation or imagery).ti,kf. (30268)
37 21 and 33 and (35 or 36) (1049)
38 34 or 37 (2685)
39 limit 38 to yr="2014 -Current" (1372)
40 review.pt. (2453324)
41 case reports.pt. (1909175)
42 ((child* or adolescent* or infant* or p?ediatr*) not adult?).ti. (1070522)
43 39 not (or/40-42) (1132)
Search-2 (Search for condition amended to retrieve sub-clinical depression. Search terms for intervention also amended by the removal
of unwanted terms)
44 (behavio* activat* or BATD).ti,ab,kf. (1791)
45 (behavio* adj3 (reinforce* or re-inforce*)).ti,ab,kf. (2727)
46 (behavio* adj2 (contracting or modification or modify*)).ti,ab,kf. (6332)
47 reinforc*.ti,kf. or ((positive adj1 reinforc*) or (reinforc* adj3 (environment* or experience*))).ti,ab,kf. (19953)
48 (reinforce or reinforcer or reinforcement or reinforcements or re-inforcement or re-inforcements).ab. /freq=2 (10487)
49 (activit* adj2 schedul*).ti,ab,kf. (509)
50 (pleas* adj (activit* or event?)).ti,ab,kf. (319)
51 (operant conditioning or instrumental learning).ti,ab,kf. (2522)
52 (positive interaction* or avoidant coping or environmental contingenc* or contigency management).ti,ab,kf. (2716)
53 functional analysis.ti,ab,kf. (21598)
54 behavio*.mp. and (self adj (evaluat* or monitor*)).ti,ab,kf. (3268)
55 or/44-54 (64373)
56 Behavior Therapy/ and depress*.ti,hw. (1382)
57 ((behavio* adj (counsel* or intervention or train* or treatment or therapy or psychotherapy)) and depress*).ti,kf. (1562)
58 Depression/ (104912)
59 Depressive Disorder/ or Depressive Disorder, Major/ (94699)
60 depress*.ti,ab,kf. (419064)
61 (mood? or mental health).ti,kf. (72990)
62 or/58-61 (511522)
63 (55 and 62) or 56 or 57 (5331)
64 controlled clinical trial.pt. (92759)
65 randomized controlled trial.pt. (471716)
66 (randomi#ed or randomi#ation or randomi#ing).ti,ab,kf. (561767)
67 (RCT or "at random" or (random* adj3 (administ* or allocat* or assign* or class* or cluster or control* or determine* or divide* or division
or distribut* or expose* or fashion or number* or place* or pragmatic or quasi or recruit* or split or subsitut* or treat*))).ti,ab,kf. (473029)
68 placebo*.ab,ti,kf. (200526)
69 trial.ab,ti,kf. (527152)
70 (control* and (trial or study or group*) and (placebo or waitlist* or wait* list* or ((treatment or care) adj2 usual))).ti,ab,kf,hw. (182546)
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71 ((single or double or triple or treble) adj2 (blind* or mask* or dummy)).ti,ab,kf. (161075)
72 double-blind method/ or random allocation/ or single-blind method/ (259732)
73 exp animals/ not humans.sh. (4517568)
74 (or/64-72) not 73 (1139578)
75 63 and 74 (1857)
76 review.pt. (2453324)
77 case reports.pt. (1909175)
78 ((child* or adolescent* or infant* or p?ediatr*) not adult?).ti. (1070522)
79 75 not (or/76-78) (1519)
80 79 not 43 (757)
81 (43 or 80) (1831)
Ovid-MEDLINE-2 (January 2019)
Database: Ovid MEDLINE(R) and Epub Ahead of Print, In-Process & Other Non-Indexed Citations and Daily <1946 to January 17, 2019>
Search Strategy:
--------------------------------------------------------------------------------
1 ((behavio* adj1 activat*) or BATD).ti,ab,kf. (2121)
2 (behavio* adj3 (reinforce* or re-inforce*)).ti,ab,kf. (2750)
3 (behavio* adj2 (contracting or modification or modify*)).ti,ab,kf. (6377)
4 reinforc*.ti,kf. or (((positive or contingent) adj1 reinforc*) or (reinforc* adj3 (environment* or experience*))).ti,ab,kf. (20327)
5 (reinforce or reinforcer or reinforcement or reinforcements or re-inforcement or re-inforcements).ab. /freq=2 (10583)
6 (activit* adj2 schedul*).ti,ab,kf. (516)
7 ((pleas* or enjoyable or rewarding) adj (activit* or event?)).ti,ab,kf. (604)
8 (operant conditioning or instrumental learning).ti,ab,kf. (2549)
9 (positive interaction* or avoidant coping or environmental contingenc* or contigency management).ti,ab,kf. (2743)
10 functional analysis.ti,ab,kf. (21822)
11 behavio*.mp. and (self adj (evaluat* or monitor*)).ti,ab,kf. (3315)
12 ((gain? or reapprais*) adj2 focus*).ti,ab,kf. (148)
13 ((psychoeducat* or psycho-educat*) and (coping behavi* or coping skills or self manag* or (behavi* adj2 chang*))).ti,ab,kf,hw. (409)
14 or/1-13 (66190)
15 Behavior Therapy/ and depress*.ti,hw. (1390)
16 (behavio* therapy adj3 depress*).ti,ab,kf. (623)
17 ((behavio* adj (counsel* or intervention or train* or treatment or therapy or psychotherapy)) and depress*).ti,kf. (1610)
18 or/15-17 (3080)
19 Depression/ (106096)
20 Depressive Disorder/ or Depressive Disorder, Major/ (95368)
21 depress*.ti,ab,kf. (423259)
22 (mood? or mental health or ((emotion* or psychological) adj (distress or trauma*))).ti,kf. (79851)
23 or/19-22 (519901)
24 (14 and 23) or 18 (5789)
25 controlled clinical trial.pt. (92880)
26 randomized controlled trial.pt. (474938)
27 (randomi#ed or randomi#ation or randomi#ing).ti,ab,kf. (568726)
28 (RCT or "at random" or (random* adj3 (administ* or allocat* or assign* or class* or cluster or control* or determine* or divide* or division
or distribut* or expose* or fashion or number* or place* or pragmatic or quasi or recruit* or split or subsitut* or treat*))).ti,ab,kf. (479458)
29 trial.ab,ti,kf. (533987)
30 (control* and (trial or study or group*) and (placebo or waitlist* or wait* list* or ((treatment or care) adj2 usual))).ti,ab,kf,hw. (184046)
31 ((allocat* or assign* or receive*) and (placebo or no-treatment or waitlist or wait* list* or ((treatment or care) adj2 usual)) and (control
or group)).ab. (60576)
32 ((single or double or triple or treble) adj2 (blind* or mask* or dummy)).ti,ab,kf. (162166)
33 double-blind method/ or random allocation/ or single-blind method/ (261507)
34 exp animals/ not humans.sh. (4538357)
35 (or/25-33) not 34 (1136532)
36 24 and 35 (2047)
37 review.pt. (2472450)
38 case reports.pt. (1917945)
39 ((child* or adolescent* or infant* or p?ediatr*) not adult?).ti. (1078507)
40 36 not (or/37-39) (1681)
***************************
Ovid Embase <1980 to 2019 Week 02>
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Search Strategy:
--------------------------------------------------------------------------------
1 "behavioral activation"/ (81)
2 "behavioral activation system"/ (44)
3 ((behavio* adj1 activat*) or BATD).ti,ab,kw,dq. (2509)
4 (behavio* adj3 (reinforce* or re-inforce*)).ti,ab,kw. (2831)
5 reinforc*.ti. or (((contingent or positive) adj1 reinforc*) or (reinforc* adj3 (environment* or experience*))).ti,ab,kw. (16326)
6 (reinforce or reinforcer or reinforcement or reinforcements or re-inforcement or re-inforcements).ab. /freq=2 (10683)
7 (behavio* adj2 (contracting or modification or modify*)).ti,ab,kw. (7338)
8 ((activit* or event?) adj2 schedul*).ti,ab,kw. (969)
9 ((pleas* or enjoyable or rewarding) adj (activit* or event?)).ti,ab,kw. (775)
10 (operant conditioning or instrumental learning).ti,ab,kw. (2642)
11 *Task Performance/ (13223)
12 (positive interaction* or avoidant coping or environmental contingenc* or contigency management).ti,ab,kw. (3268)
13 Avoidance Behavior/ (25351)
14 ((gain? or reapprais*) adj2 focus*).ti,ab,kw. (164)
15 functional analysis.ti,ab,kw. (26291)
16 (behavio* therapy and (self adj (care or eicacy or evaluat* or monitor*))).ti,kw,hw. (1845)
17 ((psychoeducat* or psycho-educat*) and (coping behavi* or coping skills or self manag* or (behavi* adj2 chang*))).ti,ab,kw,hw. (1771)
18 behavior change/ and (self management/ or self monitoring/) (1049)
19 or/1-18 (108350)
20 *Behavior Therapy/ and depress*.ti,hw. (1876)
21 (behavio* therapy adj3 depress*).ti,ab,kw. (800)
22 ((behavio* adj (counsel* or intervention or train* or treatment or therapy or psychotherapy)) and depress*).ti. (1424)
23 or/20-22 (3279)
24 depression/ or major depression/ or late life depression/ or post-stroke depression/ or reactive depression/ (367710)
25 minor depression/ or subsyndromal depression/ (316)
26 *mood disorder/ or minor aective disorder/ (8223)
27 (depress* adj3 (acute or clinical* or diagnos* or disorder* or major or unipolar or illness or scale* or score* or adult* or patient* or
participant* or people or inpatient* or in-patient* or outpatient* or out-patient*)).ab. (193021)
28 (depressi* adj3 (symptom* or subsyndrom* or "sub syndrom*" or subclinical or "sub clinical" or minor)).ab. (85284)
29 (depress* and (Beck* or BDI* or DSM* or (Statistical Manual adj2 Mental Disorders) or Hamilton or HAM-D or HAMD or MADRS or
(International Classification adj2 Disease?) or ICD-10 or ICD-9)).ab. (61151)
30 "with depressi*".ab. (33191)
31 depress*.ti,kw. (201611)
32 (mood? or mental health or ((emotion* or psychological) adj (distress or trauma*))).ti. (71824)
33 or/24-32 (526818)
34 (19 and 33) or 23 (10015)
35 randomized controlled trial/ (526873)
36 randomization.de. (80508)
37 controlled clinical trial/ (459873)
38 trial.ti. (253670)
39 (randomi#ed or randomi#ation or randomi#ing).ti,ab,kw. (805315)
40 (RCT or "at random" or (random* adj3 (administ* or allocat* or assign* or class* or control* or determine* or divide* or division or
distribut* or expose* or fashion or number* or place* or recruit* or split or subsitut* or treat*))).ti,ab,kw. (639556)
41 ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$ or dummy)).mp. (274981)
42 ((allocat* or assign* or receive*) and (placebo or no-treatment or waitlist or wait* list* or ((treatment or care) adj2 usual)) and (control
or group)).ab. (84381)
43 (group?.ab. or study.ti,ab.) and (placebo or waitlist* or wait* list* or ((treatment or care) adj2 usual)).ti,ab,kw. (257803)
44 or/35-43 (1495495)
45 34 and 44 (2572)
46 limit 45 to (article-in-press status or conference abstract status or embase status or in-process status) (2276)
47 remove duplicates from 46 (2237)
***************************
Open Grey http://www.opengrey.eu/ (20 Jan 2019)
1. “behavioural activation” and depression (5)
2. “behavioural activation” and depressive (1)
3. “behavioural activation” and depressed (2)
4. “behavioral activation” and depression (0)
5. “behavioral activation” and depressive (0)
6. “behavioral activation” and depressed (0)
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7. or/1-6 (6)
ProQuest Dissertations & Theses Global (20 Jan 2019)
noL("behavioural activation" OR "behavioral activation") AND noL(depression OR depressive OR depressed) n=104
DART-Europe E-theses Portal (www.dart-europe.eu/)
1. “behavioural activation” and depression (6)
2. “behavioural activation” and depressive (5)
3. “behavioural activation” and depressed (3)
4. “behavioral activation” and depression (6)
5. “behavioral activation” and depressive (3)
6. “behavioral activation” and depressed (3)
7. or/1-6 (14)
British Library eTheses Online (EThOS) (20 Jan 2019)
1. “behavioural activation” and depression (23)
2. “behavioural activation” and depressive (23)
3. “behavioural activation” and depressed (23)
4. “behavioral activation” and depression (0)
5. “behavioral activation” and depressive (0)
6. “behavioral activation” and depressed (0)
7. or/1-6 (23)
(n=27)
Open Acces Theses and Dissertations (oatd.org).
Advanced search:
Exact phrase: behavioural activation
AND
Any of these words: depression depressive depressed
Any Language, Any Country
n=89 [62 (unique refs)]
[Note. Variant spelling “behavioral activation” automatically searched]
Trial Registers
ClinicalTrials.gov (20-Jan-2019)
Advanced search-1 (n=157) (n=184 (18-Jan-2019))
Condition or Disease: depression OR depressive OR depressed
Other terms: ”behavioral activation"
Applied Filters: Interventional Adult (18–64) Older Adult (65+)
[Synonyms automatically searched: Depressivity, low mood, melancholic automatically searched]
ClinicalTrials.gov (20-Jan-2019)
Advanced Search-2 (n=30) (n=43 (18-Jan-2019))
Condition or Disease: depression OR depressive OR depressed
Other terms: ”behavioural activation"
Applied Filters: Interventional Adult (18–64) Older Adult (65+)
[Synonyms automatically searched: Depressivity, low mood, melancholic automatically searched]
Records deduplicated in EndNote: Search-1 OR Search-2 = 175 trial records
WHO International Clinical Trials Registry Platform (ICTRP) (20-Jan-2019) n=101
behavioural activation and depression and randomized or behavioural activation and depressive and randomized or behavioural
activation and depressed and randomized
or
behavioral activation and depression and randomized or behavioral activation and depressive and randomized or behavioral activation
and depressed and randomized
or
behavioural activation and depression and randomised or behavioural activation and depressive and randomised or behavioural
activation and depressed and randomised
or
behavioral activation and depression and randomised or behavioral activation and depressive and randomised or behavioral activation
and depressed and randomised
or
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behavioural activation and depression and RCT or behavioural activation and depressive and RCT or behavioural activation and depressed
and RCT
or
behavioral activation and depression and RCT or behavioral activation and depressive and RCT or behavioral activation and depressed
and RCT
[Synonyms automatically searched: Feeling blue, Feeling down, Low mood, Morose mood, Melancholy, Random]
Trials de-duplicated (n=175 (CT_gov) + ICTRP (101)) =261
H I S T O R Y
Protocol first published: Issue 4, 2019
Review first published: Issue 7, 2020
C O N T R I B U T I O N S   O F   A U T H O R S
RC and DE conceived the idea for this review. All review authors contributed to the writing of the protocol. SD performed the literature
searches and contributed to screening of studies. EU, LR, ESa, and ESo performed the data extraction and 'Risk of bias' assessments. DE,
DR, and RC were available to discuss disagreements in data extraction and 'Risk of bias' assessments. NM supervised statistical analyses
conducted by EU. EU, NM, and LR contributed to GRADE assessments and constructed 'Summary of findings' tables.
D E C L A R A T I O N S   O F   I N T E R E S T
Eleonora Upho: no conflicts of interest
David Ekers, in his role of Chief Investigator, is responsible for the conduct of the ongoing CHEMIST and MODS trials in which behavioural
activation therapies are evaluated. He is a Co-Investigator of the included CASPER trial and the author of several publications reporting
on trials of behavioural activation.
Lindsay Robertson: no conflicts of interest
Sarah Dawson: no conflicts of interest
Emily Sanger: no conflicts of interest
Emily South: no conflicts of interest
Zainab Samaan: no conflicts of interest
David Richards has been involved in several trials of behavioural activation, including in his role as Chief Investigator of the UK National
Institute for Health Research funded COBRA and CADET trials. He has published extensively on the subject of behavioural activation in peer
reviewed journals and clinical text books.
Nicholas Meader: no conflicts of interest
Rachel Churchill leads and has responsibility for Cochrane Common Mental Disorders, which has supported parts of the review process
and is largely funded by a grant from the National Institute of Health and Research (NIHR) in the UK.
S O U R C E S   O F   S U P P O R T
Internal sources
• Tees, Esk and Wear Valleys NHS Foundation Trust (TEWV), UK
• University of York, UK
• University of Exeter, UK
External sources
• National Institute for Health Research (NIHR), UK
Cochrane Infrastructure funding to the Common Mental Disorders Cochrane Review Group
D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
The protocol stated that any online therapy with an element of interaction with a qualified therapist would be included. However, as our
review comprises interventions delivered by specialists as well as non-specialists, this was changed to the requirement for interaction with
a therapist, regardless of the therapist qualifications.
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During data extraction, we found it diicult in some cases to distinguish between a specialist and a non-specialist therapist. A third category
of 'specialist in training' was added for those with substantial training of more than a year who were not yet qualified.
We planned to use the revised Cochrane 'Risk of bias' tool, but this was not deemed practical. The new tool had not been integrated in
Covidence yet, the review authors performing the 'Risk of bias' assessments were not trained in using it, and the roll-out of the new tool
across Cochrane groups was ongoing. We used the original Cochrane 'Risk of bias' tool instead.
In addition to the domains which form part of the Cochrane 'Risk of bias' tool, the Cochrane Common Mental Disorders group has previously
used three domains with particular relevance to psychotherapy trials: assessment of treatment fidelity, therapist conflict of interest, and
researcher conflict of interest. Following advice from Associate Editor Nuala Livingstone, we decided to consider these items within the
'Other bias' domain, rather than using separate domains that deviate from the standard Cochrane 'Risk of bias' tool. As we excluded any
data from the second phase of cross-over trials, we assessed risk of bias for these trials with the standard Cochrane 'Risk of bias' tool,
rather than considering additional domains.
Several studies reported multiple measures of our primary outcome, treatment eicacy. We prioritised remission over clinically significant
improvement, and recovery or remission over response. If multiple components of quality of life were reported in the same trial we included
the physical domain (for example, Short Form 36 physical functioning), as this addresses an outcome relevant to mental health while being
clearly distinct from other included outcomes. If multiple measures of social adjustment and functioning were reported, we combined
these data.
We planned to conduct a subgroup analysis of depression severity, according to three categories: subtreshold or mild depression, moderate
depression, and severe depression. Upon examination of the primary data, it became clear that the distinction between moderate and
severe depression was diicult to make. Instead, we performed sensitivity analyses using the categories subtreshold/mild depression and
moderate to severe depression.
Upon examination of the data, we decided to conduct several unplanned sensitivity analyses: we removed one study from Analysis 1.1 as
this was a small study with a large weight in the analysis; we removed one outlier from Analyses 10.3 and 10.4, and we conducted fixed-
eect rather than random-eects analyses to investigate the impact of small studies on the results (Analyses 6.3, 6.5, 10.3, and 10.4).
Because the review was not finished a year aLer the literature was first searched, we performed an update search in January 2020 to identify
newly published studies. Two additional studies were included in the review as a result.
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